TCGA-19-1390.13	110	0_HALLMARK_E2F_TARGETS	169	41	0.0000000000000000000000000
TCGA-19-5952.11	193	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	45	0.0000000000000000000000000
TCGA-02-0038.3	199	0_HALLMARK_E2F_TARGETS	169	44	0.0000000000000000000000000
TCGA-02-0043.10	184	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	42	0.0000000000000000000000000
TCGA-19-5947.4	267	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	48	0.0000000000000000000000000
TCGA-32-2634.10	118	1_KEGG_CELL_CYCLE	114	31	0.0000000000000000000000000
TCGA-32-2634.10	118	0_HALLMARK_E2F_TARGETS	169	35	0.0000000000000000000000000
TCGA-19-1390.13	110	1_KEGG_CELL_CYCLE	114	30	0.0000000000000000000000000
TCGA-19-2624.29	130	0_HALLMARK_G2M_CHECKPOINT	174	36	0.0000000000000000000000000
TCGA-06-0129.11	110	0_HALLMARK_G2M_CHECKPOINT	174	33	0.0000000000000000000000000
TCGA-19-1390.13	110	0_HALLMARK_G2M_CHECKPOINT	174	33	0.0000000000000000000000000
TCGA-14-0781.7	155	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	37	0.0000000000000000000000000
TCGA-76-6193.13	271	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	45	0.0000000000000000000000000
TCGA-19-5960.9	134	0_HALLMARK_E2F_TARGETS	169	34	0.0000000000000000000000000
TCGA-02-0026.1	61	0_HALLMARK_E2F_TARGETS	169	26	0.0000000000000000000000000
TCGA-32-1986.8	87	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	29	0.0000000000000000000000000
TCGA-14-4157.7	101	0_HALLMARK_E2F_TARGETS	169	30	0.0000000000000000000000001
TCGA-06-0644.16	142	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	34	0.0000000000000000000000001
TCGA-32-4210.14	109	0_HALLMARK_E2F_TARGETS	169	30	0.0000000000000000000000008
TCGA-19-2625.9	146	1_KEGG_CELL_CYCLE	114	29	0.0000000000000000000000010
TCGA-41-5651.5	112	0_HALLMARK_E2F_TARGETS	169	30	0.0000000000000000000000021
TCGA-19-5960.9	134	0_HALLMARK_G2M_CHECKPOINT	174	32	0.0000000000000000000000045
TCGA-28-2501.3	51	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	23	0.0000000000000000000000070
TCGA-02-2483.10	100	1_KEGG_CELL_CYCLE	114	25	0.0000000000000000000000136
TCGA-02-0038.3	199	1_KEGG_CELL_CYCLE	114	31	0.0000000000000000000000296
TCGA-02-0114.20	132	1_KEGG_CELL_CYCLE	114	27	0.0000000000000000000000362
TCGA-06-5858.19	205	0_HALLMARK_E2F_TARGETS	169	36	0.0000000000000000000000648
TCGA-06-1804.6	30	1_KEGG_DNA_REPLICATION	32	13	0.0000000000000000000000895
TCGA-06-0881.7	203	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	36	0.0000000000000000000001659
TCGA-19-2624.29	130	0_HALLMARK_E2F_TARGETS	169	30	0.0000000000000000000002658
TCGA-14-4157.7	101	1_KEGG_CELL_CYCLE	114	24	0.0000000000000000000005979
TCGA-32-2634.10	118	0_HALLMARK_G2M_CHECKPOINT	174	29	0.0000000000000000000006147
TCGA-06-0129.11	110	0_HALLMARK_E2F_TARGETS	169	28	0.0000000000000000000006416
TCGA-06-0648.6	17	1_KEGG_CELL_CYCLE	114	14	0.0000000000000000000006797
TCGA-02-2483.10	100	0_HALLMARK_E2F_TARGETS	169	27	0.0000000000000000000008447
TCGA-02-0026.1	61	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000000000000000009943
TCGA-06-2559.11	101	0_HALLMARK_E2F_TARGETS	169	27	0.0000000000000000000011360
TCGA-06-1804.6	30	0_HALLMARK_E2F_TARGETS	169	18	0.0000000000000000000017004
TCGA-02-0009.6	188	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	34	0.0000000000000000000022294
TCGA-02-0038.3	199	1_KEGG_DNA_REPLICATION	32	19	0.0000000000000000000027203
TCGA-41-4097.6	48	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	21	0.0000000000000000000030238
TCGA-02-0026.1	61	1_KEGG_CELL_CYCLE	114	20	0.0000000000000000000052928
TCGA-08-0356.2	23	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	14	0.0000000000000000000080250
TCGA-02-0038.3	199	0_HALLMARK_G2M_CHECKPOINT	174	34	0.0000000000000000000129321
TCGA-02-0024.6	206	0_HALLMARK_E2F_TARGETS	169	34	0.0000000000000000000153162
TCGA-02-0060.19	281	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	39	0.0000000000000000000155185
TCGA-02-2483.10	100	0_HALLMARK_G2M_CHECKPOINT	174	26	0.0000000000000000000434341
TCGA-14-4157.7	101	0_HALLMARK_G2M_CHECKPOINT	174	26	0.0000000000000000000576012
TCGA-06-0129.11	110	2_CELL_CYCLE_GO_0007049	265	31	0.0000000000000000000686979
TCGA-06-2567.9	156	0_HALLMARK_E2F_TARGETS	169	30	0.0000000000000000000828093
TCGA-27-2521.10	94	1_KEGG_CELL_CYCLE	114	22	0.0000000000000000000991182
TCGA-02-0014.10	70	1_KEGG_CELL_CYCLE	114	20	0.0000000000000000001260429
TCGA-06-0174.37	141	0_HALLMARK_G2M_CHECKPOINT	174	29	0.0000000000000000001470573
TCGA-12-3653.55	255	0_HALLMARK_E2F_TARGETS	169	36	0.0000000000000000001624295
TCGA-27-1833.7	17	1_KEGG_CELL_CYCLE	114	13	0.0000000000000000002199852
TCGA-41-5651.5	112	1_KEGG_CELL_CYCLE	114	23	0.0000000000000000002430949
TCGA-76-6192.6	43	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000000000004168283
TCGA-32-2615.7	77	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	23	0.0000000000000000005754774
TCGA-19-5960.9	134	1_KEGG_CELL_CYCLE	114	24	0.0000000000000000008505533
TCGA-19-1390.13	110	2_CELL_CYCLE_GO_0007049	265	30	0.0000000000000000010347575
TCGA-41-5651.5	112	0_HALLMARK_G2M_CHECKPOINT	174	26	0.0000000000000000010437327
TCGA-19-2619.14	100	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	25	0.0000000000000000010791939
TCGA-02-0011.1	288	0_HALLMARK_E2F_TARGETS	169	37	0.0000000000000000011093415
TCGA-32-2491.14	244	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	35	0.0000000000000000013706983
TCGA-08-0356.2	23	1_KEGG_ALLOGRAFT_REJECTION	37	11	0.0000000000000000014210599
TCGA-76-6285.5	106	1_KEGG_CELL_CYCLE	114	22	0.0000000000000000017237696
TCGA-08-0389.4	56	1_KEGG_CELL_CYCLE	114	18	0.0000000000000000017977499
TCGA-06-0195.8	56	1_KEGG_CELL_CYCLE	114	18	0.0000000000000000017977499
TCGA-76-6285.5	106	0_HALLMARK_E2F_TARGETS	169	25	0.0000000000000000021243772
TCGA-06-2558.6	74	0_HALLMARK_E2F_TARGETS	169	22	0.0000000000000000024894464
TCGA-19-1390.13	110	1_KEGG_DNA_REPLICATION	32	15	0.0000000000000000029645981
TCGA-19-1790.18	201	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	32	0.0000000000000000036078933
TCGA-06-2570.8	95	1_KEGG_CELL_CYCLE	114	21	0.0000000000000000037916415
TCGA-06-2558.6	74	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000000000000048046802
TCGA-76-6191.6	96	1_KEGG_CELL_CYCLE	114	21	0.0000000000000000048073226
TCGA-08-0389.4	56	0_HALLMARK_G2M_CHECKPOINT	174	20	0.0000000000000000049842795
TCGA-08-0360.3	144	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	28	0.0000000000000000051330764
TCGA-08-0356.2	23	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	11	0.0000000000000000052267569
TCGA-28-2509.6	59	1_KEGG_CELL_CYCLE	114	18	0.0000000000000000053249165
TCGA-28-2502.9	56	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000000000000056066517
TCGA-12-0616.1	20	1_KEGG_CELL_CYCLE	114	13	0.0000000000000000069536297
TCGA-08-0356.2	23	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	11	0.0000000000000000070731360
TCGA-06-5408.3	99	0_HALLMARK_E2F_TARGETS	169	24	0.0000000000000000071393444
TCGA-19-2624.29	130	1_KEGG_CELL_CYCLE	114	23	0.0000000000000000090521291
TCGA-19-5958.4	35	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000000000000092994176
TCGA-06-5859.9	125	0_HALLMARK_E2F_TARGETS	169	26	0.0000000000000000098168280
TCGA-28-5218.5	208	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	32	0.0000000000000000106528408
TCGA-02-2486.9	141	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	26	0.0000000000000000107032944
TCGA-12-3653.55	255	1_KEGG_CELL_CYCLE	114	29	0.0000000000000000148810668
TCGA-08-0347.4	16	1_KEGG_CELL_CYCLE	114	12	0.0000000000000000155599920
TCGA-02-0115.1	36	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000000000000173409068
TCGA-12-3650.17	101	0_HALLMARK_G2M_CHECKPOINT	174	24	0.0000000000000000243616783
TCGA-06-2559.11	101	0_HALLMARK_G2M_CHECKPOINT	174	24	0.0000000000000000243616783
TCGA-06-0241.8	53	1_KEGG_CELL_CYCLE	114	17	0.0000000000000000270509488
TCGA-19-2623.11	153	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	28	0.0000000000000000291304907
TCGA-14-1825.8	80	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000000000000324828928
TCGA-06-0750.12	52	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000000000344708413
TCGA-27-2521.10	94	0_HALLMARK_E2F_TARGETS	169	23	0.0000000000000000397025342
TCGA-06-0141.1	45	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000000000510965906
TCGA-02-0085.1	45	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000000000510965906
TCGA-02-0107.3	71	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	21	0.0000000000000000516200574
TCGA-02-0086.2	17	1_KEGG_CELL_CYCLE	114	12	0.0000000000000000523760081
TCGA-28-5216.8	162	0_HALLMARK_E2F_TARGETS	169	28	0.0000000000000000551995911
TCGA-32-2491.14	244	1_KEGG_CELL_CYCLE	114	28	0.0000000000000000604248085
TCGA-06-0174.37	141	1_KEGG_CELL_CYCLE	114	23	0.0000000000000000627421427
TCGA-06-0190.8	143	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	27	0.0000000000000000629350353
TCGA-76-6191.6	96	0_HALLMARK_E2F_TARGETS	169	23	0.0000000000000000668492759
TCGA-14-4157.7	101	1_KEGG_DNA_REPLICATION	32	14	0.0000000000000000681756422
TCGA-02-0024.6	206	0_HALLMARK_G2M_CHECKPOINT	174	31	0.0000000000000000763586472
TCGA-08-0356.2	23	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	11	0.0000000000000000778722132
TCGA-14-1825.8	80	1_KEGG_CELL_CYCLE	114	19	0.0000000000000000802394565
TCGA-08-0389.4	56	0_HALLMARK_E2F_TARGETS	169	19	0.0000000000000000913680983
TCGA-06-0129.11	110	1_KEGG_CELL_CYCLE	114	21	0.0000000000000001012646624
TCGA-76-6191.6	96	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000000000001319591211
TCGA-19-2624.29	130	2_CELL_CYCLE_GO_0007049	265	30	0.0000000000000001975024401
TCGA-41-2575.49	136	0_HALLMARK_G2M_CHECKPOINT	174	26	0.0000000000000002040612250
TCGA-06-0139.1	179	0_HALLMARK_COMPLEMENT	176	29	0.0000000000000002335841181
TCGA-27-1830.7	57	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000000002656063819
TCGA-28-2509.6	59	0_HALLMARK_E2F_TARGETS	169	19	0.0000000000000002871797666
TCGA-41-2571.7	72	1_KEGG_CELL_CYCLE	114	18	0.0000000000000003002559023
TCGA-26-5132.7	100	1_KEGG_CELL_CYCLE	114	20	0.0000000000000003129825527
TCGA-14-0787.6	40	1_KEGG_CELL_CYCLE	114	15	0.0000000000000003428635078
TCGA-14-1825.8	80	0_HALLMARK_E2F_TARGETS	169	21	0.0000000000000003933751483
TCGA-02-0014.10	70	0_HALLMARK_E2F_TARGETS	169	20	0.0000000000000004557312696
TCGA-32-2491.14	244	0_HALLMARK_E2F_TARGETS	169	32	0.0000000000000005036615183
TCGA-06-2558.6	74	1_KEGG_CELL_CYCLE	114	18	0.0000000000000005164686592
TCGA-06-0130.3	155	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	27	0.0000000000000005718526264
TCGA-02-0074.5	118	0_HALLMARK_E2F_TARGETS	169	24	0.0000000000000006151251662
TCGA-06-0122.8	90	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	22	0.0000000000000006209604752
TCGA-19-2625.9	146	0_HALLMARK_E2F_TARGETS	169	26	0.0000000000000006257030762
TCGA-02-0114.20	132	0_HALLMARK_E2F_TARGETS	169	25	0.0000000000000006646888094
TCGA-32-2634.10	118	1_KEGG_DNA_REPLICATION	32	14	0.0000000000000006725431740
TCGA-02-0015.16	115	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	24	0.0000000000000007502433179
TCGA-06-0881.7	203	0_HALLMARK_COMPLEMENT	176	30	0.0000000000000007794892720
TCGA-02-0014.10	70	0_HALLMARK_G2M_CHECKPOINT	174	20	0.0000000000000008241529930
TCGA-06-2570.8	95	0_HALLMARK_E2F_TARGETS	169	22	0.0000000000000010216295632
TCGA-06-0139.1	179	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	20	0.0000000000000010621104059
TCGA-76-4935.7	15	1_KEGG_CELL_CYCLE	114	11	0.0000000000000010691056973
TCGA-28-1753.13	174	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	28	0.0000000000000010827959635
TCGA-28-5214.11	124	1_KEGG_CELL_CYCLE	114	21	0.0000000000000014007497587
TCGA-27-2521.10	94	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000000000015224030909
TCGA-02-0060.19	281	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	23	0.0000000000000018774962208
TCGA-32-4210.14	109	1_KEGG_CELL_CYCLE	114	20	0.0000000000000019254633243
TCGA-06-2570.8	95	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000000000019504947851
TCGA-02-0024.6	206	1_KEGG_CELL_CYCLE	114	25	0.0000000000000020889115197
TCGA-32-1977.11	107	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	23	0.0000000000000021171602306
TCGA-06-0176.8	95	1_KEGG_CELL_CYCLE	114	19	0.0000000000000026968658452
TCGA-06-0195.8	56	0_HALLMARK_E2F_TARGETS	169	18	0.0000000000000028037325692
TCGA-76-6193.13	271	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	31	0.0000000000000028753931508
TCGA-02-0069.13	16	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0000000000000032206705969
TCGA-06-0645.9	136	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	25	0.0000000000000034034458883
TCGA-08-0356.2	23	1_KEGG_VIRAL_MYOCARDITIS	70	11	0.0000000000000034601716436
TCGA-02-2485.14	172	0_HALLMARK_E2F_TARGETS	169	27	0.0000000000000037039743017
TCGA-02-0007.17	217	0_HALLMARK_G2M_CHECKPOINT	174	30	0.0000000000000038720223022
TCGA-27-2524.5	75	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000000000042432824640
TCGA-06-6391.9	26	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000000000000044581426872
TCGA-19-2620.7	47	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000000000046382588137
TCGA-76-4925.9	83	1_KEGG_CELL_CYCLE	114	18	0.0000000000000048650802986
TCGA-76-6192.6	43	1_KEGG_FOCAL_ADHESION	195	17	0.0000000000000049361765623
TCGA-28-2501.3	51	1_KEGG_FOCAL_ADHESION	195	18	0.0000000000000054484365640
TCGA-76-6282.11	185	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	28	0.0000000000000058764097973
TCGA-06-0648.6	17	0_HALLMARK_E2F_TARGETS	169	12	0.0000000000000070118840444
TCGA-08-0245.4	85	1_KEGG_CELL_CYCLE	114	18	0.0000000000000077039118384
TCGA-14-0817.9	85	1_KEGG_CELL_CYCLE	114	18	0.0000000000000077039118384
TCGA-06-5858.19	205	0_HALLMARK_G2M_CHECKPOINT	174	29	0.0000000000000079542663460
TCGA-12-3650.17	101	1_KEGG_CELL_CYCLE	114	19	0.0000000000000092102581144
TCGA-06-2559.11	101	1_KEGG_CELL_CYCLE	114	19	0.0000000000000092102581144
TCGA-06-5411.4	23	1_KEGG_CELL_CYCLE	114	12	0.0000000000000107756881869
TCGA-32-2494.10	173	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	27	0.0000000000000109605047374
TCGA-28-1753.13	174	0_HALLMARK_G2M_CHECKPOINT	174	27	0.0000000000000109708720119
TCGA-06-0881.7	203	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	27	0.0000000000000121917123691
TCGA-06-0881.7	203	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	20	0.0000000000000133365884512
TCGA-06-0129.11	110	2_CELL_CYCLE_PROCESS	163	22	0.0000000000000136140795933
TCGA-02-0071.12	116	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	23	0.0000000000000145725739325
TCGA-14-0871.20	216	0_HALLMARK_E2F_TARGETS	169	29	0.0000000000000149944451407
TCGA-19-2624.29	130	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	24	0.0000000000000154775694253
TCGA-02-0007.17	217	0_HALLMARK_E2F_TARGETS	169	29	0.0000000000000170547437594
TCGA-02-0114.20	132	0_HALLMARK_G2M_CHECKPOINT	174	24	0.0000000000000195871267641
TCGA-02-0069.12	62	1_KEGG_CELL_CYCLE	114	16	0.0000000000000199130095395
TCGA-28-5216.8	162	2_NON_MEMBRANE_BOUND_ORGANELLE	476	40	0.0000000000000220497914942
TCGA-28-5216.8	162	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	40	0.0000000000000220497914942
TCGA-02-0069.13	16	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000000000000230288817368
TCGA-08-0354.5	18	1_KEGG_CELL_CYCLE	114	11	0.0000000000000241846645382
TCGA-06-5858.19	205	1_KEGG_CELL_CYCLE	114	24	0.0000000000000261323877383
TCGA-06-0241.8	53	0_HALLMARK_E2F_TARGETS	169	17	0.0000000000000272439844285
TCGA-06-0155.10	74	1_KEGG_FOCAL_ADHESION	195	20	0.0000000000000277757931643
TCGA-06-0650.2	82	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000000000293593516337
TCGA-08-0245.4	85	0_HALLMARK_E2F_TARGETS	169	20	0.0000000000000314546619094
TCGA-28-2513.12	134	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	24	0.0000000000000323391165166
TCGA-06-5859.9	125	1_KEGG_CELL_CYCLE	114	20	0.0000000000000328617126128
TCGA-14-0871.20	216	0_HALLMARK_G2M_CHECKPOINT	174	29	0.0000000000000342268377688
TCGA-19-5959.13	92	1_KEGG_CELL_CYCLE	114	18	0.0000000000000350314962891
TCGA-06-0686.5	14	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000000000000376675934528
TCGA-06-2567.9	156	1_KEGG_DNA_REPLICATION	32	14	0.0000000000000382708006379
TCGA-14-0781.7	155	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	18	0.0000000000000387133151126
TCGA-02-0083.21	135	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	24	0.0000000000000387213324891
TCGA-06-0875.7	78	1_KEGG_CELL_CYCLE	114	17	0.0000000000000411114158277
TCGA-76-6192.6	43	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000000000000411659677146
TCGA-12-3653.55	255	0_HALLMARK_G2M_CHECKPOINT	174	31	0.0000000000000438381983985
TCGA-19-1390.13	110	2_DNA_METABOLIC_PROCESS	218	24	0.0000000000000458005784007
TCGA-32-4210.14	109	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000000000464537252941
TCGA-06-0174.37	141	0_HALLMARK_E2F_TARGETS	169	24	0.0000000000000483468732047
TCGA-19-5954.17	208	0_HALLMARK_E2F_TARGETS	169	28	0.0000000000000544730030156
TCGA-08-0245.4	85	0_HALLMARK_G2M_CHECKPOINT	174	20	0.0000000000000564465760129
TCGA-06-0143.6	63	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000000578709950491
TCGA-08-0359.5	37	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000000000628581556387
TCGA-19-5955.9	110	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	22	0.0000000000000647945779245
TCGA-19-1790.18	201	0_HALLMARK_COMPLEMENT	176	28	0.0000000000000655238140463
TCGA-19-5951.10	138	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	24	0.0000000000000658443605806
TCGA-32-2632.16	229	0_HALLMARK_E2F_TARGETS	169	29	0.0000000000000757970719361
TCGA-28-6450.11	139	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	24	0.0000000000000783510623657
TCGA-76-4934.7	47	0_HALLMARK_E2F_TARGETS	169	16	0.0000000000000842656378571
TCGA-19-5950.7	113	1_KEGG_CELL_CYCLE	114	19	0.0000000000000848548560385
TCGA-06-5408.3	99	0_HALLMARK_G2M_CHECKPOINT	174	21	0.0000000000000867474629145
TCGA-02-2485.14	172	0_HALLMARK_G2M_CHECKPOINT	174	26	0.0000000000000924329614360
TCGA-06-5408.3	99	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	21	0.0000000000000977879878700
TCGA-02-2485.14	172	1_KEGG_CELL_CYCLE	114	22	0.0000000000000996552846173
TCGA-06-0124.6	55	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000000001016255912446
TCGA-06-0875.7	78	0_HALLMARK_E2F_TARGETS	169	19	0.0000000000001032108111775
TCGA-27-1838.17	131	0_HALLMARK_E2F_TARGETS	169	23	0.0000000000001137712484794
TCGA-28-1753.13	174	1_KEGG_CELL_CYCLE	114	22	0.0000000000001282404906272
TCGA-06-5408.3	99	1_KEGG_CELL_CYCLE	114	18	0.0000000000001400899077140
TCGA-19-5954.17	208	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	28	0.0000000000001408273452433
TCGA-08-0345.2	77	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000001540861268009
TCGA-02-0011.1	288	0_HALLMARK_G2M_CHECKPOINT	174	32	0.0000000000001836617980135
TCGA-06-2567.9	156	1_KEGG_CELL_CYCLE	114	21	0.0000000000001883855136511
TCGA-32-2634.10	118	2_CELL_CYCLE_GO_0007049	265	26	0.0000000000002074923872601
TCGA-41-4097.6	48	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000000000002096382992818
TCGA-02-0038.3	199	2_DNA_METABOLIC_PROCESS	218	30	0.0000000000002153307043606
TCGA-02-0011.1	288	1_KEGG_DNA_REPLICATION	32	16	0.0000000000002408123722426
TCGA-32-2632.16	229	1_KEGG_DNA_REPLICATION	32	15	0.0000000000002457795274590
TCGA-87-5896.6	131	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	23	0.0000000000002510944317778
TCGA-27-2527.6	79	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000002598205713794
TCGA-02-0074.5	118	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000000002782662097499
TCGA-02-0079.2	10	1_KEGG_ASTHMA	30	7	0.0000000000003083468337844
TCGA-26-5136.6	160	1_KEGG_CELL_CYCLE	114	21	0.0000000000003201463472565
TCGA-12-0692.3	9	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0000000000003531851063507
TCGA-76-6193.13	271	0_HALLMARK_COMPLEMENT	176	31	0.0000000000003578081504414
TCGA-02-0038.3	199	2_DNA_REPLICATION	82	20	0.0000000000003791271322362
TCGA-08-0352.2	59	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000000003876394309069
TCGA-06-2565.10	38	1_KEGG_CELL_CYCLE	114	13	0.0000000000004057336979607
TCGA-12-0692.3	9	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000000000004193118008849
TCGA-14-1034.9	9	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0000000000004193118008849
TCGA-19-5954.17	208	1_KEGG_CELL_CYCLE	114	23	0.0000000000004818942050666
TCGA-06-0882.6	21	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0000000000004837584960243
TCGA-26-5133.10	75	1_KEGG_CELL_CYCLE	114	16	0.0000000000005479337044675
TCGA-06-6390.9	82	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000005524394561341
TCGA-02-0102.8	82	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000005524394561341
TCGA-06-2569.5	144	1_KEGG_CELL_CYCLE	114	20	0.0000000000005793103860910
TCGA-14-0817.9	85	0_HALLMARK_E2F_TARGETS	169	19	0.0000000000005877546758550
TCGA-32-4211.14	71	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000006114926299813
TCGA-06-0211.8	62	1_KEGG_CELL_CYCLE	114	15	0.0000000000006377864378577
TCGA-06-1804.6	30	1_KEGG_CELL_CYCLE	114	12	0.0000000000006425732101883
TCGA-28-1753.13	174	0_HALLMARK_E2F_TARGETS	169	25	0.0000000000006563028967501
TCGA-41-2571.7	72	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000000007238709440792
TCGA-02-0068.1	72	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000008024266587886
TCGA-06-0882.6	21	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0000000000008115563005444
TCGA-06-0139.1	179	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	24	0.0000000000008201124210346
TCGA-06-0128.9	11	1_KEGG_ASTHMA	30	7	0.0000000000008461459173948
TCGA-41-2575.49	136	2_CELL_CYCLE_GO_0007049	265	27	0.0000000000008651553454966
TCGA-76-6282.11	185	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	18	0.0000000000009504008604317
TCGA-12-0692.3	9	1_KEGG_FOCAL_ADHESION	195	9	0.0000000000009559301340624
TCGA-28-2514.9	62	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000000009847895279454
TCGA-06-2569.5	144	0_HALLMARK_E2F_TARGETS	169	23	0.0000000000010026347053577
TCGA-12-3650.17	101	0_HALLMARK_E2F_TARGETS	169	20	0.0000000000011733916886711
TCGA-32-1970.14	94	1_KEGG_CELL_CYCLE	114	17	0.0000000000011796819430174
TCGA-06-0241.8	53	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000000000012132090219233
TCGA-06-0882.6	21	1_KEGG_ASTHMA	30	8	0.0000000000012478974455167
TCGA-14-0813.10	53	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000000000013302945260151
TCGA-02-0099.11	141	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	23	0.0000000000013596601335690
TCGA-27-2523.12	112	1_KEGG_CELL_CYCLE	114	18	0.0000000000013919878304244
TCGA-02-0079.2	10	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0000000000015563357153310
TCGA-06-5856.13	152	1_KEGG_CELL_CYCLE	114	20	0.0000000000017066874935112
TCGA-32-2638.17	159	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	24	0.0000000000019089399277300
TCGA-02-0075.8	128	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	22	0.0000000000019170676606248
TCGA-06-5411.4	23	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000000000019935843905972
TCGA-06-0139.1	179	2_IMMUNE_SYSTEM_PROCESS	283	31	0.0000000000020221175156920
TCGA-19-5952.11	193	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	18	0.0000000000020258706041961
TCGA-02-0079.2	10	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0000000000020815553031780
TCGA-41-2572.8	76	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000022765601726671
TCGA-28-5216.8	162	2_CYTOSKELETON	293	30	0.0000000000023213469064854
TCGA-06-0878.10	115	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	21	0.0000000000024786755013668
TCGA-19-2625.9	146	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000000026398305271722
TCGA-06-1804.6	30	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000000000027545412046103
TCGA-26-5134.6	18	1_KEGG_CELL_CYCLE	114	10	0.0000000000029873025140989
TCGA-08-0356.2	23	1_KEGG_ASTHMA	30	8	0.0000000000029943821590913
TCGA-08-0356.2	23	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0000000000030418384597709
TCGA-41-2575.49	136	1_KEGG_CELL_CYCLE	114	19	0.0000000000030497288512578
TCGA-06-0195.8	56	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000000000032451378749621
TCGA-06-0875.7	78	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000000033769904471006
TCGA-06-2565.10	38	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000000000033947299374106
TCGA-02-0079.2	10	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0000000000033947387714515
TCGA-41-2575.49	136	0_HALLMARK_E2F_TARGETS	169	22	0.0000000000034200414000513
TCGA-19-2619.14	100	1_KEGG_CELL_CYCLE	114	17	0.0000000000035125965126517
TCGA-02-0074.5	118	1_KEGG_CELL_CYCLE	114	18	0.0000000000036289707126058
TCGA-02-0069.13	16	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0000000000036722777756452
TCGA-02-0048.9	84	1_KEGG_CELL_CYCLE	114	16	0.0000000000037453971535964
TCGA-02-0079.2	10	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0000000000040725504014933
TCGA-19-4068.7	14	0_HALLMARK_E2F_TARGETS	169	10	0.0000000000040848687572959
TCGA-06-0128.9	11	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0000000000042680214288603
TCGA-19-5958.4	35	1_KEGG_FOCAL_ADHESION	195	14	0.0000000000042750410467789
TCGA-19-5952.11	193	2_EXTRACELLULAR_REGION_PART	269	31	0.0000000000042787116202314
TCGA-76-4934.7	47	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000000042974199961717
TCGA-06-1804.7	47	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000000042974199961717
TCGA-32-1970.14	94	0_HALLMARK_E2F_TARGETS	169	19	0.0000000000043376569486876
TCGA-06-5412.1	28	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	10	0.0000000000043783041200383
TCGA-02-0069.13	16	2_EXTRACELLULAR_MATRIX	85	9	0.0000000000045938314702741
TCGA-28-2513.12	134	1_KEGG_FOCAL_ADHESION	195	23	0.0000000000047639184548167
TCGA-27-1836.8	49	0_HALLMARK_E2F_TARGETS	169	15	0.0000000000051591398873323
TCGA-14-0787.6	40	0_HALLMARK_E2F_TARGETS	169	14	0.0000000000052293641538882
TCGA-12-0692.3	9	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000000000052513610197252
TCGA-06-0686.10	26	1_KEGG_CELL_CYCLE	114	11	0.0000000000054175562912582
TCGA-28-5216.8	162	1_KEGG_CELL_CYCLE	114	20	0.0000000000060294200895959
TCGA-76-6285.5	106	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000000062855898557770
TCGA-41-5651.5	112	2_CELL_CYCLE_GO_0007049	265	24	0.0000000000063975990147320
TCGA-28-5216.8	162	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	20	11	0.0000000000066536022930253
TCGA-28-5216.8	162	2_INTERMEDIATE_FILAMENT	20	11	0.0000000000066536022930253
TCGA-02-0038.3	199	2_CELL_CYCLE_GO_0007049	265	31	0.0000000000067648011573020
TCGA-19-2631.15	84	1_KEGG_FOCAL_ADHESION	195	19	0.0000000000068308223584304
TCGA-02-0115.1	36	1_KEGG_FOCAL_ADHESION	195	14	0.0000000000068702119564122
TCGA-14-0790.9	104	1_KEGG_CELL_CYCLE	114	17	0.0000000000069766688849452
TCGA-08-0350.2	46	1_KEGG_CELL_CYCLE	114	13	0.0000000000070387511464209
TCGA-02-2483.10	100	1_KEGG_P53_SIGNALING_PATHWAY	66	14	0.0000000000072205215450030
TCGA-32-1970.14	94	0_HALLMARK_G2M_CHECKPOINT	174	19	0.0000000000074952082247602
TCGA-19-4068.2	11	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0000000000075777492950117
TCGA-19-2624.29	130	2_CELL_CYCLE_PROCESS	163	21	0.0000000000076103309581670
TCGA-12-0619.11	123	1_KEGG_CELL_CYCLE	114	18	0.0000000000077335635003593
TCGA-06-2563.10	123	1_KEGG_CELL_CYCLE	114	18	0.0000000000077335635003593
TCGA-27-1836.8	49	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000000000080036107621107
TCGA-28-2509.6	59	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000000000081497657933594
TCGA-06-0882.6	21	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000000000081611689662164
TCGA-02-0048.9	84	0_HALLMARK_E2F_TARGETS	169	18	0.0000000000081747159957740
TCGA-02-0043.10	184	2_EXTRACELLULAR_REGION_PART	269	30	0.0000000000081769819039983
TCGA-41-2571.7	72	0_HALLMARK_E2F_TARGETS	169	17	0.0000000000085376186587514
TCGA-06-0128.9	11	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0000000000093061100930634
TCGA-06-0686.10	26	0_HALLMARK_E2F_TARGETS	169	12	0.0000000000095204781590004
TCGA-12-0616.1	20	0_HALLMARK_E2F_TARGETS	169	11	0.0000000000106862940185670
TCGA-41-3915.10	109	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000000110793339859178
TCGA-02-0079.2	10	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0000000000110961853497039
TCGA-06-0128.9	11	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0000000000111631796610375
TCGA-06-2558.6	74	2_CELL_CYCLE_GO_0007049	265	20	0.0000000000114072564804503
TCGA-19-5950.7	113	0_HALLMARK_E2F_TARGETS	169	20	0.0000000000115914782280418
TCGA-19-2629.15	146	1_KEGG_CELL_CYCLE	114	19	0.0000000000117113969622753
TCGA-06-2567.9	156	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000000117260077887541
TCGA-02-0085.1	45	1_KEGG_ASTHMA	30	9	0.0000000000121041447747654
TCGA-76-6191.6	96	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000125959196898327
TCGA-14-0871.20	216	1_KEGG_CELL_CYCLE	114	22	0.0000000000132305224925096
TCGA-06-0686.10	26	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000000000135735449291056
TCGA-12-0692.6	11	0_HALLMARK_E2F_TARGETS	169	9	0.0000000000136574553464186
TCGA-02-0048.9	84	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000000137373075514540
TCGA-12-0692.3	9	2_COLLAGEN	23	6	0.0000000000144620505141940
TCGA-02-0007.17	217	1_KEGG_CELL_CYCLE	114	22	0.0000000000145835202964680
TCGA-12-0616.1	20	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000000000148054948377144
TCGA-02-0021.4	170	1_KEGG_CELL_CYCLE	114	20	0.0000000000155401457613020
TCGA-06-0139.1	179	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	29	0.0000000000157161748939606
TCGA-06-0877.8	61	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000000000159879316405430
TCGA-76-4935.7	15	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0000000000162409712073953
TCGA-06-0139.1	179	2_IMMUNE_RESPONSE	206	26	0.0000000000169044606782473
TCGA-02-0079.2	10	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0000000000174331498176603
TCGA-02-0024.6	206	2_CELL_CYCLE_GO_0007049	265	31	0.0000000000181567092872114
TCGA-28-2514.9	62	1_KEGG_CELL_CYCLE	114	14	0.0000000000185696318403148
TCGA-06-0882.6	21	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000000000200985422810000
TCGA-06-0174.37	141	2_CELL_CYCLE_GO_0007049	265	26	0.0000000000201653409499409
TCGA-12-0688.10	93	1_KEGG_CELL_CYCLE	114	16	0.0000000000204321290145724
TCGA-06-0190.8	143	1_KEGG_FOCAL_ADHESION	195	23	0.0000000000206899626077858
TCGA-19-5952.11	193	2_EXTRACELLULAR_REGION	346	34	0.0000000000206968534329354
TCGA-06-0214.9	62	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000000000212064158536128
TCGA-27-2528.10	99	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000229253302044416
TCGA-06-0882.6	21	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000000000247971390720569
TCGA-32-2495.11	67	1_KEGG_FOCAL_ADHESION	195	17	0.0000000000256429488565135
TCGA-26-1439.11	10	1_KEGG_CELL_CYCLE	114	8	0.0000000000261279666081873
TCGA-08-0360.3	144	0_HALLMARK_COMPLEMENT	176	22	0.0000000000280844006930545
TCGA-19-2623.11	153	1_KEGG_CELL_CYCLE	114	19	0.0000000000282426310327376
TCGA-19-2624.29	130	2_MITOTIC_CELL_CYCLE	134	19	0.0000000000283793528146126
TCGA-06-0139.1	179	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	24	0.0000000000296899035797343
TCGA-06-0128.9	11	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0000000000303985455031127
TCGA-41-4097.6	48	1_KEGG_FOCAL_ADHESION	195	15	0.0000000000311294018040864
TCGA-06-5417.5	79	1_KEGG_CELL_CYCLE	114	15	0.0000000000312194280883446
TCGA-12-1597.6	51	1_KEGG_CELL_CYCLE	114	13	0.0000000000313334421747464
TCGA-19-1390.13	110	2_REGULATION_OF_CELL_CYCLE	160	19	0.0000000000328986018245190
TCGA-06-0166.5	35	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000000000337908615982771
TCGA-41-3393.5	88	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000362896603091413
TCGA-02-0043.10	184	1_KEGG_ECM_RECEPTOR_INTERACTION	84	18	0.0000000000369554377050119
TCGA-06-5856.13	152	0_HALLMARK_E2F_TARGETS	169	22	0.0000000000378254725611619
TCGA-32-1979.10	116	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000000387841339355360
TCGA-12-3653.55	255	1_KEGG_DNA_REPLICATION	32	14	0.0000000000394347675015505
TCGA-06-0154.13	76	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000000406860089649213
TCGA-19-5947.4	267	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	19	0.0000000000434919247214473
TCGA-32-2632.16	229	1_KEGG_CELL_CYCLE	114	22	0.0000000000451161416296951
TCGA-02-0071.12	116	1_KEGG_CELL_CYCLE	114	17	0.0000000000461392373268576
TCGA-19-1390.13	110	2_CELL_CYCLE_PROCESS	163	19	0.0000000000465143480815705
TCGA-12-5295.8	66	1_KEGG_CELL_CYCLE	114	14	0.0000000000475032887860827
TCGA-06-0188.11	66	1_KEGG_CELL_CYCLE	114	14	0.0000000000475032887860827
TCGA-06-0128.9	11	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0000000000477456429221004
TCGA-02-0026.1	61	2_CELL_CYCLE_GO_0007049	265	18	0.0000000000488962830143852
TCGA-19-5960.9	134	2_CELL_CYCLE_GO_0007049	265	25	0.0000000000505094951270217
TCGA-08-0357.4	36	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000000000520465271219067
TCGA-02-2483.10	100	2_CELL_CYCLE_GO_0007049	265	22	0.0000000000525958672375025
TCGA-02-0074.5	118	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000000545674040104487
TCGA-76-6193.13	271	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	19	0.0000000000570750202011512
TCGA-27-2528.10	99	1_KEGG_CELL_CYCLE	114	16	0.0000000000571665212448120
TCGA-14-1825.8	80	2_CELL_CYCLE_GO_0007049	265	20	0.0000000000588915117568037
TCGA-06-0650.2	82	1_KEGG_FOCAL_ADHESION	195	18	0.0000000000654342059776904
TCGA-14-4157.7	101	2_CELL_CYCLE_GO_0007049	265	22	0.0000000000655782886363384
TCGA-08-0353.8	100	1_KEGG_CELL_CYCLE	114	16	0.0000000000673863164318796
TCGA-02-0089.5	91	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000675693780161731
TCGA-28-5218.5	208	1_KEGG_CELL_CYCLE	114	21	0.0000000000692989939711008
TCGA-27-1833.7	17	0_HALLMARK_E2F_TARGETS	169	10	0.0000000000757729105841950
TCGA-06-0178.2	17	0_HALLMARK_E2F_TARGETS	169	10	0.0000000000757729105841950
TCGA-06-1804.6	30	2_REPLICATION_FORK	18	7	0.0000000000803888951470539
TCGA-19-2623.11	153	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000000806198370369172
TCGA-06-2564.7	92	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000826750111917358
TCGA-19-5959.13	92	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000000826750111917358
TCGA-02-0113.4	9	1_KEGG_ASTHMA	30	6	0.0000000000849041426854587
TCGA-14-1034.9	9	1_KEGG_ASTHMA	30	6	0.0000000000849041426854587
TCGA-02-0054.2	9	1_KEGG_ASTHMA	30	6	0.0000000000849041426854587
TCGA-14-0789.10	106	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000000855290008715447
TCGA-19-1390.13	110	2_CELL_CYCLE_PHASE	146	18	0.0000000000878765710205893
TCGA-06-0877.8	61	1_KEGG_FOCAL_ADHESION	195	16	0.0000000000888091599899388
TCGA-02-2486.9	141	0_HALLMARK_ALLOGRAFT_REJECTION	190	22	0.0000000000898725100739123
TCGA-19-5954.17	208	0_HALLMARK_G2M_CHECKPOINT	174	25	0.0000000000927526639266408
TCGA-27-1837.5	85	1_KEGG_CELL_CYCLE	114	15	0.0000000000981147810030304
TCGA-12-0688.10	93	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000001008936490733636
TCGA-76-4934.7	47	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000000001038870854072663
TCGA-26-5136.6	160	0_HALLMARK_E2F_TARGETS	169	22	0.0000000001125999929584314
TCGA-14-1034.7	97	0_HALLMARK_E2F_TARGETS	169	18	0.0000000001182543524943736
TCGA-06-0133.6	57	1_KEGG_ASTHMA	30	9	0.0000000001199536638472075
TCGA-06-0686.5	14	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0000000001221899398104946
TCGA-14-0781.7	155	1_KEGG_FOCAL_ADHESION	195	23	0.0000000001242155131318782
TCGA-32-2634.10	118	2_REGULATION_OF_CELL_CYCLE	160	19	0.0000000001252829625596160
TCGA-08-0360.3	144	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	15	0.0000000001260889827668063
TCGA-16-1045.10	81	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000001262130492640302
TCGA-27-2523.12	112	0_HALLMARK_E2F_TARGETS	169	19	0.0000000001282494333787100
TCGA-06-0882.6	21	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0000000001323074266297165
TCGA-06-0686.5	14	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000000001349752299969147
TCGA-02-0069.13	16	1_KEGG_FOCAL_ADHESION	195	10	0.0000000001354225889662468
TCGA-06-0166.5	35	1_KEGG_FOCAL_ADHESION	195	13	0.0000000001384967101256362
TCGA-76-6193.13	271	0_HALLMARK_COAGULATION	125	24	0.0000000001427912402105928
TCGA-06-0686.5	14	2_EXTRACELLULAR_MATRIX	85	8	0.0000000001489138823480285
TCGA-06-5859.9	125	0_HALLMARK_G2M_CHECKPOINT	174	20	0.0000000001531527212971391
TCGA-14-0813.10	53	1_KEGG_FOCAL_ADHESION	195	15	0.0000000001625991768956272
TCGA-16-1048.13	97	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000000001639547032897004
TCGA-26-5134.6	18	0_HALLMARK_E2F_TARGETS	169	10	0.0000000001678785787054752
TCGA-02-0079.2	10	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0000000001795530117853876
TCGA-02-0079.2	10	1_KEGG_VIRAL_MYOCARDITIS	70	7	0.0000000001795530117853876
TCGA-06-2570.8	95	2_CELL_CYCLE_GO_0007049	265	21	0.0000000001866514698747600
TCGA-12-0692.3	9	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0000000001872040310642979
TCGA-06-0141.1	45	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000000001875316682332364
TCGA-02-0085.1	45	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000000001875316682332364
TCGA-08-0356.2	23	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0000000001881923911388646
TCGA-02-0054.2	9	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	7	0.0000000002041844600882315
TCGA-08-0353.8	100	0_HALLMARK_E2F_TARGETS	169	18	0.0000000002061981942196187
TCGA-08-0386.4	73	1_KEGG_CELL_CYCLE	114	14	0.0000000002115817400977629
TCGA-16-1048.13	97	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000002182731273143463
TCGA-32-1980.1	24	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000000002199904870749889
TCGA-12-0692.3	9	2_EXTRACELLULAR_MATRIX	85	7	0.0000000002224671702327100
TCGA-26-5134.6	18	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0000000002256176511992762
TCGA-12-0618.5	41	0_HALLMARK_E2F_TARGETS	169	13	0.0000000002327142004533168
TCGA-06-2569.5	144	0_HALLMARK_G2M_CHECKPOINT	174	21	0.0000000002371088423749463
TCGA-26-1439.10	84	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000002392757358970715
TCGA-41-5651.5	112	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000002439810032243303
TCGA-02-0069.12	62	0_HALLMARK_E2F_TARGETS	169	15	0.0000000002492635427779728
TCGA-08-0345.2	77	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	13	0.0000000002612083687858474
TCGA-28-5216.8	162	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000002699947554480213
TCGA-76-6193.13	271	2_DEFENSE_RESPONSE	222	31	0.0000000002751631189654893
TCGA-41-3393.4	12	1_KEGG_CELL_CYCLE	114	8	0.0000000002816993779050884
TCGA-06-0129.11	110	2_MITOTIC_CELL_CYCLE	134	17	0.0000000002905891247811139
TCGA-32-4213.15	198	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	24	0.0000000002915934915469779
TCGA-27-2524.5	75	1_KEGG_CELL_CYCLE	114	14	0.0000000003145043743900206
TCGA-06-5411.4	23	2_CELL_CYCLE_GO_0007049	265	12	0.0000000003216191563687725
TCGA-76-4934.7	47	1_KEGG_CELL_CYCLE	114	12	0.0000000003272862506675612
TCGA-02-0113.4	9	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0000000003317871713826499
TCGA-14-1034.9	9	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0000000003317871713826499
TCGA-02-0054.2	9	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0000000003317871713826499
TCGA-08-0386.4	73	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000000003428864023881835
TCGA-26-5132.7	100	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000003436903422987836
TCGA-19-2625.9	146	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	21	0.0000000003520358205557560
TCGA-41-4097.6	48	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	11	0.0000000003563919665692970
TCGA-06-0881.7	203	2_IMMUNE_RESPONSE	206	26	0.0000000003591731544095386
TCGA-19-5955.9	110	1_KEGG_ALLOGRAFT_REJECTION	37	11	0.0000000003592550366517631
TCGA-28-5220.7	15	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0000000003606230753325213
TCGA-87-5896.6	131	1_KEGG_CELL_CYCLE	114	17	0.0000000003647077890791953
TCGA-02-0060.19	281	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	26	0.0000000003783589410999188
TCGA-08-0357.4	36	1_KEGG_CELL_CYCLE	114	11	0.0000000003809618606337252
TCGA-02-0069.12	62	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000000003841680131435140
TCGA-08-0347.7	25	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000000003865835331875315
TCGA-06-5412.7	153	1_KEGG_LEISHMANIA_INFECTION	70	15	0.0000000003917599395049196
TCGA-02-0060.19	281	0_HALLMARK_COMPLEMENT	176	28	0.0000000004005522482395499
TCGA-02-0021.4	170	0_HALLMARK_E2F_TARGETS	169	22	0.0000000004029789195449384
TCGA-76-6193.13	271	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	27	0.0000000004109491431742512
TCGA-27-1838.17	131	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000004292193822928214
TCGA-06-0155.10	74	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000000004305185625499509
TCGA-32-1980.1	24	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000000004435449050715868
TCGA-02-0043.10	184	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	17	0.0000000004459038533538494
TCGA-19-2623.11	153	0_HALLMARK_E2F_TARGETS	169	21	0.0000000004509758413639222
TCGA-06-2559.11	101	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000004549654486416315
TCGA-41-4097.6	48	2_EXTRACELLULAR_MATRIX	85	11	0.0000000004676573559042139
TCGA-76-6193.13	271	0_HALLMARK_INFLAMMATORY_RESPONSE	170	27	0.0000000004762267363006156
TCGA-12-3653.55	255	1_KEGG_FOCAL_ADHESION	195	28	0.0000000004844796509449148
TCGA-06-0128.9	11	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0000000004908877007090522
TCGA-06-0128.9	11	1_KEGG_VIRAL_MYOCARDITIS	70	7	0.0000000004908877007090522
TCGA-02-0038.3	199	1_KEGG_MISMATCH_REPAIR	23	11	0.0000000005033048428136233
TCGA-19-4068.6	42	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000000005219101229041489
TCGA-06-0169.5	42	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000000005219101229041489
TCGA-06-0646.4	63	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000005401400079627918
TCGA-02-0085.1	45	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0000000006230647328592538
TCGA-02-0115.1	36	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000000006334801025050585
TCGA-02-0113.4	9	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	6	0.0000000006410121391510756
TCGA-14-1034.9	9	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	6	0.0000000006410121391510756
TCGA-02-0054.2	9	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	6	0.0000000006410121391510756
TCGA-06-0139.1	179	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	17	0.0000000006420367132736530
TCGA-06-0189.3	118	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000006520724924673226
TCGA-26-5134.2	14	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0000000006528693151338458
TCGA-12-5301.1	14	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0000000006528693151338458
TCGA-02-0043.10	184	2_EXTRACELLULAR_MATRIX	85	17	0.0000000006755587886463256
TCGA-06-5856.13	152	0_HALLMARK_G2M_CHECKPOINT	174	21	0.0000000007081445758908061
TCGA-02-0047.8	185	2_ENDOPLASMIC_RETICULUM	177	23	0.0000000007197089796310305
TCGA-41-3392.31	136	1_KEGG_FOCAL_ADHESION	195	21	0.0000000007228615015713713
TCGA-02-0021.4	170	0_HALLMARK_G2M_CHECKPOINT	174	22	0.0000000007400917229736568
TCGA-32-2638.17	159	1_KEGG_ALLOGRAFT_REJECTION	37	12	0.0000000007401078650204763
TCGA-02-0113.4	9	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	6	0.0000000007476432054169457
TCGA-14-1034.9	9	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	6	0.0000000007476432054169457
TCGA-02-0054.2	9	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	6	0.0000000007476432054169457
TCGA-06-0156.4	80	1_KEGG_CELL_CYCLE	114	14	0.0000000008048423459585941
TCGA-28-2501.3	51	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000000008430484246341113
TCGA-41-2575.49	136	2_MITOTIC_CELL_CYCLE	134	18	0.0000000008530778308595623
TCGA-02-0079.2	10	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	7	0.0000000008710663204422831
TCGA-19-5951.10	138	1_KEGG_CELL_CYCLE	114	17	0.0000000008735681536927838
TCGA-02-0038.3	199	2_REPLICATION_FORK	18	10	0.0000000008760257647167888
TCGA-41-3392.31	136	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000008896401077142338
TCGA-06-0221.13	45	0_HALLMARK_E2F_TARGETS	169	13	0.0000000009063245920491369
TCGA-19-1390.13	110	2_CHROMOSOME	102	15	0.0000000009389894496983145
TCGA-08-0375.6	65	1_KEGG_CELL_CYCLE	114	13	0.0000000009390765090556631
TCGA-12-0821.9	81	1_KEGG_CELL_CYCLE	114	14	0.0000000009633584197030362
TCGA-28-1747.5	81	1_KEGG_CELL_CYCLE	114	14	0.0000000009633584197030362
TCGA-27-2518.5	20	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0000000009777268464943316
TCGA-76-6285.5	106	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000009836244228346675
TCGA-19-5952.11	193	0_HALLMARK_ANGIOGENESIS	32	12	0.0000000010012162189162924
TCGA-06-1804.6	30	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	44	8	0.0000000010361703515736810
TCGA-06-6391.9	26	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000000010448310870670319
TCGA-06-0750.12	52	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000000010616361751787904
TCGA-02-2483.10	100	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000000011031080769526044
TCGA-19-5952.11	193	0_HALLMARK_COAGULATION	125	20	0.0000000011130169258343192
TCGA-19-1390.13	110	2_NUCLEUS	1110	42	0.0000000011212848972082933
TCGA-14-3476.4	7	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	7	0.0000000011219322198703281
TCGA-76-4926.9	66	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000011310677418491271
TCGA-02-0043.10	184	2_EXTRACELLULAR_REGION	346	31	0.0000000011322511535198424
TCGA-19-1790.18	201	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	16	0.0000000011625377888520998
TCGA-26-5135.9	71	1_KEGG_FOCAL_ADHESION	195	16	0.0000000011704242257972397
TCGA-41-2571.7	72	2_CELL_CYCLE_GO_0007049	265	18	0.0000000011705978647277719
TCGA-06-2565.10	38	2_CELL_CYCLE_GO_0007049	265	14	0.0000000011868209470384652
TCGA-06-0141.1	45	1_KEGG_ASTHMA	30	8	0.0000000012575900719624268
TCGA-06-0173.35	120	1_KEGG_CELL_CYCLE	114	16	0.0000000012754945071917981
TCGA-19-5955.9	110	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	11	0.0000000012771868338285359
TCGA-14-4157.7	101	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000000013072795674095125
TCGA-14-0813.10	53	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000000013301660133901528
TCGA-19-5960.9	134	2_REGULATION_OF_CELL_CYCLE	160	19	0.0000000013505156895805500
TCGA-02-0069.13	16	2_COLLAGEN	23	6	0.0000000013638849280445497
TCGA-06-0644.16	142	1_KEGG_CELL_CYCLE	114	17	0.0000000014068593698198969
TCGA-06-5413.11	142	1_KEGG_CELL_CYCLE	114	17	0.0000000014068593698198969
TCGA-16-1048.13	97	1_KEGG_FOCAL_ADHESION	195	18	0.0000000014335906122928281
TCGA-06-5859.9	125	1_KEGG_ALLOGRAFT_REJECTION	37	11	0.0000000015038666595520417
TCGA-02-0107.3	71	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0000000015350694356488341
TCGA-06-0156.4	80	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000000015672766337009811
TCGA-19-1790.18	201	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	23	0.0000000015700519420862208
TCGA-27-2521.10	94	2_CELL_CYCLE_GO_0007049	265	20	0.0000000015832819860808684
TCGA-02-0069.13	16	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000000016217018352423708
TCGA-06-0139.1	179	0_HALLMARK_ALLOGRAFT_REJECTION	190	23	0.0000000016242423842589700
TCGA-19-4068.7	14	1_KEGG_CELL_CYCLE	114	8	0.0000000016750360719330261
TCGA-19-5955.9	110	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	11	0.0000000017137279793134667
TCGA-19-1390.13	110	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	11	0.0000000017137279793134667
TCGA-02-0026.1	61	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000000017217044560174862
TCGA-02-0113.4	9	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	6	0.0000000017461026151342671
TCGA-14-1034.9	9	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	6	0.0000000017461026151342671
TCGA-02-0054.2	9	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	6	0.0000000017461026151342671
TCGA-26-5134.2	14	1_KEGG_FOCAL_ADHESION	195	9	0.0000000017500100232793333
TCGA-32-2634.10	118	1_KEGG_P53_SIGNALING_PATHWAY	66	13	0.0000000018198353932829296
TCGA-02-0015.16	115	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000000018400957594871276
TCGA-06-0128.9	11	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	7	0.0000000018450731763488631
TCGA-32-2634.10	118	2_DNA_REPLICATION	82	14	0.0000000018680288256435095
TCGA-14-3476.4	7	2_COLLAGEN	23	5	0.0000000018994980966271459
TCGA-32-2632.16	229	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	23	0.0000000019049138482627406
TCGA-06-0882.6	21	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0000000019162197772606116
TCGA-06-0882.6	21	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0000000019162197772606116
TCGA-06-0176.8	95	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000020141786078293461
TCGA-06-0124.6	55	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000000020584857255328237
TCGA-08-0345.2	77	1_KEGG_ASTHMA	30	9	0.0000000020660990948789921
TCGA-06-0197.1	57	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000000021585062766226805
TCGA-06-6391.9	26	1_KEGG_FOCAL_ADHESION	195	11	0.0000000021767559733017219
TCGA-28-5208.28	220	1_KEGG_CELL_CYCLE	114	20	0.0000000021843500444448008
TCGA-06-0192.10	126	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000022117494734763198
TCGA-02-2486.9	141	1_KEGG_LEISHMANIA_INFECTION	70	14	0.0000000022644501609555084
TCGA-06-0128.9	11	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	7	0.0000000023776728387377385
TCGA-76-6191.6	96	2_CELL_CYCLE_GO_0007049	265	20	0.0000000024090654750160370
TCGA-87-5896.6	131	0_HALLMARK_E2F_TARGETS	169	19	0.0000000024094833873642810
TCGA-14-3476.4	7	1_KEGG_FOCAL_ADHESION	195	7	0.0000000024233530428720127
TCGA-02-0113.4	9	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	6	0.0000000025604492379861396
TCGA-14-1034.9	9	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	6	0.0000000025604492379861396
TCGA-02-0054.2	9	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	6	0.0000000025604492379861396
TCGA-06-0155.10	74	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0000000025757439342149968
TCGA-32-5222.9	70	1_KEGG_CELL_CYCLE	114	13	0.0000000025818688534956793
TCGA-27-2523.12	112	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000026276257213907308
TCGA-08-0347.4	16	0_HALLMARK_E2F_TARGETS	169	9	0.0000000026306216048454522
TCGA-02-0038.3	199	2_NUCLEUS	1110	60	0.0000000026758672408007608
TCGA-26-5132.7	100	0_HALLMARK_E2F_TARGETS	169	17	0.0000000027211857010554747
TCGA-19-1390.13	110	0_HALLMARK_MYC_TARGETS_V1	178	18	0.0000000028247109791035423
TCGA-06-0876.9	106	1_KEGG_CELL_CYCLE	114	15	0.0000000028710704051352007
TCGA-02-0015.16	115	1_KEGG_FOCAL_ADHESION	195	19	0.0000000028727182732388736
TCGA-06-0139.1	179	0_HALLMARK_COAGULATION	125	19	0.0000000028740315438313456
TCGA-06-0881.7	203	0_HALLMARK_COAGULATION	125	20	0.0000000028900178010891194
TCGA-06-0881.7	203	2_IMMUNE_SYSTEM_PROCESS	283	29	0.0000000029423507876728397
TCGA-27-1835.6	86	0_HALLMARK_E2F_TARGETS	169	16	0.0000000029699258858806203
TCGA-06-6391.6	30	0_HALLMARK_E2F_TARGETS	169	11	0.0000000029776473863142860
TCGA-32-2638.17	159	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	12	0.0000000029780047725786129
TCGA-76-6191.6	96	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000000031286193279419937
TCGA-28-1753.13	174	1_KEGG_ECM_RECEPTOR_INTERACTION	84	16	0.0000000031860673848341509
TCGA-06-0168.4	22	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0000000033141780883320352
TCGA-06-0173.35	120	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000000033414397794461081
TCGA-08-0347.4	16	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0000000034300447450820743
TCGA-19-2631.15	84	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000000034825998778088542
TCGA-19-4068.2	11	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	6	0.0000000035031967952767651
TCGA-81-5910.12	128	1_KEGG_CELL_CYCLE	114	16	0.0000000035432640700696215
TCGA-28-5220.7	15	1_KEGG_CELL_CYCLE	114	8	0.0000000035535437311996418
TCGA-32-2634.10	118	2_DNA_METABOLIC_PROCESS	218	20	0.0000000036034436521050924
TCGA-06-1804.6	30	2_DNA_REPLICATION	82	9	0.0000000037155686677539547
TCGA-06-0171.7	57	1_KEGG_CELL_CYCLE	114	12	0.0000000040069055495658613
TCGA-06-2558.6	74	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000000040568835184236983
TCGA-06-6391.6	30	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000000041051610395760116
TCGA-32-2638.17	159	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	12	0.0000000041092370020914104
TCGA-41-3915.10	109	1_KEGG_CELL_CYCLE	114	15	0.0000000043644209824786756
TCGA-06-2561.5	42	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000000044691905677320927
TCGA-08-0356.2	23	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0000000045634085761917547
TCGA-14-1823.12	6	1_KEGG_CELL_CYCLE	114	6	0.0000000045696244811171052
TCGA-14-4157.7	101	2_CHROMOSOME	102	14	0.0000000046859996337364310
TCGA-08-0353.8	100	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000048210759107603310
TCGA-14-3476.4	7	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0000000048408575067236245
TCGA-02-0011.1	288	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	25	0.0000000048589837477467026
TCGA-02-0011.1	288	1_KEGG_CELL_CYCLE	114	22	0.0000000049503606643872753
TCGA-26-5133.10	75	0_HALLMARK_E2F_TARGETS	169	15	0.0000000049959935768610461
TCGA-06-0139.1	179	2_RESPONSE_TO_WOUNDING	163	21	0.0000000049998460012686029
TCGA-06-0881.7	203	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	17	0.0000000050535782055564531
TCGA-06-5859.9	125	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	11	0.0000000053150470920844946
TCGA-27-2521.10	94	2_REGULATION_OF_CELL_CYCLE	160	16	0.0000000053415965106643991
TCGA-19-5947.4	267	0_HALLMARK_COMPLEMENT	176	26	0.0000000053502633010485915
TCGA-76-6282.11	185	0_HALLMARK_COMPLEMENT	176	22	0.0000000053535791578360517
TCGA-76-6193.13	271	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	14	0.0000000054411261220681301
TCGA-02-0086.2	17	0_HALLMARK_E2F_TARGETS	169	9	0.0000000055048263858957396
TCGA-06-0129.11	110	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000000055393410808820176
TCGA-28-5218.5	208	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	20	10	0.0000000055560270556764209
TCGA-28-5218.5	208	2_INTERMEDIATE_FILAMENT	20	10	0.0000000055560270556764209
TCGA-06-0129.11	110	2_NON_MEMBRANE_BOUND_ORGANELLE	476	27	0.0000000056024818493472611
TCGA-06-0129.11	110	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	27	0.0000000056024818493472611
TCGA-02-0089.5	91	1_KEGG_FOCAL_ADHESION	195	17	0.0000000056699194592795500
TCGA-06-2559.11	101	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000000058934920303027492
TCGA-06-0139.1	179	2_DEFENSE_RESPONSE	222	24	0.0000000060378618579171787
TCGA-14-0786.2	10	1_KEGG_CELL_CYCLE	114	7	0.0000000060874775506108218
TCGA-06-0173.35	120	1_KEGG_FOCAL_ADHESION	195	19	0.0000000063174727463503871
TCGA-06-5418.4	24	2_GABA_RECEPTOR_ACTIVITY	8	5	0.0000000063864511078409525
TCGA-12-3653.55	255	2_CELL_CYCLE_GO_0007049	265	31	0.0000000064951605590876108
TCGA-06-2559.11	101	2_CELL_CYCLE_GO_0007049	265	20	0.0000000065680328978223240
TCGA-06-0141.1	45	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000000065891887499308883
TCGA-02-0085.1	45	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000000065891887499308883
TCGA-02-0060.19	281	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	26	0.0000000066616258059293069
TCGA-76-6193.13	271	0_HALLMARK_KRAS_SIGNALING_UP	148	24	0.0000000067274792726821810
TCGA-06-2558.6	74	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000067607353354269157
TCGA-06-0238.4	24	0_HALLMARK_E2F_TARGETS	169	10	0.0000000068591439903476087
TCGA-06-0139.1	179	0_HALLMARK_KRAS_SIGNALING_UP	148	20	0.0000000069160878875241349
TCGA-14-0789.10	106	1_KEGG_FOCAL_ADHESION	195	18	0.0000000070065979158438376
TCGA-06-5859.9	125	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	11	0.0000000071212498141121669
TCGA-27-1833.7	17	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0000000071742261156520881
TCGA-02-0086.2	17	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0000000071742261156520881
TCGA-06-0648.6	17	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0000000071742261156520881
TCGA-28-2502.9	56	1_KEGG_FOCAL_ADHESION	195	14	0.0000000073176544283411149
TCGA-76-6193.13	271	0_HALLMARK_ALLOGRAFT_REJECTION	190	27	0.0000000073283762578591476
TCGA-02-0085.1	45	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0000000074542775447540041
TCGA-41-5651.5	112	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000000074913111499409821
TCGA-19-5960.9	134	2_NUCLEUS	1110	46	0.0000000075989407709359190
TCGA-06-2561.5	42	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0000000077787130295443165
TCGA-02-2486.9	141	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	13	0.0000000078297363719568286
TCGA-32-1982.9	89	1_KEGG_ASTHMA	30	9	0.0000000079461070184979735
TCGA-02-0085.1	45	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000000080950587941825376
TCGA-02-0083.21	135	1_KEGG_CELL_CYCLE	114	16	0.0000000081700189043159777
TCGA-32-1977.11	107	1_KEGG_FOCAL_ADHESION	195	18	0.0000000082732662499750145
TCGA-06-0141.1	45	2_EXTRACELLULAR_MATRIX	85	10	0.0000000084195555211456424
TCGA-02-0085.1	45	2_EXTRACELLULAR_MATRIX	85	10	0.0000000084195555211456424
TCGA-06-5412.7	153	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000084927407876948832
TCGA-06-0882.6	21	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0000000086977530171948948
TCGA-14-4157.7	101	2_REPLICATION_FORK	18	8	0.0000000087175279264615185
TCGA-12-0618.5	41	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000000087358980622760297
TCGA-19-5951.10	138	1_KEGG_FOCAL_ADHESION	195	20	0.0000000090895887204633154
TCGA-41-3392.31	136	1_KEGG_CELL_CYCLE	114	16	0.0000000091681220276160259
TCGA-76-6193.13	271	2_EXTRACELLULAR_REGION_PART	269	32	0.0000000094708361015244078
TCGA-06-0743.14	63	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000000095236619686730965
TCGA-27-1830.7	57	1_KEGG_FOCAL_ADHESION	195	14	0.0000000095263465360127986
TCGA-06-0173.35	120	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000097813422999754823
TCGA-06-0168.4	22	1_KEGG_FOCAL_ADHESION	195	10	0.0000000098175607438517985
TCGA-28-5215.7	192	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	22	0.0000000101419099276955030
TCGA-76-6285.5	106	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000000105946258447607300
TCGA-06-2561.5	42	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000000109192855062538430
TCGA-02-0052.3	116	1_KEGG_CELL_CYCLE	114	15	0.0000000110361850872623940
TCGA-28-2509.6	59	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000000110529375691524010
TCGA-19-2624.29	130	2_NON_MEMBRANE_BOUND_ORGANELLE	476	29	0.0000000114733329693019760
TCGA-19-2624.29	130	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	29	0.0000000114733329693019760
TCGA-06-0882.6	21	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	8	0.0000000116151698634351390
TCGA-32-2638.17	159	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	15	0.0000000116320550738427000
TCGA-06-1804.7	47	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000000119271234532418370
TCGA-19-2620.7	47	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000000119271234532418370
TCGA-02-0024.6	206	1_KEGG_P53_SIGNALING_PATHWAY	66	15	0.0000000122432708723823650
TCGA-02-0079.2	10	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	7	0.0000000124491567057810920
TCGA-06-0686.1	7	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000000124663337974922760
TCGA-28-5209.15	194	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	22	0.0000000125084358967793440
TCGA-08-0345.2	77	1_KEGG_LEISHMANIA_INFECTION	70	11	0.0000000125284591136505650
TCGA-16-1048.13	97	1_KEGG_CELL_CYCLE	114	14	0.0000000125951061109563350
TCGA-14-1034.7	97	1_KEGG_CELL_CYCLE	114	14	0.0000000125951061109563350
TCGA-19-5952.11	193	0_HALLMARK_COMPLEMENT	176	22	0.0000000126508555041799770
TCGA-02-0003.9	227	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	22	0.0000000127055094708955100
TCGA-06-2561.5	42	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000000134452674635816880
TCGA-06-0168.4	22	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000000135700803486005630
TCGA-32-4213.15	198	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	15	0.0000000137785932516217250
TCGA-08-0389.4	56	1_KEGG_DNA_REPLICATION	32	8	0.0000000144252411818519200
TCGA-06-0195.8	56	1_KEGG_DNA_REPLICATION	32	8	0.0000000144252411818519200
TCGA-06-0176.8	95	0_HALLMARK_E2F_TARGETS	169	16	0.0000000147565844701834090
TCGA-06-0132.1	18	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0000000148755669460415410
TCGA-06-0129.11	110	2_CELL_CYCLE_PHASE	146	16	0.0000000157360099351194560
TCGA-14-0871.20	216	2_CELL_CYCLE_GO_0007049	265	28	0.0000000162003943015943390
TCGA-27-1836.8	49	1_KEGG_CELL_CYCLE	114	11	0.0000000162091775570419330
TCGA-02-0107.3	71	1_KEGG_FOCAL_ADHESION	195	15	0.0000000171883811614818360
TCGA-19-5955.9	110	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	11	0.0000000174774933599461940
TCGA-19-1390.13	110	2_REPLICATION_FORK	18	8	0.0000000175225169217963790
TCGA-06-0141.1	45	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0000000178342536710104980
TCGA-27-2519.7	113	1_KEGG_ALLOGRAFT_REJECTION	37	10	0.0000000179633524647801760
TCGA-12-3653.55	255	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	23	0.0000000180729453107054610
TCGA-02-0007.17	217	2_CELL_CYCLE_GO_0007049	265	28	0.0000000181428545000276720
TCGA-02-0113.4	9	1_KEGG_LEISHMANIA_INFECTION	70	6	0.0000000185444079746296870
TCGA-02-0113.4	9	1_KEGG_VIRAL_MYOCARDITIS	70	6	0.0000000185444079746296870
TCGA-14-1034.9	9	1_KEGG_LEISHMANIA_INFECTION	70	6	0.0000000185444079746296870
TCGA-14-1034.9	9	1_KEGG_VIRAL_MYOCARDITIS	70	6	0.0000000185444079746296870
TCGA-02-0054.2	9	1_KEGG_LEISHMANIA_INFECTION	70	6	0.0000000185444079746296870
TCGA-02-0054.2	9	1_KEGG_VIRAL_MYOCARDITIS	70	6	0.0000000185444079746296870
TCGA-26-5134.2	14	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0000000187809096036923780
TCGA-06-0188.11	66	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000000187911614747834980
TCGA-06-0645.9	136	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000000189671454313454600
TCGA-06-0142.3	8	1_KEGG_FOCAL_ADHESION	195	7	0.0000000190490282827709870
TCGA-02-2486.9	141	0_HALLMARK_COMPLEMENT	176	19	0.0000000191583156358686460
TCGA-06-0142.3	8	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0000000192263286593030120
TCGA-02-0102.8	82	0_HALLMARK_E2F_TARGETS	169	15	0.0000000196006085791165770
TCGA-06-5413.11	142	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000196619665660029630
TCGA-02-0060.19	281	0_HALLMARK_APOPTOSIS	150	24	0.0000000197113701402069240
TCGA-02-0085.1	45	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000000197557185420479290
TCGA-14-4157.7	101	2_DNA_METABOLIC_PROCESS	218	18	0.0000000198031906698016090
TCGA-19-5958.4	35	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0000000198111483103271950
TCGA-19-2624.29	130	2_CELL_CYCLE_PHASE	146	17	0.0000000198407053843952880
TCGA-02-0114.20	132	2_CELL_CYCLE_GO_0007049	265	22	0.0000000201371058862861360
TCGA-14-1823.12	6	2_CELL_CYCLE_PHASE	146	6	0.0000000207713095361000800
TCGA-02-0060.19	281	0_HALLMARK_COAGULATION	125	22	0.0000000208970547392184040
TCGA-02-0102.8	82	1_KEGG_CELL_CYCLE	114	13	0.0000000215170073523672040
TCGA-06-0166.5	35	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000000221331899976258080
TCGA-19-5958.4	35	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000000221331899976258080
TCGA-02-0038.3	199	2_NON_MEMBRANE_BOUND_ORGANELLE	476	36	0.0000000228831644162804100
TCGA-02-0038.3	199	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	36	0.0000000228831644162804100
TCGA-76-4925.9	83	0_HALLMARK_E2F_TARGETS	169	15	0.0000000235572511618874330
TCGA-27-2528.10	99	1_KEGG_FOCAL_ADHESION	195	17	0.0000000235745271765030870
TCGA-06-0129.11	110	0_HALLMARK_MITOTIC_SPINDLE	175	17	0.0000000238431666872048680
TCGA-19-5955.9	110	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	16	0.0000000239021775753956760
TCGA-06-0745.4	55	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000000240812105262452280
TCGA-02-0085.1	45	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000000243189556419133140
TCGA-06-2561.5	42	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0000000245450027370221110
TCGA-19-5958.4	35	2_EXTRACELLULAR_MATRIX	85	9	0.0000000246925310956483970
TCGA-06-0750.13	8	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000000249242175442869330
TCGA-06-5415.3	8	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000000249242175442869330
TCGA-06-0221.4	8	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000000249242175442869330
TCGA-32-2491.14	244	0_HALLMARK_G2M_CHECKPOINT	174	24	0.0000000249366398785091190
TCGA-02-0060.19	281	2_EXTRACELLULAR_REGION_PART	269	32	0.0000000251939330960100720
TCGA-41-2575.49	136	2_CELL_CYCLE_PROCESS	163	18	0.0000000255225034112659880
TCGA-26-5139.10	163	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	20	9	0.0000000261878219940410160
TCGA-26-5139.10	163	2_INTERMEDIATE_FILAMENT	20	9	0.0000000261878219940410160
TCGA-02-0015.16	115	0_HALLMARK_UV_RESPONSE_DN	122	15	0.0000000264556251688606780
TCGA-08-0356.2	23	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	8	0.0000000275721937000082430
TCGA-14-0781.7	155	0_HALLMARK_COAGULATION	125	17	0.0000000275820279117518040
TCGA-26-5139.10	163	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000000279218545943136730
TCGA-06-0176.8	95	1_KEGG_DNA_REPLICATION	32	9	0.0000000279858719540218230
TCGA-12-0616.4	7	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	5	0.0000000282597221235202870
TCGA-19-2625.9	146	1_KEGG_P53_SIGNALING_PATHWAY	66	13	0.0000000286328451568295690
TCGA-06-2558.6	74	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000000288548668038702620
TCGA-32-4210.14	109	2_CELL_CYCLE_GO_0007049	265	20	0.0000000288940672283833650
TCGA-19-2629.15	146	0_HALLMARK_G2M_CHECKPOINT	174	19	0.0000000292792270099887350
TCGA-06-0221.13	45	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000000298396526524097990
TCGA-06-0744.10	36	0_HALLMARK_E2F_TARGETS	169	11	0.0000000298474872743275770
TCGA-81-5910.12	128	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000000300351151648772310
TCGA-06-2565.10	38	1_KEGG_ASTHMA	30	7	0.0000000305457979169928520
TCGA-06-0216.6	67	1_KEGG_CELL_CYCLE	114	12	0.0000000307266462712287050
TCGA-06-0750.12	52	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000000310986166493724520
TCGA-27-1838.17	131	1_KEGG_FOCAL_ADHESION	195	19	0.0000000313357203490665730
TCGA-28-5218.5	208	2_STRUCTURAL_MOLECULE_ACTIVITY	206	24	0.0000000313649721244689780
TCGA-08-0355.1	45	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0000000319316898664720830
TCGA-19-1790.18	201	1_KEGG_FOCAL_ADHESION	195	23	0.0000000324726850460847180
TCGA-06-0878.10	115	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000000331216483530455930
TCGA-19-2619.14	100	0_HALLMARK_E2F_TARGETS	169	16	0.0000000333135469614607560
TCGA-06-0128.9	11	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	7	0.0000000338576948528555900
TCGA-06-0881.7	203	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	16	0.0000000341068405265710720
TCGA-19-5955.9	110	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0000000344641557619439780
TCGA-19-1390.13	110	2_NON_MEMBRANE_BOUND_ORGANELLE	476	26	0.0000000358926117491733130
TCGA-19-1390.13	110	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	26	0.0000000358926117491733130
TCGA-06-0190.8	143	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000000377636324115253080
TCGA-32-1979.4	12	1_KEGG_CELL_CYCLE	114	7	0.0000000393846179001579520
TCGA-32-2634.10	118	1_KEGG_SMALL_CELL_LUNG_CANCER	83	13	0.0000000394355582670863770
TCGA-06-0750.12	52	2_EXTRACELLULAR_MATRIX	85	10	0.0000000396834150286997480
TCGA-76-4931.10	86	1_KEGG_CELL_CYCLE	114	13	0.0000000403306718427233530
TCGA-06-2569.5	144	1_KEGG_DNA_REPLICATION	32	10	0.0000000404495545370887670
TCGA-27-1838.17	131	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000406304452099935360
TCGA-87-5896.6	131	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0000000406304452099935360
TCGA-14-1823.12	6	2_CELL_CYCLE_PROCESS	163	6	0.0000000406667739779418760
TCGA-32-2634.10	118	2_CHROMOSOME	102	14	0.0000000410441474890611770
TCGA-19-5960.9	134	2_DNA_METABOLIC_PROCESS	218	20	0.0000000410522777683997630
TCGA-41-2575.49	136	2_CELL_CYCLE_PHASE	146	17	0.0000000415385918223573860
TCGA-02-0083.21	135	0_HALLMARK_E2F_TARGETS	169	18	0.0000000415658780645915270
TCGA-06-2561.5	42	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0000000421645110743023990
TCGA-27-1837.5	85	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0000000428772873353342060
TCGA-06-0137.9	53	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000000430245290069803210
TCGA-41-2575.49	136	1_KEGG_PATHWAYS_IN_CANCER	323	24	0.0000000436054523010831330
TCGA-06-0750.12	52	1_KEGG_FOCAL_ADHESION	195	13	0.0000000438113253878523120
TCGA-32-2632.16	229	0_HALLMARK_G2M_CHECKPOINT	174	23	0.0000000448205904609074230
TCGA-19-5947.4	267	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	23	0.0000000465522972761447490
TCGA-06-0879.9	84	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000467504241188143190
TCGA-14-4157.7	101	2_CHROMOSOMAL_PART	78	12	0.0000000468015766445650160
TCGA-08-0347.7	25	1_KEGG_FOCAL_ADHESION	195	10	0.0000000470231004025121900
TCGA-08-0345.2	77	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0000000470969944812792300
TCGA-32-2638.17	159	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	17	0.0000000474988830742379710
TCGA-41-2572.8	76	1_KEGG_FOCAL_ADHESION	195	15	0.0000000487651057269380990
TCGA-28-5218.5	208	1_KEGG_ECM_RECEPTOR_INTERACTION	84	16	0.0000000493654319652341520
TCGA-08-0386.4	73	0_HALLMARK_E2F_TARGETS	169	14	0.0000000500028186859303800
TCGA-76-6282.11	185	0_HALLMARK_COAGULATION	125	18	0.0000000510775659284583830
TCGA-02-2486.9	141	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	14	0.0000000510904679450177280
TCGA-41-3915.10	109	1_KEGG_ASTHMA	30	9	0.0000000511896296903985970
TCGA-06-5859.9	125	2_CELL_CYCLE_GO_0007049	265	21	0.0000000514350722649638170
TCGA-14-0817.9	85	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000000514372405266221310
TCGA-06-2557.11	177	1_KEGG_CELL_CYCLE	114	17	0.0000000517087542240350240
TCGA-32-2638.17	159	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	12	0.0000000517811121487530690
TCGA-19-2619.14	100	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000000520214031351279130
TCGA-02-0038.3	199	2_CHROMOSOME	102	17	0.0000000537525311181497650
TCGA-26-5139.10	163	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	50	12	0.0000000538949200070213220
TCGA-26-5135.9	71	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000000539185458260970710
TCGA-06-0881.7	203	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	12	0.0000000540648937896758240
TCGA-32-1979.10	116	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	12	0.0000000545103544246837350
TCGA-12-3652.19	88	1_KEGG_CELL_CYCLE	114	13	0.0000000545303879846245560
TCGA-27-2519.7	113	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	10	0.0000000555538001733613910
TCGA-27-1837.5	85	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000558636782451116210
TCGA-06-0124.6	55	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000000562900480372922980
TCGA-06-0173.35	120	0_HALLMARK_E2F_TARGETS	169	17	0.0000000571026290212128440
TCGA-02-0113.4	9	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	6	0.0000000572706170577482420
TCGA-19-5947.4	267	0_HALLMARK_COAGULATION	125	21	0.0000000593171648156826040
TCGA-12-3650.17	101	2_CELL_CYCLE_GO_0007049	265	19	0.0000000597298862305052100
TCGA-06-0139.1	179	1_KEGG_LEISHMANIA_INFECTION	70	14	0.0000000597445787737205920
TCGA-06-0133.6	57	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000000600476890107025590
TCGA-12-0618.5	41	1_KEGG_CELL_CYCLE	114	10	0.0000000607123319564402400
TCGA-06-0686.10	26	2_CELL_CYCLE_GO_0007049	265	11	0.0000000618510127316962360
TCGA-02-0060.19	281	2_EXTRACELLULAR_REGION	346	36	0.0000000630010467886332190
TCGA-06-0157.7	89	1_KEGG_CELL_CYCLE	114	13	0.0000000632210672574959110
TCGA-06-2557.11	177	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	19	0.0000000643005319407264190
TCGA-06-2561.5	42	1_KEGG_ASTHMA	30	7	0.0000000647416963442307690
TCGA-32-1982.9	89	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0000000654856794422953610
TCGA-41-2571.7	72	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000000658658651602390350
TCGA-27-1838.17	131	1_KEGG_CELL_CYCLE	114	15	0.0000000659313404862387460
TCGA-28-5215.7	192	2_ECTODERM_DEVELOPMENT	66	14	0.0000000660855366911744100
TCGA-06-0157.7	89	0_HALLMARK_E2F_TARGETS	169	15	0.0000000673490750297299270
TCGA-28-2502.9	56	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000000680443743637666410
TCGA-02-0060.19	281	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	31	0.0000000682043792731195050
TCGA-76-4935.7	15	2_CELL_CYCLE_GO_0007049	265	9	0.0000000685633323044143540
TCGA-06-2561.5	42	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0000000704684082686174840
TCGA-02-0113.4	9	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	6	0.0000000710900901211554950
TCGA-14-1034.9	9	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	6	0.0000000710900901211554950
TCGA-02-0054.2	9	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	6	0.0000000710900901211554950
TCGA-27-2519.7	113	1_KEGG_ASTHMA	30	9	0.0000000711038617375755100
TCGA-06-0881.7	203	0_HALLMARK_KRAS_SIGNALING_UP	148	20	0.0000000714517930096350000
TCGA-06-5859.9	125	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	11	0.0000000716720946611181670
TCGA-06-0124.6	55	2_EXTRACELLULAR_MATRIX	85	10	0.0000000717872130016081300
TCGA-19-5954.17	208	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	12	0.0000000719420357979439650
TCGA-27-2519.7	113	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	10	0.0000000721907095104364980
TCGA-02-0058.1	110	1_KEGG_CELL_CYCLE	114	14	0.0000000726633316789568910
TCGA-14-1823.12	6	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0000000737920469271301010
TCGA-08-0386.4	73	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000000742178716023720250
TCGA-32-2634.10	118	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000000759229762130119410
TCGA-02-0085.1	45	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0000000761348889467752760
TCGA-02-0009.6	188	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	18	0.0000000767860087967420460
TCGA-28-2502.9	56	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000000768958480135527460
TCGA-06-6391.6	30	1_KEGG_CELL_CYCLE	114	9	0.0000000770426778774140500
TCGA-06-0139.1	179	1_KEGG_ALLOGRAFT_REJECTION	37	11	0.0000000781906073784164080
TCGA-06-2565.3	60	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000000791161057979205500
TCGA-76-6193.13	271	1_KEGG_FOCAL_ADHESION	195	26	0.0000000812229868214128620
TCGA-06-0876.9	106	0_HALLMARK_E2F_TARGETS	169	16	0.0000000831994469270444000
TCGA-76-4929.8	91	1_KEGG_CELL_CYCLE	114	13	0.0000000844993743281629850
TCGA-41-2572.8	76	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000000848199773890899150
TCGA-06-2563.10	123	0_HALLMARK_E2F_TARGETS	169	17	0.0000000855248941313699190
TCGA-06-0882.6	21	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0000000857294226056963150
TCGA-28-2502.9	56	2_EXTRACELLULAR_MATRIX	85	10	0.0000000867607983814453800
TCGA-28-5220.7	15	0_HALLMARK_E2F_TARGETS	169	8	0.0000000868216138246380250
TCGA-76-4935.7	15	0_HALLMARK_E2F_TARGETS	169	8	0.0000000868216138246380250
TCGA-19-2624.29	130	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000000874967962925525480
TCGA-27-2527.6	79	1_KEGG_FOCAL_ADHESION	195	15	0.0000000876711261106444580
TCGA-41-2571.7	72	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000000879096653888889860
TCGA-06-0686.5	14	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0000000896815437949753930
TCGA-27-1830.7	57	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000000925908592575517260
TCGA-02-0025.5	88	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000000939256756134516100
TCGA-06-5412.7	153	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000000948076305646764790
TCGA-06-0124.6	55	1_KEGG_FOCAL_ADHESION	195	13	0.0000000948366457780749500
TCGA-76-6193.13	271	2_EXTRACELLULAR_REGION	346	35	0.0000000955363445026233490
TCGA-02-0010.18	184	1_KEGG_CELL_CYCLE	114	17	0.0000000962595334975112500
TCGA-02-2486.9	141	0_HALLMARK_INFLAMMATORY_RESPONSE	170	18	0.0000000965253544125648800
TCGA-06-5859.9	125	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	13	0.0000000967302231742443340
TCGA-15-0742.13	74	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000000973300169274542560
TCGA-06-2564.7	92	1_KEGG_CELL_CYCLE	114	13	0.0000000974227771199188710
TCGA-32-4210.14	109	1_KEGG_DNA_REPLICATION	32	9	0.0000000984514224061798480
TCGA-32-2634.10	118	1_KEGG_PATHWAYS_IN_CANCER	323	22	0.0000000985594272818445520
TCGA-06-1804.6	30	1_KEGG_MISMATCH_REPAIR	23	6	0.0000000989636654104851370
TCGA-02-0014.10	70	2_CELL_CYCLE_GO_0007049	265	16	0.0000001008293622264436400
TCGA-32-2638.17	159	1_KEGG_CELL_CYCLE	114	16	0.0000001020257102119889700
TCGA-12-3653.55	255	2_CELL_CYCLE_PROCESS	163	23	0.0000001038024718953932700
TCGA-14-1823.12	6	2_INTERPHASE	62	5	0.0000001041743886408225300
TCGA-14-0781.7	155	0_HALLMARK_COMPLEMENT	176	19	0.0000001041847125546445500
TCGA-06-0189.3	118	1_KEGG_ASTHMA	30	9	0.0000001054156338075831800
TCGA-02-0038.3	199	1_KEGG_P53_SIGNALING_PATHWAY	66	14	0.0000001070359048399386300
TCGA-14-0781.7	155	2_EXTRACELLULAR_REGION_PART	269	23	0.0000001078033212649900000
TCGA-02-0038.3	199	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	44	12	0.0000001080824539449646900
TCGA-02-0009.6	188	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	15	0.0000001092515914238013800
TCGA-12-3649.15	89	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000001111642009878943900
TCGA-14-0781.7	155	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000001130462514998194100
TCGA-28-5215.7	192	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	20	9	0.0000001147317382721717600
TCGA-28-5215.7	192	2_INTERMEDIATE_FILAMENT	20	9	0.0000001147317382721717600
TCGA-26-5136.6	160	1_KEGG_DNA_REPLICATION	32	10	0.0000001158106299543742600
TCGA-26-5139.10	163	2_ECTODERM_DEVELOPMENT	66	13	0.0000001162276468562015400
TCGA-27-1837.5	85	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0000001172860083836396400
TCGA-06-0125.9	75	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000001177593996957833000
TCGA-06-2569.5	144	2_CELL_CYCLE_GO_0007049	265	22	0.0000001189365088467704100
TCGA-06-0750.13	8	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	7	0.0000001202346051520946800
TCGA-02-0060.19	281	2_RESPONSE_TO_WOUNDING	163	24	0.0000001205457342371334300
TCGA-19-2624.29	130	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000001220697202108255700
TCGA-06-0211.8	62	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000001231917093837001700
TCGA-32-1977.3	8	1_KEGG_CELL_CYCLE	114	6	0.0000001254530362564220000
TCGA-06-0141.1	45	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000001271339926522644700
TCGA-02-0085.1	45	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0000001271339926522644700
TCGA-02-0085.1	45	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000001271339926522644700
TCGA-12-0616.4	7	2_KINESIN_COMPLEX	13	4	0.0000001271729045179478300
TCGA-06-1804.6	30	2_CHROMOSOMAL_PART	78	8	0.0000001277146287613727500
TCGA-19-1390.13	110	2_CHROMOSOMAL_PART	78	12	0.0000001302335531585212800
TCGA-06-0686.5	14	1_KEGG_FOCAL_ADHESION	195	8	0.0000001302672314712207600
TCGA-02-0009.6	188	1_KEGG_ECM_RECEPTOR_INTERACTION	84	15	0.0000001307111227987206000
TCGA-14-3476.4	7	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0000001319497446307968300
TCGA-76-6193.13	271	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	30	0.0000001324154778845882100
TCGA-08-0352.2	59	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000001327965947757257200
TCGA-14-4157.7	101	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000001334049807239234300
TCGA-27-1838.17	131	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000001336639131747199000
TCGA-06-2565.10	38	2_MITOTIC_CELL_CYCLE	134	10	0.0000001338743978317694800
TCGA-02-0015.16	115	1_KEGG_CELL_CYCLE	114	14	0.0000001339315112253723400
TCGA-76-6193.13	271	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	13	0.0000001370248830843350400
TCGA-02-0010.18	184	0_HALLMARK_E2F_TARGETS	169	20	0.0000001375822390288246000
TCGA-76-6193.13	271	1_KEGG_LEISHMANIA_INFECTION	70	16	0.0000001410343275118404000
TCGA-76-6193.13	271	1_KEGG_VIRAL_MYOCARDITIS	70	16	0.0000001410343275118404000
TCGA-06-5859.9	125	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	15	0.0000001436735678639795500
TCGA-76-6285.5	106	2_CELL_CYCLE_GO_0007049	265	19	0.0000001444527894037943000
TCGA-06-0133.6	57	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000001458810009280764900
TCGA-02-0058.1	110	0_HALLMARK_E2F_TARGETS	169	16	0.0000001480738065557370900
TCGA-27-1837.5	85	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0000001481906650705097600
TCGA-26-5139.10	163	1_KEGG_CELL_CYCLE	114	16	0.0000001488433788920873700
TCGA-26-5136.6	160	0_HALLMARK_G2M_CHECKPOINT	174	19	0.0000001493369125614183200
TCGA-12-0619.11	123	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000001494128740076295300
TCGA-06-2563.10	123	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000001494128740076295300
TCGA-76-6192.6	43	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0000001495064459491247800
TCGA-06-2565.10	38	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0000001513926164467367600
TCGA-02-0060.19	281	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	13	0.0000001527635552681581400
TCGA-08-0347.4	16	2_CELL_CYCLE_GO_0007049	265	9	0.0000001528945020938357000
TCGA-06-5417.5	79	0_HALLMARK_E2F_TARGETS	169	14	0.0000001533471349922741000
TCGA-76-6191.6	96	1_KEGG_FOCAL_ADHESION	195	16	0.0000001541325386302308300
TCGA-06-2562.7	57	1_KEGG_FOCAL_ADHESION	195	13	0.0000001543186911619581600
TCGA-28-5214.11	124	0_HALLMARK_G2M_CHECKPOINT	174	17	0.0000001555286560942085300
TCGA-28-6450.11	139	1_KEGG_CELL_CYCLE	114	15	0.0000001556855058599502700
TCGA-32-4213.15	198	0_HALLMARK_COMPLEMENT	176	21	0.0000001558581699651707500
TCGA-02-0009.6	188	2_EXTRACELLULAR_MATRIX	85	15	0.0000001559868023630273400
TCGA-02-2486.9	141	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000001570253511291523200
TCGA-14-0787.6	40	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000001575947767557515300
TCGA-19-2629.15	146	0_HALLMARK_E2F_TARGETS	169	18	0.0000001577837696412188300
TCGA-06-5859.9	125	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0000001583958473558255800
TCGA-32-4213.15	198	0_HALLMARK_COAGULATION	125	18	0.0000001594046158092923300
TCGA-06-1804.6	30	0_HALLMARK_MYC_TARGETS_V1	178	10	0.0000001603541780732264900
TCGA-02-2486.9	141	1_KEGG_ALLOGRAFT_REJECTION	37	10	0.0000001659712003617673000
TCGA-28-5216.8	162	2_CYTOSKELETAL_PART	194	20	0.0000001661563718764180500
TCGA-19-1390.13	110	2_INTERPHASE	62	11	0.0000001676914701220006700
TCGA-06-0132.1	18	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0000001692328304988967000
TCGA-19-1390.13	110	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	15	0.0000001699166325689721400
TCGA-32-2615.7	77	1_KEGG_CELL_CYCLE	114	12	0.0000001702893925258111000
TCGA-06-5859.9	125	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	16	0.0000001741865283781577600
TCGA-02-0069.13	16	2_EXTRACELLULAR_REGION_PART	269	9	0.0000001748472155752710400
TCGA-06-0744.3	12	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000001760109665507479300
TCGA-32-1982.9	89	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0000001788541043287621500
TCGA-06-0686.5	14	2_COLLAGEN	23	5	0.0000001790810516222564400
TCGA-06-0133.6	57	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000001793734831232289300
TCGA-27-2523.12	112	1_KEGG_FOCAL_ADHESION	195	17	0.0000001815209303440380300
TCGA-41-2575.49	136	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000001816277283107446300
TCGA-08-0345.2	77	0_HALLMARK_COMPLEMENT	176	14	0.0000001844393816958913100
TCGA-81-5910.12	128	1_KEGG_FOCAL_ADHESION	195	18	0.0000001851660530615666300
TCGA-32-2638.17	159	1_KEGG_VIRAL_MYOCARDITIS	70	13	0.0000001858829458671310900
TCGA-76-6192.6	43	2_EXTRACELLULAR_MATRIX	85	9	0.0000001860585427997282700
TCGA-02-0099.11	141	1_KEGG_CELL_CYCLE	114	15	0.0000001912776023494793500
TCGA-41-2573.4	31	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0000001968090014911257200
TCGA-06-0174.37	141	2_MITOTIC_CELL_CYCLE	134	16	0.0000001970001026305089600
TCGA-14-0781.7	155	0_HALLMARK_UV_RESPONSE_DN	122	16	0.0000001973515334761562200
TCGA-06-0650.2	82	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000001986852358916773700
TCGA-06-6390.9	82	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000001986852358916773700
TCGA-02-0028.9	182	1_KEGG_ASTHMA	30	10	0.0000001998478383372800500
TCGA-06-2559.11	101	2_REGULATION_OF_CELL_CYCLE	160	15	0.0000001999163482573758800
TCGA-06-1804.7	47	1_KEGG_FOCAL_ADHESION	195	12	0.0000001999259469567108000
TCGA-19-2620.7	47	1_KEGG_FOCAL_ADHESION	195	12	0.0000001999259469567108000
TCGA-06-0241.8	53	2_CELL_CYCLE_GO_0007049	265	14	0.0000002023970347576905900
TCGA-12-3650.17	101	2_MITOTIC_CELL_CYCLE	134	14	0.0000002038998546297035600
TCGA-19-1790.18	201	0_HALLMARK_COAGULATION	125	18	0.0000002047030508502148500
TCGA-12-5301.7	46	2_GABA_RECEPTOR_ACTIVITY	8	5	0.0000002047638266959742300
TCGA-19-5952.11	193	1_KEGG_CELL_CYCLE	114	17	0.0000002057421937028074100
TCGA-32-4210.14	109	2_CHROMOSOME	102	13	0.0000002081877312895843300
TCGA-02-0038.3	199	2_REGULATION_OF_CELL_CYCLE	160	20	0.0000002100883375632067400
TCGA-14-1456.4	41	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000002119504353088806000
TCGA-02-0038.3	199	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	21	0.0000002126379110180283000
TCGA-08-0345.2	77	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0000002154093218623290600
TCGA-02-0075.8	128	1_KEGG_ASTHMA	30	9	0.0000002202580650851747800
TCGA-28-5209.15	194	1_KEGG_CELL_CYCLE	114	17	0.0000002232862490861496600
TCGA-06-2569.5	144	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000002240823979340117400
TCGA-32-1982.9	89	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0000002258951965495815700
TCGA-06-0158.4	65	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000002320171379392971500
TCGA-19-5960.9	134	2_CHROMOSOME	102	14	0.0000002335224353419349500
TCGA-28-2513.12	134	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000002344002148137426600
TCGA-06-0155.10	74	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0000002345220244576891900
TCGA-19-2629.15	146	1_KEGG_ALLOGRAFT_REJECTION	37	10	0.0000002347610222272402700
TCGA-19-5947.4	267	0_HALLMARK_KRAS_SIGNALING_UP	148	22	0.0000002386918641508866500
TCGA-19-1390.13	110	2_DNA_REPLICATION	82	12	0.0000002390179737045696700
TCGA-08-0352.2	59	1_KEGG_FOCAL_ADHESION	195	13	0.0000002460531646051206500
TCGA-14-1829.3	8	2_KINESIN_COMPLEX	13	4	0.0000002541518658034503700
TCGA-14-1825.8	80	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000002584674170747842300
TCGA-32-2632.16	229	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	19	0.0000002588964796123987400
TCGA-19-2631.15	84	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000002598162418274806000
TCGA-06-0129.11	110	2_SPINDLE	35	9	0.0000002616148522361343600
TCGA-06-0197.1	57	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000002630099527134935500
TCGA-06-0176.8	95	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000002690972907957453800
TCGA-06-5858.19	205	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	21	0.0000002697020731527758800
TCGA-19-5947.4	267	2_EXTRACELLULAR_REGION	346	34	0.0000002698742558679327900
TCGA-06-0139.1	179	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	11	0.0000002705458534731093400
TCGA-06-0747.12	80	1_KEGG_CELL_CYCLE	114	12	0.0000002708789938441844300
TCGA-02-0038.3	199	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	19	0.0000002740936373907570500
TCGA-87-5896.6	131	1_KEGG_FOCAL_ADHESION	195	18	0.0000002743170223539513900
TCGA-08-0345.2	77	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	10	0.0000002766583610240123500
TCGA-06-2570.8	95	2_CELL_CYCLE_PHASE	146	14	0.0000002793659971403653000
TCGA-76-6193.13	271	1_KEGG_ECM_RECEPTOR_INTERACTION	84	17	0.0000002809483127269260600
TCGA-76-6191.6	96	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	9	0.0000002810141956901722100
TCGA-06-0133.6	57	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0000002832703735636918500
TCGA-19-5955.9	110	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	14	0.0000002854619051570978200
TCGA-41-3915.10	109	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0000002868975097426835400
TCGA-41-2571.7	72	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000002918860155405311600
TCGA-14-1825.8	80	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000002922988196908593900
TCGA-06-0881.7	203	1_KEGG_ALLOGRAFT_REJECTION	37	11	0.0000003046996367306609700
TCGA-02-0038.3	199	2_CELL_CYCLE_PHASE	146	19	0.0000003093500580675582900
TCGA-32-2498.13	133	1_KEGG_ASTHMA	30	9	0.0000003112547645477465700
TCGA-06-2565.10	38	2_CELL_CYCLE_PHASE	146	10	0.0000003144324767332327700
TCGA-02-0003.9	227	0_HALLMARK_COMPLEMENT	176	22	0.0000003166148301261686000
TCGA-27-1833.7	17	2_CELL_CYCLE_GO_0007049	265	9	0.0000003169790682492048000
TCGA-02-0086.2	17	2_CELL_CYCLE_GO_0007049	265	9	0.0000003169790682492048000
TCGA-06-0648.6	17	2_CELL_CYCLE_GO_0007049	265	9	0.0000003169790682492048000
TCGA-19-5955.9	110	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	12	0.0000003197477523136701600
TCGA-06-0881.7	203	1_KEGG_LEISHMANIA_INFECTION	70	14	0.0000003236293127391821300
TCGA-06-0174.37	141	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000003243210653213882100
TCGA-28-5215.7	192	2_CYTOSKELETON	293	26	0.0000003250302653390434700
TCGA-06-2565.10	38	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0000003268032561637031900
TCGA-19-5952.11	193	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	20	0.0000003280411134021596300
TCGA-32-2634.10	118	1_KEGG_MISMATCH_REPAIR	23	8	0.0000003302690424978703200
TCGA-28-2513.12	134	1_KEGG_ASTHMA	30	9	0.0000003329906924992298300
TCGA-32-4719.15	123	1_KEGG_CELL_CYCLE	114	14	0.0000003351627822083324900
TCGA-32-1986.8	87	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	11	0.0000003357105838792875200
TCGA-02-0071.12	116	0_HALLMARK_E2F_TARGETS	169	16	0.0000003359540398187954400
TCGA-19-1790.18	201	1_KEGG_ECM_RECEPTOR_INTERACTION	84	15	0.0000003381070529038172400
TCGA-06-0129.11	110	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000003409124890192902500
TCGA-06-0238.4	24	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0000003453512262491554900
TCGA-19-5950.7	113	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000003482676563482920600
TCGA-06-1804.7	47	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0000003511674552132763500
TCGA-32-1977.11	107	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	12	0.0000003513269052600077800
TCGA-14-0787.7	14	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000003556919683056903000
TCGA-06-0645.9	136	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	12	0.0000003591356134859704800
TCGA-06-0139.1	179	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	11	0.0000003605685030089560800
TCGA-02-0023.3	24	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0000003635472879252209200
TCGA-02-0069.8	7	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	6	0.0000003754449669765610600
TCGA-76-4925.9	83	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000003756616853199226900
TCGA-28-5218.5	208	2_CYTOSKELETON	293	27	0.0000003810788568047451500
TCGA-06-2565.10	38	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0000003910353429463127600
TCGA-19-5954.17	208	0_HALLMARK_COMPLEMENT	176	21	0.0000003947701447579558700
TCGA-19-5954.17	208	1_KEGG_ALLOGRAFT_REJECTION	37	11	0.0000003957893636469985900
TCGA-06-0178.2	17	0_HALLMARK_G2M_CHECKPOINT	174	8	0.0000004019472768881724800
TCGA-76-6193.13	271	1_KEGG_ALLOGRAFT_REJECTION	37	12	0.0000004022563718724383500
TCGA-27-2519.7	113	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	15	0.0000004085334255056347300
TCGA-27-2519.7	113	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	14	0.0000004120527064836109800
TCGA-32-1991.11	82	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000004126438701992474800
TCGA-76-6193.13	271	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	86	17	0.0000004157085957041903600
TCGA-06-2565.10	38	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0000004168640650372584600
TCGA-06-5412.7	153	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	17	0.0000004274408062730058500
TCGA-14-3476.17	53	2_GABA_RECEPTOR_ACTIVITY	8	5	0.0000004278780756328496000
TCGA-06-0750.12	52	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000004313999294828916000
TCGA-41-3393.5	88	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000004350949400497563400
TCGA-06-0174.37	141	2_CELL_CYCLE_PROCESS	163	17	0.0000004355163928686620500
TCGA-06-1804.7	47	2_EXTRACELLULAR_MATRIX	85	9	0.0000004366876860272544500
TCGA-32-1986.8	87	2_EXTRACELLULAR_MATRIX	85	11	0.0000004371719835270121800
TCGA-41-3393.5	88	1_KEGG_FOCAL_ADHESION	195	15	0.0000004384848978436755400
TCGA-27-2519.7	113	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	12	0.0000004397559828328921500
TCGA-14-4157.7	101	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	9	0.0000004459359708925211800
TCGA-02-2486.9	141	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	13	0.0000004459977676382976100
TCGA-08-0389.4	56	2_CELL_CYCLE_GO_0007049	265	14	0.0000004532341718671887100
TCGA-06-2569.5	144	2_REGULATION_OF_CELL_CYCLE	160	17	0.0000004539051262988415000
TCGA-19-5950.7	113	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000004574255750771268800
TCGA-14-0817.9	85	1_KEGG_DNA_REPLICATION	32	8	0.0000004575487850681242200
TCGA-28-5218.5	208	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	15	0.0000004590599785241142400
TCGA-19-1790.18	201	0_HALLMARK_KRAS_SIGNALING_UP	148	19	0.0000004668887482064502800
TCGA-06-0744.10	36	1_KEGG_CELL_CYCLE	114	9	0.0000004772578477855216800
TCGA-28-2514.9	62	1_KEGG_FOCAL_ADHESION	195	13	0.0000004784296140138582100
TCGA-06-0214.9	62	1_KEGG_FOCAL_ADHESION	195	13	0.0000004784296140138582100
TCGA-08-0356.2	23	0_HALLMARK_ALLOGRAFT_REJECTION	190	9	0.0000004822318819147567700
TCGA-06-0644.16	142	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000004874860750290005900
TCGA-06-0879.9	84	1_KEGG_CELL_CYCLE	114	12	0.0000004880113369493627500
TCGA-19-2631.15	84	1_KEGG_CELL_CYCLE	114	12	0.0000004880113369493627500
TCGA-32-2495.11	67	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000004949644237284131100
TCGA-02-0026.1	61	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000004960299350432837600
TCGA-02-2486.9	141	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	10	0.0000005077316586942958500
TCGA-02-0003.9	227	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	20	9	0.0000005139076573972074200
TCGA-02-0003.9	227	2_INTERMEDIATE_FILAMENT	20	9	0.0000005139076573972074200
TCGA-02-2486.9	141	1_KEGG_ASTHMA	30	9	0.0000005264426866621999800
TCGA-06-0141.1	45	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0000005338493280076158600
TCGA-19-4068.2	11	1_KEGG_ALLOGRAFT_REJECTION	37	5	0.0000005339307708701927400
TCGA-14-1823.15	87	2_CELL_CELL_SIGNALING	353	19	0.0000005382651301504766000
TCGA-06-0195.8	56	1_KEGG_ASTHMA	30	7	0.0000005401264690139036300
TCGA-19-5951.10	138	0_HALLMARK_E2F_TARGETS	169	17	0.0000005473457231538124900
TCGA-19-5954.17	208	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	15	0.0000005481240103846302000
TCGA-02-0011.1	288	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	15	0.0000005494197801476362000
TCGA-14-0781.7	155	2_EXTRACELLULAR_REGION	346	25	0.0000005524878576311193800
TCGA-32-1986.8	87	0_HALLMARK_ANGIOGENESIS	32	8	0.0000005530419892342817900
TCGA-06-5856.13	152	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000005544370782644205700
TCGA-08-0345.2	77	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0000005558040215525268100
TCGA-06-0133.6	57	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0000005577526663906158200
TCGA-02-0084.1	25	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0000005590610647485889500
TCGA-08-0354.5	18	0_HALLMARK_E2F_TARGETS	169	8	0.0000005639617189809095400
TCGA-02-0052.3	116	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000005669832248469126200
TCGA-27-2519.7	113	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	10	0.0000005730642548287485700
TCGA-06-2569.5	144	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000005811755726776956500
TCGA-02-2485.14	172	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000005838967050111624600
TCGA-06-0154.13	76	1_KEGG_FOCAL_ADHESION	195	14	0.0000006034756262219647900
TCGA-06-0882.6	21	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0000006052098277315163000
TCGA-02-0060.19	281	1_KEGG_ALLOGRAFT_REJECTION	37	12	0.0000006114310703204546200
TCGA-06-5859.9	125	2_CELL_PROLIFERATION_GO_0008283	436	25	0.0000006186547389549774800
TCGA-27-1837.5	85	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000006296172884321135500
TCGA-06-0184.11	108	1_KEGG_MELANOMA	71	11	0.0000006339709946000573100
TCGA-28-2513.12	134	0_HALLMARK_ANGIOGENESIS	32	9	0.0000006373603821307109400
TCGA-32-1979.4	12	0_HALLMARK_E2F_TARGETS	169	7	0.0000006425303343705631700
TCGA-41-3393.4	12	0_HALLMARK_E2F_TARGETS	169	7	0.0000006425303343705631700
TCGA-27-1835.6	86	1_KEGG_CELL_CYCLE	114	12	0.0000006472320753558314600
TCGA-12-3650.17	101	2_CELL_CYCLE_PHASE	146	14	0.0000006477909952047827200
TCGA-28-5218.5	208	2_EXTRACELLULAR_MATRIX	85	15	0.0000006527980261290882000
TCGA-02-2486.9	141	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0000006534999079338884000
TCGA-02-2486.9	141	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	10	0.0000006579924208881490100
TCGA-28-1753.13	174	1_KEGG_FOCAL_ADHESION	195	20	0.0000006702765473058854200
TCGA-02-0113.4	9	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	6	0.0000006859617668116556500
TCGA-14-1034.9	9	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	6	0.0000006859617668116556500
TCGA-02-0054.2	9	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	6	0.0000006859617668116556500
TCGA-08-0360.3	144	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	21	0.0000006933721246673613700
TCGA-06-0127.3	5	1_KEGG_ASTHMA	30	4	0.0000006963963464443090100
TCGA-02-0038.3	199	2_INTRACELLULAR_ORGANELLE_PART	912	49	0.0000007014141581133581800
TCGA-02-0099.11	141	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	13	0.0000007019886328939603300
TCGA-06-5859.9	125	0_HALLMARK_ALLOGRAFT_REJECTION	190	17	0.0000007111212310422945700
TCGA-32-2494.10	173	0_HALLMARK_COMPLEMENT	176	19	0.0000007123337548801645200
TCGA-06-2557.11	177	1_KEGG_LEISHMANIA_INFECTION	70	13	0.0000007130053797064124800
TCGA-12-3650.17	101	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000007146604037368702300
TCGA-19-2629.15	146	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	10	0.0000007167754737977997200
TCGA-19-2629.15	146	1_KEGG_ASTHMA	30	9	0.0000007196350881312263400
TCGA-06-0174.37	141	2_CELL_CYCLE_PHASE	146	16	0.0000007230094275202690200
TCGA-08-0345.2	77	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000007238211167714576000
TCGA-06-0130.3	155	1_KEGG_CELL_CYCLE	114	15	0.0000007396876802608929000
TCGA-27-1835.6	86	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000007401200263546509200
TCGA-19-5947.4	267	2_EXTRACELLULAR_REGION_PART	269	29	0.0000007620318487323479500
TCGA-08-0350.2	46	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000007767067798118412000
TCGA-14-1823.12	6	2_CELL_CYCLE_GO_0007049	265	6	0.0000007784984083532479800
TCGA-06-0139.1	179	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	14	0.0000007790121165899119500
TCGA-06-0881.7	203	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	13	0.0000007887506005237789400
TCGA-41-3393.4	12	0_HALLMARK_G2M_CHECKPOINT	174	7	0.0000007890444898066865500
TCGA-02-0107.3	71	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000007935884817782301000
TCGA-27-1835.6	86	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000007986880745514355100
TCGA-41-4097.6	48	2_EXTRACELLULAR_REGION_PART	269	13	0.0000008103756325101920000
TCGA-02-2486.9	141	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	15	0.0000008112258026574440600
TCGA-76-6193.13	271	2_IMMUNE_SYSTEM_PROCESS	283	30	0.0000008128850279795699700
TCGA-12-0692.3	9	2_EXTRACELLULAR_REGION_PART	269	7	0.0000008137904804117657200
TCGA-02-0038.3	199	2_ORGANELLE_PART	916	49	0.0000008162034530878172500
TCGA-12-0619.11	123	0_HALLMARK_E2F_TARGETS	169	16	0.0000008212686059230318300
TCGA-32-4719.15	123	0_HALLMARK_E2F_TARGETS	169	16	0.0000008212686059230318300
TCGA-06-0645.9	136	0_HALLMARK_COMPLEMENT	176	17	0.0000008217557062261378500
TCGA-02-0014.10	70	2_DNA_METABOLIC_PROCESS	218	14	0.0000008332566333015846500
TCGA-06-5858.19	205	2_CELL_CYCLE_GO_0007049	265	25	0.0000008386940191848160500
TCGA-19-1390.13	110	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	36	0.0000008477485723386465900
TCGA-28-1753.13	174	2_CELL_CYCLE_GO_0007049	265	23	0.0000008582220476855914600
TCGA-06-2557.11	177	0_HALLMARK_G2M_CHECKPOINT	174	19	0.0000008676342939849377000
TCGA-27-1837.5	85	1_KEGG_VIRAL_MYOCARDITIS	70	10	0.0000008731551085505317700
TCGA-02-0115.1	36	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0000008795775327579365600
TCGA-19-5958.4	35	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000008820038096284692600
TCGA-27-2519.7	113	1_KEGG_VIRAL_MYOCARDITIS	70	11	0.0000008854964137852405600
TCGA-32-4211.14	71	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000008955194078322671900
TCGA-06-0879.9	84	1_KEGG_MELANOMA	71	10	0.0000008955194078322671900
TCGA-06-2561.5	42	1_KEGG_FOCAL_ADHESION	195	11	0.0000009039106940864425500
TCGA-06-0881.7	203	0_HALLMARK_INFLAMMATORY_RESPONSE	170	20	0.0000009054333208202007400
TCGA-16-0846.2	27	0_HALLMARK_E2F_TARGETS	169	9	0.0000009101739830146378400
TCGA-06-0178.2	17	1_KEGG_CELL_CYCLE	114	7	0.0000009201206864576569400
TCGA-06-0133.6	57	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0000009282009494861080900
TCGA-19-2629.15	146	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	10	0.0000009284505298392474400
TCGA-28-5214.11	124	0_HALLMARK_E2F_TARGETS	169	16	0.0000009284792713909712100
TCGA-28-5218.5	208	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	50	12	0.0000009290416568401004400
TCGA-06-0173.35	120	1_KEGG_PATHWAYS_IN_CANCER	323	21	0.0000009330982192404122100
TCGA-06-0881.7	203	2_EXTRACELLULAR_REGION_PART	269	25	0.0000009336237844826888500
TCGA-06-2565.10	38	2_CELL_CYCLE_PROCESS	163	10	0.0000009338656549199235200
TCGA-02-0026.1	61	2_NON_MEMBRANE_BOUND_ORGANELLE	476	18	0.0000009409408034928678900
TCGA-02-0026.1	61	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	18	0.0000009409408034928678900
TCGA-27-1837.5	85	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	9	0.0000009469914700111400400
TCGA-28-5216.8	162	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	50	11	0.0000009499780830403708800
TCGA-32-1980.1	24	1_KEGG_FOCAL_ADHESION	195	9	0.0000009558125704149861000
TCGA-02-0023.3	24	1_KEGG_FOCAL_ADHESION	195	9	0.0000009558125704149861000
TCGA-32-2638.17	159	1_KEGG_FOCAL_ADHESION	195	19	0.0000009656272304415352000
TCGA-08-0360.3	144	0_HALLMARK_COAGULATION	125	15	0.0000009762474324079960500
TCGA-19-2629.15	146	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0000009811844748574347600
TCGA-28-2509.6	59	2_DNA_METABOLIC_PROCESS	218	13	0.0000009854583026176658100
TCGA-27-2524.5	75	0_HALLMARK_E2F_TARGETS	169	13	0.0000009877225755116804600
TCGA-14-2554.5	59	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0000009925002531243423100
TCGA-76-6192.6	43	2_COLLAGEN	23	6	0.0000009958540106227829900
TCGA-08-0359.5	37	0_HALLMARK_E2F_TARGETS	169	10	0.0000009969043548655745600
TCGA-02-0009.6	188	2_EXTRACELLULAR_REGION_PART	269	24	0.0000009999728483481222100
TCGA-02-0028.9	182	1_KEGG_LEISHMANIA_INFECTION	70	13	0.0000010081581175161848000
TCGA-02-0003.9	227	1_KEGG_ALLOGRAFT_REJECTION	37	11	0.0000010087263507024144000
TCGA-02-0107.3	71	2_EXTRACELLULAR_MATRIX	85	10	0.0000010089383541896231000
TCGA-12-3652.19	88	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000010159405184989328000
TCGA-02-0068.1	72	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000010325295356101849000
TCGA-19-4068.2	11	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	5	0.0000010392214913276962000
TCGA-14-0787.7	14	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	8	0.0000010462628946281276000
TCGA-06-2565.10	38	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0000010489128575792130000
TCGA-02-0115.1	36	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0000010534976747090009000
TCGA-02-0114.20	132	2_REGULATION_OF_CELL_CYCLE	160	16	0.0000010552204129764295000
TCGA-19-5954.17	208	0_HALLMARK_APOPTOSIS	150	19	0.0000010615728628189222000
TCGA-19-4068.7	14	1_KEGG_DNA_REPLICATION	32	5	0.0000010640815036472880000
TCGA-06-0644.16	142	0_HALLMARK_ANGIOGENESIS	32	9	0.0000010719959163397401000
TCGA-02-0001.5	117	2_AXON	10	6	0.0000010807094562798009000
TCGA-27-1832.11	88	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000010961157222280808000
TCGA-06-0649.13	88	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000010961157222280808000
TCGA-41-3915.10	109	1_KEGG_FOCAL_ADHESION	195	16	0.0000010977438417453204000
TCGA-76-6191.6	96	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000010987150777016621000
TCGA-06-0645.9	136	2_EXTRACELLULAR_REGION	346	23	0.0000010988668634981150000
TCGA-32-2632.16	229	1_KEGG_ALLOGRAFT_REJECTION	37	11	0.0000011076250153471613000
TCGA-02-0038.3	199	2_CHROMOSOMAL_PART	78	14	0.0000011338949402522095000
TCGA-06-1804.6	30	2_CHROMOSOME	102	8	0.0000011361820945409458000
TCGA-06-5412.7	153	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	10	0.0000011375845643545155000
TCGA-26-5135.9	71	1_KEGG_CELL_CYCLE	114	11	0.0000011415057795232795000
TCGA-06-0141.1	45	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0000011493970711298409000
TCGA-14-1825.8	80	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000011543253526777153000
TCGA-08-0357.4	36	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000011613079815243156000
TCGA-19-2624.29	130	2_SPINDLE	35	9	0.0000011799259726783085000
TCGA-06-1804.6	30	2_DNA_METABOLIC_PROCESS	218	10	0.0000011810153653217590000
TCGA-06-5859.9	125	2_CHROMOSOME	102	13	0.0000011834852901075384000
TCGA-06-0157.7	89	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000011864686084430017000
TCGA-06-2558.6	74	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0000012088045929352062000
TCGA-06-2570.8	95	2_CELL_CYCLE_PROCESS	163	14	0.0000012188431358101006000
TCGA-14-0781.7	155	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	13	0.0000012500307400926754000
TCGA-19-1390.13	110	2_CELL_PROLIFERATION_GO_0008283	436	23	0.0000012614858239741047000
TCGA-19-5959.13	92	0_HALLMARK_E2F_TARGETS	169	14	0.0000012697608465652617000
TCGA-02-0115.1	36	2_EXTRACELLULAR_MATRIX	85	8	0.0000012785675471055378000
TCGA-32-1982.9	89	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000012799733395260197000
TCGA-27-2521.10	94	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000013154147516039650000
TCGA-02-0026.1	61	2_CHROMOSOME	102	10	0.0000013260494568135046000
TCGA-06-0141.1	45	2_COLLAGEN	23	6	0.0000013263805229460670000
TCGA-02-0085.1	45	2_COLLAGEN	23	6	0.0000013263805229460670000
TCGA-06-2565.10	38	0_HALLMARK_E2F_TARGETS	169	10	0.0000013322416856913081000
TCGA-06-5858.19	205	1_KEGG_DNA_REPLICATION	32	10	0.0000013361537896242876000
TCGA-06-0122.8	90	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	10	0.0000013393540358824593000
TCGA-06-0129.11	110	2_MICROTUBULE_CYTOSKELETON	117	13	0.0000013403714229584015000
TCGA-06-5413.11	142	0_HALLMARK_G2M_CHECKPOINT	174	17	0.0000013611942550903301000
TCGA-06-0141.1	45	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0000013744126942272494000
TCGA-32-4719.15	123	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000013801678243786048000
TCGA-32-1982.9	89	1_KEGG_LEISHMANIA_INFECTION	70	10	0.0000013862792824316149000
TCGA-06-0881.7	203	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	11	0.0000013885996773659796000
TCGA-26-5136.6	160	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000013893548334380003000
TCGA-32-2615.7	77	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	13	0.0000013898517086477909000
TCGA-02-0003.9	227	0_HALLMARK_ALLOGRAFT_REJECTION	190	22	0.0000014076496675070343000
TCGA-27-2524.5	75	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000014186497733958635000
TCGA-26-5133.10	75	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000014186497733958635000
TCGA-06-0187.10	55	2_SYNAPTIC_TRANSMISSION	152	11	0.0000014304562828048959000
TCGA-32-1982.9	89	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	9	0.0000014385790088172137000
TCGA-08-0359.5	37	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000014710645287492776000
TCGA-26-1439.10	84	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000014710645287492776000
TCGA-06-5412.7	153	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	10	0.0000014725289093205031000
TCGA-19-2624.29	130	2_CELL_PROLIFERATION_GO_0008283	436	25	0.0000014794946900367843000
TCGA-06-0187.10	55	2_CELL_CELL_SIGNALING	353	15	0.0000014815738402259637000
TCGA-06-0745.4	55	2_CELL_CELL_SIGNALING	353	15	0.0000014815738402259637000
TCGA-08-0360.3	144	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	16	0.0000014866262838234778000
TCGA-02-0033.5	144	0_HALLMARK_APOPTOSIS	150	16	0.0000014866262838234778000
TCGA-76-6193.13	271	2_IMMUNE_RESPONSE	206	25	0.0000014934630354662334000
TCGA-81-5910.12	128	0_HALLMARK_E2F_TARGETS	169	16	0.0000014992021679597600000
TCGA-14-4157.7	101	2_DNA_REPLICATION	82	11	0.0000015107762190978705000
TCGA-02-2483.10	100	2_DNA_METABOLIC_PROCESS	218	16	0.0000015266998889867027000
TCGA-02-2483.10	100	1_KEGG_SMALL_CELL_LUNG_CANCER	83	11	0.0000015491914503338013000
TCGA-02-0009.6	188	2_EXTRACELLULAR_REGION	346	27	0.0000015664227435469211000
TCGA-06-2557.11	177	1_KEGG_ALLOGRAFT_REJECTION	37	10	0.0000015695931890381725000
TCGA-76-4934.7	47	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000015700678979746354000
TCGA-02-0028.9	182	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	14	0.0000015737550645268563000
TCGA-06-0192.10	126	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0000015796722092863786000
TCGA-32-1977.11	107	0_HALLMARK_UV_RESPONSE_DN	122	13	0.0000015993682375562537000
TCGA-32-2491.14	244	1_KEGG_P53_SIGNALING_PATHWAY	66	14	0.0000016027634174617938000
TCGA-28-5216.8	162	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000016040995749422720000
TCGA-14-3476.4	7	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	5	0.0000016216650616897428000
TCGA-76-6191.6	96	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000016233878986790946000
TCGA-06-0877.8	61	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000016274968706322791000
TCGA-06-2565.10	38	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0000016351176213206201000
TCGA-02-0069.13	16	2_EXTRACELLULAR_REGION	346	9	0.0000016474677718494578000
TCGA-02-0046.8	148	0_HALLMARK_E2F_TARGETS	169	17	0.0000016562017028370966000
TCGA-32-1977.11	107	1_KEGG_ASTHMA	30	8	0.0000016712316797722946000
TCGA-06-0127.3	5	1_KEGG_ALLOGRAFT_REJECTION	37	4	0.0000016772911432171115000
TCGA-14-0781.7	155	2_EXTRACELLULAR_MATRIX	85	13	0.0000016974048688071025000
TCGA-02-0028.9	182	0_HALLMARK_COMPLEMENT	176	19	0.0000017026414082158935000
TCGA-06-0686.5	14	2_EXTRACELLULAR_REGION_PART	269	8	0.0000017044861734596893000
TCGA-28-5215.7	192	1_KEGG_CELL_CYCLE	114	16	0.0000017252267641487779000
TCGA-02-0026.1	61	2_NUCLEUS	1110	26	0.0000017294065579693296000
TCGA-32-1977.11	107	2_EXTRACELLULAR_REGION_PART	269	18	0.0000017308833454049119000
TCGA-32-1991.11	82	1_KEGG_FOCAL_ADHESION	195	14	0.0000017321299045592071000
TCGA-06-6390.9	82	1_KEGG_FOCAL_ADHESION	195	14	0.0000017321299045592071000
TCGA-06-1804.7	47	2_COLLAGEN	23	6	0.0000017431521203606226000
TCGA-02-0003.9	227	1_KEGG_ASTHMA	30	10	0.0000017536399552638190000
TCGA-02-0085.1	45	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0000017635874678299732000
TCGA-02-0085.1	45	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0000017635874678299732000
TCGA-02-0075.8	128	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000017658963890091950000
TCGA-19-2619.14	100	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000017671829757034274000
TCGA-06-0154.13	76	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000017860753989450353000
TCGA-19-5952.11	193	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	14	0.0000017868654733259360000
TCGA-19-5954.17	208	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	11	0.0000017992854303408754000
TCGA-06-0184.11	108	1_KEGG_ASTHMA	30	8	0.0000018011655822715517000
TCGA-15-0742.13	74	1_KEGG_CELL_CYCLE	114	11	0.0000018079369762062690000
TCGA-32-2634.10	118	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	9	0.0000018149054009206980000
TCGA-27-1837.5	85	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0000018187919419355273000
TCGA-08-0246.6	62	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0000018249767166812435000
TCGA-02-0043.10	184	1_KEGG_FOCAL_ADHESION	195	20	0.0000018251848804862068000
TCGA-02-0048.9	84	2_CELL_CYCLE_GO_0007049	265	16	0.0000018256446342601952000
TCGA-19-5947.4	267	1_KEGG_FOCAL_ADHESION	195	24	0.0000018308312293157444000
TCGA-14-3476.4	7	2_EXTRACELLULAR_MATRIX	85	5	0.0000018314199366585135000
TCGA-12-1597.6	51	0_HALLMARK_E2F_TARGETS	169	11	0.0000018763523949956752000
TCGA-32-2634.10	118	2_REPLICATION_FORK	18	7	0.0000019022603436915624000
TCGA-19-2624.29	130	2_CHROMOSOME	102	13	0.0000019343760788947119000
TCGA-06-0881.7	203	2_EXTRACELLULAR_REGION	346	28	0.0000019461690240898511000
TCGA-41-4097.6	48	2_COLLAGEN	23	6	0.0000019890918157180559000
TCGA-12-0692.6	11	1_KEGG_CELL_CYCLE	114	6	0.0000020097070625419020000
TCGA-02-2470.4	11	1_KEGG_CELL_CYCLE	114	6	0.0000020097070625419020000
TCGA-06-5858.19	205	1_KEGG_P53_SIGNALING_PATHWAY	66	13	0.0000020312395564347939000
TCGA-08-0345.2	77	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0000020379892119161675000
TCGA-06-0139.1	179	2_EXTRACELLULAR_REGION_PART	269	23	0.0000020384522784343212000
TCGA-06-0195.8	56	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	9	0.0000020423297893936529000
TCGA-19-5955.9	110	1_KEGG_ASTHMA	30	8	0.0000020875531419609427000
TCGA-02-0038.3	199	2_CELL_CYCLE_PROCESS	163	19	0.0000020941947246118057000
TCGA-76-6193.13	271	2_RESPONSE_TO_WOUNDING	163	22	0.0000021207098629199069000
TCGA-08-0345.2	77	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000021418404730365077000
TCGA-06-0877.7	4	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0000021610089566548806000
TCGA-08-0348.3	4	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0000021610089566548806000
TCGA-08-0245.4	85	2_CELL_CYCLE_GO_0007049	265	16	0.0000021930944898035946000
TCGA-19-5952.11	193	0_HALLMARK_APOPTOSIS	150	18	0.0000022166213629261059000
TCGA-28-5209.15	194	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000022541464456409045000
TCGA-06-0168.4	22	2_COLLAGEN	23	5	0.0000023258191702817373000
TCGA-02-0007.17	217	1_KEGG_DNA_REPLICATION	32	10	0.0000023287262392991397000
TCGA-06-0152.10	19	1_KEGG_CELL_CYCLE	114	7	0.0000023369336804905238000
TCGA-06-0645.9	136	2_EXTRACELLULAR_REGION_PART	269	20	0.0000023494568447256551000
TCGA-12-5299.5	6	1_KEGG_CELL_CYCLE	114	5	0.0000023524342982457800000
TCGA-06-5412.7	153	0_HALLMARK_ALLOGRAFT_REJECTION	190	18	0.0000023789063880861213000
TCGA-26-1439.11	10	2_CELL_CYCLE_GO_0007049	265	7	0.0000023831509431784003000
TCGA-28-5209.15	194	0_HALLMARK_APOPTOSIS	150	18	0.0000024105878576381671000
TCGA-76-6282.11	185	1_KEGG_ALLOGRAFT_REJECTION	37	10	0.0000024185583371876597000
TCGA-41-2572.8	76	1_KEGG_CELL_CYCLE	114	11	0.0000024278275089267067000
TCGA-08-0347.7	25	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0000024312941994943036000
TCGA-02-0114.20	132	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000024579758528259186000
TCGA-19-5952.11	193	2_EXTRACELLULAR_MATRIX	85	14	0.0000024768572205117368000
TCGA-12-0692.7	23	2_SYNAPTIC_TRANSMISSION	152	8	0.0000025202357047115182000
TCGA-06-0139.1	179	2_EXTRACELLULAR_REGION	346	26	0.0000025317321004607895000
TCGA-12-1597.6	51	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000025602934068390093000
TCGA-06-0127.3	5	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	4	0.0000025709979211826923000
TCGA-02-0113.3	46	1_KEGG_FOCAL_ADHESION	195	11	0.0000026212786132284097000
TCGA-41-5651.5	112	2_CELL_CYCLE_PHASE	146	14	0.0000026243247802175715000
TCGA-76-6192.6	43	2_EXTRACELLULAR_REGION_PART	269	12	0.0000026246010525057433000
TCGA-27-2527.6	79	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000026383816050508411000
TCGA-06-0195.8	56	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0000026458284086521089000
TCGA-28-1747.5	81	0_HALLMARK_E2F_TARGETS	169	13	0.0000026688426443434476000
TCGA-19-5954.17	208	1_KEGG_FOCAL_ADHESION	195	21	0.0000026710549197616823000
TCGA-14-0790.9	104	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000027046193740613020000
TCGA-26-5134.6	18	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0000027067471089554685000
TCGA-02-2486.9	141	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	10	0.0000027103711150634422000
TCGA-06-0241.8	53	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0000027391350482196113000
TCGA-06-0139.1	179	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	16	0.0000027683878540180056000
TCGA-06-5417.5	79	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000027743339644643310000
TCGA-12-3650.17	101	2_CELL_CYCLE_PROCESS	163	14	0.0000027975685020101847000
TCGA-02-0115.1	36	0_HALLMARK_ANGIOGENESIS	32	6	0.0000028172481071041787000
TCGA-19-2619.14	100	1_KEGG_FOCAL_ADHESION	195	15	0.0000028179585816437666000
TCGA-28-5215.7	192	2_NON_MEMBRANE_BOUND_ORGANELLE	476	32	0.0000028265896162841984000
TCGA-28-5215.7	192	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	32	0.0000028265896162841984000
TCGA-02-0014.10	70	2_REGULATION_OF_CELL_CYCLE	160	12	0.0000028323555158952548000
TCGA-06-0877.7	4	2_INTERPHASE	62	4	0.0000028413699800239502000
TCGA-08-0348.3	4	2_INTERPHASE	62	4	0.0000028413699800239502000
TCGA-06-0127.3	5	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	4	0.0000028413878104298748000
TCGA-32-4211.14	71	1_KEGG_FOCAL_ADHESION	195	13	0.0000028436485626589513000
TCGA-02-0046.8	148	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000028496632869994837000
TCGA-19-4068.2	11	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	5	0.0000028560483030091884000
TCGA-14-0787.6	40	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000028677991210919729000
TCGA-28-5215.7	192	2_EPIDERMIS_DEVELOPMENT	59	12	0.0000028880041795156412000
TCGA-19-5954.17	208	0_HALLMARK_COAGULATION	125	17	0.0000029021267704700775000
TCGA-76-6191.6	96	2_CELL_PROLIFERATION_GO_0008283	436	21	0.0000029317858103104977000
TCGA-06-5417.5	79	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000029773007641537408000
TCGA-06-6391.9	26	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0000030333936191031448000
TCGA-14-0787.6	40	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0000030797549805695131000
TCGA-19-1390.13	110	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	15	0.0000030971937807860704000
TCGA-19-5958.4	35	2_EXTRACELLULAR_REGION_PART	269	11	0.0000031266338494304737000
TCGA-19-2619.10	8	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0000031369134873509892000
TCGA-12-0692.7	23	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000031369134873509892000
TCGA-06-5412.1	28	0_HALLMARK_COAGULATION	125	8	0.0000031532766226430666000
TCGA-27-2523.12	112	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000031593900801513904000
TCGA-19-5960.9	134	2_CELL_CYCLE_PHASE	146	15	0.0000031798142920936905000
TCGA-02-0060.19	281	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	12	0.0000031950614442329629000
TCGA-02-2485.14	172	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000031984757158459209000
TCGA-06-0129.11	110	2_CHROMOSOME	102	12	0.0000032127486091291456000
TCGA-06-0187.10	55	2_TRANSMISSION_OF_NERVE_IMPULSE	164	11	0.0000032208681394138667000
TCGA-02-0038.3	199	2_DNA_DEPENDENT_DNA_REPLICATION	46	11	0.0000032514185890993039000
TCGA-06-5856.13	152	1_KEGG_FOCAL_ADHESION	195	18	0.0000032547348329006053000
TCGA-19-4068.7	14	0_HALLMARK_G2M_CHECKPOINT	174	7	0.0000033142595771393276000
TCGA-14-0789.10	106	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000033230943604024705000
TCGA-76-6285.5	106	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000033230943604024705000
TCGA-02-0038.3	199	2_CELL_PROLIFERATION_GO_0008283	436	31	0.0000033332797195116885000
TCGA-28-5216.8	162	2_STRUCTURAL_MOLECULE_ACTIVITY	206	19	0.0000033835679582720730000
TCGA-06-0650.2	82	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000034015572100648473000
TCGA-02-0102.8	82	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000034015572100648473000
TCGA-02-0068.1	72	1_KEGG_FOCAL_ADHESION	195	13	0.0000034080627368264305000
TCGA-02-0003.9	227	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	11	0.0000034249058380963574000
TCGA-06-0139.1	179	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	11	0.0000034599858139786161000
TCGA-06-0174.37	141	1_KEGG_PATHWAYS_IN_CANCER	323	22	0.0000034720074489916434000
TCGA-06-0126.7	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	5	0.0000034818092934545920000
TCGA-26-1439.10	84	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000035375225431243789000
TCGA-26-5139.10	163	2_NON_MEMBRANE_BOUND_ORGANELLE	476	29	0.0000035463808930644254000
TCGA-26-5139.10	163	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	29	0.0000035463808930644254000
TCGA-19-5950.7	113	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000035848733257596995000
TCGA-06-6391.9	26	2_EXTRACELLULAR_MATRIX	85	7	0.0000035933791602617637000
TCGA-02-0083.21	135	1_KEGG_FOCAL_ADHESION	195	17	0.0000036003483515566648000
TCGA-06-0141.1	45	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0000036723598813486365000
TCGA-02-0043.10	184	0_HALLMARK_COAGULATION	125	16	0.0000036834403147214617000
TCGA-14-0813.10	53	2_COLLAGEN	23	6	0.0000036924815856742482000
TCGA-08-0358.9	43	2_TRANSMISSION_OF_NERVE_IMPULSE	164	10	0.0000037332145461431025000
TCGA-32-1980.1	24	2_COLLAGEN	23	5	0.0000037420276684258902000
TCGA-08-0390.3	6	0_HALLMARK_COAGULATION	125	5	0.0000037545391988748486000
TCGA-32-2632.16	229	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	11	0.0000037577288369122693000
TCGA-19-5950.7	113	2_REGULATION_OF_PHOSPHORYLATION	45	9	0.0000037926799385754064000
TCGA-06-2557.11	177	0_HALLMARK_E2F_TARGETS	169	18	0.0000038186854793424672000
TCGA-14-1034.7	97	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000038254494456925650000
TCGA-41-3392.31	136	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0000038324044486582022000
TCGA-02-0102.8	82	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000038343777471147805000
TCGA-32-1980.1	24	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0000038583423804394678000
TCGA-06-2565.3	60	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000038723461668558524000
TCGA-27-1830.7	57	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0000038862488097421149000
TCGA-19-4068.7	14	0_HALLMARK_MYC_TARGETS_V1	178	7	0.0000038863864254231996000
TCGA-32-1986.8	87	1_KEGG_FOCAL_ADHESION	195	14	0.0000038926641843605655000
TCGA-76-6192.6	43	2_EXTRACELLULAR_REGION	346	13	0.0000038951474494358110000
TCGA-32-4208.28	140	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0000039326520716758001000
TCGA-19-1790.18	201	2_EXTRACELLULAR_REGION_PART	269	24	0.0000039610567695434109000
TCGA-41-5651.5	112	2_CHROMOSOME	102	12	0.0000039634148233515205000
TCGA-02-0114.20	132	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000039749054847984487000
TCGA-06-2557.11	177	1_KEGG_ASTHMA	30	9	0.0000039980274162025739000
TCGA-41-5651.5	112	0_HALLMARK_MYC_TARGETS_V1	178	15	0.0000040016704653316202000
TCGA-06-0686.1	7	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	6	0.0000040232038795346168000
TCGA-06-0650.2	82	2_GABA_RECEPTOR_ACTIVITY	8	5	0.0000040370397272058267000
TCGA-08-0359.5	37	1_KEGG_FOCAL_ADHESION	195	10	0.0000040395047187260711000
TCGA-76-6192.6	43	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000040905366676525239000
TCGA-12-0821.9	81	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000041005788542736695000
TCGA-06-0221.13	45	1_KEGG_CELL_CYCLE	114	9	0.0000041035432972316301000
TCGA-02-0099.11	141	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0000041894712219925218000
TCGA-76-6285.5	106	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000041949215895773526000
TCGA-06-0137.9	53	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000042177808423361715000
TCGA-06-0241.8	53	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000042177808423361715000
TCGA-06-0241.8	53	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000042821647475682426000
TCGA-06-0650.2	82	2_EXTRACELLULAR_MATRIX	85	10	0.0000043154094260874455000
TCGA-14-0817.9	85	2_DNA_REPLICATION	82	10	0.0000043154094260874455000
TCGA-02-0102.8	82	2_EXTRACELLULAR_MATRIX	85	10	0.0000043154094260874455000
TCGA-19-5954.17	208	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	13	0.0000043312653911086259000
TCGA-26-1439.10	84	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000043386054641353802000
TCGA-19-4068.6	42	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000043386054641353802000
TCGA-06-2561.5	42	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000043386054641353802000
TCGA-76-6193.13	271	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	16	0.0000043460564378379774000
TCGA-19-1390.13	110	1_KEGG_SMALL_CELL_LUNG_CANCER	83	11	0.0000043460751023504229000
TCGA-06-0139.1	179	1_KEGG_ASTHMA	30	9	0.0000044159064688050232000
TCGA-02-0014.10	70	1_KEGG_DNA_REPLICATION	32	7	0.0000044274734484536952000
TCGA-02-0099.11	141	2_EXTRACELLULAR_REGION_PART	269	20	0.0000044958453272581638000
TCGA-06-0877.8	61	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000045100405112792161000
TCGA-19-5951.10	138	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0000045353414916858996000
TCGA-02-0003.9	227	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	11	0.0000045430115821754267000
TCGA-06-0241.8	53	1_KEGG_BLADDER_CANCER	42	7	0.0000045485422488530059000
TCGA-02-0007.17	217	2_NON_MEMBRANE_BOUND_ORGANELLE	476	34	0.0000045795853916932806000
TCGA-02-0007.17	217	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	34	0.0000045795853916932806000
TCGA-12-0692.7	23	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0000046135716711015504000
TCGA-41-5651.5	112	2_DNA_REPLICATION	82	11	0.0000046210069366795754000
TCGA-02-0043.10	184	2_EXTRACELLULAR_MATRIX_PART	51	11	0.0000046334630747870311000
TCGA-02-0003.9	227	0_HALLMARK_APOPTOSIS	150	19	0.0000046550727771342644000
TCGA-02-0085.1	45	2_EXTRACELLULAR_REGION_PART	269	12	0.0000046772798418450688000
TCGA-32-2634.10	118	2_CHROMOSOMAL_PART	78	11	0.0000046810906051470801000
TCGA-06-2557.11	177	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	10	0.0000047348362403317135000
TCGA-06-0645.9	136	0_HALLMARK_KRAS_SIGNALING_UP	148	15	0.0000047363743709491505000
TCGA-19-2625.9	146	2_REGULATION_OF_CELL_CYCLE	160	16	0.0000047453730633874478000
TCGA-12-0692.3	9	2_EXTRACELLULAR_REGION	346	7	0.0000047540165522644484000
TCGA-02-0021.4	170	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	12	0.0000047785621904994214000
TCGA-14-1825.8	80	2_CELL_CYCLE_PHASE	146	12	0.0000048688840748685100000
TCGA-26-1439.10	84	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0000048783026542909135000
TCGA-76-6192.6	43	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0000048841395034381517000
TCGA-27-2518.5	20	1_KEGG_FOCAL_ADHESION	195	8	0.0000049125553747945367000
TCGA-02-0080.3	20	1_KEGG_FOCAL_ADHESION	195	8	0.0000049125553747945367000
TCGA-28-6450.11	139	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0000049286799842950133000
TCGA-06-0127.3	5	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	4	0.0000049369724625534553000
TCGA-27-1837.5	85	0_HALLMARK_E2F_TARGETS	169	13	0.0000049371153251355720000
TCGA-08-0358.9	43	2_CELL_CELL_SIGNALING	353	13	0.0000049699242973591589000
TCGA-32-2632.16	229	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	11	0.0000049835067744093295000
TCGA-27-2528.10	99	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000050345661406730977000
TCGA-06-0139.1	179	0_HALLMARK_INFLAMMATORY_RESPONSE	170	18	0.0000050387608687492378000
TCGA-32-2491.14	244	1_KEGG_ECM_RECEPTOR_INTERACTION	84	15	0.0000050511796299859190000
TCGA-08-0360.3	144	2_RESPONSE_TO_WOUNDING	163	16	0.0000050856287468879243000
TCGA-02-2486.9	141	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	10	0.0000050970738729605235000
TCGA-02-0083.21	135	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000051011021432198796000
TCGA-28-6450.11	139	0_HALLMARK_E2F_TARGETS	169	16	0.0000051268556038840517000
TCGA-06-0214.9	62	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000052381265110891833000
TCGA-27-1833.7	17	2_CELL_CYCLE_PHASE	146	7	0.0000052616263369696058000
TCGA-32-2634.10	118	2_CELL_CYCLE_PHASE	146	14	0.0000052653022281598684000
TCGA-02-0064.3	26	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000052906979753562400000
TCGA-06-5415.7	7	2_CELL_CYCLE_GO_0007049	265	6	0.0000053213606518873984000
TCGA-14-1823.12	6	2_MITOTIC_CELL_CYCLE	134	5	0.0000053403643149918210000
TCGA-06-0644.16	142	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000053633538205975419000
TCGA-32-2632.16	229	0_HALLMARK_APOPTOSIS	150	19	0.0000053906232139075237000
TCGA-06-0195.8	56	2_CELL_CYCLE_GO_0007049	265	13	0.0000053974308304625643000
TCGA-06-0140.2	25	2_SYNAPTIC_TRANSMISSION	152	8	0.0000054097879558416288000
TCGA-06-0126.8	15	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	7	0.0000054173295508437817000
TCGA-06-0881.7	203	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	19	0.0000054210786812786016000
TCGA-06-0644.16	142	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0000054697682785963629000
TCGA-27-1837.5	85	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0000054892344323307717000
TCGA-02-0011.1	288	0_HALLMARK_COMPLEMENT	176	23	0.0000055056608011306303000
TCGA-06-0646.4	63	1_KEGG_CELL_CYCLE	114	10	0.0000055456050487450574000
TCGA-12-0616.1	20	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0000055900703141882240000
TCGA-08-0380.4	6	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	4	0.0000056071852293288258000
TCGA-02-0107.3	71	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000056454963416275461000
TCGA-32-2494.10	173	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000056592755009754777000
TCGA-06-0195.8	56	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0000056733157379310808000
TCGA-28-6450.11	139	1_KEGG_FOCAL_ADHESION	195	17	0.0000056785870742247878000
TCGA-06-0644.16	142	0_HALLMARK_UV_RESPONSE_DN	122	14	0.0000056860129046390284000
TCGA-32-2634.10	118	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0000056866352093117285000
TCGA-32-2634.10	118	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0000056866352093117285000
TCGA-41-3392.31	136	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000056896912395576967000
TCGA-28-5218.5	208	2_NON_MEMBRANE_BOUND_ORGANELLE	476	33	0.0000057132321026937094000
TCGA-28-5218.5	208	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	33	0.0000057132321026937094000
TCGA-06-0141.1	45	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0000057135655170246749000
TCGA-06-2561.5	42	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	8	0.0000057594234144670860000
TCGA-08-0353.8	100	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000057613163173249354000
TCGA-06-0125.9	75	1_KEGG_FOCAL_ADHESION	195	13	0.0000057637432313523837000
TCGA-19-1790.18	201	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	14	0.0000057774464487510081000
TCGA-28-5215.7	192	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	50	11	0.0000057987374006986415000
TCGA-06-0645.9	136	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	12	0.0000057991921516935441000
TCGA-27-1830.7	57	2_COLLAGEN	23	6	0.0000058005522324711023000
TCGA-06-5859.9	125	1_KEGG_ASTHMA	30	8	0.0000058079968288915607000
TCGA-02-0009.6	188	2_EXTRACELLULAR_MATRIX_PART	51	11	0.0000058166314923173195000
TCGA-12-0692.7	23	2_CELL_CELL_SIGNALING	353	10	0.0000058537098981476299000
TCGA-06-5411.4	23	0_HALLMARK_E2F_TARGETS	169	8	0.0000058551085094232517000
TCGA-19-5954.17	208	2_CELL_CYCLE_GO_0007049	265	24	0.0000058736089804783237000
TCGA-32-1979.10	116	0_HALLMARK_COAGULATION	125	13	0.0000059584442585746549000
TCGA-06-5859.9	125	2_DNA_METABOLIC_PROCESS	218	17	0.0000059611900464159612000
TCGA-27-2523.12	112	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000060098009008944642000
TCGA-06-0143.6	63	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000060673973363177748000
TCGA-32-4210.14	109	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000060900079674899212000
TCGA-06-2557.11	177	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	10	0.0000061146466247808860000
TCGA-06-0122.8	90	1_KEGG_FOCAL_ADHESION	195	14	0.0000061616251429034660000
TCGA-32-2494.10	173	0_HALLMARK_ANGIOGENESIS	32	9	0.0000062030902180611666000
TCGA-26-5132.7	100	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000062085280254114143000
TCGA-02-0058.1	110	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000062550279039115840000
TCGA-19-1390.13	110	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000062550279039115840000
TCGA-32-2632.16	229	2_REPLICATION_FORK	18	8	0.0000063277321661197743000
TCGA-02-0099.11	141	0_HALLMARK_E2F_TARGETS	169	16	0.0000063304881072767985000
TCGA-02-2486.9	141	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	16	0.0000063304881072767985000
TCGA-06-0127.3	5	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	4	0.0000063389593645694791000
TCGA-06-2569.5	144	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0000064228171378983059000
TCGA-02-0028.9	182	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	17	0.0000064269394709742104000
TCGA-32-2638.17	159	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	16	0.0000064441639166128597000
TCGA-19-2629.15	146	2_CELL_CYCLE_GO_0007049	265	20	0.0000064511661849638950000
TCGA-19-2625.9	146	2_CELL_CYCLE_GO_0007049	265	20	0.0000064511661849638950000
TCGA-28-2502.9	56	2_EXTRACELLULAR_REGION_PART	269	13	0.0000064747387571990747000
TCGA-06-0645.9	136	1_KEGG_LEISHMANIA_INFECTION	70	11	0.0000064922532399747612000
TCGA-08-0389.4	56	2_DNA_METABOLIC_PROCESS	218	12	0.0000064957168424346603000
TCGA-06-0881.7	203	0_HALLMARK_ALLOGRAFT_REJECTION	190	20	0.0000065261673430077208000
TCGA-06-6391.9	26	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0000065459784504887686000
TCGA-08-0360.3	144	0_HALLMARK_ALLOGRAFT_REJECTION	190	17	0.0000066032503458487445000
TCGA-26-5139.10	163	2_EPIDERMIS_DEVELOPMENT	59	11	0.0000066513244309807541000
TCGA-14-0790.9	104	0_HALLMARK_E2F_TARGETS	169	14	0.0000066547517144343240000
TCGA-06-2557.11	177	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000067116602959561572000
TCGA-06-0195.8	56	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0000067770399231100285000
TCGA-76-4929.8	91	2_GABA_RECEPTOR_ACTIVITY	8	5	0.0000068641433790871673000
TCGA-32-2634.10	118	2_DNA_DEPENDENT_DNA_REPLICATION	46	9	0.0000068683448157492942000
TCGA-02-0010.18	184	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000069163253612232704000
TCGA-32-1986.8	87	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000069182399804004931000
TCGA-27-2519.7	113	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0000069664731147552584000
TCGA-06-0644.16	142	0_HALLMARK_E2F_TARGETS	169	16	0.0000070248976270287638000
TCGA-06-5413.11	142	0_HALLMARK_E2F_TARGETS	169	16	0.0000070248976270287638000
TCGA-06-0744.10	36	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0000070441029489266728000
TCGA-06-0174.37	141	1_KEGG_FOCAL_ADHESION	195	17	0.0000070887099092220936000
TCGA-02-0024.6	206	2_MICROTUBULE_CYTOSKELETON	117	16	0.0000071337750847212842000
TCGA-19-2629.15	146	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	10	0.0000071607920811518134000
TCGA-28-5216.8	162	2_CELL_CYCLE_GO_0007049	265	21	0.0000071900659811535638000
TCGA-08-0345.2	77	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0000072377463150948505000
TCGA-06-0644.16	142	2_EXTRACELLULAR_MATRIX	85	12	0.0000072423895716808822000
TCGA-27-2524.5	75	0_HALLMARK_ANGIOGENESIS	32	7	0.0000072457923199582441000
TCGA-19-1390.13	110	2_MITOTIC_CELL_CYCLE	134	13	0.0000072672269906955753000
TCGA-76-6282.11	185	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	10	0.0000072731272317207887000
TCGA-02-0085.1	45	2_EXTRACELLULAR_REGION	346	13	0.0000072746499947963792000
TCGA-06-2557.11	177	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	13	0.0000074844804798409327000
TCGA-08-0345.2	77	0_HALLMARK_COAGULATION	125	11	0.0000075258097998367327000
TCGA-41-2575.49	136	2_MITOSIS	71	11	0.0000075891822897224468000
TCGA-02-2485.14	172	1_KEGG_MELANOMA	71	12	0.0000076873233723120306000
TCGA-06-2569.5	144	2_REPLICATION_FORK	18	7	0.0000077169151129132425000
TCGA-06-0127.2	23	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	8	0.0000077189238658789165000
TCGA-06-0173.35	120	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000077359572885573445000
TCGA-06-0649.13	88	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000077494124214700981000
TCGA-32-4209.2	56	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000078522155208938598000
TCGA-06-1804.7	47	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000078538963328114950000
TCGA-12-3653.55	255	1_KEGG_MELANOMA	71	14	0.0000078613130916270210000
TCGA-06-0155.10	74	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000079004399417815257000
TCGA-19-1390.13	110	1_KEGG_PATHWAYS_IN_CANCER	323	19	0.0000079317857017156528000
TCGA-14-0787.7	14	2_RECEPTOR_ACTIVITY	499	9	0.0000079529187501797685000
TCGA-06-1804.7	47	2_EXTRACELLULAR_REGION_PART	269	12	0.0000080767044004641190000
TCGA-06-5414.13	102	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000080897931753069643000
TCGA-32-4208.28	140	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	12	0.0000080898520693592427000
TCGA-06-5415.7	7	1_KEGG_CELL_CYCLE	114	5	0.0000081543356433654217000
TCGA-32-2491.14	244	2_NON_MEMBRANE_BOUND_ORGANELLE	476	36	0.0000081628281571109363000
TCGA-32-2491.14	244	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	36	0.0000081628281571109363000
TCGA-76-6282.11	185	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	17	0.0000082544148687640740000
TCGA-02-0054.2	9	0_HALLMARK_ALLOGRAFT_REJECTION	190	6	0.0000082561039389499289000
TCGA-27-1831.9	85	1_KEGG_CELL_CYCLE	114	11	0.0000082605628450929110000
TCGA-19-5959.13	92	1_KEGG_FOCAL_ADHESION	195	14	0.0000082838501579421462000
TCGA-06-2569.5	144	2_EXTRACELLULAR_MATRIX	85	12	0.0000085009463235436001000
TCGA-06-0139.1	179	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000085840370535624459000
TCGA-06-5412.7	153	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0000086376134495753091000
TCGA-08-0359.5	37	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0000086402137367285031000
TCGA-19-2629.15	146	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	12	0.0000086617034117118975000
TCGA-32-1982.9	89	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000086679555369683725000
TCGA-32-1982.9	89	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0000086679555369683725000
TCGA-76-6192.6	43	0_HALLMARK_ANGIOGENESIS	32	6	0.0000086729287322823509000
TCGA-32-2615.7	77	0_HALLMARK_ANGIOGENESIS	32	7	0.0000087381673112795498000
TCGA-02-0071.12	116	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000087482284246493229000
TCGA-26-5135.9	71	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000087690384711683746000
TCGA-76-4931.10	86	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000087730502431006435000
TCGA-32-4208.28	140	1_KEGG_LEISHMANIA_INFECTION	70	11	0.0000088330292081933980000
TCGA-41-2575.49	136	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	11	0.0000088489160249462110000
TCGA-06-2557.11	177	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0000089950012115648648000
TCGA-41-5651.5	112	2_MITOTIC_CELL_CYCLE	134	13	0.0000090909723083981383000
TCGA-14-0786.4	62	2_CELL_CELL_SIGNALING	353	15	0.0000091256342075529732000
TCGA-14-0871.20	216	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0000091324453301936638000
TCGA-14-1034.7	97	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000091394957698087256000
TCGA-26-5139.10	163	2_CYTOSKELETON	293	22	0.0000091482755322992516000
TCGA-41-4097.6	48	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000091572675806452436000
TCGA-06-0210.6	103	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000092129578163908701000
TCGA-19-5947.4	267	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	27	0.0000092795210502453361000
TCGA-06-0188.11	66	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000092865154168219819000
TCGA-12-0616.4	7	2_MICROTUBULE_CYTOSKELETON	117	5	0.0000093017448703004796000
TCGA-76-6282.11	185	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	10	0.0000093853281603488677000
TCGA-06-2558.6	74	2_CHROMOSOME	102	10	0.0000094085767800266452000
TCGA-28-1753.13	174	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	13	0.0000094653136933204091000
TCGA-32-4208.28	140	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000094801408910536937000
TCGA-06-0122.8	90	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000096817549301175165000
TCGA-02-0099.11	141	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0000096827838787799844000
TCGA-06-0138.2	30	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000096852722412992600000
TCGA-06-0197.1	57	2_APOPTOSIS_GO	389	15	0.0000096980742700359858000
TCGA-06-5411.4	23	1_KEGG_GLIOMA	62	6	0.0000097506594212092533000
TCGA-06-0219.2	4	1_KEGG_ECM_RECEPTOR_INTERACTION	84	4	0.0000098278665540048264000
TCGA-02-0033.1	4	1_KEGG_ECM_RECEPTOR_INTERACTION	84	4	0.0000098278665540048264000
TCGA-06-0140.2	25	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0000098806409220924019000
TCGA-26-1439.10	84	1_KEGG_ASTHMA	30	7	0.0000099346640551005061000
TCGA-26-1439.11	10	0_HALLMARK_E2F_TARGETS	169	6	0.0000100280394380069230000
TCGA-14-0786.2	10	0_HALLMARK_E2F_TARGETS	169	6	0.0000100280394380069230000
TCGA-06-0197.1	57	2_PROGRAMMED_CELL_DEATH	390	15	0.0000100425789437509160000
TCGA-08-0350.2	46	0_HALLMARK_E2F_TARGETS	169	10	0.0000101550015011403750000
TCGA-06-0139.1	179	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0000102201280638623390000
TCGA-41-2575.49	136	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	9	0.0000102472830902086470000
TCGA-06-2570.8	95	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000102698074811478930000
TCGA-02-0085.1	45	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	8	0.0000102851961661538220000
TCGA-06-0197.1	57	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	15	0.0000103982540475450610000
TCGA-14-0790.9	104	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000104762118899445020000
TCGA-06-0189.3	118	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000104975520509850010000
TCGA-02-0074.5	118	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000104975520509850010000
TCGA-06-0174.37	141	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000105231562690575770000
TCGA-32-4208.28	140	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0000105325755590924430000
TCGA-06-0877.7	4	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0000105761694503922050000
TCGA-08-0348.3	4	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0000105761694503922050000
TCGA-28-2509.6	59	2_CELL_CYCLE_GO_0007049	265	13	0.0000107215856862534390000
TCGA-19-2624.29	130	2_MICROTUBULE_CYTOSKELETON	117	13	0.0000107547263949362250000
TCGA-06-0143.6	63	2_COLLAGEN	23	6	0.0000107603567747189480000
TCGA-19-1390.12	10	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	6	0.0000107649834830737090000
TCGA-02-0089.5	91	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000107992911517690840000
TCGA-06-0744.3	12	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	7	0.0000108549442273673910000
TCGA-08-0345.2	77	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0000108963921300287080000
TCGA-12-0619.11	123	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000109303052847844570000
TCGA-06-2563.10	123	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000109303052847844570000
TCGA-06-5418.5	13	0_HALLMARK_UV_RESPONSE_DN	122	6	0.0000110363441885344450000
TCGA-06-0184.11	108	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000111202818244348440000
TCGA-41-5651.5	112	2_CELL_CYCLE_PROCESS	163	14	0.0000111236904421173640000
TCGA-08-0375.6	65	1_KEGG_FOCAL_ADHESION	195	12	0.0000111360288297793800000
TCGA-76-4934.7	47	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000111512061757893680000
TCGA-27-2519.7	113	0_HALLMARK_ALLOGRAFT_REJECTION	190	15	0.0000111575283639025790000
TCGA-28-5215.7	192	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000112158536619060870000
TCGA-02-0099.11	141	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0000112160876432101190000
TCGA-06-5859.9	125	2_CELL_CYCLE_PHASE	146	14	0.0000112714102529162240000
TCGA-19-2623.11	153	2_EXTRACELLULAR_MATRIX_PART	51	10	0.0000112877871898443760000
TCGA-19-5955.9	110	1_KEGG_LEISHMANIA_INFECTION	70	10	0.0000113143148801595430000
TCGA-06-0645.9	136	1_KEGG_ASTHMA	30	8	0.0000113566779384444020000
TCGA-27-1833.7	17	2_CELL_CYCLE_PROCESS	163	7	0.0000113694930248595390000
TCGA-02-0043.10	184	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	8	0.0000114734273768737030000
TCGA-06-2557.11	177	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	13	0.0000116546391841178430000
TCGA-02-2483.10	100	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000116616487878869000000
TCGA-76-4929.8	91	0_HALLMARK_E2F_TARGETS	169	13	0.0000116755912871952210000
TCGA-19-5947.4	267	1_KEGG_LEISHMANIA_INFECTION	70	14	0.0000116927041233947010000
TCGA-26-1439.10	84	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	12	0.0000117928801598154800000
TCGA-41-3915.10	109	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000119681271453873100000
TCGA-02-0001.5	117	2_ENZYME_REGULATOR_ACTIVITY	277	18	0.0000121942497027387980000
TCGA-28-5208.28	220	2_TRANSMISSION_OF_NERVE_IMPULSE	164	19	0.0000124873256168274360000
TCGA-06-0686.5	14	2_EXTRACELLULAR_REGION	346	8	0.0000125027070548342010000
TCGA-19-2629.15	146	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	14	0.0000125141132589215140000
TCGA-06-0876.9	106	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0000125225321821292920000
TCGA-76-4935.7	15	2_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0000125236115635470900000
TCGA-76-4935.7	15	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0000125236115635470900000
TCGA-02-0026.1	61	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0000125427434588309720000
TCGA-06-0133.6	57	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0000126014477351506060000
TCGA-06-0133.6	57	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0000126014477351506060000
TCGA-06-0176.8	95	1_KEGG_FOCAL_ADHESION	195	14	0.0000127292867407897660000
TCGA-41-2573.4	31	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0000127407442468885980000
TCGA-32-1979.10	116	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	11	0.0000127900581406572480000
TCGA-14-0781.7	155	2_EXTRACELLULAR_MATRIX_PART	51	10	0.0000128015541802678460000
TCGA-19-2623.11	153	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0000128404895885767020000
TCGA-12-3653.55	255	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	13	0.0000128516873843401850000
TCGA-06-0881.7	203	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	11	0.0000130450343517577760000
TCGA-06-0145.4	7	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	4	0.0000130457525722702740000
TCGA-06-0137.9	53	1_KEGG_FOCAL_ADHESION	195	11	0.0000132029968044276270000
TCGA-32-4208.28	140	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0000132378505581213850000
TCGA-14-1034.7	97	2_REGULATION_OF_CELL_CYCLE	160	13	0.0000133220807235623060000
TCGA-06-0188.11	66	1_KEGG_FOCAL_ADHESION	195	12	0.0000133672760450439430000
TCGA-06-0881.7	203	1_KEGG_ASTHMA	30	9	0.0000133743025248470240000
TCGA-12-0688.10	93	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000133826886584808280000
TCGA-19-2631.1	6	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0000134541669570486570000
TCGA-41-3915.10	109	2_CELL_CYCLE_GO_0007049	265	17	0.0000134610613907802480000
TCGA-06-2567.9	156	2_REPLICATION_FORK	18	7	0.0000135027057065662130000
TCGA-06-0157.7	89	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000135046233060459980000
TCGA-27-1837.5	85	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	12	0.0000135459204362427270000
TCGA-12-3649.15	89	1_KEGG_CELL_CYCLE	114	11	0.0000135813185653992590000
TCGA-06-2570.8	95	2_MITOTIC_CELL_CYCLE	134	12	0.0000136854694842739820000
TCGA-06-0877.7	4	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0000137479277349670470000
TCGA-08-0348.3	4	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0000137479277349670470000
TCGA-41-3393.5	88	1_KEGG_ASTHMA	30	7	0.0000138054750970141950000
TCGA-06-0649.13	88	1_KEGG_ASTHMA	30	7	0.0000138054750970141950000
TCGA-02-0099.11	141	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0000140955681583869370000
TCGA-32-4208.28	140	1_KEGG_ASTHMA	30	8	0.0000142883090099584640000
TCGA-06-5411.4	23	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0000143223212414943170000
TCGA-76-6191.6	96	2_DNA_REPLICATION	82	10	0.0000144064649003589520000
TCGA-06-2567.9	156	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000145094481333152270000
TCGA-19-5947.4	267	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	15	0.0000145420585970674300000
TCGA-19-4068.2	11	1_KEGG_VIRAL_MYOCARDITIS	70	5	0.0000145672113079965420000
TCGA-19-5960.9	134	2_CELL_CYCLE_PROCESS	163	15	0.0000146647341604642680000
TCGA-06-0744.4	11	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0000147170090595288040000
TCGA-12-3653.55	255	2_REPLICATION_FORK	18	8	0.0000147763334618686450000
TCGA-87-5896.6	131	1_KEGG_DNA_REPLICATION	32	8	0.0000148106005755786780000
TCGA-76-6282.11	185	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0000148497873469711350000
TCGA-06-1804.6	30	2_NON_MEMBRANE_BOUND_ORGANELLE	476	12	0.0000148551417193129420000
TCGA-06-1804.6	30	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	12	0.0000148551417193129420000
TCGA-27-2521.10	94	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000148688179650067430000
TCGA-02-0075.8	128	0_HALLMARK_UV_RESPONSE_DN	122	13	0.0000148903988774072660000
TCGA-06-5858.19	205	2_NON_MEMBRANE_BOUND_ORGANELLE	476	32	0.0000149683549103243500000
TCGA-06-5858.19	205	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	32	0.0000149683549103243500000
TCGA-32-1979.4	12	2_CELL_CYCLE_GO_0007049	265	7	0.0000149863502458863320000
TCGA-28-2501.3	51	2_STRUCTURAL_MOLECULE_ACTIVITY	206	11	0.0000152111697176153010000
TCGA-19-2629.15	146	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	15	0.0000152978749474719490000
TCGA-06-0189.3	118	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	11	0.0000153386054499645210000
TCGA-28-2514.9	62	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000155488449611236400000
TCGA-27-2523.12	112	1_KEGG_MELANOMA	71	10	0.0000155534865700295190000
TCGA-06-0881.7	203	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	23	0.0000155754197501470170000
TCGA-06-0140.2	25	2_CELL_CELL_SIGNALING	353	10	0.0000156408562311362480000
TCGA-02-0028.9	182	2_AXON	10	6	0.0000156695345217941250000
TCGA-06-5415.3	8	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	6	0.0000157321117026843480000
TCGA-06-0221.4	8	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	6	0.0000157321117026843480000
TCGA-06-0744.10	36	1_KEGG_BLADDER_CANCER	42	6	0.0000158693464658523800000
TCGA-19-5950.7	113	1_KEGG_FOCAL_ADHESION	195	15	0.0000159146188626409530000
TCGA-08-0357.4	36	0_HALLMARK_E2F_TARGETS	169	9	0.0000159232674243116750000
TCGA-06-5413.11	142	1_KEGG_ASTHMA	30	8	0.0000159850552530360880000
TCGA-06-2565.10	38	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0000160276388718845920000
TCGA-12-5299.5	6	2_CELL_CYCLE_ARREST_GO_0007050	49	4	0.0000160646048090857120000
TCGA-19-2625.9	146	1_KEGG_MELANOMA	71	11	0.0000160785562454272290000
TCGA-26-5136.6	160	2_REPLICATION_FORK	18	7	0.0000161101117394870310000
TCGA-12-3650.17	101	2_CHROMOSOME	102	11	0.0000161182250368258070000
TCGA-06-2559.11	101	2_CHROMOSOME	102	11	0.0000161182250368258070000
TCGA-06-5415.7	7	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0000161436537986494570000
TCGA-32-4211.14	71	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0000161900904575125060000
TCGA-12-0619.11	123	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000163137804491124220000
TCGA-14-1034.7	97	2_CELL_CYCLE_GO_0007049	265	16	0.0000163438511306788210000
TCGA-28-5215.7	192	2_TISSUE_DEVELOPMENT	115	15	0.0000164569474683428940000
TCGA-06-0176.8	95	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000164993004470758270000
TCGA-08-0380.5	47	2_CELL_CELL_SIGNALING	353	13	0.0000166884238773504050000
TCGA-02-0010.18	184	2_AXON	10	6	0.0000167344512698869260000
TCGA-19-5954.17	208	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	11	0.0000168285465490981570000
TCGA-28-5218.5	208	2_EXTRACELLULAR_MATRIX_PART	51	11	0.0000168285465490981570000
TCGA-02-0024.6	206	2_NON_MEMBRANE_BOUND_ORGANELLE	476	32	0.0000169045932748299450000
TCGA-02-0024.6	206	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	32	0.0000169045932748299450000
TCGA-19-2623.11	153	2_EXTRACELLULAR_MATRIX	85	12	0.0000169649569756253670000
TCGA-14-1825.8	80	2_CELL_CYCLE_PROCESS	163	12	0.0000171132994181023020000
TCGA-06-5411.3	19	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	6	0.0000172300523339083310000
TCGA-41-4097.6	48	0_HALLMARK_ANGIOGENESIS	32	6	0.0000172522859225261100000
TCGA-06-0184.11	108	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000172632903185168230000
TCGA-02-0003.9	227	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	14	0.0000173057056608048250000
TCGA-41-4097.6	48	2_EXTRACELLULAR_REGION	346	13	0.0000174004822129067130000
TCGA-19-2629.15	146	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0000175002426820883990000
TCGA-02-2483.10	100	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0000175892440117574730000
TCGA-06-2565.10	38	2_MITOSIS	71	7	0.0000177294232756024470000
TCGA-08-0354.7	47	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0000177873107019476070000
TCGA-02-0024.6	206	2_REGULATION_OF_CELL_CYCLE	160	18	0.0000179231252288004610000
TCGA-14-0789.10	106	2_CELL_CELL_SIGNALING	353	19	0.0000179731942901439050000
TCGA-06-0195.8	56	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0000179971864759703500000
TCGA-06-0645.9	136	2_RESPONSE_TO_WOUNDING	163	15	0.0000179993254483535100000
TCGA-26-5135.9	71	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000180254389834722440000
TCGA-06-0650.2	82	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000180847621122237060000
TCGA-02-0102.8	82	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000180847621122237060000
TCGA-02-0026.1	61	2_DNA_METABOLIC_PROCESS	218	12	0.0000183070439179860890000
TCGA-02-0068.1	72	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0000183722330538363200000
TCGA-32-1979.4	12	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0000183795761374016600000
TCGA-06-2567.9	156	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0000184163664035224500000
TCGA-06-2563.10	123	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000186433835470053140000
TCGA-14-0813.10	53	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000187826428533347300000
TCGA-06-0152.11	56	2_CELL_CELL_SIGNALING	353	14	0.0000188420636590739260000
TCGA-06-5859.9	125	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0000189497862360620730000
TCGA-06-5859.9	125	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0000189497862360620730000
TCGA-02-0038.3	199	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	10	0.0000189643849286789850000
TCGA-76-4929.8	91	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000190288837294583740000
TCGA-14-4157.7	101	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0000190408369580790120000
TCGA-19-5959.13	92	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000190671282016464720000
TCGA-06-0881.7	203	2_RESPONSE_TO_WOUNDING	163	18	0.0000191189829282912350000
TCGA-06-2565.10	38	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0000195821501107180960000
TCGA-76-6282.11	185	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	13	0.0000199119053810696450000
TCGA-41-3392.31	136	0_HALLMARK_ANGIOGENESIS	32	8	0.0000199207656864934320000
TCGA-08-0354.5	18	2_CELL_CYCLE_GO_0007049	265	8	0.0000199925612588358760000
TCGA-32-4211.14	71	2_EXTRACELLULAR_MATRIX	85	9	0.0000200405509000956030000
TCGA-28-5214.11	124	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000201687710642964850000
TCGA-12-3653.55	255	2_CELL_CYCLE_PHASE	146	19	0.0000202251036117634840000
TCGA-06-0878.10	115	1_KEGG_FOCAL_ADHESION	195	15	0.0000203260852176080230000
TCGA-76-4927.8	93	1_KEGG_ASTHMA	30	7	0.0000203821812268258190000
TCGA-19-5947.4	267	2_EXTRACELLULAR_MATRIX	85	15	0.0000204345507014421250000
TCGA-06-0648.6	17	0_HALLMARK_MYC_TARGETS_V1	178	7	0.0000209936157806948980000
TCGA-26-1439.10	84	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0000210502563530014860000
TCGA-76-6193.13	271	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	15	0.0000211041619654636270000
TCGA-32-1982.9	89	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0000211193922772986020000
TCGA-32-1982.6	8	1_KEGG_CELL_CYCLE	114	5	0.0000215358066552167030000
TCGA-14-0787.7	14	2_PLASMA_MEMBRANE	1096	11	0.0000215695650837669490000
TCGA-76-4927.8	93	1_KEGG_CELL_CYCLE	114	11	0.0000217761713110223440000
TCGA-06-5859.9	125	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000218036582626169660000
TCGA-26-1439.10	84	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0000219411813835201750000
TCGA-32-2494.10	173	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	16	0.0000219496430654383420000
TCGA-27-2528.10	99	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000219640978011983310000
TCGA-06-0130.3	155	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	11	0.0000220717872770686360000
TCGA-32-2634.10	118	2_CELL_CYCLE_PROCESS	163	14	0.0000220917952123652960000
TCGA-06-2565.10	38	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0000223453618799138320000
TCGA-14-0813.5	5	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	5	0.0000223862403344606070000
TCGA-06-5411.4	23	1_KEGG_MELANOMA	71	6	0.0000224016982718205270000
TCGA-02-0107.3	71	2_COLLAGEN	23	6	0.0000224016982718205270000
TCGA-06-0189.3	118	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000224811520270881500000
TCGA-06-5412.7	153	1_KEGG_VIRAL_MYOCARDITIS	70	11	0.0000225344159566936780000
TCGA-06-0148.6	69	1_KEGG_FOCAL_ADHESION	195	12	0.0000226745463791758200000
TCGA-02-0068.1	72	2_EXTRACELLULAR_MATRIX	85	9	0.0000227373169734555530000
TCGA-41-3915.10	109	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0000229127364822058350000
TCGA-28-2514.9	62	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000229282548642992630000
TCGA-76-4926.9	66	2_CELL_CELL_SIGNALING	353	15	0.0000229643567338759990000
TCGA-08-0386.4	73	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000231621550839131350000
TCGA-06-0127.3	5	1_KEGG_LEISHMANIA_INFECTION	70	4	0.0000232203607622899700000
TCGA-06-0127.3	5	1_KEGG_VIRAL_MYOCARDITIS	70	4	0.0000232203607622899700000
TCGA-28-2514.9	62	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0000233449047873461690000
TCGA-19-5952.11	193	0_HALLMARK_HYPOXIA	154	17	0.0000234735298785789550000
TCGA-32-1979.10	116	2_GABA_RECEPTOR_ACTIVITY	8	5	0.0000235163117851873790000
TCGA-14-1825.8	80	2_MITOTIC_CELL_CYCLE	134	11	0.0000238063828092273260000
TCGA-76-6282.11	185	2_EXTRACELLULAR_REGION	346	25	0.0000238757785304009040000
TCGA-41-3393.5	88	1_KEGG_LEISHMANIA_INFECTION	70	9	0.0000240365918790445940000
TCGA-76-6193.13	271	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	12	0.0000240859037358523110000
TCGA-02-0024.6	206	2_CELL_CYCLE_PROCESS	163	18	0.0000240931852476232080000
TCGA-19-2619.14	100	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000242324207290699550000
TCGA-14-0786.4	62	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000243437186424922860000
TCGA-06-0157.7	89	1_KEGG_DNA_REPLICATION	32	7	0.0000243464143340124940000
TCGA-14-0787.7	14	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	4	0.0000243697473341584180000
TCGA-06-0124.6	55	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000245256294636712530000
TCGA-27-2528.10	99	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000247181555994125080000
TCGA-32-1979.4	12	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	5	0.0000248291807738108160000
TCGA-81-5910.12	128	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000248550346592462080000
TCGA-06-2557.11	177	0_HALLMARK_ALLOGRAFT_REJECTION	190	18	0.0000248892569964086090000
TCGA-19-1390.13	110	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000249078524161759280000
TCGA-02-2483.10	100	2_INTERPHASE	62	9	0.0000249517386729046650000
TCGA-02-0010.18	184	1_KEGG_PATHWAYS_IN_CANCER	323	24	0.0000249843446071832300000
TCGA-06-0190.8	143	1_KEGG_CELL_CYCLE	114	13	0.0000250335188449002260000
TCGA-06-0881.7	203	0_HALLMARK_ANGIOGENESIS	32	9	0.0000252609896051935860000
TCGA-19-2624.29	130	0_HALLMARK_MITOTIC_SPINDLE	175	15	0.0000254767821239504650000
TCGA-02-0034.4	88	2_AXON	10	5	0.0000256617461205582550000
TCGA-06-0241.8	53	2_REGULATION_OF_CELL_CYCLE	160	10	0.0000257938750317481930000
TCGA-12-5299.6	38	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000260163653507219890000
TCGA-14-1829.3	8	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	4	0.0000260163653507219890000
TCGA-32-2494.10	173	1_KEGG_FOCAL_ADHESION	195	18	0.0000261059496238096940000
TCGA-06-5415.7	7	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0000262858069668899940000
TCGA-06-0122.8	90	0_HALLMARK_ANGIOGENESIS	32	7	0.0000263382736920893480000
TCGA-06-0184.11	108	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000264996078322308760000
TCGA-32-1982.9	89	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0000265847520461610140000
TCGA-27-2521.10	94	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000266965443597020630000
TCGA-14-4157.7	101	2_INTERPHASE	62	9	0.0000272537024634114770000
TCGA-06-2559.11	101	1_KEGG_GLIOMA	62	9	0.0000272537024634114770000
TCGA-06-0646.4	63	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000273391405880206630000
TCGA-06-5856.13	152	1_KEGG_ASTHMA	30	8	0.0000273462147954512840000
TCGA-06-0138.2	30	2_SYNAPTIC_TRANSMISSION	152	8	0.0000273462147954512840000
TCGA-14-0813.10	53	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0000273538972106616250000
TCGA-41-3393.4	12	2_NON_MEMBRANE_BOUND_ORGANELLE	476	8	0.0000274157701222360540000
TCGA-41-3393.4	12	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	8	0.0000274157701222360540000
TCGA-19-5954.17	208	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000276483866437784190000
TCGA-28-5218.5	208	2_ECTODERM_DEVELOPMENT	66	12	0.0000276483866437784190000
TCGA-27-2528.10	99	2_EXTRACELLULAR_MATRIX	85	10	0.0000277733833234450650000
TCGA-06-2570.8	95	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000279102034757556930000
TCGA-28-2502.9	56	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000279148368377380460000
TCGA-06-0195.8	56	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0000279148368377380460000
TCGA-27-1837.5	85	1_KEGG_FOCAL_ADHESION	195	13	0.0000280747016147077000000
TCGA-06-0211.8	62	1_KEGG_MELANOMA	71	8	0.0000280758482272784800000
TCGA-06-0166.5	35	2_COLLAGEN	23	5	0.0000280844371239482520000
TCGA-19-5958.4	35	2_COLLAGEN	23	5	0.0000280844371239482520000
TCGA-06-0750.12	52	2_EXTRACELLULAR_REGION_PART	269	12	0.0000280962126705582740000
TCGA-08-0245.4	85	2_REGULATION_OF_CELL_CYCLE	160	12	0.0000281426320436552800000
TCGA-02-0028.9	182	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	15	0.0000282182248443157530000
TCGA-02-0060.19	281	0_HALLMARK_ANGIOGENESIS	32	10	0.0000282199539183953430000
TCGA-06-0750.12	52	0_HALLMARK_ANGIOGENESIS	32	6	0.0000283518935256280970000
TCGA-08-0375.6	65	0_HALLMARK_E2F_TARGETS	169	11	0.0000284031584587181540000
TCGA-41-3915.10	109	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000285092301188488020000
TCGA-41-2571.7	72	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000285807300153317790000
TCGA-06-2559.11	101	1_KEGG_FOCAL_ADHESION	195	14	0.0000286616227265451670000
TCGA-41-5651.5	112	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000287322973969167840000
TCGA-06-5412.7	153	1_KEGG_ASTHMA	30	8	0.0000287946021071175240000
TCGA-06-0155.10	74	2_COLLAGEN	23	6	0.0000288416519421330040000
TCGA-08-0354.5	18	0_HALLMARK_G2M_CHECKPOINT	174	7	0.0000288757349325422460000
TCGA-27-2528.10	99	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0000288928255789906660000
TCGA-06-1804.6	30	2_NUCLEAR_REPLICATION_FORK	10	4	0.0000289279715567004870000
TCGA-19-1790.18	201	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	17	0.0000289751281669422550000
TCGA-27-1834.10	39	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000289798166042582140000
TCGA-32-1986.8	87	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000290523119749571280000
TCGA-02-0074.5	118	1_KEGG_FOCAL_ADHESION	195	15	0.0000290572986029978000000
TCGA-41-3392.31	136	0_HALLMARK_E2F_TARGETS	169	15	0.0000294813816743062600000
TCGA-26-5133.10	75	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000295374313807081990000
TCGA-32-2634.10	118	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	10	0.0000297050981252557110000
TCGA-12-0821.9	81	0_HALLMARK_E2F_TARGETS	169	12	0.0000297608242847511050000
TCGA-02-0089.5	91	0_HALLMARK_APOPTOSIS	150	12	0.0000299377234698626160000
TCGA-32-4210.14	109	2_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0000300182529331470150000
TCGA-32-4210.14	109	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0000300182529331470150000
TCGA-28-5218.5	208	2_COLLAGEN	23	8	0.0000300978667908969150000
TCGA-32-2494.10	173	1_KEGG_CELL_CYCLE	114	14	0.0000302681161845450840000
TCGA-06-0173.35	120	1_KEGG_MELANOMA	71	10	0.0000304227398080615710000
TCGA-06-0126.7	5	2_EXTRACELLULAR_REGION_PART	269	5	0.0000304910843021999970000
TCGA-19-2619.14	100	2_EXTRACELLULAR_MATRIX	85	10	0.0000306357280336073660000
TCGA-19-1790.18	201	2_EXTRACELLULAR_REGION	346	26	0.0000307059718439595270000
TCGA-27-1833.2	41	2_CELL_CELL_SIGNALING	353	12	0.0000308321614785311140000
TCGA-32-1979.4	12	2_REGULATION_OF_CELL_CYCLE	160	6	0.0000308369992448347180000
TCGA-19-5960.9	134	2_DNA_REPLICATION	82	11	0.0000310592123242197650000
TCGA-32-4719.15	123	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000312174257536811200000
TCGA-27-2519.7	113	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0000312610382022237100000
TCGA-08-0353.8	100	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0000312953292150508550000
TCGA-41-2571.7	72	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0000314131229523928000000
TCGA-19-1390.13	110	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	9	0.0000315845055961958180000
TCGA-32-4719.15	123	2_GABA_RECEPTOR_ACTIVITY	8	5	0.0000316211694109516310000
TCGA-06-2562.7	57	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000316929658620893990000
TCGA-27-1830.7	57	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000316929658620893990000
TCGA-27-1838.17	131	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000317167213112838470000
TCGA-87-5896.6	131	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000317167213112838470000
TCGA-06-0141.1	45	1_KEGG_FOCAL_ADHESION	195	10	0.0000320479690304862310000
TCGA-02-0085.1	45	1_KEGG_FOCAL_ADHESION	195	10	0.0000320479690304862310000
TCGA-02-0114.20	132	1_KEGG_PATHWAYS_IN_CANCER	323	20	0.0000320805639782723990000
TCGA-06-0219.6	6	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0000321192726401386170000
TCGA-08-0244.4	6	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0000321192726401386170000
TCGA-12-5299.5	6	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0000321192726401386170000
TCGA-14-1829.11	6	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0000321192726401386170000
TCGA-14-2554.9	6	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0000321192726401386170000
TCGA-06-0184.11	108	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000324268493978309920000
TCGA-27-1835.6	86	1_KEGG_FOCAL_ADHESION	195	13	0.0000324820296141422190000
TCGA-02-0115.1	36	2_COLLAGEN	23	5	0.0000325623081685260550000
TCGA-06-2565.10	38	2_NON_MEMBRANE_BOUND_ORGANELLE	476	13	0.0000329121964997441960000
TCGA-06-2565.10	38	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	13	0.0000329121964997441960000
TCGA-41-3915.10	109	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0000330772437911600110000
TCGA-14-0813.10	53	2_EXTRACELLULAR_MATRIX	85	8	0.0000330912797743217370000
TCGA-06-2561.5	42	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0000334690865792562440000
TCGA-12-5295.8	66	0_HALLMARK_E2F_TARGETS	169	11	0.0000335612186026464480000
TCGA-14-1034.7	97	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000335779855016678210000
TCGA-06-0152.10	19	2_CELL_CYCLE_GO_0007049	265	8	0.0000336987779400110290000
TCGA-06-5411.4	23	2_MITOTIC_CELL_CYCLE	134	7	0.0000338257655512209420000
TCGA-14-4157.7	101	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0000338684414390854620000
TCGA-12-3650.17	101	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0000338684414390854620000
TCGA-02-0054.3	93	2_AXON	10	5	0.0000339678092860909900000
TCGA-06-6391.9	26	0_HALLMARK_ANGIOGENESIS	32	5	0.0000339756882720064850000
TCGA-06-0877.7	4	1_KEGG_CELL_CYCLE	114	4	0.0000339881320918470230000
TCGA-16-0861.5	4	1_KEGG_CELL_CYCLE	114	4	0.0000339881320918470230000
TCGA-06-2561.7	4	1_KEGG_CELL_CYCLE	114	4	0.0000339881320918470230000
TCGA-08-0348.3	4	1_KEGG_CELL_CYCLE	114	4	0.0000339881320918470230000
TCGA-08-0358.9	43	2_SYNAPTIC_TRANSMISSION	152	9	0.0000340332067670048620000
TCGA-06-6389.4	39	0_HALLMARK_E2F_TARGETS	169	9	0.0000342304396992077040000
TCGA-28-5218.6	8	1_KEGG_AXON_GUIDANCE	125	5	0.0000343043458932707540000
TCGA-06-0154.2	5	2_KINESIN_COMPLEX	13	3	0.0000343425263974143570000
TCGA-02-0060.19	281	1_KEGG_ECM_RECEPTOR_INTERACTION	84	15	0.0000343713800643082320000
TCGA-14-0813.10	53	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0000344442726662133560000
TCGA-06-2558.6	74	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000347009045955434330000
TCGA-06-0130.3	155	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	15	0.0000347234637977747820000
TCGA-76-4929.8	91	2_SYNAPTIC_TRANSMISSION	152	12	0.0000347626318375521380000
TCGA-41-3915.10	109	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000348826704383860170000
TCGA-02-0089.5	91	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0000353313735374513340000
TCGA-27-1833.2	41	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000356566154822464870000
TCGA-32-4211.14	71	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0000356991924705184030000
TCGA-02-0107.3	71	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0000356991924705184030000
TCGA-06-0192.10	126	2_GABA_RECEPTOR_ACTIVITY	8	5	0.0000357123283055712930000
TCGA-06-0645.9	136	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0000358286156215219100000
TCGA-06-0210.6	103	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000363710065827575130000
TCGA-14-4157.7	101	2_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0000366428408527500980000
TCGA-14-4157.7	101	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0000366428408527500980000
TCGA-12-3650.17	101	2_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0000366428408527500980000
TCGA-12-3650.17	101	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0000366428408527500980000
TCGA-06-2559.11	101	2_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0000366428408527500980000
TCGA-06-2559.11	101	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0000366428408527500980000
TCGA-32-2615.7	77	2_COLLAGEN	23	6	0.0000367417327357153780000
TCGA-06-5859.9	125	2_REGULATION_OF_CELL_CYCLE	160	14	0.0000368421430392171870000
TCGA-06-0145.19	81	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0000369946866383000360000
TCGA-06-0210.6	103	1_KEGG_FOCAL_ADHESION	195	14	0.0000370816035643790170000
TCGA-06-0139.1	179	2_INFLAMMATORY_RESPONSE	112	14	0.0000371714576101692470000
TCGA-06-0174.37	141	1_KEGG_GLIOMA	62	10	0.0000373018652269800900000
TCGA-14-0871.20	216	2_REGULATION_OF_CELL_CYCLE	160	18	0.0000377337168207728710000
TCGA-27-1838.17	131	2_CELL_CYCLE_GO_0007049	265	18	0.0000379455054362123710000
TCGA-02-0046.8	148	1_KEGG_CELL_CYCLE	114	13	0.0000379519482853631870000
TCGA-06-0213.9	74	2_SYNAPTIC_TRANSMISSION	152	11	0.0000384540918582652720000
TCGA-08-0375.6	65	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000384912927399604270000
TCGA-32-4213.15	198	1_KEGG_FOCAL_ADHESION	195	19	0.0000387697143985528550000
TCGA-02-0001.5	117	2_NEURON_PROJECTION	16	6	0.0000387832531836604900000
TCGA-08-0389.4	56	2_DNA_REPLICATION	82	8	0.0000389571688532891250000
TCGA-06-0195.8	56	2_DNA_REPLICATION	82	8	0.0000389571688532891250000
TCGA-32-2638.17	159	1_KEGG_ASTHMA	30	8	0.0000389580199746635950000
TCGA-06-5414.13	102	1_KEGG_ASTHMA	30	7	0.0000389712361848288870000
TCGA-06-0939.7	58	2_SYNAPTIC_TRANSMISSION	152	10	0.0000392835875090650150000
TCGA-02-0028.9	182	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0000395947596201484950000
TCGA-19-5952.11	193	0_HALLMARK_UV_RESPONSE_DN	122	15	0.0000400365934019124340000
TCGA-06-0129.11	110	2_MITOTIC_SPINDLE_ORGANIZATION_AND_BIOGENESIS	9	5	0.0000400666024833400580000
TCGA-02-0048.9	84	2_MITOTIC_CELL_CYCLE	134	11	0.0000402204553003617210000
TCGA-27-2528.10	99	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000402284818039793100000
TCGA-06-5408.3	99	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000402284818039793100000
TCGA-06-0174.37	141	2_CELL_PROLIFERATION_GO_0008283	436	24	0.0000403297070160974010000
TCGA-06-0745.4	55	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000407659041047705350000
TCGA-08-0375.6	65	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000408555291550606040000
TCGA-41-2571.7	72	1_KEGG_BLADDER_CANCER	42	7	0.0000408612673645173810000
TCGA-16-0846.2	27	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0000410906015691244510000
TCGA-12-0821.9	81	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000412917615412728130000
TCGA-76-6191.6	96	1_KEGG_DNA_REPLICATION	32	7	0.0000414342680757787010000
TCGA-02-0014.10	70	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000415503671530844720000
TCGA-28-5214.11	124	1_KEGG_MELANOMA	71	10	0.0000417693130866214740000
TCGA-02-0003.9	227	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	11	0.0000417815694967670310000
TCGA-14-0790.9	104	1_KEGG_FOCAL_ADHESION	195	14	0.0000420819501591299090000
TCGA-06-0881.7	203	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0000421635309362218570000
TCGA-06-0219.6	6	2_INTERPHASE	62	4	0.0000422027988152758620000
TCGA-08-0244.4	6	2_INTERPHASE	62	4	0.0000422027988152758620000
TCGA-12-5299.5	6	2_INTERPHASE	62	4	0.0000422027988152758620000
TCGA-14-1829.11	6	2_INTERPHASE	62	4	0.0000422027988152758620000
TCGA-14-2554.9	6	2_INTERPHASE	62	4	0.0000422027988152758620000
TCGA-06-0192.10	126	1_KEGG_LEISHMANIA_INFECTION	70	10	0.0000423435850964800250000
TCGA-76-6285.5	106	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0000427368842558296700000
TCGA-76-6285.5	106	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000427368842558296700000
TCGA-02-0075.8	128	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000427444108002026480000
TCGA-06-0168.4	22	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0000431338361411160500000
TCGA-06-0197.1	57	2_REGULATION_OF_APOPTOSIS	309	13	0.0000431605283975804040000
TCGA-28-5204.3	4	2_ION_CHANNEL_ACTIVITY	121	4	0.0000432711648252336000000
TCGA-08-0358.9	43	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000434224654082676620000
TCGA-19-5958.4	35	2_EXTRACELLULAR_REGION	346	11	0.0000434429561302217510000
TCGA-02-0083.21	135	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000434762117116488170000
TCGA-32-4210.14	109	2_DNA_METABOLIC_PROCESS	218	15	0.0000436123637002696710000
TCGA-28-5207.12	188	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	15	0.0000437635055319693410000
TCGA-08-0353.8	100	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000439660297003461920000
TCGA-02-0027.3	81	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0000440297627206825120000
TCGA-02-0026.1	61	2_CELL_CYCLE_PHASE	146	10	0.0000442983271869796390000
TCGA-76-4927.8	93	2_SYNAPTIC_TRANSMISSION	152	12	0.0000446500741261120490000
TCGA-28-2502.9	56	0_HALLMARK_ANGIOGENESIS	32	6	0.0000447902864565153510000
TCGA-06-0197.1	57	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	13	0.0000448502569273404790000
TCGA-06-5412.7	153	2_IMMUNE_SYSTEM_PROCESS	283	20	0.0000449122861348035340000
TCGA-08-0389.4	56	2_REGULATION_OF_CELL_CYCLE	160	10	0.0000450923549926338010000
TCGA-32-2634.10	118	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	13	0.0000451306801673480390000
TCGA-06-5415.7	7	2_REGULATION_OF_CELL_CYCLE	160	5	0.0000451963692773974030000
TCGA-02-0028.9	182	0_HALLMARK_APOPTOSIS	150	16	0.0000453570397100813600000
TCGA-19-4068.2	11	1_KEGG_ASTHMA	30	4	0.0000453581235851108150000
TCGA-06-0188.11	66	2_CELL_CYCLE_GO_0007049	265	13	0.0000454537236389150390000
TCGA-28-1753.13	174	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0000454591209713526450000
TCGA-06-0188.11	66	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0000454591209713526450000
TCGA-32-2632.16	229	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	11	0.0000457516359635555770000
TCGA-06-2557.11	177	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	10	0.0000458988155549145560000
TCGA-02-0074.5	118	2_CELL_CYCLE_GO_0007049	265	17	0.0000459480207176642250000
TCGA-06-0875.7	78	2_CELL_CYCLE_GO_0007049	265	14	0.0000460030306840629020000
TCGA-02-0052.3	116	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0000466136268675800840000
TCGA-06-5859.9	125	2_CELL_CYCLE_PROCESS	163	14	0.0000467334057395963340000
TCGA-32-1977.11	107	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0000468101653516278370000
TCGA-06-5411.3	19	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	7	0.0000468362608114481320000
TCGA-41-2575.49	136	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0000473010255702326450000
TCGA-02-0060.19	281	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	86	15	0.0000479202371947711910000
TCGA-02-0060.19	281	0_HALLMARK_INFLAMMATORY_RESPONSE	170	21	0.0000485060863612085010000
TCGA-28-5218.5	208	2_TISSUE_DEVELOPMENT	115	15	0.0000486254556572596550000
TCGA-06-0127.3	5	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	4	0.0000488063258558699490000
TCGA-06-0686.6	3	1_KEGG_ASTHMA	30	3	0.0000488294966402187400000
TCGA-19-5958.2	3	1_KEGG_ASTHMA	30	3	0.0000488294966402187400000
TCGA-28-5215.7	192	0_HALLMARK_ESTROGEN_RESPONSE_LATE	143	16	0.0000488498522487722720000
TCGA-28-5208.28	220	2_AXON	10	6	0.0000489066708471230800000
TCGA-28-5204.3	4	2_SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY	125	4	0.0000493627835511306150000
TCGA-27-1830.7	57	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0000495714794889067130000
TCGA-06-2558.6	74	1_KEGG_BLADDER_CANCER	42	7	0.0000495927174794517620000
TCGA-06-0138.2	30	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0000496622670941343330000
TCGA-02-0099.11	141	1_KEGG_FOCAL_ADHESION	195	16	0.0000497173489915476750000
TCGA-28-5220.7	15	1_KEGG_GLIOMA	62	5	0.0000498264069603652620000
TCGA-06-0168.4	22	2_EXTRACELLULAR_MATRIX	85	6	0.0000498340285341400210000
TCGA-02-0011.1	288	2_CELL_DEVELOPMENT	511	40	0.0000499297689113142070000
TCGA-76-4934.7	47	1_KEGG_FOCAL_ADHESION	195	10	0.0000501844587099218390000
TCGA-02-0060.19	281	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	18	0.0000505337227158413680000
TCGA-06-0122.8	90	2_EXTRACELLULAR_REGION_PART	269	15	0.0000506512516454080640000
TCGA-76-6285.5	106	1_KEGG_ASTHMA	30	7	0.0000509890936563905750000
TCGA-08-0345.2	77	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	11	0.0000513880506007643110000
TCGA-06-5408.3	99	0_HALLMARK_ANGIOGENESIS	32	7	0.0000513905465641681660000
TCGA-06-5415.7	7	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	4	0.0000515551033627357800000
TCGA-14-0813.5	5	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	299	5	0.0000519283653287860910000
TCGA-06-2565.3	60	1_KEGG_FOCAL_ADHESION	195	11	0.0000523316256677772290000
TCGA-02-0026.1	61	2_CHROMOSOMAL_PART	78	8	0.0000523432059051807600000
TCGA-12-0616.7	45	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000523890585525554260000
TCGA-08-0355.1	45	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000523890585525554260000
TCGA-19-5954.17	208	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0000524498192634690150000
TCGA-32-2495.11	67	1_KEGG_MELANOMA	71	8	0.0000525710709325765670000
TCGA-32-1977.11	107	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000526389053466568010000
TCGA-06-0197.1	57	2_CELL_DEVELOPMENT	511	16	0.0000527400698468931070000
TCGA-06-0219.6	6	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0000528052860087732780000
TCGA-08-0244.4	6	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0000528052860087732780000
TCGA-12-5299.5	6	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0000528052860087732780000
TCGA-14-1823.12	6	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0000528052860087732780000
TCGA-14-1829.11	6	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0000528052860087732780000
TCGA-14-2554.9	6	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0000528052860087732780000
TCGA-02-0115.1	36	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0000531587696227093000000
TCGA-02-0043.10	184	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	40	0.0000532519242444637750000
TCGA-06-0189.3	118	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000533701632582743500000
TCGA-19-5951.10	138	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000534190912063695630000
TCGA-06-0650.2	82	2_COLLAGEN	23	6	0.0000538443061415290130000
TCGA-02-0102.8	82	2_COLLAGEN	23	6	0.0000538443061415290130000
TCGA-06-0876.9	106	1_KEGG_FOCAL_ADHESION	195	14	0.0000539578806539421770000
TCGA-76-6285.5	106	1_KEGG_FOCAL_ADHESION	195	14	0.0000539578806539421770000
TCGA-76-6285.5	106	2_EXTRACELLULAR_MATRIX	85	10	0.0000539672457019201140000
TCGA-14-0871.20	216	2_NON_MEMBRANE_BOUND_ORGANELLE	476	32	0.0000544149229220312370000
TCGA-14-0871.20	216	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	32	0.0000544149229220312370000
TCGA-15-1444.3	107	1_KEGG_ASTHMA	30	7	0.0000544413439947505880000
TCGA-06-2562.7	57	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0000545360661889141050000
TCGA-06-0133.6	57	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0000545360661889141050000
TCGA-76-4925.9	83	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0000547682929998206620000
TCGA-12-0616.1	20	2_CELL_CYCLE_GO_0007049	265	8	0.0000548087840258199280000
TCGA-06-0644.16	142	1_KEGG_FOCAL_ADHESION	195	16	0.0000550263990841480100000
TCGA-28-2513.12	134	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0000550594073720056240000
TCGA-02-2483.10	100	1_KEGG_DNA_REPLICATION	32	7	0.0000551299508736093230000
TCGA-19-5954.17	208	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0000553053693871649870000
TCGA-06-0141.1	45	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0000553172217423915920000
TCGA-06-0141.1	45	1_KEGG_VIRAL_MYOCARDITIS	70	7	0.0000553172217423915920000
TCGA-06-0124.6	55	2_EXTRACELLULAR_REGION_PART	269	12	0.0000553472582467935350000
TCGA-06-0127.3	5	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	4	0.0000562891443176195780000
TCGA-02-0060.19	281	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	15	0.0000563750351003033890000
TCGA-32-2634.10	118	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0000565797228168159720000
TCGA-02-0074.5	118	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0000565797228168159720000
TCGA-02-2483.10	100	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	15	0.0000565916855167968120000
TCGA-19-5951.10	138	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000566214756866077170000
TCGA-06-0190.8	143	0_HALLMARK_UV_RESPONSE_DN	122	13	0.0000572214948276356400000
TCGA-02-2483.10	100	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0000572226789679186740000
TCGA-28-2501.3	51	2_CYTOSKELETON	293	12	0.0000574708924714665180000
TCGA-06-0184.11	108	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0000575953890697764300000
TCGA-32-2498.13	133	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000577757876002020990000
TCGA-06-2565.10	38	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	7	0.0000581590996107976270000
TCGA-76-4925.9	83	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0000583883928147178780000
TCGA-06-0176.8	95	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000584966162544855280000
TCGA-16-1045.10	81	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000587658489897829930000
TCGA-06-6390.9	82	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0000589270959699463790000
TCGA-06-0141.1	45	2_EXTRACELLULAR_REGION_PART	269	11	0.0000590560958017290020000
TCGA-12-3650.17	101	1_KEGG_DNA_REPLICATION	32	7	0.0000590974016853543790000
TCGA-32-1977.11	107	2_EXTRACELLULAR_MATRIX	85	10	0.0000590994698018041870000
TCGA-02-2485.14	172	2_CHROMOSOME	102	13	0.0000592963848476808050000
TCGA-28-2509.6	59	2_DNA_REPLICATION	82	8	0.0000595516422408865370000
TCGA-14-0789.11	3	2_CALCIUM_CHANNEL_ACTIVITY	32	3	0.0000596537692944526500000
TCGA-26-1439.7	3	2_CALCIUM_CHANNEL_ACTIVITY	32	3	0.0000596537692944526500000
TCGA-14-1825.5	3	2_CALCIUM_CHANNEL_ACTIVITY	32	3	0.0000596537692944526500000
TCGA-27-1830.7	57	2_EXTRACELLULAR_MATRIX	85	8	0.0000599236385290823330000
TCGA-14-1825.8	80	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0000601370114520732950000
TCGA-02-0099.11	141	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	11	0.0000602339382743447860000
TCGA-27-2524.5	75	1_KEGG_FOCAL_ADHESION	195	12	0.0000603021635121397950000
TCGA-28-6450.11	139	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000606795700425122710000
TCGA-02-0003.9	227	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000610013331941538140000
TCGA-06-0645.9	136	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	18	0.0000612430714722349330000
TCGA-28-2513.12	134	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000612750452632828530000
TCGA-08-0345.2	77	0_HALLMARK_ALLOGRAFT_REJECTION	190	12	0.0000613008027991295950000
TCGA-06-5411.4	23	2_CELL_CYCLE_PHASE	146	7	0.0000613693592240778810000
TCGA-28-2509.6	59	1_KEGG_DNA_REPLICATION	32	6	0.0000617168586453749930000
TCGA-32-1980.1	24	2_BLOOD_COAGULATION	39	5	0.0000623304906715201870000
TCGA-32-1980.1	24	2_COAGULATION	39	5	0.0000623304906715201870000
TCGA-19-1790.18	201	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	22	0.0000625729796072867920000
TCGA-08-0354.7	47	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000626734017819563390000
TCGA-08-0380.5	47	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000626734017819563390000
TCGA-28-5219.9	47	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000626734017819563390000
TCGA-28-1753.13	174	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	12	0.0000628841607793531450000
TCGA-41-3915.10	109	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0000629596224563955680000
TCGA-02-2486.9	141	2_GABA_RECEPTOR_ACTIVITY	8	5	0.0000629606394399150330000
TCGA-76-6191.6	96	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000635551493470800150000
TCGA-06-0132.1	18	1_KEGG_FOCAL_ADHESION	195	7	0.0000635740403992074960000
TCGA-06-0877.7	4	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0000638920249990072900000
TCGA-08-0348.3	4	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0000638920249990072900000
TCGA-02-0099.11	141	2_EXTRACELLULAR_REGION	346	21	0.0000639008478701867470000
TCGA-06-5412.1	28	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	9	0.0000643077795445472060000
TCGA-06-0143.6	63	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0000647141133621330390000
TCGA-08-0350.2	46	2_CELL_CYCLE_GO_0007049	265	11	0.0000648705320176515930000
TCGA-32-4208.28	140	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000649925071037936260000
TCGA-02-2483.10	100	2_CELL_CYCLE_PHASE	146	12	0.0000651826392336738470000
TCGA-06-0189.3	118	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000652458814920670190000
TCGA-32-2634.10	118	1_KEGG_BLADDER_CANCER	42	8	0.0000652458814920670190000
TCGA-32-2634.10	118	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0000652458814920670190000
TCGA-06-0877.7	4	2_MITOTIC_CELL_CYCLE	134	4	0.0000654040538362039540000
TCGA-08-0348.3	4	2_MITOTIC_CELL_CYCLE	134	4	0.0000654040538362039540000
TCGA-19-2623.11	153	2_NON_MEMBRANE_BOUND_ORGANELLE	476	26	0.0000655651550339064620000
TCGA-19-2623.11	153	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	26	0.0000655651550339064620000
TCGA-08-0352.2	59	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0000655865638375807700000
TCGA-19-2624.29	130	2_MITOSIS	71	10	0.0000658106960683533830000
TCGA-02-0075.8	128	1_KEGG_CELL_CYCLE	114	12	0.0000658209376199239520000
TCGA-32-2491.14	244	1_KEGG_ASTHMA	30	9	0.0000664241026239897770000
TCGA-19-2629.15	146	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0000665978235782922600000
TCGA-12-0692.3	9	0_HALLMARK_UV_RESPONSE_DN	122	5	0.0000675692107931674290000
TCGA-02-0054.3	93	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	8	0.0000676816233053267360000
TCGA-32-2634.10	118	0_HALLMARK_MYC_TARGETS_V1	178	14	0.0000681063407635317060000
TCGA-06-5858.19	205	1_KEGG_FOCAL_ADHESION	195	19	0.0000682280538892367260000
TCGA-02-0099.11	141	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0000684349657544669870000
TCGA-06-0219.6	6	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0000686305085328362960000
TCGA-08-0380.4	6	2_KINESIN_COMPLEX	13	3	0.0000686305085328362960000
TCGA-14-0817.3	6	2_KINESIN_COMPLEX	13	3	0.0000686305085328362960000
TCGA-08-0244.4	6	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0000686305085328362960000
TCGA-12-5299.5	6	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0000686305085328362960000
TCGA-14-1823.12	6	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0000686305085328362960000
TCGA-14-1829.11	6	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0000686305085328362960000
TCGA-14-2554.9	6	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0000686305085328362960000
TCGA-08-0360.3	144	2_DEFENSE_RESPONSE	222	17	0.0000686416531310127560000
TCGA-19-5955.9	110	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0000687603065056990480000
TCGA-06-0219.6	6	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0000692716744472813840000
TCGA-08-0244.4	6	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0000692716744472813840000
TCGA-12-5299.5	6	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0000692716744472813840000
TCGA-14-1829.11	6	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0000692716744472813840000
TCGA-14-2554.9	6	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0000692716744472813840000
TCGA-06-0174.37	141	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000695740220746922890000
TCGA-76-6282.11	185	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	10	0.0000699584095940649470000
TCGA-06-2569.5	144	2_CHROMOSOME	102	12	0.0000699690056917034770000
TCGA-32-2632.16	229	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000702795455617926100000
TCGA-02-0080.3	20	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	7	0.0000709360238991845650000
TCGA-06-0192.10	126	1_KEGG_FOCAL_ADHESION	195	15	0.0000715176169854189450000
TCGA-06-0133.6	57	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	8	0.0000720885550506303270000
TCGA-26-5133.10	75	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000722468245534739740000
TCGA-27-1833.7	17	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0000722799935177201920000
TCGA-06-0648.6	17	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0000722799935177201920000
TCGA-06-5411.4	23	1_KEGG_BLADDER_CANCER	42	5	0.0000727770424549086590000
TCGA-06-6390.9	82	2_EXTRACELLULAR_MATRIX	85	9	0.0000727882920852944630000
TCGA-06-6391.6	30	1_KEGG_DNA_REPLICATION	32	5	0.0000729056774724421400000
TCGA-14-4157.7	101	2_CELL_CYCLE_PHASE	146	12	0.0000730006239677824570000
TCGA-06-0876.9	106	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000734492791289091620000
TCGA-32-4719.15	123	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0000739699165120897820000
TCGA-06-0877.7	4	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0000739743565080539060000
TCGA-08-0348.3	4	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0000739743565080539060000
TCGA-08-0356.2	23	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	7	0.0000740002361282178730000
TCGA-26-5135.9	71	0_HALLMARK_E2F_TARGETS	169	11	0.0000740601720752905460000
TCGA-12-0618.5	41	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0000743045194797219730000
TCGA-06-2565.10	38	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	7	0.0000743840926535172350000
TCGA-06-5415.7	7	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0000746022171870706030000
TCGA-06-2564.7	92	1_KEGG_FOCAL_ADHESION	195	13	0.0000747660839072024300000
TCGA-06-2565.3	60	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0000751422807554619900000
TCGA-19-2624.29	130	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	10	0.0000755422964014754830000
TCGA-02-0026.1	61	1_KEGG_DNA_REPLICATION	32	6	0.0000756957043535024430000
TCGA-02-0114.20	132	1_KEGG_MELANOMA	71	10	0.0000761816261978862500000
TCGA-28-2513.12	134	1_KEGG_VIRAL_MYOCARDITIS	70	10	0.0000764926906038933930000
TCGA-28-5204.5	5	1_KEGG_PATHWAYS_IN_CANCER	323	5	0.0000765863038705428520000
TCGA-02-0014.12	5	1_KEGG_PATHWAYS_IN_CANCER	323	5	0.0000765863038705428520000
TCGA-27-2523.12	112	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0000766700998310768860000
TCGA-32-1980.1	24	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0000767270658872099120000
TCGA-08-0245.4	85	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0000768094117324901590000
TCGA-27-1831.9	85	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0000768094117324901590000
TCGA-06-0195.8	56	2_DNA_METABOLIC_PROCESS	218	11	0.0000775762749304553050000
TCGA-02-0099.11	141	2_EXTRACELLULAR_MATRIX	85	11	0.0000776149999439466340000
TCGA-06-0148.6	69	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0000780754499805859830000
TCGA-28-1753.13	174	2_CELL_CYCLE_PROCESS	163	16	0.0000784293776164293000000
TCGA-06-0145.19	81	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0000785920213284398100000
TCGA-06-0141.1	45	2_EXTRACELLULAR_REGION	346	12	0.0000786239496837178380000
TCGA-06-0644.16	142	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0000787176509095925680000
TCGA-28-1753.13	174	1_KEGG_ASTHMA	30	8	0.0000788779747119831200000
TCGA-08-0352.2	59	2_EXTRACELLULAR_MATRIX	85	8	0.0000792532710163570430000
TCGA-06-5412.7	153	2_MEMBRANE	1443	50	0.0000793669556247340470000
TCGA-06-0129.11	110	2_SPINDLE_ORGANIZATION_AND_BIOGENESIS	10	5	0.0000793912081054874320000
TCGA-02-0058.1	110	2_AXON	10	5	0.0000793912081054874320000
TCGA-06-0190.8	143	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0000796008309122063330000
TCGA-06-0211.7	10	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0000805968417693215900000
TCGA-32-2632.16	229	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0000807394738334605740000
TCGA-32-2494.10	173	1_KEGG_LEISHMANIA_INFECTION	70	11	0.0000809611951099929670000
TCGA-32-2494.10	173	1_KEGG_VIRAL_MYOCARDITIS	70	11	0.0000809611951099929670000
TCGA-27-2528.10	99	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000810594630207564860000
TCGA-26-1439.10	84	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000811551715818010720000
TCGA-19-5960.9	134	2_MITOTIC_CELL_CYCLE	134	13	0.0000812114225738025610000
TCGA-06-0939.7	58	2_TRANSMISSION_OF_NERVE_IMPULSE	164	10	0.0000812203890847975550000
TCGA-06-0189.3	118	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0000813907183538091410000
TCGA-06-0137.9	53	2_CELL_CELL_SIGNALING	353	13	0.0000814355571781840110000
TCGA-76-4929.8	91	2_TRANSMISSION_OF_NERVE_IMPULSE	164	12	0.0000814531691466079690000
TCGA-15-0742.13	74	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0000818748130537060090000
TCGA-06-0192.10	126	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	14	0.0000820312237087770490000
TCGA-32-4213.15	198	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0000822870971080854410000
TCGA-06-5411.3	19	0_HALLMARK_ALLOGRAFT_REJECTION	190	7	0.0000826911726054323460000
TCGA-27-2526.7	71	1_KEGG_MELANOMA	71	8	0.0000837337811571148700000
TCGA-02-0038.3	199	0_HALLMARK_DNA_REPAIR	125	15	0.0000841725409753911040000
TCGA-02-0003.9	227	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	16	0.0000842181222429849390000
TCGA-06-0213.9	74	2_TRANSMISSION_OF_NERVE_IMPULSE	164	11	0.0000846736308391375810000
TCGA-02-0033.1	4	2_COLLAGEN	23	3	0.0000850637445751083380000
TCGA-12-0688.10	93	1_KEGG_FOCAL_ADHESION	195	13	0.0000853592916901684860000
TCGA-02-0099.11	141	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0000858262669305613420000
TCGA-14-1825.8	80	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0000858489059335427510000
TCGA-06-0877.8	61	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0000858736509899881350000
TCGA-14-0790.9	104	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0000862343321018926320000
TCGA-08-0347.4	16	2_MITOTIC_CELL_CYCLE	134	6	0.0000876337797135359570000
TCGA-12-1597.6	51	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0000876898272882109520000
TCGA-19-2619.14	100	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0000877499840261000820000
TCGA-76-6192.6	43	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	17	0.0000877887421722213780000
TCGA-06-2557.11	177	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	11	0.0000877922758403458610000
TCGA-06-0176.8	95	2_CELL_CYCLE_GO_0007049	265	15	0.0000881099431343416400000
TCGA-32-1980.1	24	2_EXTRACELLULAR_MATRIX	85	6	0.0000886131617947083820000
TCGA-41-3915.10	109	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	10	0.0000886417602945935660000
TCGA-06-0747.12	80	2_SYNAPTIC_TRANSMISSION	152	11	0.0000887421319704125150000
TCGA-06-0143.6	63	1_KEGG_FOCAL_ADHESION	195	11	0.0000890905664349825390000
TCGA-12-1597.6	51	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0000899806493462107290000
TCGA-27-1837.5	85	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0000901156115073881430000
TCGA-02-0083.21	135	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0000903427759712926300000
TCGA-02-0083.21	135	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0000903427759712926300000
TCGA-32-4719.15	123	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0000903866565672918930000
TCGA-02-0021.4	170	2_CELL_CYCLE_GO_0007049	265	20	0.0000904165586358932910000
TCGA-32-1977.11	107	2_EXTRACELLULAR_REGION	346	18	0.0000904881831404230110000
TCGA-06-2565.3	60	2_EXTRACELLULAR_MATRIX	85	8	0.0000907830386136313640000
TCGA-06-0881.7	203	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	10	0.0000912081685574321300000
TCGA-06-0644.16	142	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0000912644921512131060000
TCGA-08-0352.2	59	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0000915245906466558120000
TCGA-06-0143.6	63	0_HALLMARK_ANGIOGENESIS	32	6	0.0000921898704962878260000
TCGA-02-0038.3	199	2_INTERPHASE	62	11	0.0000922875475777916550000
TCGA-06-5415.7	7	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0000923432016349153140000
TCGA-12-3650.17	101	2_MITOSIS	71	9	0.0000924223339681393480000
TCGA-06-0877.7	4	2_CELL_CYCLE_PHASE	146	4	0.0000925171804447448350000
TCGA-08-0348.3	4	2_CELL_CYCLE_PHASE	146	4	0.0000925171804447448350000
TCGA-76-4935.7	15	2_CELL_CYCLE_PHASE	146	6	0.0000926636917950863210000
TCGA-19-2624.29	130	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0000929225707116601160000
TCGA-19-2624.29	130	2_MITOTIC_SPINDLE_ORGANIZATION_AND_BIOGENESIS	9	5	0.0000930405037300324350000
TCGA-06-0686.6	3	1_KEGG_ALLOGRAFT_REJECTION	37	3	0.0000934495539148811320000
TCGA-19-5958.2	3	1_KEGG_ALLOGRAFT_REJECTION	37	3	0.0000934495539148811320000
TCGA-06-0145.19	81	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0000936640124313405060000
TCGA-06-0881.7	203	2_DEFENSE_RESPONSE	222	20	0.0000937076349395454010000
TCGA-41-3915.10	109	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000938065738065533000000
TCGA-32-4210.14	109	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0000938065738065533000000
TCGA-32-4213.15	198	2_EXTRACELLULAR_REGION	346	25	0.0000947653919670227280000
TCGA-19-5952.11	193	0_HALLMARK_E2F_TARGETS	169	17	0.0000948226980511822810000
TCGA-76-4928.15	78	1_KEGG_FOCAL_ADHESION	195	12	0.0000949705877632535890000
TCGA-19-2619.14	100	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0000958943844962549710000
TCGA-02-0009.6	188	1_KEGG_FOCAL_ADHESION	195	18	0.0000959089181242296150000
TCGA-26-1439.11	10	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0000959786041261883190000
TCGA-06-5413.11	142	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0000964902476159285810000
TCGA-28-5215.7	192	0_HALLMARK_APOPTOSIS	150	16	0.0000966475753668715500000
TCGA-02-0007.17	217	2_CYTOSKELETON	293	24	0.0000967240017428987030000
TCGA-19-2624.29	130	2_M_PHASE	94	11	0.0000968231821826178050000
TCGA-06-6391.7	5	2_CYTOKINESIS	18	3	0.0000979064201585514590000
TCGA-06-5415.7	7	1_KEGG_GLIOMA	62	4	0.0000979894953653834650000
TCGA-06-5415.7	7	2_INTERPHASE	62	4	0.0000979894953653834650000
TCGA-12-0616.7	45	2_CELL_CELL_SIGNALING	353	12	0.0000980676177546857250000
TCGA-08-0355.1	45	2_CELL_CELL_SIGNALING	353	12	0.0000980676177546857250000
TCGA-02-0048.9	84	2_CELL_CYCLE_PHASE	146	11	0.0000982444258564001960000
TCGA-06-0875.7	78	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0000987676969239956980000
TCGA-08-0347.4	16	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0000992022045737016780000
TCGA-28-5220.7	15	1_KEGG_MELANOMA	71	5	0.0000994560770351951080000
TCGA-02-0075.8	128	0_HALLMARK_E2F_TARGETS	169	14	0.0001003586272181376600000
TCGA-06-5414.13	102	1_KEGG_MELANOMA	71	9	0.0001007653685259813700000
TCGA-02-0075.8	128	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0001010916752379695700000
TCGA-32-2498.13	133	1_KEGG_CELL_CYCLE	114	12	0.0001011933403459824800000
TCGA-02-0027.3	81	2_SYNAPTIC_TRANSMISSION	152	11	0.0001012815869032297200000
TCGA-27-1833.7	17	2_INTERPHASE	62	5	0.0001016428608859326600000
TCGA-06-0648.6	17	2_INTERPHASE	62	5	0.0001016428608859326600000
TCGA-76-6191.6	96	2_REGULATION_OF_CELL_PROLIFERATION	265	15	0.0001018348002413287300000
TCGA-19-5947.4	267	0_HALLMARK_INFLAMMATORY_RESPONSE	170	20	0.0001024595607778329200000
TCGA-06-5859.9	125	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0001025627348173026100000
TCGA-06-0137.9	53	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001026823286498538200000
TCGA-06-2569.5	144	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0001030507990540228600000
TCGA-06-0877.8	61	2_EXTRACELLULAR_MATRIX	85	8	0.0001037285490723704800000
TCGA-19-1390.12	10	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	116	5	0.0001037617325452496600000
TCGA-02-0011.1	288	2_REGULATION_OF_APOPTOSIS	309	29	0.0001039862947180882900000
TCGA-02-0028.9	182	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0001043454795706315200000
TCGA-76-4927.8	93	2_TRANSMISSION_OF_NERVE_IMPULSE	164	12	0.0001043737366028669200000
TCGA-12-3650.17	101	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	9	0.0001046988396247122900000
TCGA-41-3915.10	109	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0001053139480133158400000
TCGA-14-0817.9	85	2_DNA_METABOLIC_PROCESS	218	13	0.0001059405462216945800000
TCGA-14-0787.3	4	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	4	0.0001060032525913648400000
TCGA-06-0645.9	136	2_INFLAMMATORY_RESPONSE	112	12	0.0001063857335791892100000
TCGA-32-2634.10	118	2_INTERPHASE	62	9	0.0001070143998527989600000
TCGA-19-4068.7	14	2_CHROMOSOMAL_PART	78	5	0.0001075352990694099900000
TCGA-28-2514.9	62	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0001076530734267602700000
TCGA-02-2486.9	141	2_IMMUNE_RESPONSE	206	16	0.0001077376946563531000000
TCGA-06-0650.2	82	2_EXTRACELLULAR_REGION_PART	269	14	0.0001078003510542830600000
TCGA-02-0102.8	82	2_EXTRACELLULAR_REGION_PART	269	14	0.0001078003510542830600000
TCGA-02-0099.11	141	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	10	0.0001079433036893786100000
TCGA-02-0033.5	144	0_HALLMARK_P53_PATHWAY	151	14	0.0001081938023316033900000
TCGA-06-0126.7	5	2_EXTRACELLULAR_REGION	346	5	0.0001082482503095086700000
TCGA-02-0014.10	70	0_HALLMARK_MYC_TARGETS_V1	178	11	0.0001086020160679652900000
TCGA-06-5417.5	79	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0001092952609790032000000
TCGA-06-0879.9	84	2_CELL_CELL_SIGNALING	353	16	0.0001093328615961609400000
TCGA-08-0349.1	31	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	8	0.0001094292998779374400000
TCGA-41-3393.5	88	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0001101013595769643100000
TCGA-02-2485.14	172	2_CELL_CYCLE_GO_0007049	265	20	0.0001101744770403781500000
TCGA-02-0046.8	148	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0001104536773093979300000
TCGA-08-0390.1	54	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001108592018406266900000
TCGA-76-4925.9	83	1_KEGG_BLADDER_CANCER	42	7	0.0001111115147929869000000
TCGA-06-0143.6	63	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0001113470980118594300000
TCGA-08-0389.4	56	2_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0001115689642456572900000
TCGA-08-0389.4	56	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0001115689642456572900000
TCGA-02-0011.1	288	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	29	0.0001116151412654955000000
TCGA-06-5418.4	24	2_SYNAPTIC_TRANSMISSION	152	7	0.0001129586498813683100000
TCGA-19-5955.9	110	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0001131440951131286200000
TCGA-28-5220.7	15	2_CELL_CYCLE_GO_0007049	265	7	0.0001132515113744702100000
TCGA-06-5859.9	125	2_CHROMOSOMAL_PART	78	10	0.0001137713555763358400000
TCGA-12-3652.19	88	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0001142553901528656700000
TCGA-15-0742.13	74	0_HALLMARK_E2F_TARGETS	169	11	0.0001154205536580054900000
TCGA-06-0876.9	106	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0001162844929985747300000
TCGA-15-0742.13	74	1_KEGG_MELANOMA	71	8	0.0001165171142859554500000
TCGA-06-0155.10	74	1_KEGG_MELANOMA	71	8	0.0001165171142859554500000
TCGA-32-1980.1	24	2_HEMOSTASIS	44	5	0.0001165855587009587600000
TCGA-19-1390.13	110	2_DNA_REPAIR	113	11	0.0001170655811042422700000
TCGA-06-0192.10	126	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0001183824820631934100000
TCGA-14-0813.10	53	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0001184934736261114500000
TCGA-06-0143.3	3	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0001188264598042314600000
TCGA-06-0213.9	74	2_CELL_CELL_SIGNALING	353	15	0.0001188458005420380200000
TCGA-06-0155.10	74	2_CELL_CELL_SIGNALING	353	15	0.0001188458005420380200000
TCGA-41-5651.5	112	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0001189269869855042400000
TCGA-14-0871.20	216	2_CHROMOSOME	102	14	0.0001189723422934332500000
TCGA-12-0616.4	7	2_CYTOSKELETAL_PART	194	5	0.0001190438780082450100000
TCGA-06-0187.10	55	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001195133810207321700000
TCGA-06-0745.4	55	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001195133810207321700000
TCGA-06-0145.4	7	2_KINESIN_COMPLEX	13	3	0.0001200080102540832500000
TCGA-06-5415.7	7	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0001200080102540832500000
TCGA-08-0355.2	7	2_KINESIN_COMPLEX	13	3	0.0001200080102540832500000
TCGA-06-0189.3	118	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0001201010776646347800000
TCGA-06-0169.5	42	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0001208181429137841100000
TCGA-06-2561.5	42	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	7	0.0001208181429137841100000
TCGA-41-5651.5	112	1_KEGG_DNA_REPLICATION	32	7	0.0001213246147078230600000
TCGA-06-0138.2	30	2_CELL_CELL_SIGNALING	353	10	0.0001216040827744352400000
TCGA-02-0026.1	61	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0001217248619359907500000
TCGA-06-0881.7	203	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	15	0.0001222156743424602400000
TCGA-76-4926.9	66	0_HALLMARK_ANGIOGENESIS	32	6	0.0001224060307783025800000
TCGA-06-0646.4	63	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0001224291717671687600000
TCGA-02-0075.8	128	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0001234693616108818800000
TCGA-08-0360.3	144	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	11	0.0001234902767124435900000
TCGA-02-0047.8	185	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	12	0.0001242174180749923300000
TCGA-76-6282.11	185	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	12	0.0001242174180749923300000
TCGA-76-6285.5	106	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0001243421552597053200000
TCGA-08-0389.4	56	0_HALLMARK_MYC_TARGETS_V1	178	10	0.0001244245466925788600000
TCGA-06-0195.8	56	0_HALLMARK_MYC_TARGETS_V1	178	10	0.0001244245466925788600000
TCGA-32-2491.14	244	1_KEGG_DNA_REPLICATION	32	9	0.0001244700827891430600000
TCGA-06-0877.7	4	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0001248520416170792500000
TCGA-08-0348.3	4	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0001248520416170792500000
TCGA-02-0007.17	217	2_INTRACELLULAR_ORGANELLE_PART	912	47	0.0001248666769155603400000
TCGA-06-0171.7	57	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0001264181337718707200000
TCGA-02-0026.1	61	2_CELL_CYCLE_PROCESS	163	10	0.0001266655691963512500000
TCGA-12-3653.55	255	2_INTERPHASE	62	12	0.0001270464333654541300000
TCGA-76-6282.11	185	1_KEGG_ASTHMA	30	8	0.0001271121276324184100000
TCGA-06-0192.10	126	0_HALLMARK_KRAS_SIGNALING_UP	148	13	0.0001273069750217896700000
TCGA-06-2565.10	38	2_M_PHASE	94	7	0.0001276912370925882700000
TCGA-06-0686.6	3	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	3	0.0001282074961045579300000
TCGA-19-5958.2	3	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	3	0.0001282074961045579300000
TCGA-06-0152.11	56	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001286629417773311800000
TCGA-02-0026.1	61	2_REPLICATION_FORK	18	5	0.0001288844993414404100000
TCGA-41-3393.4	12	2_SPINDLE	35	4	0.0001292659359758315500000
TCGA-76-4934.7	47	2_COLLAGEN	23	5	0.0001301919896787317800000
TCGA-76-6193.13	271	0_HALLMARK_HYPOXIA	154	19	0.0001301987003652388000000
TCGA-15-1444.3	107	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	13	0.0001302547059656648900000
TCGA-02-0027.3	81	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0001302989533119800700000
TCGA-02-0028.9	182	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0001306183841883261100000
TCGA-28-2502.9	56	2_EXTRACELLULAR_REGION	346	13	0.0001306903370348518300000
TCGA-28-2513.12	134	2_EXTRACELLULAR_REGION	346	20	0.0001309321225762034200000
TCGA-06-0176.8	95	2_COLLAGEN	23	6	0.0001309730455263748200000
TCGA-02-0033.5	144	2_CELL_CELL_SIGNALING	353	21	0.0001311860824972632700000
TCGA-06-5411.4	23	2_CELL_CYCLE_PROCESS	163	7	0.0001313496809005255600000
TCGA-19-2631.1	6	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	5	0.0001313778107439524800000
TCGA-19-2620.8	6	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	5	0.0001313778107439524800000
TCGA-06-2558.6	74	2_MITOTIC_CELL_CYCLE	134	10	0.0001320270116380086500000
TCGA-28-5220.7	15	2_PHOSPHORYLATION	271	7	0.0001321014295083803300000
TCGA-41-2575.49	136	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0001322074288375246700000
TCGA-06-1804.7	47	2_EXTRACELLULAR_REGION	346	12	0.0001336984796107560000000
TCGA-27-1833.7	17	2_MITOTIC_CELL_CYCLE	134	6	0.0001338627491442765900000
TCGA-02-0086.2	17	2_MITOTIC_CELL_CYCLE	134	6	0.0001338627491442765900000
TCGA-06-0648.6	17	2_MITOTIC_CELL_CYCLE	134	6	0.0001338627491442765900000
TCGA-26-5139.10	163	2_TISSUE_DEVELOPMENT	115	13	0.0001338750865837774600000
TCGA-06-0143.6	63	2_EXTRACELLULAR_MATRIX	85	8	0.0001344476981841807700000
TCGA-27-2523.12	112	2_CELL_CYCLE_GO_0007049	265	16	0.0001344684023695876500000
TCGA-28-5208.28	220	2_SYNAPTIC_TRANSMISSION	152	17	0.0001347071465617143700000
TCGA-19-5947.4	267	1_KEGG_ECM_RECEPTOR_INTERACTION	84	14	0.0001347428294988483000000
TCGA-32-2634.10	118	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0001349123649097059100000
TCGA-06-6389.1	18	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0001349364060043436100000
TCGA-15-1444.3	107	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0001349691069158948900000
TCGA-41-3393.5	88	2_EXTRACELLULAR_MATRIX	85	9	0.0001358441663708604600000
TCGA-02-0107.3	71	2_EXTRACELLULAR_REGION_PART	269	13	0.0001358762700506160100000
TCGA-32-2498.13	133	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0001363828925842886000000
TCGA-06-6391.7	5	2_CELL_DIVISION	20	3	0.0001367375361253355300000
TCGA-02-0046.8	148	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0001373959098740100200000
TCGA-06-0686.6	3	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	3	0.0001380696111895146800000
TCGA-19-5958.2	3	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	3	0.0001380696111895146800000
TCGA-06-0133.6	57	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001383262848823495900000
TCGA-06-0171.7	57	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001383262848823495900000
TCGA-12-0692.7	23	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	8	0.0001385231651930798300000
TCGA-76-6285.5	106	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0001387766109552435800000
TCGA-19-2624.29	130	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0001393618041000123300000
TCGA-76-6191.6	96	2_COLLAGEN	23	6	0.0001394878286703471700000
TCGA-32-2638.17	159	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0001395561408635526100000
TCGA-02-0086.2	17	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0001397804655694664100000
TCGA-06-0648.6	17	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0001397804655694664100000
TCGA-02-0011.1	288	2_APOPTOSIS_GO	389	33	0.0001401724359429399600000
TCGA-02-2485.14	172	0_HALLMARK_APOPTOSIS	150	15	0.0001409904298755146500000
TCGA-06-0173.35	120	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0001410276158533678200000
TCGA-06-0645.9	136	0_HALLMARK_ALLOGRAFT_REJECTION	190	15	0.0001422065733656977200000
TCGA-76-4926.9	66	2_SYNAPTIC_TRANSMISSION	152	10	0.0001422878616573112600000
TCGA-02-0007.17	217	2_ORGANELLE_PART	916	47	0.0001426845407474733200000
TCGA-14-0817.9	85	2_CELL_CYCLE_GO_0007049	265	14	0.0001432288953443474000000
TCGA-32-4719.15	123	1_KEGG_ASTHMA	30	7	0.0001432785024531521600000
TCGA-02-0003.9	227	0_HALLMARK_KRAS_SIGNALING_UP	148	17	0.0001433305010866888200000
TCGA-06-0125.9	75	2_CELL_CELL_SIGNALING	353	15	0.0001435829046923306100000
TCGA-19-5952.11	193	1_KEGG_FOCAL_ADHESION	195	18	0.0001437375433159364400000
TCGA-28-5207.12	188	1_KEGG_ASTHMA	30	8	0.0001440186841062905700000
TCGA-06-0877.7	4	2_CELL_CYCLE_PROCESS	163	4	0.0001443615308488250200000
TCGA-08-0348.3	4	2_CELL_CYCLE_PROCESS	163	4	0.0001443615308488250200000
TCGA-28-2513.12	134	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0001445883328374595200000
TCGA-81-5910.12	128	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0001449212949266675100000
TCGA-02-2485.14	172	1_KEGG_PATHWAYS_IN_CANCER	323	22	0.0001450742658334511500000
TCGA-08-0357.4	36	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0001453254438753693700000
TCGA-06-0744.10	36	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0001453254438753693700000
TCGA-02-0003.9	227	1_KEGG_LEISHMANIA_INFECTION	70	12	0.0001454551385724826000000
TCGA-12-0688.10	93	0_HALLMARK_E2F_TARGETS	169	12	0.0001455891975148371700000
TCGA-06-0184.11	108	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0001463797965296478800000
TCGA-08-0347.4	16	2_CELL_CYCLE_PHASE	146	6	0.0001463806519212457900000
TCGA-02-0027.3	81	1_KEGG_FOCAL_ADHESION	195	12	0.0001465059231391486300000
TCGA-32-1980.1	24	2_WOUND_HEALING	46	5	0.0001466598402374378900000
TCGA-06-0650.2	82	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0001467951230531938800000
TCGA-06-6390.9	82	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0001467951230531938800000
TCGA-76-4926.9	66	1_KEGG_FOCAL_ADHESION	195	11	0.0001472275573486772700000
TCGA-28-5218.5	208	2_CORNIFIED_ENVELOPE	12	6	0.0001481833769429472600000
TCGA-06-0939.7	58	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001485221357135819700000
TCGA-02-0011.1	288	2_PROGRAMMED_CELL_DEATH	390	33	0.0001490013378191833600000
TCGA-32-1977.11	107	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0001493810517794451800000
TCGA-28-5216.8	162	2_REGULATION_OF_CELL_CYCLE	160	15	0.0001503525463539325000000
TCGA-06-0145.17	11	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0001503636853511089400000
TCGA-32-4211.14	71	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0001505417534171422000000
TCGA-06-0189.3	118	2_EXTRACELLULAR_MATRIX	85	10	0.0001513096809828806000000
TCGA-28-5218.5	208	0_HALLMARK_COAGULATION	125	15	0.0001514822995166956100000
TCGA-14-0871.20	216	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0001527518980129223700000
TCGA-41-2575.49	136	2_M_PHASE	94	11	0.0001544912268392120000000
TCGA-28-5209.15	194	1_KEGG_FOCAL_ADHESION	195	18	0.0001556004876146123000000
TCGA-06-0168.4	22	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0001556731344736114400000
TCGA-12-3653.55	255	2_DNA_METABOLIC_PROCESS	218	22	0.0001557877333892681800000
TCGA-26-1439.11	10	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0001560776360463167300000
TCGA-32-1977.3	8	0_HALLMARK_E2F_TARGETS	169	5	0.0001564413977421306000000
TCGA-02-0007.17	217	2_CYTOSKELETAL_PART	194	19	0.0001566273186501890300000
TCGA-76-4929.8	91	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0001570191518026568700000
TCGA-06-0122.8	90	0_HALLMARK_COMPLEMENT	176	12	0.0001571398055049112700000
TCGA-08-0375.6	65	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0001572811292034301500000
TCGA-06-0158.4	65	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0001572811292034301500000
TCGA-02-0011.1	288	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	33	0.0001583486480318499100000
TCGA-41-3915.10	109	1_KEGG_LEISHMANIA_INFECTION	70	9	0.0001586228556345858100000
TCGA-41-3915.10	109	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0001586228556345858100000
TCGA-19-1390.13	110	2_BIOPOLYMER_METABOLIC_PROCESS	1367	38	0.0001591357707748435500000
TCGA-14-2554.5	59	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001592695436762300100000
TCGA-32-2494.10	173	2_REGULATION_OF_PHOSPHORYLATION	45	9	0.0001597382530492459500000
TCGA-28-5215.7	192	0_HALLMARK_COMPLEMENT	176	17	0.0001599667272615997800000
TCGA-28-5220.7	15	2_REGULATION_OF_CELL_CYCLE	160	6	0.0001601355928977711900000
TCGA-32-2632.16	229	1_KEGG_LEISHMANIA_INFECTION	70	12	0.0001601687988085591200000
TCGA-32-2632.16	229	1_KEGG_VIRAL_MYOCARDITIS	70	12	0.0001601687988085591200000
TCGA-06-1804.6	30	0_HALLMARK_DNA_REPAIR	125	7	0.0001601690088008339100000
TCGA-06-0130.3	155	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	11	0.0001604036462583494200000
TCGA-06-0184.11	108	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0001606755702612180400000
TCGA-06-5415.7	7	1_KEGG_PANCREATIC_CANCER	70	4	0.0001607305003550419200000
TCGA-06-5415.7	7	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0001607305003550419200000
TCGA-76-6282.11	185	1_KEGG_LEISHMANIA_INFECTION	70	11	0.0001613446721013780300000
TCGA-02-0071.12	116	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0001614367482631001300000
TCGA-06-0645.9	136	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0001622819504470324800000
TCGA-19-5959.13	92	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0001627295473131049600000
TCGA-32-2632.16	229	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	13	0.0001635239607998589200000
TCGA-06-5856.13	152	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0001639775644094401300000
TCGA-06-5858.19	205	2_CELL_CYCLE_PHASE	146	16	0.0001648474872696266700000
TCGA-19-2624.29	130	2_CHROMOSOMAL_PART	78	10	0.0001653340083120949100000
TCGA-06-0219.6	6	2_CELL_CYCLE_GO_0007049	265	5	0.0001657542880369776800000
TCGA-08-0244.4	6	2_CELL_CYCLE_GO_0007049	265	5	0.0001657542880369776800000
TCGA-12-5299.5	6	2_CELL_CYCLE_GO_0007049	265	5	0.0001657542880369776800000
TCGA-14-1823.12	6	2_REGULATION_OF_CELL_PROLIFERATION	265	5	0.0001657542880369776800000
TCGA-14-1829.11	6	2_CELL_CYCLE_GO_0007049	265	5	0.0001657542880369776800000
TCGA-14-2554.9	6	2_CELL_CYCLE_GO_0007049	265	5	0.0001657542880369776800000
TCGA-06-0125.6	8	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	5	0.0001659478049853058500000
TCGA-02-0068.1	72	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0001660727455681342700000
TCGA-32-2498.13	133	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0001664938961884410600000
TCGA-06-0649.13	88	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0001666856377948005000000
TCGA-19-5954.17	208	2_CELL_CYCLE_PROCESS	163	17	0.0001667297893881537000000
TCGA-27-1836.8	49	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0001675450438196108200000
TCGA-27-2528.10	99	2_COLLAGEN	23	6	0.0001678162073185403700000
TCGA-28-5204.5	5	1_KEGG_CELL_CYCLE	114	4	0.0001683571388454677300000
TCGA-06-0881.7	203	2_EXTRACELLULAR_MATRIX_PART	51	10	0.0001684536741216904300000
TCGA-19-5954.17	208	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	15	0.0001686502767532419100000
TCGA-06-0192.10	126	1_KEGG_ASTHMA	30	7	0.0001692266676668777500000
TCGA-06-5415.7	7	1_KEGG_MELANOMA	71	4	0.0001702828433269841800000
TCGA-06-2567.9	156	2_CHROMOSOME	102	12	0.0001705495511315090700000
TCGA-06-2565.3	60	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001705878816249717700000
TCGA-06-0143.3	3	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0001706626988483258600000
TCGA-06-0130.3	155	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0001712178230146338300000
TCGA-06-5418.4	24	2_CELL_CELL_SIGNALING	353	9	0.0001723399024326596600000
TCGA-06-0145.17	11	1_KEGG_CELL_CYCLE	114	5	0.0001725962475219382100000
TCGA-06-6390.6	11	1_KEGG_CELL_CYCLE	114	5	0.0001725962475219382100000
TCGA-32-4210.14	109	2_CELL_CYCLE_PHASE	146	12	0.0001726564292175207200000
TCGA-41-3915.10	109	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0001726972749902726600000
TCGA-41-3915.10	109	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0001726972749902726600000
TCGA-28-5207.12	188	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0001727062069482532500000
TCGA-19-2629.15	146	1_KEGG_LEISHMANIA_INFECTION	70	10	0.0001730913868802252000000
TCGA-06-2567.9	156	2_DNA_METABOLIC_PROCESS	218	17	0.0001731338705733151100000
TCGA-14-0787.6	40	2_CELL_CYCLE_GO_0007049	265	10	0.0001734421385505525100000
TCGA-02-0001.5	117	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0001739354427558654300000
TCGA-06-5412.7	153	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	9	0.0001741213176008080500000
TCGA-06-0174.37	141	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0001751405358012799000000
TCGA-28-5204.3	4	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	4	0.0001751636632978574100000
TCGA-08-0389.4	56	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0001753712355880748600000
TCGA-06-2558.6	74	2_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0001758591090733464600000
TCGA-06-2558.6	74	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0001758591090733464600000
TCGA-32-2615.7	77	0_HALLMARK_E2F_TARGETS	169	11	0.0001761516336511815900000
TCGA-28-2513.12	134	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0001764942620660634200000
TCGA-19-5960.9	134	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0001764942620660634200000
TCGA-06-5859.9	125	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	9	0.0001766057284096354600000
TCGA-06-5859.9	125	2_INTERPHASE	62	9	0.0001766057284096354600000
TCGA-27-1833.7	17	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0001768887721086989900000
TCGA-06-0648.6	17	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0001768887721086989900000
TCGA-76-4926.9	66	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0001776941793808656000000
TCGA-02-0048.9	84	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0001776941793808656000000
TCGA-12-3653.55	255	2_MITOTIC_CELL_CYCLE	134	17	0.0001780345781310479300000
TCGA-19-2619.14	100	2_COLLAGEN	23	6	0.0001782508263243233300000
TCGA-26-5132.7	100	2_CELL_CYCLE_GO_0007049	265	15	0.0001783538996126849800000
TCGA-76-4935.7	15	2_CELL_CYCLE_PROCESS	163	6	0.0001788887105573047100000
TCGA-12-0688.10	93	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0001788914941649814300000
TCGA-02-0011.1	288	0_HALLMARK_KRAS_SIGNALING_UP	148	19	0.0001792298809719273700000
TCGA-02-0113.3	46	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0001795212275341136300000
TCGA-02-0060.19	281	0_HALLMARK_UV_RESPONSE_DN	122	17	0.0001795459050760582100000
TCGA-02-2483.10	100	2_CHROMOSOME	102	10	0.0001798086644299665500000
TCGA-06-5415.7	7	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	4	0.0001802534222691193100000
TCGA-06-2564.7	92	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0001808135319063446700000
TCGA-19-5959.13	92	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0001808135319063446700000
TCGA-32-1977.3	8	0_HALLMARK_G2M_CHECKPOINT	174	5	0.0001810643781262149800000
TCGA-06-5859.9	125	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0001811934754248395100000
TCGA-02-0011.1	288	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	22	0.0001830559500863525000000
TCGA-06-0645.9	136	2_DEFENSE_RESPONSE	222	16	0.0001831643450923479900000
TCGA-76-6193.13	271	2_INFLAMMATORY_RESPONSE	112	16	0.0001833377105666913700000
TCGA-19-2624.29	130	2_SPINDLE_ORGANIZATION_AND_BIOGENESIS	10	5	0.0001840302128549712400000
TCGA-32-1982.9	89	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0001840568611408042400000
TCGA-06-5418.5	13	1_KEGG_FOCAL_ADHESION	195	6	0.0001840634548371187200000
TCGA-06-5414.13	102	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0001852701314094224800000
TCGA-27-2521.10	94	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0001856086942564629500000
TCGA-06-0142.3	8	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	5	0.0001863397519882088400000
TCGA-02-0074.5	118	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0001872695185247289300000
TCGA-06-0645.9	136	2_IMMUNE_SYSTEM_PROCESS	283	18	0.0001876923643115396700000
TCGA-02-0114.20	132	2_CELL_CYCLE_PHASE	146	13	0.0001886956231287300500000
TCGA-06-5412.7	153	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	13	0.0001887818057292483000000
TCGA-41-2571.7	72	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0001890619180239389000000
TCGA-15-1444.3	107	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	12	0.0001892048695116746000000
TCGA-02-0060.19	281	1_KEGG_VIRAL_MYOCARDITIS	70	13	0.0001898791770362411900000
TCGA-06-5418.4	24	2_TRANSMISSION_OF_NERVE_IMPULSE	164	7	0.0001906044776713583400000
TCGA-02-0107.3	71	0_HALLMARK_ANGIOGENESIS	32	6	0.0001906741201272002900000
TCGA-06-0214.9	62	2_REGULATION_OF_CELL_PROLIFERATION	265	12	0.0001937106576597224800000
TCGA-41-3393.4	12	1_KEGG_OOCYTE_MEIOSIS	105	5	0.0001938294366745466400000
TCGA-06-0747.12	80	2_TRANSMISSION_OF_NERVE_IMPULSE	164	11	0.0001940351378608814900000
TCGA-06-0139.1	179	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	16	0.0001942152822442439200000
TCGA-06-0130.3	155	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0001947471401381560700000
TCGA-06-0129.11	110	2_MITOSIS	71	9	0.0001947874978762620900000
TCGA-28-2509.5	4	1_KEGG_ASTHMA	30	3	0.0001948992264520511000000
TCGA-06-0126.3	4	1_KEGG_ASTHMA	30	3	0.0001948992264520511000000
TCGA-08-0246.6	62	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0001950164526820988100000
TCGA-32-2634.10	118	2_NUCLEUS	1110	35	0.0001950550928128759000000
TCGA-08-0245.4	85	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0001950827048844313800000
TCGA-14-0817.9	85	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0001950827048844313800000
TCGA-06-0189.3	118	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0001959804372368834800000
TCGA-06-0129.11	110	2_CELL_PROLIFERATION_GO_0008283	436	20	0.0001964048630961299200000
TCGA-27-2521.10	94	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0001964346886468276300000
TCGA-06-0241.8	53	1_KEGG_MELANOMA	71	7	0.0001980611041728537500000
TCGA-28-2501.3	51	2_COLLAGEN	23	5	0.0001981085529833945700000
TCGA-06-0141.1	45	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	7	0.0001989090549965582900000
TCGA-02-0048.9	84	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0001989090549965582900000
TCGA-08-0355.1	45	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0001989090549965582900000
TCGA-32-4719.15	123	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0002003557070029904600000
TCGA-06-0645.9	136	1_KEGG_FOCAL_ADHESION	195	15	0.0002005091343065173200000
TCGA-41-2575.49	136	1_KEGG_FOCAL_ADHESION	195	15	0.0002005091343065173200000
TCGA-19-5959.13	92	2_EXTRACELLULAR_MATRIX	85	9	0.0002006239294040812900000
TCGA-12-0688.10	93	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0002008079371763274900000
TCGA-08-0360.3	144	2_INFLAMMATORY_RESPONSE	112	12	0.0002008430374803186300000
TCGA-02-0075.8	128	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0002022668044680900900000
TCGA-28-2501.3	51	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	207	10	0.0002023886021525426600000
TCGA-06-5418.4	24	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	8	0.0002030062468982163500000
TCGA-06-0878.10	115	1_KEGG_CELL_CYCLE	114	11	0.0002036284679865120100000
TCGA-06-0129.11	110	2_M_PHASE	94	10	0.0002043743156004110200000
TCGA-19-1390.13	110	2_M_PHASE	94	10	0.0002043743156004110200000
TCGA-12-1597.6	51	2_CELL_CYCLE_GO_0007049	265	11	0.0002044794188579715600000
TCGA-12-5299.6	38	2_SYNAPTIC_TRANSMISSION	152	8	0.0002048953608638638000000
TCGA-06-0130.3	155	2_EXTRACELLULAR_MATRIX	85	11	0.0002061253972163874200000
TCGA-76-6193.13	271	2_CELLULAR_DEFENSE_RESPONSE	50	11	0.0002064850181748913700000
TCGA-02-0026.1	61	2_INTERPHASE	62	7	0.0002068040115138066700000
TCGA-06-0686.6	3	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	3	0.0002080184664749895200000
TCGA-19-5958.2	3	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	3	0.0002080184664749895200000
TCGA-06-0646.4	63	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0002081670435519371400000
TCGA-06-0743.14	63	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0002081670435519371400000
TCGA-76-6193.13	271	1_KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	99	15	0.0002085588085682332700000
TCGA-02-0064.3	26	2_SYNAPTIC_TRANSMISSION	152	7	0.0002089686890271401400000
TCGA-28-2514.9	62	0_HALLMARK_E2F_TARGETS	169	10	0.0002093326638367415300000
TCGA-06-0211.8	62	0_HALLMARK_E2F_TARGETS	169	10	0.0002093326638367415300000
TCGA-08-0357.4	36	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0002093456271257260500000
TCGA-06-0744.10	36	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0002093456271257260500000
TCGA-06-0881.7	203	0_HALLMARK_APOPTOSIS	150	16	0.0002103739670849067300000
TCGA-02-0089.5	91	1_KEGG_BLADDER_CANCER	42	7	0.0002110316344623626200000
TCGA-08-0360.3	144	2_EXTRACELLULAR_REGION_PART	269	18	0.0002114955953289261200000
TCGA-19-2624.19	5	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	3	0.0002123216354215716600000
TCGA-12-3650.17	101	2_CHROMOSOMAL_PART	78	9	0.0002127770332133370100000
TCGA-76-4934.4	20	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0002129619242056561300000
TCGA-06-0145.19	81	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0002130965016529693200000
TCGA-06-0174.37	141	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0002132853485689930200000
TCGA-06-0174.37	141	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0002132853485689930200000
TCGA-06-0184.11	108	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0002141519527928169900000
TCGA-28-2513.12	134	2_AXON	10	5	0.0002142606997407539700000
TCGA-32-2634.10	118	1_KEGG_FOCAL_ADHESION	195	14	0.0002143676498539738300000
TCGA-02-0038.3	199	2_MITOTIC_CELL_CYCLE	134	15	0.0002149420907712107000000
TCGA-06-0176.8	95	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0002154581127887234000000
TCGA-32-4213.15	198	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0002155230574503542800000
TCGA-27-1837.5	85	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0002159943356688088600000
TCGA-27-2519.7	113	1_KEGG_LEISHMANIA_INFECTION	70	9	0.0002169789112046757300000
TCGA-87-5896.6	131	2_NON_MEMBRANE_BOUND_ORGANELLE	476	23	0.0002178724240554491500000
TCGA-87-5896.6	131	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	23	0.0002178724240554491500000
TCGA-06-0216.6	67	2_CELL_CELL_SIGNALING	353	14	0.0002185529758891702600000
TCGA-76-6285.5	106	2_DNA_METABOLIC_PROCESS	218	14	0.0002188037416374619200000
TCGA-06-0750.12	52	2_COLLAGEN	23	5	0.0002188350437254720700000
TCGA-08-0389.4	56	2_CHROMOSOME	102	8	0.0002188738748723423400000
TCGA-06-0195.8	56	2_CHROMOSOME	102	8	0.0002188738748723423400000
TCGA-08-0359.5	37	0_HALLMARK_ANGIOGENESIS	32	5	0.0002193084626669682200000
TCGA-06-0129.11	110	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	9	0.0002204714593694399400000
TCGA-12-0688.10	93	2_EXTRACELLULAR_MATRIX	85	9	0.0002205073267989434500000
TCGA-27-2524.5	75	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0002210309337326538800000
TCGA-02-0027.3	81	2_TRANSMISSION_OF_NERVE_IMPULSE	164	11	0.0002211933783360149500000
TCGA-02-2483.10	100	2_CELL_CYCLE_PROCESS	163	12	0.0002215606629714709200000
TCGA-26-1439.10	84	1_KEGG_FOCAL_ADHESION	195	12	0.0002217361789717220400000
TCGA-02-0038.3	199	2_NUCLEAR_PART	466	29	0.0002227626807729372600000
TCGA-02-0086.2	17	2_CELL_CYCLE_PHASE	146	6	0.0002233546658764804900000
TCGA-06-0648.6	17	2_CELL_CYCLE_PHASE	146	6	0.0002233546658764804900000
TCGA-32-1979.4	12	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0002248579053701090300000
TCGA-02-0003.9	227	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	13	0.0002263265109282665200000
TCGA-06-5413.11	142	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0002269957108374782300000
TCGA-06-0122.8	90	2_EXTRACELLULAR_REGION	346	16	0.0002275820518143942100000
TCGA-28-1753.13	174	0_HALLMARK_COMPLEMENT	176	16	0.0002304783966759529300000
TCGA-02-0048.9	84	2_NON_MEMBRANE_BOUND_ORGANELLE	476	18	0.0002315119854663926000000
TCGA-02-0048.9	84	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	18	0.0002315119854663926000000
TCGA-02-0043.10	184	2_SYSTEM_DEVELOPMENT	694	35	0.0002329631208066671700000
TCGA-14-3476.17	53	2_SYNAPTIC_TRANSMISSION	152	9	0.0002332053319723867800000
TCGA-32-1986.8	87	2_EXTRACELLULAR_REGION_PART	269	14	0.0002334472755212119000000
TCGA-02-0014.10	70	2_DNA_REPLICATION	82	8	0.0002347535339969909700000
TCGA-06-0197.1	57	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	16	0.0002354090308231112700000
TCGA-76-6191.6	96	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0002360664657521178600000
TCGA-76-6191.6	96	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0002360664657521178600000
TCGA-32-2638.17	159	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0002362628664290842100000
TCGA-08-0375.6	65	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0002364441398093618800000
TCGA-06-0158.4	65	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0002364441398093618800000
TCGA-28-5204.3	4	2_CALCIUM_CHANNEL_ACTIVITY	32	3	0.0002380655930138500300000
TCGA-06-0686.1	7	2_RECEPTOR_ACTIVITY	499	6	0.0002383692346187669300000
TCGA-02-0043.10	184	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	14	0.0002387918761678675300000
TCGA-06-5411.4	23	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	5	0.0002412457272816744300000
TCGA-06-0137.9	53	2_COLLAGEN	23	5	0.0002412457272816744300000
TCGA-14-0789.10	106	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0002417727616277016000000
TCGA-76-6285.5	106	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0002417727616277016000000
TCGA-41-5651.5	112	2_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0002420664586492267100000
TCGA-41-5651.5	112	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0002420664586492267100000
TCGA-02-0034.4	88	2_SYNAPTIC_TRANSMISSION	152	11	0.0002427774337826904100000
TCGA-06-0646.4	63	0_HALLMARK_E2F_TARGETS	169	10	0.0002450267291503145300000
TCGA-28-5214.11	124	1_KEGG_DNA_REPLICATION	32	7	0.0002451279961424922600000
TCGA-19-1790.18	201	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0002451628714736949100000
TCGA-06-2558.6	74	2_CHROMOSOMAL_PART	78	8	0.0002458100660136370000000
TCGA-02-0083.21	135	1_KEGG_PATHWAYS_IN_CANCER	323	19	0.0002458432120046962800000
TCGA-19-2624.29	130	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0002458560163096333000000
TCGA-06-0750.13	8	2_INTEGRAL_TO_PLASMA_MEMBRANE	751	7	0.0002459428602136226900000
TCGA-14-0789.10	106	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0002460035564240914900000
TCGA-76-6193.13	271	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	12	0.0002473457436517473300000
TCGA-02-0026.1	61	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0002476424692227652000000
TCGA-14-4157.7	101	2_CELL_CYCLE_PROCESS	163	12	0.0002477199729697173600000
TCGA-06-0195.8	56	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0002477531412726847600000
TCGA-02-2483.10	100	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	8	0.0002485520832281277100000
TCGA-02-0009.6	188	0_HALLMARK_ANGIOGENESIS	32	8	0.0002501419308105630200000
TCGA-06-0686.6	3	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	3	0.0002504616422491228100000
TCGA-19-5958.2	3	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	3	0.0002504616422491228100000
TCGA-76-4926.9	66	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0002516129280860250900000
TCGA-12-5295.8	66	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0002516129280860250900000
TCGA-06-0127.3	5	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	4	0.0002522718229588345800000
TCGA-08-0347.4	16	2_REGULATION_OF_CELL_CYCLE	160	6	0.0002526416717586655800000
TCGA-76-6285.5	106	2_COLLAGEN	23	6	0.0002527220663351096400000
TCGA-02-0011.1	288	1_KEGG_LEISHMANIA_INFECTION	70	13	0.0002529304055407907300000
TCGA-08-0360.3	144	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0002529998898647401700000
TCGA-41-2573.4	31	1_KEGG_FOCAL_ADHESION	195	8	0.0002531485611764437700000
TCGA-06-0148.6	69	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0002531715438125145000000
TCGA-06-0141.1	45	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	7	0.0002539041501188215100000
TCGA-41-4097.6	48	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0002540813218984048700000
TCGA-27-1834.10	39	2_SYNAPTIC_TRANSMISSION	152	8	0.0002542851091548813500000
TCGA-76-6282.11	185	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	14	0.0002554588483147694700000
TCGA-19-5947.4	267	2_RESPONSE_TO_WOUNDING	163	19	0.0002570912926831382900000
TCGA-02-0024.6	206	0_HALLMARK_APOPTOSIS	150	16	0.0002577395768482540500000
TCGA-32-1977.11	107	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0002579741105485037900000
TCGA-15-1444.3	107	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0002579741105485037900000
TCGA-16-1048.13	97	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0002583704122636359400000
TCGA-06-0174.37	141	2_MICROTUBULE_CYTOSKELETON	117	12	0.0002589694097363045700000
TCGA-28-5216.8	162	2_ECTODERM_DEVELOPMENT	66	10	0.0002597148594214211000000
TCGA-32-1986.8	87	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0002600355337223106900000
TCGA-27-2521.10	94	2_INTERPHASE	62	8	0.0002611872604992544600000
TCGA-32-4213.15	198	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0002620740720586012700000
TCGA-32-4213.15	198	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	12	0.0002620740720586012700000
TCGA-06-0174.37	141	1_KEGG_BLADDER_CANCER	42	8	0.0002621231436789601800000
TCGA-26-5134.3	21	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0002626470627561734900000
TCGA-76-4935.8	21	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0002626470627561734900000
TCGA-27-2521.10	94	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0002642783837324524000000
TCGA-06-0750.13	8	2_INTRINSIC_TO_PLASMA_MEMBRANE	759	7	0.0002647462634411639100000
TCGA-06-0195.8	56	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0002650693259508397700000
TCGA-06-0195.8	56	1_KEGG_VIRAL_MYOCARDITIS	70	7	0.0002650693259508397700000
TCGA-06-0176.8	95	2_EXTRACELLULAR_MATRIX	85	9	0.0002654790393847721900000
TCGA-27-2524.5	75	1_KEGG_DNA_REPLICATION	32	6	0.0002655502400227436300000
TCGA-32-2615.7	77	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0002656160766749218200000
TCGA-32-1977.11	107	2_COLLAGEN	23	6	0.0002673195929371621700000
TCGA-06-0216.6	67	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0002674972644651567500000
TCGA-14-1829.14	67	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0002674972644651567500000
TCGA-32-2495.11	67	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0002674972644651567500000
TCGA-12-3653.55	255	1_KEGG_PATHWAYS_IN_CANCER	323	27	0.0002675140296877533400000
TCGA-14-4157.7	101	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	8	0.0002686581267921574600000
TCGA-32-4213.15	198	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0002693744827176389300000
TCGA-32-1977.11	107	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0002711252082698468900000
TCGA-15-1444.3	107	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0002711252082698468900000
TCGA-06-0241.8	53	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0002711840631606273900000
TCGA-06-2558.6	74	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0002711954104149839100000
TCGA-08-0354.7	47	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0002717505597807310100000
TCGA-32-1979.4	12	1_KEGG_BLADDER_CANCER	42	4	0.0002750210108871978000000
TCGA-32-1980.1	24	2_REGULATION_OF_BODY_FLUID_LEVELS	52	5	0.0002752773029427804900000
TCGA-06-0197.1	57	1_KEGG_BLADDER_CANCER	42	6	0.0002759946033959377100000
TCGA-06-0645.9	136	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0002766604868391945200000
TCGA-06-5413.11	142	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0002768766654723836400000
TCGA-12-3653.55	255	2_NUCLEUS	1110	59	0.0002793042832235212600000
TCGA-16-1045.10	81	1_KEGG_ASTHMA	30	6	0.0002802816620898605900000
TCGA-02-0071.12	116	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0002806703021240038300000
TCGA-08-0347.4	16	2_CELL_CYCLE_PROCESS	163	6	0.0002821503822919852300000
TCGA-28-5218.5	208	0_HALLMARK_E2F_TARGETS	169	17	0.0002832312543323415400000
TCGA-02-0038.3	199	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	47	0.0002834172105708921000000
TCGA-26-1439.10	84	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0002837931571137858600000
TCGA-28-5218.5	208	1_KEGG_P53_SIGNALING_PATHWAY	66	11	0.0002842265305044098800000
TCGA-06-0176.8	95	1_KEGG_BLADDER_CANCER	42	7	0.0002843717766071773900000
TCGA-19-4068.2	11	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	5	0.0002852970622843756300000
TCGA-76-4928.15	78	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0002882508734935296600000
TCGA-19-5952.11	193	1_KEGG_MELANOMA	71	11	0.0002889162879229043900000
TCGA-76-4931.10	86	1_KEGG_FOCAL_ADHESION	195	12	0.0002894231984958264600000
TCGA-02-0026.1	61	0_HALLMARK_MYC_TARGETS_V1	178	10	0.0002904854769496138000000
TCGA-06-5856.13	152	1_KEGG_MELANOMA	71	10	0.0002907110562353791200000
TCGA-76-6191.6	96	2_EXTRACELLULAR_MATRIX	85	9	0.0002908162836414397600000
TCGA-76-4926.9	66	2_TRANSMISSION_OF_NERVE_IMPULSE	164	10	0.0002914628944363231100000
TCGA-06-0124.6	55	2_COLLAGEN	23	5	0.0002915185258238049000000
TCGA-02-0075.8	128	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0002922785728216425900000
TCGA-02-0075.8	128	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0002922785728216425900000
TCGA-08-0358.9	43	1_KEGG_FOCAL_ADHESION	195	9	0.0002936484372692298600000
TCGA-28-5208.28	220	2_CELL_CELL_SIGNALING	353	26	0.0002944870755752614000000
TCGA-28-5213.9	143	2_AXON	10	5	0.0002967841465132662800000
TCGA-06-2558.6	74	2_CELL_CYCLE_PHASE	146	10	0.0002973733661652643200000
TCGA-02-0033.1	4	1_KEGG_FOCAL_ADHESION	195	4	0.0002975074737158271700000
TCGA-02-0016.4	4	1_KEGG_FOCAL_ADHESION	195	4	0.0002975074737158271700000
TCGA-06-2567.9	156	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0002985427235952237300000
TCGA-41-3915.10	109	2_COLLAGEN	23	6	0.0002986028680806571900000
TCGA-06-0881.7	203	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0003004917373751708600000
TCGA-06-0148.6	69	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0003015006585980916000000
TCGA-02-0043.10	184	2_COLLAGEN	23	7	0.0003017853982516836400000
TCGA-02-2483.10	100	2_DNA_REPLICATION	82	9	0.0003027799535770058100000
TCGA-28-1753.13	174	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0003029767662707166300000
TCGA-14-0790.9	104	2_CELL_CYCLE_GO_0007049	265	15	0.0003037618728497849600000
TCGA-02-0048.9	84	2_CELL_CYCLE_PROCESS	163	11	0.0003044412263628137700000
TCGA-06-2565.10	38	2_REGULATION_OF_CELL_CYCLE	160	8	0.0003047634517516081800000
TCGA-06-2559.11	101	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0003052412885639516900000
TCGA-76-6191.6	96	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0003057395193450498400000
TCGA-06-5859.9	125	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0003068494032728554700000
TCGA-02-0033.5	144	2_AXON	10	5	0.0003073226946849441800000
TCGA-19-5958.4	35	1_KEGG_PANCREATIC_CANCER	70	6	0.0003079865020620581600000
TCGA-02-0026.1	61	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0003080460022208656100000
TCGA-76-6282.11	185	0_HALLMARK_KRAS_SIGNALING_UP	148	15	0.0003088928521096930900000
TCGA-06-2558.6	74	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0003091735113648103500000
TCGA-28-2513.12	134	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	13	0.0003101272458300955300000
TCGA-06-0877.7	4	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0003140659813711730600000
TCGA-08-0348.3	4	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0003140659813711730600000
TCGA-19-5954.17	208	1_KEGG_ASTHMA	30	8	0.0003146274613130459200000
TCGA-19-1390.13	110	1_KEGG_MISMATCH_REPAIR	23	6	0.0003153395358269347300000
TCGA-06-0189.3	118	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0003155766380510724000000
TCGA-26-1439.10	84	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0003158787106807992200000
TCGA-26-1439.11	10	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0003159268233975435200000
TCGA-28-5204.3	4	2_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	198	4	0.0003163917133322919000000
TCGA-02-0038.3	199	0_HALLMARK_MYC_TARGETS_V1	178	17	0.0003177702646316341400000
TCGA-16-1048.13	97	2_EXTRACELLULAR_MATRIX	85	9	0.0003182322892863111000000
TCGA-06-0219.6	6	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0003185475659797437800000
TCGA-08-0244.4	6	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0003185475659797437800000
TCGA-12-5299.5	6	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0003185475659797437800000
TCGA-14-1823.12	6	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0003185475659797437800000
TCGA-14-1829.11	6	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0003185475659797437800000
TCGA-14-2554.9	6	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0003185475659797437800000
TCGA-19-4068.2	11	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	4	0.0003186225524812704900000
TCGA-06-0145.17	11	2_CELL_CYCLE_GO_0007049	265	6	0.0003193576976994510400000
TCGA-28-2502.9	56	2_COLLAGEN	23	5	0.0003195891642548654700000
TCGA-02-0014.10	70	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0003196645499842647800000
TCGA-27-2521.10	94	2_CELL_CYCLE_PHASE	146	11	0.0003200374067368724400000
TCGA-02-0071.12	116	0_HALLMARK_G2M_CHECKPOINT	174	13	0.0003201864439145646400000
TCGA-06-0189.3	118	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0003205567842135642600000
TCGA-06-0189.3	118	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0003205567842135642600000
TCGA-06-5415.7	7	1_KEGG_SMALL_CELL_LUNG_CANCER	83	4	0.0003210638311410397900000
TCGA-06-0148.6	69	2_CELL_CELL_SIGNALING	353	14	0.0003225878688744217300000
TCGA-32-1986.12	17	1_KEGG_ASTHMA	30	4	0.0003228292685771626300000
TCGA-41-2571.7	72	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0003228465895186709700000
TCGA-06-0745.4	55	2_SYNAPTIC_TRANSMISSION	152	9	0.0003255572058427578500000
TCGA-32-1980.1	24	2_EXTRACELLULAR_REGION_PART	269	8	0.0003256851418187678100000
TCGA-06-0178.2	17	2_CELL_CYCLE_GO_0007049	265	7	0.0003261393864812887900000
TCGA-41-4097.6	48	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	8	0.0003264120269005010200000
TCGA-28-5214.11	124	1_KEGG_PATHWAYS_IN_CANCER	323	18	0.0003268646786930788500000
TCGA-32-4213.15	198	2_EXTRACELLULAR_REGION_PART	269	21	0.0003269912927214812200000
TCGA-02-2486.9	141	2_IMMUNE_SYSTEM_PROCESS	283	18	0.0003280692497800997100000
TCGA-14-0787.6	40	1_KEGG_DNA_REPLICATION	32	5	0.0003286944318526843400000
TCGA-26-1439.11	10	2_CELL_CYCLE_PHASE	146	5	0.0003292916978446608600000
TCGA-08-0354.5	18	2_CELL_CYCLE_PHASE	146	6	0.0003307824270028672600000
TCGA-06-2570.8	95	2_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0003315896478560012900000
TCGA-06-2570.8	95	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0003315896478560012900000
TCGA-02-0089.5	91	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0003333554737734674200000
TCGA-41-3393.4	12	2_MICROTUBULE_CYTOSKELETON	117	5	0.0003338243251135973700000
TCGA-14-1034.7	97	1_KEGG_GLIOMA	62	8	0.0003339400079161761400000
TCGA-12-0616.1	20	2_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0003349153166938438100000
TCGA-12-0616.1	20	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0003349153166938438100000
TCGA-28-2513.12	134	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0003357464229957970200000
TCGA-02-0060.19	281	0_HALLMARK_ALLOGRAFT_REJECTION	190	21	0.0003376208469893718200000
TCGA-19-2624.29	130	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0003383485950309168300000
TCGA-06-0185.13	71	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0003386336555915159900000
TCGA-02-0107.3	71	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0003386336555915159900000
TCGA-27-2526.7	71	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0003386336555915159900000
TCGA-19-2624.29	130	1_KEGG_DNA_REPLICATION	32	7	0.0003392144681850870100000
TCGA-06-5412.7	153	2_IMMUNE_RESPONSE	206	16	0.0003396939655032276200000
TCGA-19-2623.11	153	2_STRUCTURAL_MOLECULE_ACTIVITY	206	16	0.0003396939655032276200000
TCGA-02-0043.10	184	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	39	0.0003398475554469323700000
TCGA-28-5204.3	4	2_LIGAND_GATED_CHANNEL_ACTIVITY	36	3	0.0003425901586604368200000
TCGA-06-5408.3	99	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0003425976267976255100000
TCGA-14-1034.7	97	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0003432024073929372300000
TCGA-19-2625.9	146	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0003432594164447453900000
TCGA-06-0130.3	155	2_NON_MEMBRANE_BOUND_ORGANELLE	476	25	0.0003433725905272269400000
TCGA-06-0130.3	155	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	25	0.0003433725905272269400000
TCGA-02-0114.20	132	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0003482644674082947800000
TCGA-27-1831.9	85	1_KEGG_MELANOMA	71	8	0.0003484506219375225700000
TCGA-02-0009.6	188	2_COLLAGEN	23	7	0.0003495809839269672400000
TCGA-06-2562.7	57	2_COLLAGEN	23	5	0.0003497611461800636900000
TCGA-06-0197.1	57	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	10	0.0003498124254883372400000
TCGA-06-2557.11	177	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0003506709997842795400000
TCGA-02-0064.3	26	2_TRANSMISSION_OF_NERVE_IMPULSE	164	7	0.0003518208471002867600000
TCGA-06-0747.12	80	2_CELL_CELL_SIGNALING	353	15	0.0003524721931701770100000
TCGA-02-0046.8	148	2_AXON	10	5	0.0003524908335851261700000
TCGA-19-5947.4	267	0_HALLMARK_APOPTOSIS	150	18	0.0003542388777026690000000
TCGA-06-0156.4	80	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0003547759953418520600000
TCGA-06-5413.11	142	1_KEGG_FOCAL_ADHESION	195	15	0.0003560198123702940900000
TCGA-02-0085.1	45	0_HALLMARK_ALLOGRAFT_REJECTION	190	9	0.0003568426369426314600000
TCGA-27-1838.17	131	0_HALLMARK_ANGIOGENESIS	32	7	0.0003575275897436725800000
TCGA-26-5139.10	163	2_CYTOSKELETAL_PART	194	16	0.0003581253798659175700000
TCGA-41-2571.7	72	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0003584311847567845600000
TCGA-02-0068.1	72	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0003584311847567845600000
TCGA-02-0024.6	206	2_CYTOSKELETAL_PART	194	18	0.0003584795576864898000000
TCGA-06-2565.10	38	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0003608914466162710000000
TCGA-12-0619.11	123	1_KEGG_FOCAL_ADHESION	195	14	0.0003621959554121452300000
TCGA-27-2527.6	79	0_HALLMARK_ANGIOGENESIS	32	6	0.0003631145356468040900000
TCGA-32-1979.4	12	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0003653471827327128300000
TCGA-41-2575.49	136	1_KEGG_GLIOMA	62	9	0.0003655257448981491400000
TCGA-32-1979.10	116	0_HALLMARK_COMPLEMENT	176	13	0.0003658845200310733500000
TCGA-02-0099.11	141	1_KEGG_ASTHMA	30	7	0.0003667445899024224400000
TCGA-14-4157.7	101	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0003669787219460607800000
TCGA-02-0107.3	71	2_EXTRACELLULAR_REGION	346	14	0.0003672294263878198000000
TCGA-76-6191.6	96	0_HALLMARK_MYC_TARGETS_V1	178	12	0.0003679727354216809600000
TCGA-12-5299.6	38	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0003687298592025452500000
TCGA-06-0219.6	6	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0003687565745190076500000
TCGA-08-0244.4	6	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0003687565745190076500000
TCGA-12-5299.5	6	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0003687565745190076500000
TCGA-14-1823.12	6	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0003687565745190076500000
TCGA-14-1829.11	6	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0003687565745190076500000
TCGA-14-2554.9	6	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0003687565745190076500000
TCGA-02-0075.8	128	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0003687704247989938700000
TCGA-32-2615.7	77	2_EXTRACELLULAR_REGION_PART	269	13	0.0003688542991650602400000
TCGA-06-0645.9	136	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	13	0.0003692561911279386600000
TCGA-02-0060.19	281	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	11	0.0003702051012208447700000
TCGA-02-0115.4	3	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	3	0.0003711041744650904600000
TCGA-06-0750.9	3	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	3	0.0003711041744650904600000
TCGA-27-1834.9	3	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	3	0.0003711041744650904600000
TCGA-06-0882.9	3	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	3	0.0003711041744650904600000
TCGA-06-0882.5	3	1_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	58	3	0.0003711041744650904600000
TCGA-06-0744.10	36	0_HALLMARK_G2M_CHECKPOINT	174	8	0.0003711217535779454600000
TCGA-41-2571.7	72	1_KEGG_FOCAL_ADHESION	195	11	0.0003718797655913877400000
TCGA-27-2523.12	112	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0003719782572538455800000
TCGA-28-2509.5	4	1_KEGG_ALLOGRAFT_REJECTION	37	3	0.0003727890198417063500000
TCGA-06-0126.3	4	1_KEGG_ALLOGRAFT_REJECTION	37	3	0.0003727890198417063500000
TCGA-08-0353.8	100	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0003737840473268338000000
TCGA-19-5959.13	92	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0003739858251524433500000
TCGA-27-1837.5	85	1_KEGG_ASTHMA	30	6	0.0003744177815768404600000
TCGA-02-0079.2	10	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	5	0.0003769703371939812000000
TCGA-06-0145.19	81	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0003778272969479998900000
TCGA-32-4209.2	56	2_AXON	10	4	0.0003825972923970864500000
TCGA-06-5858.19	205	1_KEGG_ECM_RECEPTOR_INTERACTION	84	12	0.0003827618443131989100000
TCGA-28-5207.12	188	0_HALLMARK_E2F_TARGETS	169	16	0.0003832015958746078000000
TCGA-06-5856.13	152	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0003843034336820432000000
TCGA-28-2513.12	134	2_EXTRACELLULAR_REGION_PART	269	17	0.0003846154814505734100000
TCGA-02-0086.2	17	2_REGULATION_OF_CELL_CYCLE	160	6	0.0003849990469876109200000
TCGA-06-0178.2	17	2_REGULATION_OF_CELL_CYCLE	160	6	0.0003849990469876109200000
TCGA-02-0064.3	26	2_CELL_CELL_SIGNALING	353	9	0.0003853734398567196200000
TCGA-06-0139.1	179	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0003859849823385528100000
TCGA-12-0692.7	23	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0003873444537525720000000
TCGA-02-2470.4	11	2_MITOTIC_CELL_CYCLE	134	5	0.0003883448536117864500000
TCGA-32-4213.15	198	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	12	0.0003893689225374041800000
TCGA-32-5222.9	70	2_CELL_CELL_SIGNALING	353	14	0.0003897670308655914500000
TCGA-19-5951.10	138	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0003904803667952529900000
TCGA-06-5414.13	102	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0003905303228530834000000
TCGA-06-0881.7	203	2_EXTRACELLULAR_MATRIX	85	12	0.0003931192950087789500000
TCGA-02-0003.9	227	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	50	10	0.0003934161041989056900000
TCGA-76-6191.6	96	2_CELL_CYCLE_PHASE	146	11	0.0003981398052142337700000
TCGA-08-0359.5	37	1_KEGG_CELL_CYCLE	114	7	0.0003991770229764805400000
TCGA-12-5295.8	66	2_CELL_CYCLE_GO_0007049	265	12	0.0003994895024679959200000
TCGA-06-0197.1	57	0_HALLMARK_APOPTOSIS	150	9	0.0004001935679771150200000
TCGA-19-2623.11	153	2_CYTOSKELETON	293	19	0.0004002097081230952700000
TCGA-06-0213.9	74	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0004006059304299646900000
TCGA-06-0128.8	74	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0004006059304299646900000
TCGA-06-0155.10	74	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0004008083713430766800000
TCGA-28-5214.11	124	1_KEGG_FOCAL_ADHESION	195	14	0.0004009772621404696600000
TCGA-14-0787.7	14	2_MEMBRANE	1443	11	0.0004010469427791974900000
TCGA-32-1979.10	116	0_HALLMARK_KRAS_SIGNALING_UP	148	12	0.0004010803296184090100000
TCGA-28-2513.12	134	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0004012218269043012200000
TCGA-19-1390.12	10	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	152	5	0.0004027817448057558700000
TCGA-02-0060.19	281	2_EXTRACELLULAR_SPACE	192	21	0.0004036643282666455000000
TCGA-26-5132.7	100	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0004038388159324143000000
TCGA-06-5858.19	205	2_DNA_METABOLIC_PROCESS	218	19	0.0004038631727653816600000
TCGA-06-0190.8	143	1_KEGG_ASTHMA	30	7	0.0004038751098027822000000
TCGA-27-2524.5	75	2_DNA_REPLICATION	82	8	0.0004051157207653602100000
TCGA-06-0190.8	143	0_HALLMARK_E2F_TARGETS	169	14	0.0004065552960432695600000
TCGA-14-0781.7	155	2_STRUCTURAL_MOLECULE_ACTIVITY	206	16	0.0004067910245311665300000
TCGA-06-0649.13	88	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0004087265783982968600000
TCGA-02-0001.5	117	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	8	0.0004091236431385158700000
TCGA-28-6450.11	139	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0004094805507725196000000
TCGA-26-1439.11	10	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0004104764824658850700000
TCGA-06-0645.9	136	2_IMMUNE_RESPONSE	206	15	0.0004115945929116674000000
TCGA-32-4210.14	109	2_CHROMOSOMAL_PART	78	9	0.0004119997932218299300000
TCGA-06-5412.7	153	2_AXON	10	5	0.0004162033768181583000000
TCGA-19-4068.7	14	2_CHROMOSOME	102	5	0.0004162100396457748100000
TCGA-26-5136.6	160	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0004166527155417902600000
TCGA-08-0352.2	59	2_COLLAGEN	23	5	0.0004168673276805995200000
TCGA-06-0145.19	81	2_CELL_CELL_SIGNALING	353	15	0.0004181015287250709800000
TCGA-19-1790.18	201	0_HALLMARK_ANGIOGENESIS	32	8	0.0004186541238274681600000
TCGA-28-5208.28	220	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	9	0.0004217131288755325800000
TCGA-06-0648.6	17	1_KEGG_DNA_REPLICATION	32	4	0.0004226731583098804900000
TCGA-08-0360.3	144	1_KEGG_ASTHMA	30	7	0.0004235988444869779800000
TCGA-16-0861.4	6	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	3	0.0004239689059652274700000
TCGA-06-0166.5	35	0_HALLMARK_UV_RESPONSE_DN	122	7	0.0004240065417184888500000
TCGA-19-2631.15	84	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	207	12	0.0004253327178389396600000
TCGA-02-0034.4	88	2_NEURON_PROJECTION	16	5	0.0004256270745522072200000
TCGA-32-1982.9	89	1_KEGG_FOCAL_ADHESION	195	12	0.0004256598253677479400000
TCGA-06-0157.7	89	1_KEGG_FOCAL_ADHESION	195	12	0.0004256598253677479400000
TCGA-76-6285.5	106	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0004258942326551097100000
TCGA-12-3653.55	255	2_DNA_REPLICATION	82	13	0.0004265758757457721200000
TCGA-06-2569.5	144	1_KEGG_FOCAL_ADHESION	195	15	0.0004282128772914401500000
TCGA-02-0086.2	17	2_CELL_CYCLE_PROCESS	163	6	0.0004298490491653002500000
TCGA-06-0648.6	17	2_CELL_CYCLE_PROCESS	163	6	0.0004298490491653002500000
TCGA-02-0054.3	93	2_SYNAPTIC_TRANSMISSION	152	11	0.0004316340720311864300000
TCGA-06-2559.11	101	1_KEGG_BLADDER_CANCER	42	7	0.0004340521427381158000000
TCGA-02-2470.4	11	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0004340888522924933700000
TCGA-06-2569.5	144	2_CHROMOSOMAL_PART	78	10	0.0004342462239973607000000
TCGA-02-0024.6	206	2_DNA_METABOLIC_PROCESS	218	19	0.0004359138655833771200000
TCGA-32-1982.9	89	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	10	0.0004384489226490176500000
TCGA-41-5651.5	112	2_DNA_METABOLIC_PROCESS	218	14	0.0004400653176822385400000
TCGA-06-2558.6	74	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0004402428939333502800000
TCGA-08-0360.3	144	2_EXTRACELLULAR_REGION	346	20	0.0004404561138698522800000
TCGA-26-1439.11	10	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0004415012873614722000000
TCGA-14-4157.7	101	2_NUCLEUS	1110	31	0.0004416141158213813000000
TCGA-32-4719.15	123	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0004421907917644935100000
TCGA-08-0360.3	144	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	14	0.0004434148323882072400000
TCGA-06-5859.9	125	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	14	0.0004434595208854156900000
TCGA-06-5414.13	102	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	9	0.0004436362343690616100000
TCGA-14-0781.7	155	2_AXON	10	5	0.0004441121508768593800000
TCGA-06-0130.3	155	2_AXON	10	5	0.0004441121508768593800000
TCGA-27-2524.5	75	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0004454971215992565400000
TCGA-26-5133.10	75	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0004454971215992565400000
TCGA-06-0129.11	110	2_CHROMOSOMAL_PART	78	9	0.0004457531415442485600000
TCGA-41-2572.8	76	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0004463807709857270500000
TCGA-14-1823.12	6	1_KEGG_PATHWAYS_IN_CANCER	323	5	0.0004466223214596150400000
TCGA-06-0216.6	67	0_HALLMARK_E2F_TARGETS	169	10	0.0004470507392907497100000
TCGA-14-3476.17	53	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0004471686563420744000000
TCGA-02-0071.12	116	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0004473624966693897800000
TCGA-28-2501.3	51	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0004474597838720144800000
TCGA-06-0750.12	52	2_EXTRACELLULAR_REGION	346	12	0.0004475974827185995700000
TCGA-28-2513.12	134	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0004500057960399167800000
TCGA-02-0071.12	116	2_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0004510090935928468400000
TCGA-02-0071.12	116	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0004510090935928468400000
TCGA-32-4719.15	123	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0004510788558028514300000
TCGA-06-0122.8	90	0_HALLMARK_COAGULATION	125	10	0.0004525337168489311500000
TCGA-14-0789.10	106	2_TRANSMISSION_OF_NERVE_IMPULSE	164	12	0.0004538331220973426000000
TCGA-02-0115.4	3	2_INTERPHASE	62	3	0.0004548599908694180400000
TCGA-06-0750.9	3	2_INTERPHASE	62	3	0.0004548599908694180400000
TCGA-27-1834.9	3	2_INTERPHASE	62	3	0.0004548599908694180400000
TCGA-06-0882.9	3	2_INTERPHASE	62	3	0.0004548599908694180400000
TCGA-19-5947.4	267	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	19	0.0004567721761299123400000
TCGA-27-1834.10	39	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0004570920366256151200000
TCGA-02-0102.8	82	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0004592599277390203200000
TCGA-41-2575.49	136	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0004611286055357744600000
TCGA-06-0645.9	136	0_HALLMARK_ANGIOGENESIS	32	7	0.0004621210279909653600000
TCGA-28-2501.3	51	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0004622331702521070000000
TCGA-76-6191.6	96	2_DNA_METABOLIC_PROCESS	218	13	0.0004626954495077637500000
TCGA-06-5418.4	24	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0004640649389694819000000
TCGA-06-5414.13	102	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0004645174166576328900000
TCGA-06-5414.13	102	1_KEGG_BLADDER_CANCER	42	7	0.0004645174166576328900000
TCGA-12-0692.7	23	2_NEUROLOGICAL_SYSTEM_PROCESS	296	8	0.0004645789739213073700000
TCGA-28-1753.13	174	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0004661220425656094800000
TCGA-14-1823.15	87	2_TRANSMISSION_OF_NERVE_IMPULSE	164	11	0.0004670807637926542700000
TCGA-06-5858.19	205	2_CHROMOSOME	102	13	0.0004677247386843749400000
TCGA-06-5856.13	152	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0004683086289130005800000
TCGA-27-2526.7	71	2_CELL_CELL_SIGNALING	353	14	0.0004692854842197684000000
TCGA-76-6282.11	185	2_EXTRACELLULAR_REGION_PART	269	20	0.0004726806691451516800000
TCGA-06-0877.7	4	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0004739093609704170300000
TCGA-16-0861.5	4	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0004739093609704170300000
TCGA-08-0348.3	4	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0004739093609704170300000
TCGA-19-5955.9	110	0_HALLMARK_ALLOGRAFT_REJECTION	190	13	0.0004749948460422719000000
TCGA-12-3653.55	255	2_REGULATION_OF_CELL_CYCLE	160	18	0.0004760269664363306500000
TCGA-26-5135.9	71	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0004763904947780492400000
TCGA-06-0152.10	19	2_CELL_CYCLE_PHASE	146	6	0.0004773202377179817400000
TCGA-06-0189.3	118	2_COLLAGEN	23	6	0.0004791405468021565300000
TCGA-02-0074.5	118	2_COLLAGEN	23	6	0.0004791405468021565300000
TCGA-76-4927.8	93	2_CELL_CELL_SIGNALING	353	16	0.0004795614355758046800000
TCGA-02-2483.10	100	2_REGULATION_OF_MOLECULAR_FUNCTION	286	15	0.0004814632638067533600000
TCGA-06-0155.10	74	2_EXTRACELLULAR_MATRIX	85	8	0.0004829591602194174100000
TCGA-06-0154.13	76	1_KEGG_CELL_CYCLE	114	9	0.0004830227451429602400000
TCGA-06-0877.8	61	2_CELL_CELL_SIGNALING	353	13	0.0004846072531929774000000
TCGA-28-5207.12	188	2_CYTOSKELETAL_PART	194	17	0.0004851853835841015000000
TCGA-02-0043.10	184	2_PROTEOLYSIS	154	15	0.0004856786273251865600000
TCGA-26-1439.10	84	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0004861432931891145600000
TCGA-27-2524.5	75	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0004892823521485406400000
TCGA-06-0130.3	155	2_CYTOSKELETON	293	19	0.0004919321385515886500000
TCGA-19-5947.4	267	2_CYTOKINE_BINDING	44	10	0.0004930569989694415300000
TCGA-32-2491.14	244	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0004931242538083115600000
TCGA-06-0877.8	61	2_COLLAGEN	23	5	0.0004937919708206452700000
TCGA-32-2498.13	133	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0004958654785513779500000
TCGA-76-4928.15	78	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0004959527186586228700000
TCGA-06-0875.7	78	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0004959527186586228700000
TCGA-15-0742.13	74	1_KEGG_FOCAL_ADHESION	195	11	0.0004961352786253582200000
TCGA-06-2558.6	74	1_KEGG_FOCAL_ADHESION	195	11	0.0004961352786253582200000
TCGA-14-0787.6	40	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0004963272110929936400000
TCGA-08-0380.5	47	2_SIGNAL_TRANSDUCTION	1442	22	0.0004963490439597311300000
TCGA-02-0047.8	185	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0004968317411072800200000
TCGA-41-4097.6	48	2_ORGAN_DEVELOPMENT	460	13	0.0004976797188728961100000
TCGA-06-0192.10	126	2_SIGNAL_TRANSDUCTION	1442	42	0.0004983644217033258500000
TCGA-32-2494.10	173	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0004990526891885216200000
TCGA-06-0157.7	89	1_KEGG_MELANOMA	71	8	0.0004993270876346669200000
TCGA-06-0219.6	6	1_KEGG_CELL_CYCLE	114	4	0.0005003665479399304300000
TCGA-08-0244.4	6	1_KEGG_CELL_CYCLE	114	4	0.0005003665479399304300000
TCGA-14-1829.11	6	1_KEGG_CELL_CYCLE	114	4	0.0005003665479399304300000
TCGA-14-2554.9	6	1_KEGG_CELL_CYCLE	114	4	0.0005003665479399304300000
TCGA-19-5947.4	267	0_HALLMARK_UV_RESPONSE_DN	122	16	0.0005011339154897024500000
TCGA-02-0038.3	199	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	10	0.0005016138942601740900000
TCGA-76-6191.6	96	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0005016748696522403200000
TCGA-28-2513.12	134	2_EXTRACELLULAR_MATRIX	85	10	0.0005039203133178386200000
TCGA-76-4934.4	20	2_CELL_CELL_SIGNALING	353	8	0.0005040030600792114000000
TCGA-06-2563.10	123	2_CELL_CYCLE_GO_0007049	265	16	0.0005071554065646211800000
TCGA-14-0789.10	106	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0005088750232033968800000
TCGA-76-6285.5	106	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0005088750232033968800000
TCGA-32-2634.10	118	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	13	0.0005106477449596139900000
TCGA-06-0877.7	4	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0005112825355504712100000
TCGA-28-2509.5	4	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	3	0.0005112825355504712100000
TCGA-06-0126.3	4	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	3	0.0005112825355504712100000
TCGA-08-0348.3	4	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0005112825355504712100000
TCGA-19-2625.9	146	1_KEGG_FOCAL_ADHESION	195	15	0.0005133960510774488600000
TCGA-06-0238.4	24	1_KEGG_CELL_CYCLE	114	6	0.0005151911967451350700000
TCGA-32-4210.14	109	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0005159478730929278200000
TCGA-06-0184.11	108	1_KEGG_FOCAL_ADHESION	195	13	0.0005164683527581918700000
TCGA-06-0645.9	136	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0005170966783444962300000
TCGA-32-1979.4	12	2_CELL_CYCLE_ARREST_GO_0007050	49	4	0.0005181257584781613900000
TCGA-08-0360.3	144	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0005182109719955743700000
TCGA-26-5136.6	160	2_AXON	10	5	0.0005204234525557468900000
TCGA-41-5651.5	112	2_CHROMOSOMAL_PART	78	9	0.0005205351353485852300000
TCGA-26-5134.6	18	2_CELL_CYCLE_GO_0007049	265	7	0.0005209600934414822000000
TCGA-28-1753.13	174	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	11	0.0005210572608241139400000
TCGA-27-2527.6	79	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0005222255444123493700000
TCGA-32-2491.14	244	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	13	0.0005231145496168154700000
TCGA-06-5411.3	19	1_KEGG_ASTHMA	30	4	0.0005234373192492676200000
TCGA-27-1838.17	131	2_DNA_METABOLIC_PROCESS	218	15	0.0005235327232167836100000
TCGA-28-2513.12	134	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0005253513930479186100000
TCGA-02-0034.4	88	2_TRANSMISSION_OF_NERVE_IMPULSE	164	11	0.0005258839883075238100000
TCGA-28-2501.3	51	2_EXTRACELLULAR_MATRIX	85	7	0.0005276067070465610700000
TCGA-19-5951.10	138	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0005287532816053760300000
TCGA-27-2523.12	112	2_NUCLEUS	1110	33	0.0005312468856957134700000
TCGA-19-2623.11	153	2_EXTRACELLULAR_REGION_PART	269	18	0.0005354206267175640100000
TCGA-06-0881.7	203	0_HALLMARK_UV_RESPONSE_DN	122	14	0.0005364349866028596500000
TCGA-27-2524.5	75	2_EXTRACELLULAR_MATRIX	85	8	0.0005367062916168862000000
TCGA-02-0001.5	117	2_CALCIUM_ION_BINDING	75	9	0.0005377418742363589800000
TCGA-14-4157.7	101	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0005381958830642495400000
TCGA-02-0068.1	72	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0005385877285045346800000
TCGA-16-1048.13	97	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0005387836746826434500000
TCGA-28-5213.9	143	2_CELL_CELL_SIGNALING	353	20	0.0005414419537139689500000
TCGA-02-0028.9	182	2_NEURON_PROJECTION	16	6	0.0005425756241955355400000
TCGA-32-1977.11	107	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0005427733245685754400000
TCGA-15-1444.3	107	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0005427733245685754400000
TCGA-32-4208.28	140	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0005428702944732254100000
TCGA-19-5954.17	208	0_HALLMARK_ANGIOGENESIS	32	8	0.0005443941049267591400000
TCGA-06-5412.7	153	2_INTEGRAL_TO_MEMBRANE	956	37	0.0005467844896054667700000
TCGA-32-2615.7	77	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0005478158044634792300000
TCGA-06-0747.12	80	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0005495237957023178400000
TCGA-06-0156.4	80	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0005495237957023178400000
TCGA-16-0861.5	4	1_KEGG_BLADDER_CANCER	42	3	0.0005505681065357978500000
TCGA-28-2509.5	4	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	3	0.0005505681065357978500000
TCGA-06-0126.3	4	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	3	0.0005505681065357978500000
TCGA-06-0140.2	25	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0005515687181915280600000
TCGA-08-0347.7	25	2_COLLAGEN	23	4	0.0005515687181915280600000
TCGA-32-2495.11	67	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0005553910298133515700000
TCGA-08-0380.4	6	2_MICROTUBULE_CYTOSKELETON	117	4	0.0005556326453842319700000
TCGA-06-5415.7	7	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0005566614758104053600000
TCGA-14-0789.10	106	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0005569611004305986500000
TCGA-28-5204.3	4	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	228	4	0.0005585404911803761600000
TCGA-19-5960.9	134	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0005597708877893743700000
TCGA-02-0054.3	93	2_NEURON_PROJECTION	16	5	0.0005618949217442722300000
TCGA-08-0389.4	56	2_CHROMOSOMAL_PART	78	7	0.0005632539108368171000000
TCGA-06-0195.8	56	2_CHROMOSOMAL_PART	78	7	0.0005632539108368171000000
TCGA-02-2486.9	141	0_HALLMARK_APOPTOSIS	150	13	0.0005636671961695302800000
TCGA-02-2470.4	11	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0005639568863392011500000
TCGA-28-5214.11	124	2_CELL_CYCLE_GO_0007049	265	16	0.0005678278090031191800000
TCGA-12-3653.55	255	1_KEGG_ECM_RECEPTOR_INTERACTION	84	13	0.0005703229616772592600000
TCGA-12-3653.55	255	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	13	0.0005703229616772592600000
TCGA-26-1439.11	10	2_CELL_CYCLE_PROCESS	163	5	0.0005709813461061227400000
TCGA-26-5133.10	75	1_KEGG_FOCAL_ADHESION	195	11	0.0005710440952853513800000
TCGA-28-5207.12	188	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0005724025128240661600000
TCGA-06-2567.9	156	2_CELL_CYCLE_GO_0007049	265	18	0.0005751200763277537200000
TCGA-19-1390.13	110	2_INTRACELLULAR_ORGANELLE_PART	912	29	0.0005754700566813327100000
TCGA-28-2509.6	59	0_HALLMARK_P53_PATHWAY	151	9	0.0005757791163747560800000
TCGA-02-0027.3	81	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0005778735051391627200000
TCGA-06-0145.19	81	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0005778735051391627200000
TCGA-28-1747.5	81	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0005778735051391627200000
TCGA-32-4210.14	109	2_CELL_CYCLE_PROCESS	163	12	0.0005781099165323098400000
TCGA-12-0618.5	41	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0005782476431106865000000
TCGA-32-1979.4	12	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0005783713772550545000000
TCGA-02-0010.18	184	2_NEURON_PROJECTION	16	6	0.0005788109416480915600000
TCGA-06-2565.10	38	2_MICROTUBULE_CYTOSKELETON	117	7	0.0005788943269294447200000
TCGA-26-1439.11	10	2_INTERPHASE	62	4	0.0005793176245407901600000
TCGA-06-0743.14	63	2_COLLAGEN	23	5	0.0005815527158580189600000
TCGA-19-1790.18	201	2_RESPONSE_TO_WOUNDING	163	16	0.0005820707188504843100000
TCGA-28-2509.6	59	2_NUCLEUS	1110	22	0.0005830213381156702000000
TCGA-06-5859.9	125	2_PROTEIN_HETERODIMERIZATION_ACTIVITY	71	9	0.0005866590050157525800000
TCGA-14-1825.8	80	2_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0005871975457016390600000
TCGA-14-1825.8	80	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0005871975457016390600000
TCGA-06-0241.8	53	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0005873936791897898800000
TCGA-06-5858.19	205	2_REGULATION_OF_CELL_CYCLE	160	16	0.0005898851081923274500000
TCGA-06-0881.7	203	2_COLLAGEN	23	7	0.0005899099368842563800000
TCGA-06-5412.1	28	2_RESPONSE_TO_WOUNDING	163	7	0.0005899420812838203700000
TCGA-08-0246.6	62	2_CELL_CELL_SIGNALING	353	13	0.0005927559811349370100000
TCGA-06-0195.8	56	2_REGULATION_OF_CELL_CYCLE	160	9	0.0005927613505724148700000
TCGA-02-0089.5	91	1_KEGG_MELANOMA	71	8	0.0005937477572913719100000
TCGA-06-0145.17	11	2_CELL_CYCLE_PHASE	146	5	0.0005961997410012625800000
TCGA-02-2470.4	11	2_CELL_CYCLE_PHASE	146	5	0.0005961997410012625800000
TCGA-02-0075.8	128	1_KEGG_FOCAL_ADHESION	195	14	0.0005963192803669587000000
TCGA-02-0083.21	135	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0005964796870188197800000
TCGA-32-1986.8	87	2_STRUCTURAL_MOLECULE_ACTIVITY	206	12	0.0005981423267139825500000
TCGA-41-4097.6	48	1_KEGG_ASTHMA	30	5	0.0005983743323003917800000
TCGA-12-0692.3	9	2_SYSTEM_DEVELOPMENT	694	7	0.0005984040312316294500000
TCGA-06-0214.9	62	1_KEGG_MELANOMA	71	7	0.0005989785699522876300000
TCGA-02-0075.8	128	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0006014758063917494600000
TCGA-32-2615.7	77	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0006015439689299934900000
TCGA-19-2629.15	146	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0006028215136803488200000
TCGA-02-0001.5	117	2_CELL_PROJECTION	76	9	0.0006037010174053140600000
TCGA-06-0129.11	110	2_CYTOSKELETAL_PART	194	13	0.0006044580900299881200000
TCGA-14-0789.10	106	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0006050580878979283100000
TCGA-76-6285.5	106	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0006050580878979283100000
TCGA-76-6285.5	106	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0006050580878979283100000
TCGA-32-4208.28	140	2_SYNAPTIC_TRANSMISSION	152	13	0.0006051837350293551100000
TCGA-32-1991.11	82	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0006073010161858995000000
TCGA-06-2567.9	156	2_REGULATION_OF_CELL_CYCLE	160	14	0.0006082266028683126900000
TCGA-02-0074.5	118	2_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0006086022386779315600000
TCGA-02-0074.5	118	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0006086022386779315600000
TCGA-19-5952.11	193	2_EXTRACELLULAR_SPACE	192	17	0.0006094574003119783200000
TCGA-14-3476.4	7	2_EXTRACELLULAR_REGION_PART	269	5	0.0006108333290806675300000
TCGA-32-2494.10	173	0_HALLMARK_ALLOGRAFT_REJECTION	190	16	0.0006112004000053478600000
TCGA-76-6193.13	271	0_HALLMARK_UV_RESPONSE_DN	122	16	0.0006131135242512010300000
TCGA-28-5220.7	15	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0006144092625768130500000
TCGA-06-0686.10	26	0_HALLMARK_MYC_TARGETS_V1	178	7	0.0006151931185406047300000
TCGA-19-2629.15	146	2_CELL_CYCLE_PHASE	146	13	0.0006176549176070583000000
TCGA-76-6285.5	106	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	9	0.0006180288638326661600000
TCGA-06-0216.6	67	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0006187726872155895200000
TCGA-06-0219.6	6	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0006219821662035950300000
TCGA-08-0244.4	6	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0006219821662035950300000
TCGA-12-5299.5	6	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0006219821662035950300000
TCGA-14-1823.12	6	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0006219821662035950300000
TCGA-14-1829.11	6	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0006219821662035950300000
TCGA-14-2554.9	6	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0006219821662035950300000
TCGA-14-1034.9	9	0_HALLMARK_ALLOGRAFT_REJECTION	190	5	0.0006225392565853752000000
TCGA-06-0745.4	55	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0006228192618121462200000
TCGA-19-1390.13	110	2_ORGANELLE_PART	916	29	0.0006313262263801193800000
TCGA-06-0173.35	120	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0006324926529548869000000
TCGA-28-5208.28	220	0_HALLMARK_E2F_TARGETS	169	17	0.0006338112221615191800000
TCGA-06-5415.7	7	2_PHOSPHORYLATION	271	5	0.0006338279667849076700000
TCGA-02-0075.8	128	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0006345735653788227900000
TCGA-06-5859.9	125	2_REGULATION_OF_CELL_PROLIFERATION	265	16	0.0006350063779364254500000
TCGA-08-0359.5	37	0_HALLMARK_UV_RESPONSE_DN	122	7	0.0006354364637808020300000
TCGA-08-0354.5	18	2_CELL_CYCLE_PROCESS	163	6	0.0006356055651050071900000
TCGA-32-4210.14	109	2_DNA_REPLICATION	82	9	0.0006371864187765824000000
TCGA-28-5207.12	188	1_KEGG_CELL_CYCLE	114	13	0.0006405068721530938800000
TCGA-19-5955.9	110	1_KEGG_FOCAL_ADHESION	195	13	0.0006414030044179665600000
TCGA-26-5136.6	160	2_NON_MEMBRANE_BOUND_ORGANELLE	476	25	0.0006418029706908328500000
TCGA-26-5136.6	160	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	25	0.0006418029706908328500000
TCGA-06-5415.7	7	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0006443504297464966600000
TCGA-32-1977.11	107	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0006453036272799692400000
TCGA-15-1444.3	107	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0006453036272799692400000
TCGA-19-5947.4	267	0_HALLMARK_ALLOGRAFT_REJECTION	190	20	0.0006475139052759164600000
TCGA-06-6391.9	26	2_COLLAGEN	23	4	0.0006508043336348971100000
TCGA-02-0064.3	26	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0006508043336348971100000
TCGA-06-0130.3	155	2_EXTRACELLULAR_REGION_PART	269	18	0.0006517233413739598000000
TCGA-02-0024.6	206	2_CYTOSKELETON	293	22	0.0006517981839699286800000
TCGA-19-5952.11	193	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	20	0.0006553051964084075700000
TCGA-32-2632.16	229	1_KEGG_ASTHMA	30	8	0.0006580739787054715000000
TCGA-06-0686.6	3	1_KEGG_LEISHMANIA_INFECTION	70	3	0.0006583563167684111100000
TCGA-06-0686.6	3	1_KEGG_VIRAL_MYOCARDITIS	70	3	0.0006583563167684111100000
TCGA-19-2620.6	3	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	3	0.0006583563167684111100000
TCGA-19-5958.2	3	1_KEGG_LEISHMANIA_INFECTION	70	3	0.0006583563167684111100000
TCGA-19-5958.2	3	1_KEGG_VIRAL_MYOCARDITIS	70	3	0.0006583563167684111100000
TCGA-06-0208.3	3	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	3	0.0006583563167684111100000
TCGA-32-2615.7	77	2_EXTRACELLULAR_MATRIX	85	8	0.0006597246169106031000000
TCGA-08-0354.7	47	1_KEGG_FOCAL_ADHESION	195	9	0.0006607160640612000200000
TCGA-19-5951.10	138	2_EXTRACELLULAR_MATRIX	85	10	0.0006635825330853793500000
TCGA-19-2619.14	100	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0006642809363266830200000
TCGA-02-2483.10	100	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0006642809363266830200000
TCGA-28-1753.13	174	2_EXTRACELLULAR_MATRIX	85	11	0.0006671023408056876400000
TCGA-06-0879.9	84	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0006694963678198753600000
TCGA-02-0048.9	84	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0006694963678198753600000
TCGA-27-2527.6	79	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0006696428565793885000000
TCGA-41-3393.5	88	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0006703064332389662600000
TCGA-06-0188.11	66	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0006709508351805413900000
TCGA-06-2559.11	101	2_CELL_CYCLE_PHASE	146	11	0.0006717443629713267700000
TCGA-06-2563.10	123	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0006718979574548017200000
TCGA-32-4208.28	140	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0006780934065368571800000
TCGA-06-0877.7	4	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0006803740881349948300000
TCGA-16-0861.5	4	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0006803740881349948300000
TCGA-08-0348.3	4	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0006803740881349948300000
TCGA-14-0813.5	5	2_RECEPTOR_ACTIVITY	499	5	0.0006814283145147419200000
TCGA-08-0360.3	144	0_HALLMARK_ANGIOGENESIS	32	7	0.0006827259124300195800000
TCGA-06-2558.6	74	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0006844172474317024000000
TCGA-06-0128.8	74	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0006844172474317024000000
TCGA-14-0789.10	106	2_EXTRACELLULAR_MATRIX	85	9	0.0006848256344007025600000
TCGA-02-0114.20	132	2_CELL_CYCLE_PROCESS	163	13	0.0006852573294863057400000
TCGA-02-2470.4	11	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0006906161010644819900000
TCGA-41-3393.5	88	0_HALLMARK_ANGIOGENESIS	32	6	0.0006930025827758942400000
TCGA-19-2619.14	100	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0006947448435143118500000
TCGA-06-5859.9	125	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	24	0.0006953280412942851000000
TCGA-02-0115.1	36	2_EXTRACELLULAR_REGION	346	10	0.0006996590581027629900000
TCGA-16-0846.2	27	0_HALLMARK_G2M_CHECKPOINT	174	7	0.0007004620450252337600000
TCGA-06-2569.5	144	2_DNA_REPLICATION	82	10	0.0007009361983359939900000
TCGA-08-0245.4	85	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0007023184444920507600000
TCGA-14-0817.9	85	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0007023184444920507600000
TCGA-27-1831.9	85	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0007023184444920507600000
TCGA-19-5950.7	113	2_REGULATION_OF_CELL_CYCLE	160	12	0.0007026120437377337300000
TCGA-06-0174.37	141	1_KEGG_OOCYTE_MEIOSIS	105	11	0.0007029415183215088700000
TCGA-76-4927.8	93	1_KEGG_MELANOMA	71	8	0.0007030712093643392200000
TCGA-06-0211.8	62	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0007033319630882367300000
TCGA-02-0014.10	70	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0007074210733570617100000
TCGA-41-3915.10	109	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0007078713883663153400000
TCGA-41-3915.10	109	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0007078713883663153400000
TCGA-06-5412.7	153	2_INTRINSIC_TO_MEMBRANE	966	37	0.0007095817543250001800000
TCGA-32-1979.4	12	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	4	0.0007141355253398267300000
TCGA-06-0241.8	53	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0007141355253398267300000
TCGA-12-3653.55	255	1_KEGG_ALLOGRAFT_REJECTION	37	9	0.0007164026724528968500000
TCGA-32-2615.7	77	0_HALLMARK_HYPOXIA	154	10	0.0007182980052059505000000
TCGA-02-0007.17	217	2_MICROTUBULE_CYTOSKELETON	117	14	0.0007192264207227343200000
TCGA-76-4928.15	78	2_SYNAPTIC_TRANSMISSION	152	10	0.0007195506161193001200000
TCGA-06-6389.4	39	0_HALLMARK_G2M_CHECKPOINT	174	8	0.0007198241272003297900000
TCGA-08-0360.3	144	0_HALLMARK_APOPTOSIS	150	13	0.0007202349769427630600000
TCGA-41-2575.49	136	1_KEGG_PROSTATE_CANCER	87	10	0.0007223536446837673200000
TCGA-28-5218.5	208	0_HALLMARK_UV_RESPONSE_DN	122	14	0.0007224893460273179000000
TCGA-19-2624.29	130	1_KEGG_FOCAL_ADHESION	195	14	0.0007230211848446276800000
TCGA-06-0174.37	141	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0007246322188103031100000
TCGA-06-2570.8	95	1_KEGG_ASTHMA	30	6	0.0007279281787117371100000
TCGA-16-0846.2	27	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	7	0.0007282810072836908000000
TCGA-26-1442.5	27	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	7	0.0007282810072836908000000
TCGA-32-4210.14	109	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0007325869312996104800000
TCGA-32-2494.10	173	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	15	0.0007326559482281025100000
TCGA-32-4208.28	140	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0007358378922688135600000
TCGA-06-0188.11	66	2_COLLAGEN	23	5	0.0007358961663151663800000
TCGA-06-0190.8	143	1_KEGG_SMALL_CELL_LUNG_CANCER	83	10	0.0007372598806882211200000
TCGA-06-0190.8	143	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0007372598806882211200000
TCGA-14-1825.8	80	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0007387924261622285000000
TCGA-02-0085.1	45	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	8	0.0007418058147024872300000
TCGA-26-1439.11	10	1_KEGG_P53_SIGNALING_PATHWAY	66	4	0.0007469354618890496900000
TCGA-19-2625.9	146	1_KEGG_DNA_REPLICATION	32	7	0.0007499683124920788200000
TCGA-28-5220.7	15	1_KEGG_BLADDER_CANCER	42	4	0.0007510941684010607800000
TCGA-32-1979.4	12	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0007513452682456848300000
TCGA-19-2619.14	100	2_DNA_METABOLIC_PROCESS	218	13	0.0007513917879833734500000
TCGA-32-2615.7	77	1_KEGG_FOCAL_ADHESION	195	11	0.0007514402485198084900000
TCGA-06-6389.4	39	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	8	0.0007520840074804876700000
TCGA-19-5954.17	208	2_EXTRACELLULAR_REGION_PART	269	21	0.0007525031552825546800000
TCGA-28-5218.5	208	2_EXTRACELLULAR_REGION_PART	269	21	0.0007525031552825546800000
TCGA-19-2620.7	47	0_HALLMARK_ANGIOGENESIS	32	5	0.0007535482331700815900000
TCGA-28-5204.3	4	2_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	246	4	0.0007584034370872165100000
TCGA-06-5858.19	205	2_CELL_CYCLE_PROCESS	163	16	0.0007609831544223909100000
TCGA-19-5955.9	110	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0007654987640257993100000
TCGA-02-0028.9	182	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	9	0.0007676555682897272400000
TCGA-76-4925.9	83	2_CELL_CYCLE_GO_0007049	265	13	0.0007681211487699625800000
TCGA-06-0125.9	75	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0007693785926841427900000
TCGA-27-2524.5	75	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0007693785926841427900000
TCGA-02-2483.10	100	2_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0007704238230701442700000
TCGA-02-2483.10	100	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0007704238230701442700000
TCGA-32-1986.8	87	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0007715493050047330100000
TCGA-14-1823.15	87	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0007715493050047330100000
TCGA-32-1986.12	17	1_KEGG_ALLOGRAFT_REJECTION	37	4	0.0007720213403900006000000
TCGA-06-5413.11	142	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0007739488722697479600000
TCGA-06-5413.11	142	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0007739488722697479600000
TCGA-28-5213.9	143	2_SYNAPTIC_TRANSMISSION	152	13	0.0007744604178814245900000
TCGA-28-5216.8	162	2_INTRACELLULAR_ORGANELLE_PART	912	37	0.0007745115243805887300000
TCGA-28-1753.13	174	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	10	0.0007792414668844373200000
TCGA-06-0129.11	110	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0007798260206403198100000
TCGA-19-1390.13	110	1_KEGG_BLADDER_CANCER	42	7	0.0007798260206403198100000
TCGA-06-2564.7	92	2_CELL_CYCLE_PROCESS	163	11	0.0007823088052818586700000
TCGA-26-5134.3	21	2_CELL_CELL_SIGNALING	353	8	0.0007878175425707637200000
TCGA-26-1439.11	10	0_HALLMARK_G2M_CHECKPOINT	174	5	0.0007906961369646460300000
TCGA-14-0786.4	62	1_KEGG_FOCAL_ADHESION	195	10	0.0007963239289211221400000
TCGA-02-0010.18	184	2_REGULATION_OF_CELL_CYCLE	160	15	0.0007996556959137585000000
TCGA-27-2527.6	79	2_EXTRACELLULAR_MATRIX	85	8	0.0008061349644537120100000
TCGA-32-2498.13	133	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0008076272348231275200000
TCGA-02-0025.5	88	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0008080141747520242900000
TCGA-02-0034.4	88	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0008080141747520242900000
TCGA-27-1832.11	88	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0008080141747520242900000
TCGA-41-3393.5	88	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0008080141747520242900000
TCGA-02-0058.1	110	2_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0008089218527391955400000
TCGA-02-0058.1	110	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0008089218527391955400000
TCGA-06-5414.13	102	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0008097841229857404300000
TCGA-06-0156.4	80	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0008110218301730202700000
TCGA-08-0358.9	43	2_SYSTEM_PROCESS	451	12	0.0008116461384044540900000
TCGA-26-5139.10	163	2_STRUCTURAL_MOLECULE_ACTIVITY	206	16	0.0008128749389792447200000
TCGA-08-0347.4	16	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0008167152132616828100000
TCGA-06-0877.8	61	2_SYNAPTIC_TRANSMISSION	152	9	0.0008178797980837611700000
TCGA-06-0152.10	19	2_REGULATION_OF_CELL_CYCLE	160	6	0.0008206575114335296700000
TCGA-12-0616.7	45	2_SYNAPTIC_TRANSMISSION	152	8	0.0008210307300281299000000
TCGA-08-0355.1	45	2_SYNAPTIC_TRANSMISSION	152	8	0.0008210307300281299000000
TCGA-28-2509.5	4	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	3	0.0008291006003653896000000
TCGA-06-0126.3	4	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	3	0.0008291006003653896000000
TCGA-28-5207.12	188	2_CELL_CELL_SIGNALING	353	23	0.0008306250172023242900000
TCGA-06-2558.6	74	2_CELL_CYCLE_PROCESS	163	10	0.0008323115515016743700000
TCGA-06-2567.9	156	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	44	8	0.0008349984115122490700000
TCGA-28-5207.12	188	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0008431874837898734100000
TCGA-06-2559.11	101	2_DNA_METABOLIC_PROCESS	218	13	0.0008450248388622636100000
TCGA-02-0089.5	91	0_HALLMARK_ANGIOGENESIS	32	6	0.0008463361220031771400000
TCGA-41-2575.46	4	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	4	0.0008490588502755491600000
TCGA-32-2634.10	118	2_INTRACELLULAR_ORGANELLE_PART	912	30	0.0008511868968955984600000
TCGA-32-1986.8	87	2_EXTRACELLULAR_REGION	346	15	0.0008535874376825488900000
TCGA-76-4934.4	20	2_SYNAPTIC_TRANSMISSION	152	6	0.0008542309069648240800000
TCGA-41-3915.10	109	0_HALLMARK_E2F_TARGETS	169	12	0.0008550084528020966900000
TCGA-28-2513.12	134	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0008554093191057198300000
TCGA-06-0166.5	35	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0008566657206775059000000
TCGA-19-5958.4	35	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0008566657206775059000000
TCGA-06-0124.6	55	2_EXTRACELLULAR_REGION	346	12	0.0008617058250209723700000
TCGA-02-0074.5	118	2_CHROMOSOME	102	10	0.0008622092960778301800000
TCGA-08-0390.1	54	2_CELL_CELL_SIGNALING	353	12	0.0008630919010335351800000
TCGA-06-0154.13	76	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0008633379874490520400000
TCGA-28-5216.8	162	2_ORGANELLE_PART	916	37	0.0008634351266438678800000
TCGA-12-3653.55	255	2_NON_MEMBRANE_BOUND_ORGANELLE	476	33	0.0008675450907602466000000
TCGA-12-3653.55	255	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	33	0.0008675450907602466000000
TCGA-19-5960.9	134	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	35	0.0008676323287849155400000
TCGA-41-3915.10	109	2_EXTRACELLULAR_MATRIX	85	9	0.0008698830138506233500000
TCGA-06-0750.13	8	2_PLASMA_MEMBRANE_PART	901	7	0.0008708172909573509500000
TCGA-08-0360.3	144	2_IMMUNE_RESPONSE	206	15	0.0008712981709848660800000
TCGA-02-0115.1	36	2_EXTRACELLULAR_REGION_PART	269	9	0.0008721662906622581100000
TCGA-02-0114.20	132	1_KEGG_FOCAL_ADHESION	195	14	0.0008734209055111532200000
TCGA-12-5299.5	6	2_NEGATIVE_REGULATION_OF_GROWTH	29	3	0.0008734985787320463400000
TCGA-27-1838.17	131	1_KEGG_MELANOMA	71	9	0.0008752339938667689400000
TCGA-28-2502.9	56	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0008775030839227612800000
TCGA-06-5411.3	19	1_KEGG_ECM_RECEPTOR_INTERACTION	84	5	0.0008777932210932066500000
TCGA-32-2498.13	133	1_KEGG_LEISHMANIA_INFECTION	70	9	0.0008797131155208268000000
TCGA-32-2498.13	133	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0008797131155208268000000
TCGA-41-5651.5	112	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0008820274727267239400000
TCGA-27-2523.12	112	1_KEGG_BLADDER_CANCER	42	7	0.0008820274727267239400000
TCGA-06-0877.7	4	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0008831019970021057200000
TCGA-08-0348.3	4	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0008831019970021057200000
TCGA-06-0122.8	90	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0008847853105281470500000
TCGA-08-0357.4	36	1_KEGG_FOCAL_ADHESION	195	8	0.0008887921560397484100000
TCGA-27-2528.10	99	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0008890288266745503600000
TCGA-76-4935.8	21	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0008893853738369877600000
TCGA-32-4213.15	198	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	15	0.0008901960646396984300000
TCGA-28-1753.13	174	0_HALLMARK_KRAS_SIGNALING_UP	148	14	0.0008905255226929675500000
TCGA-41-2575.49	136	2_SPINDLE	35	7	0.0008906216988649235800000
TCGA-28-5218.5	208	2_EPIDERMIS_DEVELOPMENT	59	10	0.0008930490896780819400000
TCGA-41-5651.5	112	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0008930702381718960900000
TCGA-27-2523.12	112	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0008930702381718960900000
TCGA-02-0027.3	81	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0008934608418094574300000
TCGA-06-0145.19	81	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0008934608418094574300000
TCGA-06-0145.19	81	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0008934608418094574300000
TCGA-28-2502.9	56	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0008939139314271117400000
TCGA-06-0644.16	142	2_EXTRACELLULAR_REGION_PART	269	17	0.0008939299485273942300000
TCGA-32-5222.9	70	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0008947941846716594500000
TCGA-28-1753.13	174	1_KEGG_VIRAL_MYOCARDITIS	70	10	0.0008947941846716606400000
TCGA-06-0241.8	53	0_HALLMARK_MYC_TARGETS_V1	178	9	0.0008966857338186491100000
TCGA-02-0007.17	217	2_CHROMOSOME	102	13	0.0009003255875985354700000
TCGA-02-0011.1	288	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	42	0.0009007797586360869900000
TCGA-06-5856.13	152	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0009030623559650917600000
TCGA-06-5856.13	152	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0009030623559650917600000
TCGA-06-2564.7	92	0_HALLMARK_ANGIOGENESIS	32	6	0.0009032382261964647700000
TCGA-02-2470.4	11	2_INTERPHASE	62	4	0.0009058867052790717500000
TCGA-02-0026.1	61	2_INTRACELLULAR_ORGANELLE_PART	912	20	0.0009068695140456881000000
TCGA-02-0003.9	227	2_CYTOSKELETON	293	23	0.0009068970504478991500000
TCGA-06-2564.7	92	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0009099777468628408500000
TCGA-19-5954.17	208	2_NON_MEMBRANE_BOUND_ORGANELLE	476	29	0.0009107000129066645300000
TCGA-19-5954.17	208	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	29	0.0009107000129066645300000
TCGA-06-0750.13	8	2_RECEPTOR_ACTIVITY	499	6	0.0009108423384729353700000
TCGA-06-5415.3	8	2_RECEPTOR_ACTIVITY	499	6	0.0009108423384729353700000
TCGA-06-0221.4	8	2_RECEPTOR_ACTIVITY	499	6	0.0009108423384729353700000
TCGA-27-1838.17	131	2_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0009120358851267733700000
TCGA-27-1838.17	131	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0009120358851267733700000
TCGA-06-0152.10	19	2_CELL_CYCLE_PROCESS	163	6	0.0009157560105049688500000
TCGA-06-2567.9	156	2_CHROMOSOMAL_PART	78	10	0.0009158685735253677300000
TCGA-02-0011.1	288	2_REPLICATION_FORK	18	7	0.0009166811823674756400000
TCGA-19-5950.7	113	2_CELL_CYCLE_GO_0007049	265	15	0.0009191909371742424700000
TCGA-12-3653.55	255	2_CHROMOSOME	102	14	0.0009201441023837561100000
TCGA-06-0190.8	143	2_EXTRACELLULAR_MATRIX	85	10	0.0009243645309074720700000
TCGA-02-0089.5	91	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0009251495021211495700000
TCGA-26-5135.9	71	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0009262193124537846800000
TCGA-02-0028.9	182	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0009269339310649422800000
TCGA-02-0028.9	182	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	11	0.0009269339310649422800000
TCGA-02-0054.3	93	2_TRANSMISSION_OF_NERVE_IMPULSE	164	11	0.0009295163565648273800000
TCGA-87-5896.6	131	2_CYTOSKELETON	293	17	0.0009296620347400321800000
TCGA-14-1823.12	6	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	4	0.0009310917031484804100000
TCGA-06-0158.4	65	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0009350052492047842300000
TCGA-32-2634.10	118	2_ORGANELLE_PART	916	30	0.0009350577320067875300000
TCGA-12-0616.4	7	2_CYTOSKELETON	293	5	0.0009353020786578065600000
TCGA-19-1790.18	201	0_HALLMARK_ALLOGRAFT_REJECTION	190	17	0.0009362595343601753000000
TCGA-28-2513.12	134	1_KEGG_LEISHMANIA_INFECTION	70	9	0.0009375449861148221900000
TCGA-32-4209.2	56	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0009396102309835021900000
TCGA-19-5955.9	110	2_EXTRACELLULAR_MATRIX	85	9	0.0009405201725871740700000
TCGA-28-2509.6	59	2_REGULATION_OF_CELL_CYCLE	160	9	0.0009414299354169444500000
TCGA-76-4931.10	86	2_CELL_CELL_SIGNALING	353	15	0.0009433620216629386900000
TCGA-06-5412.7	153	1_KEGG_FOCAL_ADHESION	195	15	0.0009458466554554754600000
TCGA-06-6391.7	5	0_HALLMARK_MITOTIC_SPINDLE	175	4	0.0009475408028079456300000
TCGA-27-2521.10	94	2_NUCLEUS	1110	29	0.0009485735422150891000000
TCGA-02-0026.1	61	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0009510810241502491800000
TCGA-02-0014.10	70	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0009556196777216318500000
TCGA-41-3392.31	136	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0009582753005235716000000
TCGA-76-6193.13	271	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	16	0.0009589167907814462700000
TCGA-06-0219.6	6	2_MITOTIC_CELL_CYCLE	134	4	0.0009595763597279654800000
TCGA-08-0244.4	6	2_MITOTIC_CELL_CYCLE	134	4	0.0009595763597279654800000
TCGA-12-5299.5	6	2_MITOTIC_CELL_CYCLE	134	4	0.0009595763597279654800000
TCGA-14-1829.11	6	2_MITOTIC_CELL_CYCLE	134	4	0.0009595763597279654800000
TCGA-14-2554.9	6	2_MITOTIC_CELL_CYCLE	134	4	0.0009595763597279654800000
TCGA-14-1825.8	80	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0009596197875249088800000
TCGA-06-2565.10	38	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	7	0.0009601984221571655600000
TCGA-28-5218.5	208	2_EXTRACELLULAR_REGION	346	24	0.0009614905465506671000000
TCGA-12-0688.10	93	1_KEGG_DNA_REPLICATION	32	6	0.0009632433494136462600000
TCGA-32-2632.16	229	2_DNA_REPLICATION	82	12	0.0009648548400933578500000
TCGA-19-5959.13	92	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0009668719022703319100000
TCGA-32-2615.7	77	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0009670852614719992300000
TCGA-06-0140.2	25	2_NEUROLOGICAL_SYSTEM_PROCESS	296	8	0.0009702005369041673400000
TCGA-02-0034.5	6	1_KEGG_ASTHMA	30	3	0.0009703223555124101200000
TCGA-76-6193.13	271	2_EXTRACELLULAR_SPACE	192	20	0.0009730191791430715700000
TCGA-02-0026.1	61	2_ORGANELLE_PART	916	20	0.0009730282328061094800000
TCGA-27-2521.10	94	2_CELL_CYCLE_PROCESS	163	11	0.0009754294168918349500000
TCGA-06-5414.13	102	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	11	0.0009755530337659792600000
TCGA-02-2483.10	100	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0009771548758053972200000
TCGA-02-0011.1	288	1_KEGG_P53_SIGNALING_PATHWAY	66	12	0.0009780274156130388000000
TCGA-06-2562.7	57	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0009794385683992046700000
TCGA-12-0688.10	93	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0009800237824497582000000
TCGA-08-0350.2	46	2_SYNAPTIC_TRANSMISSION	152	8	0.0009804453384375409400000
TCGA-12-5301.7	46	2_SYNAPTIC_TRANSMISSION	152	8	0.0009804453384375409400000
TCGA-06-1804.6	30	2_NUCLEAR_CHROMOSOME_PART	22	4	0.0009813473044121925400000
TCGA-32-1991.11	82	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0009829659898799318500000
TCGA-76-4925.9	83	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0009841215242798878600000
TCGA-06-0166.5	35	2_EXTRACELLULAR_MATRIX	85	6	0.0009873969907307164100000
TCGA-28-5204.3	4	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	263	4	0.0009923706157720759200000
TCGA-06-5412.1	28	0_HALLMARK_COMPLEMENT	176	7	0.0009936101458271999500000
TCGA-76-4935.7	15	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0009970171893207457100000
TCGA-28-2509.5	4	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	3	0.0009980279902263710200000
TCGA-02-0033.1	4	2_EXTRACELLULAR_MATRIX_PART	51	3	0.0009980279902263710200000
TCGA-06-0126.3	4	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	3	0.0009980279902263710200000
TCGA-08-0347.4	16	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	4	0.0009982368892663099000000
TCGA-19-2623.11	153	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0010008473200733244000000
TCGA-28-5220.7	15	2_DNA_METABOLIC_PROCESS	218	6	0.0010015778762815376000000
TCGA-76-6192.6	43	2_ORGAN_DEVELOPMENT	460	12	0.0010030246868339148000000
TCGA-06-0686.10	26	2_MICROTUBULE_CYTOSKELETON	117	6	0.0010078061830481656000000
TCGA-27-2528.10	99	2_CELL_CYCLE_GO_0007049	265	14	0.0010082348597869051000000
TCGA-06-0154.2	5	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	3	0.0010089636545425390000000
TCGA-32-4211.7	5	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	3	0.0010089636545425390000000
TCGA-76-4927.8	93	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0010099822364786693000000
TCGA-02-0054.3	93	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0010099822364786693000000
TCGA-08-0358.9	43	2_NEUROLOGICAL_SYSTEM_PROCESS	296	10	0.0010140346220492969000000
TCGA-06-0192.10	126	2_RECEPTOR_ACTIVITY	499	22	0.0010167544189828832000000
TCGA-28-2513.12	134	2_COLLAGEN	23	6	0.0010180796740117089000000
TCGA-06-0686.5	14	0_HALLMARK_UV_RESPONSE_DN	122	5	0.0010193741354483968000000
TCGA-08-0357.4	36	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0010208251064964563000000
TCGA-06-0877.7	4	2_CELL_CYCLE_GO_0007049	265	4	0.0010230805817773878000000
TCGA-06-0877.7	4	2_REGULATION_OF_CELL_PROLIFERATION	265	4	0.0010230805817773878000000
TCGA-16-0861.5	4	2_CELL_CYCLE_GO_0007049	265	4	0.0010230805817773878000000
TCGA-06-2561.7	4	2_CELL_CYCLE_GO_0007049	265	4	0.0010230805817773878000000
TCGA-08-0348.3	4	2_CELL_CYCLE_GO_0007049	265	4	0.0010230805817773878000000
TCGA-08-0348.3	4	2_REGULATION_OF_CELL_PROLIFERATION	265	4	0.0010230805817773878000000
TCGA-06-0221.13	45	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0010248608762027248000000
TCGA-06-0241.8	53	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0010272503934409720000000
TCGA-06-0216.6	67	1_KEGG_MELANOMA	71	7	0.0010281449406311502000000
TCGA-06-2557.11	177	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	13	0.0010306167581751484000000
TCGA-32-1979.4	12	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0010311889428938281000000
TCGA-06-0145.17	11	2_CELL_CYCLE_PROCESS	163	5	0.0010322263615828475000000
TCGA-02-2470.4	11	2_CELL_CYCLE_PROCESS	163	5	0.0010322263615828475000000
TCGA-06-2569.5	144	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0010327529718608857000000
TCGA-19-1790.18	201	0_HALLMARK_INFLAMMATORY_RESPONSE	170	16	0.0010336244416907065000000
TCGA-06-0686.1	7	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	299	5	0.0010346620888498819000000
TCGA-26-5135.9	71	1_KEGG_BLADDER_CANCER	42	6	0.0010404145083967704000000
TCGA-02-0024.6	206	2_CELL_CYCLE_PHASE	146	15	0.0010423249445846007000000
TCGA-32-2615.7	77	2_EXTRACELLULAR_REGION	346	14	0.0010496754612116684000000
TCGA-14-0787.6	40	0_HALLMARK_MYC_TARGETS_V1	178	8	0.0010534396395299823000000
TCGA-32-2491.14	244	1_KEGG_FOCAL_ADHESION	195	19	0.0010627948394970343000000
TCGA-06-0197.1	57	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0010635206140546273000000
TCGA-06-0171.7	57	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0010635206140546273000000
TCGA-32-4211.14	71	2_COLLAGEN	23	5	0.0010635904428012129000000
TCGA-02-0086.2	17	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0010647568016528468000000
TCGA-06-0178.2	17	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0010647568016528468000000
TCGA-19-5952.11	193	2_GLYCOSAMINOGLYCAN_BINDING	26	7	0.0010652084008663870000000
TCGA-32-2494.10	173	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0010679419282234540000000
TCGA-41-2571.7	72	2_REGULATION_OF_CELL_PROLIFERATION	265	12	0.0010733074089878526000000
TCGA-12-5299.5	6	2_REGULATION_OF_CELL_GROWTH	31	3	0.0010740290711921759000000
TCGA-27-1833.7	17	2_NON_MEMBRANE_BOUND_ORGANELLE	476	8	0.0010755041580235542000000
TCGA-27-1833.7	17	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	8	0.0010755041580235542000000
TCGA-12-3650.17	101	2_M_PHASE	94	9	0.0010778678047485416000000
TCGA-06-5413.11	142	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	10	0.0010792845556737358000000
TCGA-26-1439.10	84	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0010800308794765199000000
TCGA-28-1753.13	174	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0010833559966495919000000
TCGA-06-5415.7	7	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0010864810746585619000000
TCGA-19-1390.13	110	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	44	7	0.0010866815714191006000000
TCGA-02-0011.1	288	0_HALLMARK_APOPTOSIS	150	18	0.0010878935691532238000000
TCGA-14-0787.6	40	1_KEGG_PATHWAYS_IN_CANCER	323	10	0.0010911170305584097000000
TCGA-06-0882.6	21	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	6	0.0010914888988743298000000
TCGA-02-0001.5	117	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	8	0.0010989224575612439000000
TCGA-06-0130.3	155	0_HALLMARK_E2F_TARGETS	169	14	0.0010992556730292969000000
TCGA-16-0846.2	27	1_KEGG_CELL_CYCLE	114	6	0.0011001066612534454000000
TCGA-06-2570.8	95	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0011004871289035773000000
TCGA-06-0176.8	95	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0011004871289035773000000
TCGA-06-0171.7	57	0_HALLMARK_E2F_TARGETS	169	9	0.0011027172984627328000000
TCGA-02-0038.3	199	2_DNA_REPAIR	113	13	0.0011100259431391871000000
TCGA-08-0357.4	36	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0011131300528396840000000
TCGA-06-0744.10	36	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0011131300528396840000000
TCGA-02-0016.2	29	2_CELL_CELL_SIGNALING	353	9	0.0011181588101579754000000
TCGA-06-0878.10	115	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0011189075557934581000000
TCGA-02-0015.16	115	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0011189075557934581000000
TCGA-08-0352.2	59	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0011191844993782875000000
TCGA-06-0216.6	67	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0011216775815798602000000
TCGA-08-0386.4	73	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0011224015862438970000000
TCGA-16-0861.5	4	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	3	0.0011225006697692837000000
TCGA-02-0054.3	93	1_KEGG_ENDOMETRIAL_CANCER	52	7	0.0011234607499772474000000
TCGA-26-5135.9	71	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0011243039183009970000000
TCGA-32-4719.15	123	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0011264318563253609000000
TCGA-41-2571.7	72	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0011312829848541643000000
TCGA-19-2624.24	3	2_PHOTORECEPTOR_CELL_MAINTENANCE	5	2	0.0011358270105119685000000
TCGA-19-5947.4	267	1_KEGG_CELL_CYCLE	114	15	0.0011360037951628765000000
TCGA-02-0046.8	148	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0011364793101485172000000
TCGA-06-0174.37	141	2_SPINDLE	35	7	0.0011382284144542841000000
TCGA-02-0068.1	72	2_COLLAGEN	23	5	0.0011411419419444155000000
TCGA-06-5411.4	23	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	5	0.0011411419419444157000000
TCGA-08-0352.2	59	2_EXTRACELLULAR_REGION_PART	269	11	0.0011429521811988103000000
TCGA-12-1597.6	51	1_KEGG_DNA_REPLICATION	32	5	0.0011430074500473749000000
TCGA-28-2501.3	51	0_HALLMARK_ANGIOGENESIS	32	5	0.0011430074500473749000000
TCGA-19-2619.14	100	2_CELL_CYCLE_GO_0007049	265	14	0.0011433317602802114000000
TCGA-32-1979.10	116	2_RESPONSE_TO_WOUNDING	163	12	0.0011433923838150303000000
TCGA-02-0046.8	148	2_CYTOSKELETON	293	18	0.0011448002589891048000000
TCGA-06-0686.6	3	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	3	0.0011459777728703756000000
TCGA-19-5958.2	3	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	3	0.0011459777728703756000000
TCGA-76-4928.15	78	1_KEGG_GLIOMA	62	7	0.0011480635681170390000000
TCGA-19-5955.9	110	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0011492143253537819000000
TCGA-06-2562.7	57	2_EXTRACELLULAR_MATRIX	85	7	0.0011535870092939846000000
TCGA-06-0176.8	95	2_TRANSMISSION_OF_NERVE_IMPULSE	164	11	0.0011554886180929608000000
TCGA-14-4157.7	101	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0011560102089095421000000
TCGA-32-1980.1	24	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	5	0.0011568078883567336000000
TCGA-06-0875.7	78	2_REGULATION_OF_CELL_CYCLE	160	10	0.0011576351548468922000000
TCGA-19-2629.15	146	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0011606477749938578000000
TCGA-12-5295.8	66	2_CELL_CYCLE_PHASE	146	9	0.0011606477749938578000000
TCGA-02-0060.19	281	2_DEFENSE_RESPONSE	222	22	0.0011609824300662494000000
TCGA-32-4213.15	198	1_KEGG_CELL_CYCLE	114	13	0.0011612662477369546000000
TCGA-28-5207.12	188	2_AXON	10	5	0.0011620427671538889000000
TCGA-27-2518.5	20	1_KEGG_ECM_RECEPTOR_INTERACTION	84	5	0.0011622442278423953000000
TCGA-02-0080.3	20	1_KEGG_ECM_RECEPTOR_INTERACTION	84	5	0.0011622442278423953000000
TCGA-06-0241.8	53	2_MITOTIC_CELL_CYCLE	134	8	0.0011626512137363778000000
TCGA-08-0354.7	47	2_SYNAPTIC_TRANSMISSION	152	8	0.0011655930169295243000000
TCGA-08-0380.5	47	2_SYNAPTIC_TRANSMISSION	152	8	0.0011655930169295243000000
TCGA-28-5219.9	47	2_SYNAPTIC_TRANSMISSION	152	8	0.0011655930169295243000000
TCGA-06-0744.3	12	2_RECEPTOR_ACTIVITY	499	7	0.0011677207994614577000000
TCGA-02-0060.19	281	2_PLASMA_MEMBRANE	1096	61	0.0011689823857693022000000
TCGA-41-3915.10	109	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0011700575492548351000000
TCGA-08-0357.4	36	2_EXTRACELLULAR_MATRIX	85	6	0.0011763941029712948000000
TCGA-06-0210.6	103	1_KEGG_ASTHMA	30	6	0.0011767717579729679000000
TCGA-32-1986.12	17	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	4	0.0011785643785563705000000
TCGA-26-5134.3	21	2_SYNAPTIC_TRANSMISSION	152	6	0.0011801154482213600000000
TCGA-02-0028.9	182	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	10	0.0011804879461976025000000
TCGA-06-0142.3	8	2_COLLAGEN	23	3	0.0011833456061492655000000
TCGA-06-0138.2	30	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0011853305412804207000000
TCGA-76-4925.9	83	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0011907767744320811000000
TCGA-28-5220.7	15	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0011936134589285963000000
TCGA-02-0052.3	116	1_KEGG_FOCAL_ADHESION	195	13	0.0011943407589977270000000
TCGA-02-0071.12	116	1_KEGG_FOCAL_ADHESION	195	13	0.0011943407589977270000000
TCGA-06-0195.8	56	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	7	0.0011957315565933341000000
TCGA-32-4208.28	140	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0011961023287971669000000
TCGA-16-1048.13	97	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0011969080548340052000000
TCGA-41-2571.7	72	2_MITOTIC_CELL_CYCLE	134	9	0.0011980034959041558000000
TCGA-02-0048.9	84	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0012008731784658388000000
TCGA-06-5414.13	102	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0012023665382461829000000
TCGA-41-3392.31	136	1_KEGG_MELANOMA	71	9	0.0012027909236451688000000
TCGA-41-2575.49	136	1_KEGG_MELANOMA	71	9	0.0012027909236451688000000
TCGA-02-0071.12	116	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0012044450399005537000000
TCGA-27-2527.6	79	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0012073799298862895000000
TCGA-76-6191.6	96	2_CELL_CYCLE_PROCESS	163	11	0.0012094614144287962000000
TCGA-28-5214.11	124	2_CELL_CELL_SIGNALING	353	18	0.0012144211799530375000000
TCGA-81-5910.12	128	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0012157417594950910000000
TCGA-06-2567.9	156	1_KEGG_FOCAL_ADHESION	195	15	0.0012158084738608460000000
TCGA-28-5209.15	194	1_KEGG_PATHWAYS_IN_CANCER	323	22	0.0012184722618604942000000
TCGA-76-4935.7	15	2_MICROTUBULE_CYTOSKELETON	117	5	0.0012286467845243603000000
TCGA-02-0011.1	288	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	40	0.0012318550294818315000000
TCGA-26-5132.7	100	1_KEGG_MELANOMA	71	8	0.0012321925670537388000000
TCGA-06-0145.17	11	0_HALLMARK_E2F_TARGETS	169	5	0.0012354831732585649000000
TCGA-06-6390.6	11	0_HALLMARK_E2F_TARGETS	169	5	0.0012354831732585649000000
TCGA-16-1048.13	97	0_HALLMARK_ANGIOGENESIS	32	6	0.0012369538662062487000000
TCGA-06-2565.3	60	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0012384570801532442000000
TCGA-28-5214.11	124	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0012446254517948850000000
TCGA-14-0813.5	5	2_CELL_SURFACE_RECEPTOR_LINKED_SIGNAL_TRANSDUCTION_GO_0007166	563	5	0.0012486894122644204000000
TCGA-06-5411.3	19	1_KEGG_ALLOGRAFT_REJECTION	37	4	0.0012502751617508145000000
TCGA-41-5651.5	112	2_CELL_PROLIFERATION_GO_0008283	436	19	0.0012511371273755529000000
TCGA-32-2491.14	244	2_REGULATION_OF_CELL_CYCLE	160	17	0.0012523503741048922000000
TCGA-06-0158.4	65	1_KEGG_FOCAL_ADHESION	195	10	0.0012564589694477031000000
TCGA-19-5952.11	193	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0012596161223036170000000
TCGA-06-0148.6	69	1_KEGG_MELANOMA	71	7	0.0012604476264270440000000
TCGA-06-5858.19	205	2_INTERPHASE	62	10	0.0012627294345785699000000
TCGA-02-0099.11	141	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0012628858513154258000000
TCGA-32-2632.16	229	0_HALLMARK_ALLOGRAFT_REJECTION	190	18	0.0012687462114903156000000
TCGA-16-1045.10	81	1_KEGG_FOCAL_ADHESION	195	11	0.0012688816820138986000000
TCGA-32-2491.14	244	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0012688911789921614000000
TCGA-02-0003.9	227	1_KEGG_VIRAL_MYOCARDITIS	70	11	0.0012704446815790505000000
TCGA-02-0007.17	217	2_REGULATION_OF_CELL_CYCLE	160	16	0.0012730079233573960000000
TCGA-06-0241.8	53	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0012747323925743645000000
TCGA-06-0686.6	3	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	3	0.0012747986444249222000000
TCGA-19-5958.2	3	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	3	0.0012747986444249222000000
TCGA-19-5947.4	267	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	86	13	0.0012770025460612277000000
TCGA-06-0649.13	88	2_CELL_CELL_SIGNALING	353	15	0.0012837266022596306000000
TCGA-06-2570.8	95	2_CHROMOSOME	102	9	0.0012838172952895528000000
TCGA-06-0145.4	7	2_MICROTUBULE_CYTOSKELETON	117	4	0.0012840738460695733000000
TCGA-06-5414.13	102	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0012845512164678015000000
TCGA-28-2502.9	56	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0012855257643381933000000
TCGA-06-6391.9	26	0_HALLMARK_UV_RESPONSE_DN	122	6	0.0012906399913480283000000
TCGA-06-5412.7	153	2_PATTERN_BINDING	33	7	0.0012908972383417251000000
TCGA-02-0011.1	288	2_DNA_METABOLIC_PROCESS	218	22	0.0012916487961742204000000
TCGA-02-0058.1	110	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0012925355897841788000000
TCGA-02-0071.12	116	2_CELL_CYCLE_GO_0007049	265	15	0.0012965391140149498000000
TCGA-26-1439.10	84	2_EXTRACELLULAR_MATRIX	85	8	0.0012989481666078205000000
TCGA-27-2528.10	99	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0012994937279898733000000
TCGA-02-0086.2	17	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	4	0.0013011870712731177000000
TCGA-32-1986.12	17	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	4	0.0013011870712731177000000
TCGA-02-0058.1	110	2_NEURON_PROJECTION	16	5	0.0013014552732945820000000
TCGA-16-1048.13	97	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0013073189730449678000000
TCGA-02-0038.3	199	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	7	0.0013101244284506744000000
TCGA-02-0024.6	206	2_INTRACELLULAR_ORGANELLE_PART	912	43	0.0013125362370673516000000
TCGA-06-0750.13	8	2_INTEGRAL_TO_MEMBRANE	956	7	0.0013128747986550179000000
TCGA-28-2501.3	51	2_CYTOSKELETAL_PART	194	9	0.0013155535038398820000000
TCGA-02-0060.19	281	2_IMMUNE_RESPONSE	206	21	0.0013167082664191456000000
TCGA-28-1753.13	174	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0013174230780912031000000
TCGA-19-5952.11	193	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0013231740285662092000000
TCGA-08-0347.4	16	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0013247421965711494000000
TCGA-06-0877.7	4	2_PROTEIN_KINASE_BINDING	56	3	0.0013279380428747897000000
TCGA-08-0348.3	4	2_PROTEIN_KINASE_BINDING	56	3	0.0013279380428747897000000
TCGA-06-2559.11	101	1_KEGG_MELANOMA	71	8	0.0013302373182868304000000
TCGA-06-0645.9	136	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0013312583863341226000000
TCGA-06-5413.11	142	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0013328333951460893000000
TCGA-32-2632.16	229	1_KEGG_MISMATCH_REPAIR	23	7	0.0013346411898764710000000
TCGA-02-0052.3	116	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0013352314420819449000000
TCGA-76-4934.4	20	2_TRANSMISSION_OF_NERVE_IMPULSE	164	6	0.0013368838983801948000000
TCGA-02-0001.5	117	2_TRANSMISSION_OF_NERVE_IMPULSE	164	12	0.0013403767613881607000000
TCGA-14-4157.7	101	0_HALLMARK_DNA_REPAIR	125	10	0.0013446119980023673000000
TCGA-27-1836.8	49	2_CELL_CYCLE_GO_0007049	265	10	0.0013455869001770292000000
TCGA-28-5220.7	15	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	8	0.0013501946951230486000000
TCGA-02-0060.19	281	2_SIGNAL_TRANSDUCTION	1442	74	0.0013503878511759734000000
TCGA-28-2514.9	62	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0013521594282141967000000
TCGA-06-0214.9	62	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0013521594282141967000000
TCGA-06-0211.8	62	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0013521594282141967000000
TCGA-32-1979.4	12	1_KEGG_GLIOMA	62	4	0.0013521594282142157000000
TCGA-32-1979.4	12	2_INTERPHASE	62	4	0.0013521594282142157000000
TCGA-27-2524.5	75	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0013523649948850819000000
TCGA-08-0353.8	100	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0013531773863713107000000
TCGA-02-0028.9	182	1_KEGG_VIRAL_MYOCARDITIS	70	10	0.0013544930824833706000000
TCGA-06-0219.6	6	2_CELL_CYCLE_PHASE	146	4	0.0013545792962007231000000
TCGA-08-0244.4	6	2_CELL_CYCLE_PHASE	146	4	0.0013545792962007231000000
TCGA-12-5299.5	6	2_CELL_CYCLE_PHASE	146	4	0.0013545792962007231000000
TCGA-14-1829.11	6	2_CELL_CYCLE_PHASE	146	4	0.0013545792962007231000000
TCGA-14-2554.9	6	2_CELL_CYCLE_PHASE	146	4	0.0013545792962007231000000
TCGA-32-4208.28	140	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0013587975780850598000000
TCGA-19-5960.9	134	2_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0013622684660317345000000
TCGA-19-5960.9	134	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0013622684660317345000000
TCGA-06-0132.2	2	2_INTERLEUKIN_1_SECRETION	9	2	0.0013632810598856978000000
TCGA-06-0139.1	179	2_CELL_CELL_SIGNALING	353	22	0.0013665111649100972000000
TCGA-06-0878.10	115	2_EXTRACELLULAR_MATRIX	85	9	0.0013734206675169649000000
TCGA-02-0015.16	115	2_EXTRACELLULAR_MATRIX	85	9	0.0013734206675169649000000
TCGA-02-0099.11	141	2_COLLAGEN	23	6	0.0013747237908198163000000
TCGA-06-2561.5	42	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	8	0.0013760744316053729000000
TCGA-32-2634.10	118	2_MITOTIC_CELL_CYCLE	134	11	0.0013765899350040975000000
TCGA-06-5412.7	153	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0013795104492221489000000
TCGA-06-5856.13	152	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0013798092354450921000000
TCGA-06-5408.3	99	1_KEGG_FOCAL_ADHESION	195	12	0.0013840867912649881000000
TCGA-06-0879.9	84	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0013854372887423729000000
TCGA-32-1977.11	107	0_HALLMARK_KRAS_SIGNALING_UP	148	11	0.0013864129472532776000000
TCGA-28-5209.15	194	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0013874945483492909000000
TCGA-14-0789.10	106	1_KEGG_ASTHMA	30	6	0.0013947775378613178000000
TCGA-27-2524.5	75	2_COLLAGEN	23	5	0.0014009477216679130000000
TCGA-19-1790.18	201	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0014025378065021053000000
TCGA-28-5220.7	15	2_NUCLEUS	1110	10	0.0014026533598553521000000
TCGA-06-0187.10	55	2_NEUROLOGICAL_SYSTEM_PROCESS	296	11	0.0014028416175980944000000
TCGA-06-2563.10	123	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0014052826208146801000000
TCGA-06-0190.8	143	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0014060678850311122000000
TCGA-12-3650.17	101	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0014084976824505131000000
TCGA-06-0171.7	57	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0014097444179849716000000
TCGA-06-0750.13	8	2_INTRINSIC_TO_MEMBRANE	966	7	0.0014109629407907556000000
TCGA-06-0173.35	120	1_KEGG_BLADDER_CANCER	42	7	0.0014110007161067277000000
TCGA-32-2632.16	229	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	44	9	0.0014123487120628242000000
TCGA-27-1835.6	86	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0014219246171669434000000
TCGA-76-4931.10	86	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0014219246171669434000000
TCGA-06-5411.4	23	2_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0014223076860437288000000
TCGA-06-5411.4	23	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0014223076860437288000000
TCGA-76-4929.8	91	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0014238744502379646000000
TCGA-12-0692.6	11	0_HALLMARK_G2M_CHECKPOINT	174	5	0.0014280273412612264000000
TCGA-06-0644.16	142	2_COLLAGEN	23	6	0.0014331403082000714000000
TCGA-06-0644.16	142	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	6	0.0014331403082000714000000
TCGA-02-0083.21	135	2_CYTOSKELETON	293	17	0.0014332026815463829000000
TCGA-02-0048.9	84	2_MICROTUBULE_CYTOSKELETON	117	9	0.0014361366675302576000000
TCGA-02-0102.8	82	1_KEGG_FOCAL_ADHESION	195	11	0.0014393551038876290000000
TCGA-02-0099.11	141	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0014429647086067036000000
TCGA-27-2519.7	113	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0014448038376371865000000
TCGA-02-0026.1	61	2_DNA_REPLICATION	82	7	0.0014459275771509124000000
TCGA-06-5412.7	153	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0014504170573424670000000
TCGA-32-4208.28	140	2_TRANSMISSION_OF_NERVE_IMPULSE	164	13	0.0014532052992587759000000
TCGA-76-4928.15	78	2_TRANSMISSION_OF_NERVE_IMPULSE	164	10	0.0014535540729102457000000
TCGA-28-2514.9	62	2_REGULATION_OF_CELL_CYCLE	160	9	0.0014553788196204039000000
TCGA-28-5209.15	194	2_CELL_CELL_SIGNALING	353	23	0.0014573483661117286000000
TCGA-02-0014.10	70	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0014580963118312447000000
TCGA-19-5955.9	110	0_HALLMARK_COMPLEMENT	176	12	0.0014606595615439251000000
TCGA-02-0079.1	5	1_KEGG_FOCAL_ADHESION	195	4	0.0014634696314001028000000
TCGA-19-5947.4	267	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	13	0.0014639483619711068000000
TCGA-12-5299.6	38	2_CELL_CELL_SIGNALING	353	10	0.0014643292400901222000000
TCGA-06-5414.13	102	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0014654870582330661000000
TCGA-12-0616.7	45	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0014658336609732093000000
TCGA-08-0355.1	45	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0014658336609732093000000
TCGA-06-0645.9	136	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	13	0.0014674738789552662000000
TCGA-08-0347.4	16	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0014680123672726989000000
TCGA-76-4928.15	78	2_AXON	10	4	0.0014692778954676679000000
TCGA-06-2567.9	156	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0014693174871956078000000
TCGA-06-2567.9	156	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0014693174871956078000000
TCGA-06-2567.9	156	2_DNA_REPLICATION	82	10	0.0014715091848468737000000
TCGA-32-2494.10	173	1_KEGG_ASTHMA	30	7	0.0014741517661708973000000
TCGA-02-0024.6	206	2_ORGANELLE_PART	916	43	0.0014777008494376649000000
TCGA-16-0861.5	4	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	3	0.0014779336709904154000000
TCGA-06-2561.7	4	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	3	0.0014779336709904154000000
TCGA-02-0071.12	116	2_EXTRACELLULAR_MATRIX	85	9	0.0014781330598388960000000
TCGA-19-2619.14	100	0_HALLMARK_ANGIOGENESIS	32	6	0.0014815811119559881000000
TCGA-19-2619.14	100	1_KEGG_DNA_REPLICATION	32	6	0.0014815811119559881000000
TCGA-19-4068.2	11	1_KEGG_LEISHMANIA_INFECTION	70	4	0.0014818733605298461000000
TCGA-28-5219.9	47	2_CELL_CELL_SIGNALING	353	11	0.0014896821402619804000000
TCGA-28-5208.28	220	2_CELL_CYCLE_GO_0007049	265	21	0.0014926540146777503000000
TCGA-06-0190.8	143	2_COLLAGEN	23	6	0.0014935782065595485000000
TCGA-02-0060.19	281	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	13	0.0014967589400074754000000
TCGA-06-0154.13	76	2_COLLAGEN	23	5	0.0014972164819327229000000
TCGA-32-2638.17	159	0_HALLMARK_E2F_TARGETS	169	14	0.0014993588314743548000000
TCGA-19-1390.12	10	2_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	198	5	0.0015031379725826918000000
TCGA-06-2564.7	92	0_HALLMARK_G2M_CHECKPOINT	174	11	0.0015033929739612377000000
TCGA-32-4208.28	140	1_KEGG_CELL_CYCLE	114	11	0.0015080857897645794000000
TCGA-28-5216.8	162	1_KEGG_DNA_REPLICATION	32	7	0.0015180142869781602000000
TCGA-32-2634.10	118	1_KEGG_GLIOMA	62	8	0.0015182606136078427000000
TCGA-06-5415.7	7	1_KEGG_PATHWAYS_IN_CANCER	323	5	0.0015193427062773169000000
TCGA-14-3476.4	7	0_HALLMARK_UV_RESPONSE_DN	122	4	0.0015193575655872123000000
TCGA-26-5132.7	100	2_REGULATION_OF_CELL_CYCLE	160	11	0.0015215377898400108000000
TCGA-06-0210.6	103	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0015241782547620233000000
TCGA-14-1829.14	67	2_CELL_CELL_SIGNALING	353	13	0.0015282534615079055000000
TCGA-32-2495.11	67	2_CELL_CELL_SIGNALING	353	13	0.0015282534615079055000000
TCGA-28-5208.28	220	2_REGULATION_OF_CELL_CYCLE	160	16	0.0015299186184571762000000
TCGA-06-5413.11	142	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0015316096930361686000000
TCGA-02-0015.16	115	0_HALLMARK_E2F_TARGETS	169	12	0.0015334087563571061000000
TCGA-28-5215.7	192	2_STRUCTURAL_MOLECULE_ACTIVITY	206	17	0.0015354092251515514000000
TCGA-06-0140.2	25	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0015355909234347684000000
TCGA-06-5412.7	153	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0015444083481316272000000
TCGA-19-2623.11	153	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0015444083481316272000000
TCGA-08-0353.8	100	1_KEGG_FOCAL_ADHESION	195	12	0.0015447270716902064000000
TCGA-02-0084.1	25	1_KEGG_VIRAL_MYOCARDITIS	70	5	0.0015457186601497838000000
TCGA-02-0025.5	88	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0015478903372416707000000
TCGA-28-5220.7	15	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0015502186277641698000000
TCGA-06-0877.8	61	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0015539348045305727000000
TCGA-06-2569.5	144	2_COLLAGEN	23	6	0.0015560914646603600000000
TCGA-32-4213.15	198	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	9	0.0015614092737321070000000
TCGA-06-0219.6	6	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0015623605626824317000000
TCGA-08-0244.4	6	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0015623605626824317000000
TCGA-12-5299.5	6	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0015623605626824317000000
TCGA-14-1823.12	6	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0015623605626824317000000
TCGA-14-1829.11	6	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0015623605626824317000000
TCGA-14-2554.9	6	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0015623605626824317000000
TCGA-76-6285.5	106	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0015626613957100022000000
TCGA-02-0052.3	116	2_EXTRACELLULAR_REGION_PART	269	15	0.0015677477856923252000000
TCGA-06-0645.9	136	0_HALLMARK_INFLAMMATORY_RESPONSE	170	13	0.0015696689492532975000000
TCGA-06-2559.11	101	1_KEGG_DNA_REPLICATION	32	6	0.0015714221883940589000000
TCGA-06-2561.5	42	0_HALLMARK_UV_RESPONSE_DN	122	7	0.0015784640404959286000000
TCGA-32-2491.14	244	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0015789396442921096000000
TCGA-28-2501.3	51	2_NON_MEMBRANE_BOUND_ORGANELLE	476	13	0.0015838639199133922000000
TCGA-28-2501.3	51	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	13	0.0015838639199133922000000
TCGA-06-5414.13	102	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	10	0.0015871348357157967000000
TCGA-76-6191.6	96	2_MITOTIC_CELL_CYCLE	134	10	0.0015918215417059722000000
TCGA-32-2634.10	118	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	11	0.0015968073163739351000000
TCGA-06-0128.8	74	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0016028709748166278000000
TCGA-32-2632.16	229	1_KEGG_MELANOMA	71	11	0.0016054987035885784000000
TCGA-06-2562.7	57	2_CELL_CELL_SIGNALING	353	12	0.0016084039029729004000000
TCGA-12-0692.3	9	2_ORGAN_DEVELOPMENT	460	6	0.0016156783542202791000000
TCGA-19-1790.18	201	2_AXON	10	5	0.0016195774485421063000000
TCGA-12-5295.8	66	2_SYNAPTIC_TRANSMISSION	152	9	0.0016301895668562620000000
TCGA-06-0174.37	141	1_KEGG_MELANOMA	71	9	0.0016316828301561009000000
TCGA-06-0174.37	141	2_MITOSIS	71	9	0.0016316828301561009000000
TCGA-06-0211.8	62	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0016321245081841690000000
TCGA-02-0007.17	217	2_CELL_CYCLE_PROCESS	163	16	0.0016363123263827242000000
TCGA-12-5299.6	38	2_SYSTEM_PROCESS	451	11	0.0016368663589268518000000
TCGA-06-0158.4	65	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0016377300686408953000000
TCGA-32-1979.10	116	2_EXTRACELLULAR_REGION	346	17	0.0016392571577340306000000
TCGA-14-0789.10	106	2_SYNAPTIC_TRANSMISSION	152	11	0.0016454695452238410000000
TCGA-14-0817.9	85	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	7	0.0016488913999795599000000
TCGA-41-2575.49	136	2_CELL_PROLIFERATION_GO_0008283	436	21	0.0016501041782925798000000
TCGA-06-0192.10	126	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0016546985144643728000000
TCGA-06-2557.11	177	0_HALLMARK_COMPLEMENT	176	15	0.0016574157491004123000000
TCGA-32-1977.11	107	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	8	0.0016576441309449688000000
TCGA-28-5208.28	220	2_NEURON_PROJECTION	16	6	0.0016582957568735375000000
TCGA-28-2514.9	62	2_CELL_CYCLE_GO_0007049	265	11	0.0016598638826863822000000
TCGA-32-2632.16	229	2_CHROMOSOME	102	13	0.0016614169135937657000000
TCGA-32-1977.11	107	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0016656746355150206000000
TCGA-15-1444.3	107	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0016656746355150206000000
TCGA-06-2563.10	123	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0016682618136639501000000
TCGA-19-2625.9	146	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	16	0.0016705590262497982000000
TCGA-19-5954.17	208	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	15	0.0016711515295322929000000
TCGA-06-0124.6	55	0_HALLMARK_ANGIOGENESIS	32	5	0.0016766066812392343000000
TCGA-12-5299.5	6	2_ENZYME_BINDING	154	4	0.0016781161832271580000000
TCGA-14-1829.14	67	1_KEGG_FOCAL_ADHESION	195	10	0.0016793658572101554000000
TCGA-76-6285.5	106	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0016848347403671854000000
TCGA-12-3649.15	89	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0016887563355280971000000
TCGA-41-2571.7	72	1_KEGG_MELANOMA	71	7	0.0016905614296585381000000
TCGA-28-5216.8	162	2_CORNIFIED_ENVELOPE	12	5	0.0016924375708221638000000
TCGA-27-2524.5	75	2_CELL_CYCLE_GO_0007049	265	12	0.0016934326488621911000000
TCGA-26-5133.10	75	2_CELL_CYCLE_GO_0007049	265	12	0.0016934326488621911000000
TCGA-02-0079.1	5	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	3	0.0016952632202979082000000
TCGA-76-4935.4	5	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	3	0.0016952632202979082000000
TCGA-06-0197.1	57	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	15	0.0016968451848713307000000
TCGA-02-0025.5	88	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0016979436787158517000000
TCGA-27-1832.11	88	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0016979436787158517000000
TCGA-26-5139.10	163	1_KEGG_GLIOMA	62	9	0.0017014009302915387000000
TCGA-06-0876.9	106	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0017107946531146258000000
TCGA-41-3393.5	88	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0017127864966736768000000
TCGA-06-0649.13	88	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0017127864966736768000000
TCGA-02-0043.10	184	1_KEGG_MELANOMA	71	10	0.0017139214477112025000000
TCGA-02-0010.18	184	1_KEGG_MELANOMA	71	10	0.0017139214477112025000000
TCGA-02-0009.6	188	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	38	0.0017154720966429862000000
TCGA-19-2624.19	5	2_TRANSPORT	600	5	0.0017184894503128516000000
TCGA-06-0881.7	203	0_HALLMARK_HYPOXIA	154	15	0.0017196418406998919000000
TCGA-06-0141.1	45	2_ORGAN_DEVELOPMENT	460	12	0.0017204434226621341000000
TCGA-27-1836.8	49	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0017215431439845685000000
TCGA-12-3650.17	101	1_KEGG_FOCAL_ADHESION	195	12	0.0017216883360232445000000
TCGA-19-2623.11	153	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0017226132158338358000000
TCGA-02-0060.19	281	2_INFLAMMATORY_RESPONSE	112	15	0.0017228802036764286000000
TCGA-87-5896.6	131	0_HALLMARK_MYC_TARGETS_V1	178	13	0.0017229759997295219000000
TCGA-06-0152.10	19	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0017234782779342510000000
TCGA-02-2486.9	141	2_DEFENSE_RESPONSE	222	15	0.0017238623139824904000000
TCGA-41-2571.7	72	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0017251858299332002000000
TCGA-06-2570.8	95	2_CHROMOSOMAL_PART	78	8	0.0017252527271257453000000
TCGA-14-0789.10	106	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0017255838064215755000000
TCGA-06-5412.7	153	2_EXTRACELLULAR_MATRIX	85	10	0.0017262736139309804000000
TCGA-27-1833.7	17	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0017263427110997447000000
TCGA-06-0648.6	17	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0017263427110997447000000
TCGA-06-0744.4	11	2_CELL_CELL_SIGNALING	353	6	0.0017372260128938816000000
TCGA-06-0882.1	11	2_CELL_CELL_SIGNALING	353	6	0.0017372260128938816000000
TCGA-06-0130.3	155	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0017403736010319930000000
TCGA-08-0350.2	46	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0017484624550484671000000
TCGA-12-5301.7	46	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0017484624550484671000000
TCGA-28-2514.9	62	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0017587061570338599000000
TCGA-06-0214.9	62	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0017587061570338599000000
TCGA-02-0046.8	148	2_CELL_PROLIFERATION_GO_0008283	436	22	0.0017715949956898546000000
TCGA-19-2629.15	146	2_REGULATION_OF_CELL_CYCLE	160	13	0.0017735820421413623000000
TCGA-06-0184.11	108	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0017743284622301701000000
TCGA-27-2519.7	113	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0017788987340863159000000
TCGA-27-1833.7	17	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0017813118842152813000000
TCGA-02-0086.2	17	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0017813118842152813000000
TCGA-06-0648.6	17	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0017813118842152813000000
TCGA-41-4097.6	48	1_KEGG_ALLOGRAFT_REJECTION	37	5	0.0017822639730838725000000
TCGA-06-0139.1	179	2_ENDOPEPTIDASE_ACTIVITY	91	11	0.0017822878259777990000000
TCGA-06-6391.6	30	0_HALLMARK_MYC_TARGETS_V1	178	7	0.0017864796127672481000000
TCGA-28-5215.7	192	0_HALLMARK_UV_RESPONSE_DN	122	13	0.0017948173050089382000000
TCGA-06-0130.3	155	2_CONTRACTILE_FIBER	22	6	0.0017960442738493977000000
TCGA-16-0861.5	4	1_KEGG_GLIOMA	62	3	0.0018109158535375548000000
TCGA-16-0861.5	4	2_INTERPHASE	62	3	0.0018109158535375548000000
TCGA-06-2561.7	4	2_INTERPHASE	62	3	0.0018109158535375548000000
TCGA-02-0028.9	182	2_CELL_CELL_SIGNALING	353	22	0.0018189914362739179000000
TCGA-26-5133.10	75	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	10	0.0018201657895760648000000
TCGA-06-0166.5	35	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0018202751144312502000000
TCGA-12-0692.3	9	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	7	0.0018228273189724847000000
TCGA-76-4928.15	78	1_KEGG_BLADDER_CANCER	42	6	0.0018235660039633279000000
TCGA-06-0875.7	78	1_KEGG_BLADDER_CANCER	42	6	0.0018235660039633279000000
TCGA-28-5207.12	188	1_KEGG_LEISHMANIA_INFECTION	70	10	0.0018237714224299260000000
TCGA-76-6191.6	96	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0018249148738154607000000
TCGA-02-0071.12	116	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0018283744987381936000000
TCGA-02-0024.6	206	2_AXON	10	5	0.0018294327690825795000000
TCGA-32-2491.14	244	0_HALLMARK_ANGIOGENESIS	32	8	0.0018342814348722592000000
TCGA-12-3653.55	255	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	9	0.0018356252239008653000000
TCGA-06-0122.8	90	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0018404222598113389000000
TCGA-06-5414.13	102	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0018412214443327168000000
TCGA-06-0174.37	141	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	9	0.0018413712291505998000000
TCGA-06-0879.9	84	1_KEGG_FOCAL_ADHESION	195	11	0.0018418488120600192000000
TCGA-19-1790.18	201	2_DEFENSE_RESPONSE	222	18	0.0018423310731685667000000
TCGA-26-5134.3	21	2_TRANSMISSION_OF_NERVE_IMPULSE	164	6	0.0018448737084967466000000
TCGA-06-0155.10	74	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0018461666566375278000000
TCGA-32-2634.10	118	2_REGULATION_OF_KINASE_ACTIVITY	138	11	0.0018475011663616381000000
TCGA-06-0216.6	67	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0018515601554402196000000
TCGA-19-5952.11	193	2_POLYSACCHARIDE_BINDING	28	7	0.0018520842708183937000000
TCGA-06-0157.7	89	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0018522910442701627000000
TCGA-28-5213.9	143	2_TRANSMISSION_OF_NERVE_IMPULSE	164	13	0.0018530816275286769000000
TCGA-02-0034.5	6	1_KEGG_ALLOGRAFT_REJECTION	37	3	0.0018538954181749113000000
TCGA-32-1977.11	107	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0018541183275936587000000
TCGA-15-1444.3	107	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0018541183275936587000000
TCGA-32-1980.1	24	0_HALLMARK_ANGIOGENESIS	32	4	0.0018560071119806956000000
TCGA-06-0216.6	67	2_SYNAPTIC_TRANSMISSION	152	9	0.0018575517841043550000000
TCGA-14-1829.14	67	2_SYNAPTIC_TRANSMISSION	152	9	0.0018575517841043550000000
TCGA-02-0014.12	5	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	207	4	0.0018597795567781696000000
TCGA-02-0025.5	88	2_EXTRACELLULAR_MATRIX	85	8	0.0018602397319463077000000
TCGA-02-0009.6	188	0_HALLMARK_COAGULATION	125	13	0.0018696496962284268000000
TCGA-19-5952.11	193	2_RESPONSE_TO_WOUNDING	163	15	0.0018724595420709950000000
TCGA-08-0386.4	73	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0018730180656737400000000
TCGA-06-2558.6	74	0_HALLMARK_MYC_TARGETS_V1	178	10	0.0018730943696064714000000
TCGA-19-2624.29	130	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	6	0.0018764487364096559000000
TCGA-02-0060.19	281	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	10	0.0018772339897989644000000
TCGA-26-1439.11	10	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0019003819210952099000000
TCGA-06-0877.7	4	2_KINASE_BINDING	63	3	0.0019013099459527262000000
TCGA-08-0348.3	4	2_KINASE_BINDING	63	3	0.0019013099459527262000000
TCGA-02-0014.10	70	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0019027861445964690000000
TCGA-06-0241.8	53	1_KEGG_GLIOMA	62	6	0.0019032480217043650000000
TCGA-06-0241.8	53	2_INTERPHASE	62	6	0.0019032480217043650000000
TCGA-27-1834.10	39	2_CELL_CELL_SIGNALING	353	10	0.0019045891640286448000000
TCGA-14-0871.20	216	2_CELL_CYCLE_PHASE	146	15	0.0019063292281997800000000
TCGA-08-0347.4	16	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0019064457565608683000000
TCGA-06-5411.3	19	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	4	0.0019073705288265813000000
TCGA-02-0048.9	84	2_INTERPHASE	62	7	0.0019088018919071093000000
TCGA-14-0786.4	62	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0019088018919071093000000
TCGA-06-0211.8	62	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0019088018919071093000000
TCGA-41-3915.10	109	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0019139347063393856000000
TCGA-32-4210.14	109	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0019139347063393856000000
TCGA-14-0787.6	40	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0019155979948841436000000
TCGA-06-5412.7	153	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	86	10	0.0019265690219577671000000
TCGA-06-0876.9	106	1_KEGG_MELANOMA	71	8	0.0019267912594983355000000
TCGA-14-1825.8	80	2_M_PHASE	94	8	0.0019346059132841556000000
TCGA-02-0014.10	70	2_CELL_CYCLE_PHASE	146	9	0.0019350470237014371000000
TCGA-06-0156.4	80	2_COLLAGEN	23	5	0.0019358338013393585000000
TCGA-14-0813.5	5	2_NEUROTRANSMITTER_RECEPTOR_ACTIVITY	47	3	0.0019365704753599177000000
TCGA-28-2514.9	62	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0019435322692046152000000
TCGA-06-0214.9	62	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0019435322692046152000000
TCGA-06-0211.8	62	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0019435322692046152000000
TCGA-14-0789.11	3	2_CATION_CHANNEL_ACTIVITY	100	3	0.0019447609868713557000000
TCGA-26-1439.7	3	2_CATION_CHANNEL_ACTIVITY	100	3	0.0019447609868713557000000
TCGA-14-1825.5	3	2_CATION_CHANNEL_ACTIVITY	100	3	0.0019447609868713557000000
TCGA-28-5220.7	15	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	4	0.0019448811671261123000000
TCGA-28-5207.12	188	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0019493632659208584000000
TCGA-06-6391.6	30	2_NON_MEMBRANE_BOUND_ORGANELLE	476	10	0.0019560384048766285000000
TCGA-06-6391.6	30	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	10	0.0019560384048766285000000
TCGA-14-0787.6	40	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0019561107873577394000000
TCGA-14-0787.6	40	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0019561107873577394000000
TCGA-06-0219.6	6	2_REGULATION_OF_CELL_CYCLE	160	4	0.0019562130326867895000000
TCGA-08-0244.4	6	2_REGULATION_OF_CELL_CYCLE	160	4	0.0019562130326867895000000
TCGA-12-5299.5	6	2_REGULATION_OF_CELL_CYCLE	160	4	0.0019562130326867895000000
TCGA-14-1829.11	6	2_REGULATION_OF_CELL_CYCLE	160	4	0.0019562130326867895000000
TCGA-14-2554.9	6	2_REGULATION_OF_CELL_CYCLE	160	4	0.0019562130326867895000000
TCGA-08-0360.3	144	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0019594637404616901000000
TCGA-06-0939.7	58	2_CELL_CELL_SIGNALING	353	12	0.0019607337433368540000000
TCGA-06-0192.10	126	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0019638055534813041000000
TCGA-32-2638.17	159	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0019648655978928634000000
TCGA-06-5417.5	79	1_KEGG_BLADDER_CANCER	42	6	0.0019669884572090877000000
TCGA-41-5651.5	112	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0019677209709366063000000
TCGA-32-1970.14	94	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0019797869932379379000000
TCGA-02-0060.19	281	2_EXTRACELLULAR_MATRIX	85	13	0.0019821660518169553000000
TCGA-06-0129.11	110	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0019854803994793411000000
TCGA-02-0058.1	110	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0019854803994793411000000
TCGA-12-5299.5	6	2_CELL_PROLIFERATION_GO_0008283	436	5	0.0019970758490022063000000
TCGA-14-1823.12	6	2_CELL_PROLIFERATION_GO_0008283	436	5	0.0019970758490022063000000
TCGA-02-0038.3	199	2_NUCLEAR_CHROMOSOME	39	8	0.0019981079062629781000000
TCGA-76-4929.8	91	2_CELL_CELL_SIGNALING	353	15	0.0020031841190634816000000
TCGA-27-1830.7	57	0_HALLMARK_ANGIOGENESIS	32	5	0.0020083816956740618000000
TCGA-06-0197.1	57	0_HALLMARK_ANGIOGENESIS	32	5	0.0020083816956740618000000
TCGA-19-5958.4	35	1_KEGG_ENDOMETRIAL_CANCER	52	5	0.0020085863019499409000000
TCGA-14-0817.3	6	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	3	0.0020123201238557999000000
TCGA-14-1823.15	87	2_SYNAPTIC_TRANSMISSION	152	10	0.0020215958869392830000000
TCGA-06-2559.11	101	2_CELL_CYCLE_PROCESS	163	11	0.0020237917923515477000000
TCGA-06-0878.10	115	2_ENZYME_REGULATOR_ACTIVITY	277	15	0.0020278116743212477000000
TCGA-12-3649.15	89	2_EXTRACELLULAR_MATRIX	85	8	0.0020291493450646301000000
TCGA-06-0213.9	74	1_KEGG_MELANOMA	71	7	0.0020408026723403709000000
TCGA-06-5859.9	125	2_DNA_REPLICATION	82	9	0.0020430650060432039000000
TCGA-32-4208.28	140	0_HALLMARK_E2F_TARGETS	169	13	0.0020459976705617458000000
TCGA-16-1045.10	81	2_COLLAGEN	23	5	0.0020599030013037701000000
TCGA-02-0043.10	184	0_HALLMARK_APOPTOSIS	150	14	0.0020645109536729365000000
TCGA-14-0817.9	85	2_INTERPHASE	62	7	0.0020694940414083245000000
TCGA-28-2514.9	62	2_EXTRACELLULAR_MATRIX	85	7	0.0020694940414083245000000
TCGA-06-0214.9	62	2_EXTRACELLULAR_MATRIX	85	7	0.0020694940414083245000000
TCGA-02-0083.21	135	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0020721447071338200000000
TCGA-19-5960.9	134	2_BIOPOLYMER_METABOLIC_PROCESS	1367	41	0.0020742208509487146000000
TCGA-08-0354.7	47	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0020762883627409873000000
TCGA-08-0380.5	47	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0020762883627409873000000
TCGA-28-5219.9	47	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0020762883627409873000000
TCGA-27-1831.9	85	1_KEGG_FOCAL_ADHESION	195	11	0.0020779441710672818000000
TCGA-06-0148.6	69	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0020855059492871273000000
TCGA-76-6192.6	43	2_SYSTEM_DEVELOPMENT	694	14	0.0020857221103889600000000
TCGA-76-6191.6	96	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0020872981829064886000000
TCGA-14-0789.10	106	0_HALLMARK_ANGIOGENESIS	32	6	0.0020902696702111440000000
TCGA-06-0174.37	141	2_M_PHASE	94	10	0.0020903040706929162000000
TCGA-02-0015.16	115	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0020922640242567489000000
TCGA-02-0058.1	110	0_HALLMARK_APOPTOSIS	150	11	0.0020942323795293516000000
TCGA-06-5412.7	153	2_PLASMA_MEMBRANE	1096	39	0.0020987902197949376000000
TCGA-02-0024.6	206	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	8	0.0021004311381653575000000
TCGA-02-0021.4	170	1_KEGG_DNA_REPLICATION	32	7	0.0021008872136140163000000
TCGA-28-5216.8	162	2_CHROMOSOME	102	11	0.0021028293547669399000000
TCGA-19-5960.9	134	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0021043979338757810000000
TCGA-14-0787.6	40	1_KEGG_FOCAL_ADHESION	195	8	0.0021044875698721689000000
TCGA-08-0357.4	36	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0021052938797228465000000
TCGA-06-5411.3	19	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	4	0.0021054642128010702000000
TCGA-06-0219.6	6	2_CELL_CYCLE_PROCESS	163	4	0.0021074980335091557000000
TCGA-08-0244.4	6	2_CELL_CYCLE_PROCESS	163	4	0.0021074980335091557000000
TCGA-12-5299.5	6	2_CELL_CYCLE_PROCESS	163	4	0.0021074980335091557000000
TCGA-14-1829.11	6	2_CELL_CYCLE_PROCESS	163	4	0.0021074980335091557000000
TCGA-14-2554.9	6	2_CELL_CYCLE_PROCESS	163	4	0.0021074980335091557000000
TCGA-19-5947.4	267	1_KEGG_ASTHMA	30	8	0.0021115820332593431000000
TCGA-27-2519.7	113	2_IMMUNE_SYSTEM_PROCESS	283	15	0.0021147824368416279000000
TCGA-14-1825.8	80	1_KEGG_BLADDER_CANCER	42	6	0.0021195132856908255000000
TCGA-27-2524.5	75	0_HALLMARK_MYC_TARGETS_V1	178	10	0.0021264062851716133000000
TCGA-06-5410.3	3	1_KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	103	3	0.0021269816035198322000000
TCGA-06-0743.14	63	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0021320984819243158000000
TCGA-32-2634.10	118	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	11	0.0021322325935242336000000
TCGA-08-0354.5	18	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0021360458242483159000000
TCGA-06-5859.9	125	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	24	0.0021375323097543759000000
TCGA-14-3476.4	7	2_EXTRACELLULAR_REGION	346	5	0.0021385097857585154000000
TCGA-32-2491.14	244	2_CELL_CYCLE_GO_0007049	265	22	0.0021475422406195131000000
TCGA-02-0033.5	144	2_CATION_BINDING	165	13	0.0021501115401554465000000
TCGA-12-0616.1	20	0_HALLMARK_MYC_TARGETS_V1	178	6	0.0021623569561063042000000
TCGA-32-1979.10	116	2_CELL_CELL_SIGNALING	353	17	0.0021631591091825979000000
TCGA-26-5133.10	75	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0021654815975596527000000
TCGA-76-6193.13	271	0_HALLMARK_APOPTOSIS	150	17	0.0021662489868987996000000
TCGA-28-5220.7	15	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	8	0.0021718242172192605000000
TCGA-06-2564.7	92	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0021788785439280194000000
TCGA-32-1986.12	17	1_KEGG_CELL_CYCLE	114	5	0.0021816944557566135000000
TCGA-06-6390.9	82	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	9	0.0021848741829744401000000
TCGA-14-0789.11	3	2_GATED_CHANNEL_ACTIVITY	104	3	0.0021901592749114765000000
TCGA-26-1439.7	3	2_GATED_CHANNEL_ACTIVITY	104	3	0.0021901592749114765000000
TCGA-14-1825.5	3	2_GATED_CHANNEL_ACTIVITY	104	3	0.0021901592749114765000000
TCGA-06-6390.9	82	2_COLLAGEN	23	5	0.0021901665529375121000000
TCGA-16-0861.5	4	1_KEGG_P53_SIGNALING_PATHWAY	66	3	0.0021904036089462008000000
TCGA-19-2629.15	146	2_CELL_CYCLE_PROCESS	163	13	0.0021908936002376271000000
TCGA-41-2571.7	72	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0021915279786463861000000
TCGA-32-4719.15	123	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0021916678269423649000000
TCGA-02-0010.18	184	2_CELL_CELL_SIGNALING	353	22	0.0021928326013016405000000
TCGA-06-0188.11	66	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0021930780803088791000000
TCGA-26-1439.11	10	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0021992180620423285000000
TCGA-14-0813.5	5	2_NEUROTRANSMITTER_BINDING	49	3	0.0021996919564487862000000
TCGA-08-0347.7	25	0_HALLMARK_ANGIOGENESIS	32	4	0.0022042927574090062000000
TCGA-12-0692.3	9	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	7	0.0022057432538879758000000
TCGA-32-5222.9	70	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0022103954504090152000000
TCGA-32-1979.4	12	1_KEGG_PANCREATIC_CANCER	70	4	0.0022103954504090464000000
TCGA-06-0122.8	90	2_EXTRACELLULAR_MATRIX	85	8	0.0022109697573686514000000
TCGA-08-0354.5	18	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0022118804523953693000000
TCGA-19-5958.4	35	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	5	0.0022119387353426818000000
TCGA-32-2615.7	77	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0022141240424965094000000
TCGA-06-5415.7	7	2_MITOTIC_CELL_CYCLE	134	4	0.0022143734492268857000000
TCGA-08-0360.3	144	2_IMMUNE_SYSTEM_PROCESS	283	17	0.0022163231651718403000000
TCGA-32-1980.1	24	2_EXTRACELLULAR_REGION	346	8	0.0022183859436542769000000
TCGA-02-0052.3	116	0_HALLMARK_ESTROGEN_RESPONSE_LATE	143	11	0.0022185830246333714000000
TCGA-06-0143.6	63	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0022187871096360622000000
TCGA-32-2632.16	229	2_NON_MEMBRANE_BOUND_ORGANELLE	476	30	0.0022304496260847090000000
TCGA-32-2632.16	229	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	30	0.0022304496260847090000000
TCGA-06-0241.8	53	2_CELL_CYCLE_PHASE	146	8	0.0022331992540042646000000
TCGA-19-5960.9	134	0_HALLMARK_MYC_TARGETS_V1	178	13	0.0022333715561146605000000
TCGA-14-0813.10	53	1_KEGG_PATHWAYS_IN_CANCER	323	11	0.0022410884215622218000000
TCGA-06-0686.10	26	2_MITOTIC_CELL_CYCLE	134	6	0.0022421563579509874000000
TCGA-19-5960.9	134	2_CONDENSED_CHROMOSOME	26	6	0.0022421563579509874000000
TCGA-19-5960.9	134	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	6	0.0022421563579509874000000
TCGA-32-1986.12	17	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	4	0.0022470639160506733000000
TCGA-41-4097.6	48	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	16	0.0022489378140988369000000
TCGA-06-0130.3	155	2_STRUCTURAL_MOLECULE_ACTIVITY	206	15	0.0022493980563671858000000
TCGA-02-2485.14	172	2_CHROMOSOMAL_PART	78	10	0.0022494352180124524000000
TCGA-06-0649.13	88	2_SYNAPTIC_TRANSMISSION	152	10	0.0022496495347796132000000
TCGA-14-0787.6	40	2_EXTRACELLULAR_MATRIX	85	6	0.0022525760856813106000000
TCGA-19-2625.9	146	2_NUCLEUS	1110	38	0.0022546251028590096000000
TCGA-02-2483.10	100	1_KEGG_PATHWAYS_IN_CANCER	323	15	0.0022658933074371449000000
TCGA-16-0861.5	4	1_KEGG_PATHWAYS_IN_CANCER	323	4	0.0022673387264994715000000
TCGA-06-0174.35	4	2_PHOTORECEPTOR_CELL_MAINTENANCE	5	2	0.0022711730186414200000000
TCGA-27-1838.17	131	2_CHROMOSOME	102	10	0.0022724101592659280000000
TCGA-02-2485.14	172	1_KEGG_DNA_REPLICATION	32	7	0.0022728260181662159000000
TCGA-06-0143.6	63	2_EXTRACELLULAR_REGION_PART	269	11	0.0022731728915952186000000
TCGA-02-0011.1	288	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	13	0.0022745673625067793000000
TCGA-32-1986.8	87	0_HALLMARK_HYPOXIA	154	10	0.0022788476421145816000000
TCGA-12-3653.55	255	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0022817361619188285000000
TCGA-12-3653.55	255	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	9	0.0022817361619188285000000
TCGA-06-0140.2	25	2_TRANSPORT	600	10	0.0022894116412385981000000
TCGA-02-0052.3	116	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0022967345142960046000000
TCGA-28-1753.13	174	2_REGULATION_OF_CELL_CYCLE	160	14	0.0022993546904796899000000
TCGA-06-0129.11	110	2_CYTOSKELETON	293	15	0.0023071592406170914000000
TCGA-02-0058.1	110	2_CYTOSKELETON	293	15	0.0023071592406170914000000
TCGA-28-2509.6	59	0_HALLMARK_MYC_TARGETS_V1	178	9	0.0023072391832396860000000
TCGA-06-0192.10	126	0_HALLMARK_ALLOGRAFT_REJECTION	190	13	0.0023092511222082232000000
TCGA-27-1833.7	17	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0023131308416843156000000
TCGA-02-0086.2	17	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0023131308416843156000000
TCGA-06-0648.6	17	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0023131308416843156000000
TCGA-06-0650.2	82	2_EXTRACELLULAR_REGION	346	14	0.0023269281280341352000000
TCGA-02-0102.8	82	2_EXTRACELLULAR_REGION	346	14	0.0023269281280341352000000
TCGA-41-3392.31	136	0_HALLMARK_COMPLEMENT	176	13	0.0023275807256489269000000
TCGA-02-0048.9	84	2_REGULATION_OF_CELL_CYCLE	160	10	0.0023282316296128554000000
TCGA-02-2483.10	100	2_MITOTIC_CELL_CYCLE	134	10	0.0023283246421340344000000
TCGA-12-3653.55	255	0_HALLMARK_MYC_TARGETS_V1	178	18	0.0023296791346407138000000
TCGA-32-1979.4	12	1_KEGG_MELANOMA	71	4	0.0023407657100924560000000
TCGA-06-0185.13	71	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0023407657100924560000000
TCGA-32-1970.14	94	0_HALLMARK_MYC_TARGETS_V1	178	11	0.0023421205302027069000000
TCGA-28-5214.11	124	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0023462562255761299000000
TCGA-08-0386.4	73	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0023482989818496437000000
TCGA-28-2509.6	59	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	15	0.0023487026933580613000000
TCGA-06-5415.7	7	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	4	0.0023499320036133101000000
TCGA-32-1982.9	89	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	10	0.0023533427690887198000000
TCGA-06-0158.4	65	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0023533989335642810000000
TCGA-06-0219.6	6	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0023556458361826153000000
TCGA-08-0244.4	6	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0023556458361826153000000
TCGA-12-5299.5	6	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0023556458361826153000000
TCGA-14-1823.12	6	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0023556458361826153000000
TCGA-14-1829.11	6	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0023556458361826153000000
TCGA-14-2554.9	6	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0023556458361826153000000
TCGA-19-5947.4	267	2_IMMUNE_RESPONSE	206	20	0.0023615420824218136000000
TCGA-76-6193.13	271	1_KEGG_ASTHMA	30	8	0.0023620561297304698000000
TCGA-27-2528.10	99	0_HALLMARK_E2F_TARGETS	169	11	0.0023660458153231842000000
TCGA-02-0007.17	217	2_AXON	10	5	0.0023671203423117691000000
TCGA-02-0009.6	188	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0023674002209729591000000
TCGA-32-1979.10	116	1_KEGG_ASTHMA	30	6	0.0023734493087281504000000
TCGA-06-0878.10	115	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0023735381255087984000000
TCGA-02-0015.16	115	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0023735381255087984000000
TCGA-76-4927.8	93	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0023752969266459451000000
TCGA-28-5207.12	188	2_CYTOSKELETON	293	20	0.0023791442181430185000000
TCGA-08-0352.2	59	2_CELL_CELL_SIGNALING	353	12	0.0023797342601298743000000
TCGA-14-2554.5	59	2_CELL_CELL_SIGNALING	353	12	0.0023797342601298743000000
TCGA-76-6191.6	96	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0023820452102482777000000
TCGA-19-2624.24	3	2_MICROVILLUS	7	2	0.0023848999669261110000000
TCGA-19-5960.9	134	2_CHROMOSOMAL_PART	78	9	0.0023890782432533478000000
TCGA-12-3652.19	88	2_AXON	10	4	0.0023897006907099036000000
TCGA-08-0352.2	59	0_HALLMARK_ANGIOGENESIS	32	5	0.0023899138532588043000000
TCGA-14-0789.10	106	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0023902922059452721000000
TCGA-14-0789.10	106	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0023902922059452721000000
TCGA-76-6285.5	106	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0023902922059452721000000
TCGA-32-4210.14	109	2_REPLICATION_FORK	18	5	0.0023947215857795918000000
TCGA-06-0148.6	69	2_SYNAPTIC_TRANSMISSION	152	9	0.0023955699630529336000000
TCGA-12-0616.7	45	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	8	0.0023968253381514656000000
TCGA-14-0781.7	155	2_COLLAGEN	23	6	0.0023971793794809681000000
TCGA-06-0130.3	155	2_COLLAGEN	23	6	0.0023971793794809681000000
TCGA-32-2494.10	173	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	18	0.0023994474287684980000000
TCGA-27-1836.8	49	2_REGULATION_OF_CELL_CYCLE	160	8	0.0023996092779646548000000
TCGA-02-0047.8	185	2_CELL_CELL_SIGNALING	353	22	0.0024049897197118706000000
TCGA-19-5947.4	267	2_IMMUNE_SYSTEM_PROCESS	283	24	0.0024070576367121181000000
TCGA-28-5220.7	15	2_MITOTIC_CELL_CYCLE	134	5	0.0024114458128336714000000
TCGA-76-4935.7	15	2_MITOTIC_CELL_CYCLE	134	5	0.0024114458128336714000000
TCGA-06-0156.4	80	0_HALLMARK_E2F_TARGETS	169	10	0.0024298468599952641000000
TCGA-28-5220.7	15	2_PROTEIN_KINASE_BINDING	56	4	0.0024326321048459549000000
TCGA-27-2518.4	6	0_HALLMARK_E2F_TARGETS	169	4	0.0024360818622308458000000
TCGA-12-5299.5	6	0_HALLMARK_E2F_TARGETS	169	4	0.0024360818622308458000000
TCGA-76-6193.13	271	2_EXTRACELLULAR_MATRIX_PART	51	10	0.0024409074079038131000000
TCGA-02-0086.2	17	2_CELL_CYCLE_ARREST_GO_0007050	49	4	0.0024441034690318776000000
TCGA-06-0648.6	17	2_CELL_CYCLE_ARREST_GO_0007050	49	4	0.0024441034690318776000000
TCGA-41-2575.49	136	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	6	0.0024457729964249175000000
TCGA-02-0001.5	117	2_CELL_CELL_SIGNALING	353	17	0.0024459936204714989000000
TCGA-06-0154.13	76	1_KEGG_MELANOMA	71	7	0.0024499215698894927000000
TCGA-06-5859.9	125	2_MITOTIC_CELL_CYCLE	134	11	0.0024524083367559553000000
TCGA-02-0038.3	199	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0024529180152981136000000
TCGA-02-0102.8	82	1_KEGG_BLADDER_CANCER	42	6	0.0024536476831451800000000
TCGA-32-2638.17	159	2_EXTRACELLULAR_MATRIX	85	10	0.0024559239214361050000000
TCGA-28-1753.13	174	1_KEGG_DNA_REPLICATION	32	7	0.0024564246935876526000000
TCGA-02-0052.3	116	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0024574674759988138000000
TCGA-02-0071.12	116	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0024574674759988138000000
TCGA-26-5133.10	75	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	7	0.0024628951267255919000000
TCGA-32-2498.13	133	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0024644956987553580000000
TCGA-41-2571.7	72	2_CELL_CYCLE_PHASE	146	9	0.0024669638446546127000000
TCGA-02-0058.1	110	2_CELL_DEVELOPMENT	511	20	0.0024687657657963945000000
TCGA-26-1439.10	84	2_COLLAGEN	23	5	0.0024701721768679453000000
TCGA-06-0127.2	23	1_KEGG_ECM_RECEPTOR_INTERACTION	84	5	0.0024701721768679453000000
TCGA-32-1979.4	12	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	4	0.0024767714663093540000000
TCGA-19-2624.29	130	2_INTRACELLULAR_ORGANELLE_PART	912	31	0.0024805529398265855000000
TCGA-19-1790.18	201	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	11	0.0024838876037801025000000
TCGA-06-0126.7	5	2_EXTRACELLULAR_MATRIX_PART	51	3	0.0024855615365190686000000
TCGA-06-2567.9	156	1_KEGG_MISMATCH_REPAIR	23	6	0.0024891848118968446000000
TCGA-06-5415.7	7	2_REGULATION_OF_KINASE_ACTIVITY	138	4	0.0024915835543350188000000
TCGA-12-0620.1	2	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0024993486097923874000000
TCGA-06-0133.2	2	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0024993486097923874000000
TCGA-02-0023.1	2	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0024993486097923874000000
TCGA-02-0010.16	2	2_PHAGOCYTOSIS	12	2	0.0024993486097923874000000
TCGA-06-0127.4	2	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0024993486097923874000000
TCGA-08-0355.3	2	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0024993486097923874000000
TCGA-06-5858.19	205	2_NUCLEAR_CHROMOSOME	39	8	0.0025001033842613598000000
TCGA-06-0188.11	66	2_REGULATION_OF_CELL_CYCLE	160	9	0.0025062663202104476000000
TCGA-06-0192.10	126	2_PLASMA_MEMBRANE	1096	34	0.0025066232873601456000000
TCGA-06-2558.6	74	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0025137866345944573000000
TCGA-19-5947.4	267	2_RECEPTOR_ACTIVITY	499	34	0.0025148550916672331000000
TCGA-02-0010.18	184	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	15	0.0025230202748930926000000
TCGA-12-0618.5	41	2_CELL_CYCLE_GO_0007049	265	9	0.0025293993934849849000000
TCGA-02-0027.3	81	2_CELL_CELL_SIGNALING	353	14	0.0025313383943433841000000
TCGA-06-0152.10	19	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0025347406286156228000000
TCGA-06-0176.8	95	2_DNA_REPLICATION	82	8	0.0025377463690128372000000
TCGA-06-0219.6	6	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0025410108637575739000000
TCGA-02-0034.5	6	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	3	0.0025410108637575739000000
TCGA-08-0244.4	6	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0025410108637575739000000
TCGA-12-5299.5	6	2_REGULATION_OF_GROWTH	41	3	0.0025410108637575739000000
TCGA-12-5299.5	6	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0025410108637575739000000
TCGA-14-1823.12	6	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0025410108637575739000000
TCGA-14-1829.11	6	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0025410108637575739000000
TCGA-14-2554.9	6	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0025410108637575739000000
TCGA-02-0001.5	117	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0025435881093880371000000
TCGA-14-1829.3	8	2_MICROTUBULE_CYTOSKELETON	117	4	0.0025435881093880731000000
TCGA-32-1977.11	107	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0025471559867367771000000
TCGA-15-1444.3	107	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0025471559867367771000000
TCGA-14-4157.7	101	2_MITOTIC_CELL_CYCLE	134	10	0.0025533566303361892000000
TCGA-02-2483.10	100	2_CHROMOSOMAL_PART	78	8	0.0025553073543913120000000
TCGA-06-0129.11	110	2_PROTEIN_HETERODIMERIZATION_ACTIVITY	71	8	0.0025559493304398912000000
TCGA-32-1982.9	89	0_HALLMARK_ALLOGRAFT_REJECTION	190	11	0.0025646699135832844000000
TCGA-08-0246.6	62	2_SIGNAL_TRANSDUCTION	1442	25	0.0025682455564509212000000
TCGA-14-1456.4	41	1_KEGG_FOCAL_ADHESION	195	8	0.0025688339555269210000000
TCGA-27-2521.10	94	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0025690361476229488000000
TCGA-06-2559.11	101	1_KEGG_PATHWAYS_IN_CANCER	323	15	0.0025799694299850932000000
TCGA-27-2521.10	94	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0025881066519811789000000
TCGA-06-2564.7	92	2_CELL_CYCLE_GO_0007049	265	13	0.0025885633270670604000000
TCGA-19-5959.13	92	2_CELL_CYCLE_GO_0007049	265	13	0.0025885633270670604000000
TCGA-32-2491.14	244	1_KEGG_VIRAL_MYOCARDITIS	70	11	0.0025916459289346437000000
TCGA-41-5651.5	112	2_M_PHASE	94	9	0.0025929755436235949000000
TCGA-28-5220.7	15	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	5	0.0025951482227137045000000
TCGA-76-4927.8	93	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0025953610474492850000000
TCGA-06-0176.8	95	0_HALLMARK_MYC_TARGETS_V1	178	11	0.0026059678640368532000000
TCGA-02-2470.4	11	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0026092905579022546000000
TCGA-41-3392.31	136	0_HALLMARK_APOPTOSIS	150	12	0.0026094112733929921000000
TCGA-28-5216.8	162	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	126	12	0.0026131290622161468000000
TCGA-06-2564.7	92	2_EXTRACELLULAR_MATRIX	85	8	0.0026165858258491675000000
TCGA-06-0877.7	4	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	3	0.0026194147197289796000000
TCGA-16-0861.5	4	1_KEGG_PANCREATIC_CANCER	70	3	0.0026194147197289796000000
TCGA-28-2509.5	4	1_KEGG_LEISHMANIA_INFECTION	70	3	0.0026194147197289796000000
TCGA-28-2509.5	4	1_KEGG_VIRAL_MYOCARDITIS	70	3	0.0026194147197289796000000
TCGA-06-0126.3	4	1_KEGG_LEISHMANIA_INFECTION	70	3	0.0026194147197289796000000
TCGA-06-0126.3	4	1_KEGG_VIRAL_MYOCARDITIS	70	3	0.0026194147197289796000000
TCGA-08-0348.3	4	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	3	0.0026194147197289796000000
TCGA-02-0060.19	281	2_BLOOD_COAGULATION	39	9	0.0026203487618864803000000
TCGA-02-0060.19	281	2_COAGULATION	39	9	0.0026203487618864803000000
TCGA-27-1831.9	85	2_COLLAGEN	23	5	0.0026203742226190117000000
TCGA-12-0616.1	20	1_KEGG_BLADDER_CANCER	42	4	0.0026233644873580905000000
TCGA-32-2634.10	118	1_KEGG_ASTHMA	30	6	0.0026242351890139546000000
TCGA-02-0074.5	118	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0026319371856342107000000
TCGA-19-4068.6	42	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0026361829689906416000000
TCGA-32-4213.12	5	1_KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	52	3	0.0026373183680241797000000
TCGA-06-5415.7	7	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	4	0.0026395052204698185000000
TCGA-41-2575.49	136	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	8	0.0026505562160257529000000
TCGA-08-0389.4	56	2_INTERPHASE	62	6	0.0026509265291395153000000
TCGA-76-4928.15	78	1_KEGG_PANCREATIC_CANCER	70	7	0.0026546147482438762000000
TCGA-06-0216.6	67	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0026602184476162559000000
TCGA-02-0054.3	93	2_CELL_CELL_SIGNALING	353	15	0.0026660412622793316000000
TCGA-02-2485.14	172	1_KEGG_GLIOMA	62	9	0.0026677127427262521000000
TCGA-28-5207.12	188	0_HALLMARK_APOPTOSIS	150	14	0.0026713813818817086000000
TCGA-06-0745.4	55	1_KEGG_FOCAL_ADHESION	195	9	0.0026734022758272821000000
TCGA-06-0750.13	8	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	299	5	0.0026876100268588585000000
TCGA-06-5415.3	8	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	299	5	0.0026876100268588585000000
TCGA-06-0221.4	8	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	299	5	0.0026876100268588585000000
TCGA-02-0114.20	132	1_KEGG_BLADDER_CANCER	42	7	0.0026879395303217664000000
TCGA-02-0114.20	132	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0026879395303217664000000
TCGA-02-0038.3	199	2_DNA_BINDING	496	28	0.0026942322929494333000000
TCGA-06-0184.11	108	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	10	0.0026972532433933074000000
TCGA-06-0184.11	108	0_HALLMARK_ALLOGRAFT_REJECTION	190	12	0.0027006773529178532000000
TCGA-06-0188.11	66	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0027074790395044813000000
TCGA-08-0359.5	37	2_APOPTOSIS_GO	389	10	0.0027081110784026256000000
TCGA-12-0618.5	41	2_CELL_PROLIFERATION_GO_0008283	436	11	0.0027097740275991030000000
TCGA-32-5222.9	70	2_SYNAPTIC_TRANSMISSION	152	9	0.0027116538232445581000000
TCGA-19-2624.29	130	2_ORGANELLE_PART	916	31	0.0027238044543982480000000
TCGA-06-5415.7	7	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0027271852629225509000000
TCGA-06-0686.1	7	2_INTEGRAL_TO_PLASMA_MEMBRANE	751	6	0.0027312846695618448000000
TCGA-16-0861.5	4	1_KEGG_MELANOMA	71	3	0.0027347587956296584000000
TCGA-02-0034.5	6	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	3	0.0027358196436129819000000
TCGA-12-5299.5	6	1_KEGG_BLADDER_CANCER	42	3	0.0027358196436129819000000
TCGA-06-0881.7	203	1_KEGG_ECM_RECEPTOR_INTERACTION	84	11	0.0027378784526538753000000
TCGA-27-2518.4	6	0_HALLMARK_G2M_CHECKPOINT	174	4	0.0027379043167632439000000
TCGA-19-2624.19	5	2_ESTABLISHMENT_OF_LOCALIZATION	659	5	0.0027508622267822364000000
TCGA-06-2559.11	101	2_CHROMOSOMAL_PART	78	8	0.0027568153390085818000000
TCGA-26-5139.10	163	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0027585356421003446000000
TCGA-27-1838.17	131	2_CELL_CELL_SIGNALING	353	18	0.0027628415279953361000000
TCGA-02-0075.8	128	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0027658660416564691000000
TCGA-15-0742.13	74	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0027663182522523083000000
TCGA-08-0359.5	37	2_PROGRAMMED_CELL_DEATH	390	10	0.0027719434764731468000000
TCGA-02-0007.17	217	2_IDENTICAL_PROTEIN_BINDING	256	20	0.0027731072392214156000000
TCGA-08-0354.5	18	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0027735518870179898000000
TCGA-28-5215.7	192	0_HALLMARK_E2F_TARGETS	169	15	0.0027760234874671945000000
TCGA-06-0176.8	95	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0027854571163431676000000
TCGA-28-5220.7	15	2_REGULATION_OF_KINASE_ACTIVITY	138	5	0.0027897339011021616000000
TCGA-02-0003.9	227	0_HALLMARK_COAGULATION	125	14	0.0027916530750265985000000
TCGA-28-5220.7	15	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0028047737153603230000000
TCGA-06-0173.35	120	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0028109027293320562000000
TCGA-06-0173.35	120	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0028154707568384600000000
TCGA-08-0359.5	37	2_COLLAGEN	23	4	0.0028245535663696413000000
TCGA-02-0048.9	84	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0028296725709964152000000
TCGA-08-0359.5	37	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	10	0.0028370889608726399000000
TCGA-32-2634.10	118	2_CELL_PROLIFERATION_GO_0008283	436	19	0.0028464038320973810000000
TCGA-16-0861.5	4	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	3	0.0028534335207909029000000
TCGA-02-0003.9	227	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0028551319036032754000000
TCGA-32-1986.12	17	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	4	0.0028763730391878082000000
TCGA-06-5411.4	23	2_REGULATION_OF_CELL_CYCLE	160	6	0.0028866290929270922000000
TCGA-02-0115.4	3	1_KEGG_CELL_CYCLE	114	3	0.0028920532216875601000000
TCGA-06-0143.3	3	1_KEGG_CELL_CYCLE	114	3	0.0028920532216875601000000
TCGA-06-0750.9	3	1_KEGG_CELL_CYCLE	114	3	0.0028920532216875601000000
TCGA-27-1834.9	3	1_KEGG_CELL_CYCLE	114	3	0.0028920532216875601000000
TCGA-06-0882.9	3	1_KEGG_CELL_CYCLE	114	3	0.0028920532216875601000000
TCGA-02-0089.5	91	0_HALLMARK_P53_PATHWAY	151	10	0.0028943025197515262000000
TCGA-06-0686.1	7	2_INTRINSIC_TO_PLASMA_MEMBRANE	759	6	0.0029089179030689482000000
TCGA-14-4157.7	101	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0029244310490659699000000
TCGA-32-4213.15	198	1_KEGG_VIRAL_MYOCARDITIS	70	10	0.0029248144902439661000000
TCGA-12-5295.8	66	2_CELL_CYCLE_PROCESS	163	9	0.0029265780708817896000000
TCGA-14-3476.17	53	1_KEGG_OOCYTE_MEIOSIS	105	7	0.0029306481157172410000000
TCGA-41-5651.5	112	2_MITOSIS	71	8	0.0029312057870152551000000
TCGA-12-5295.8	66	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0029374594813336881000000
TCGA-06-0211.8	62	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0029374919035105402000000
TCGA-32-1986.8	87	2_COLLAGEN	23	5	0.0029423637997075449000000
TCGA-27-1832.11	88	1_KEGG_FOCAL_ADHESION	195	11	0.0029535854458754324000000
TCGA-06-0649.13	88	1_KEGG_FOCAL_ADHESION	195	11	0.0029535854458754324000000
TCGA-12-0620.1	2	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0029537756297555143000000
TCGA-32-2634.8	2	2_PHOSPHOLIPASE_C_ACTIVATION	13	2	0.0029537756297555143000000
TCGA-06-0133.2	2	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0029537756297555143000000
TCGA-02-0023.1	2	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0029537756297555143000000
TCGA-06-0127.4	2	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0029537756297555143000000
TCGA-08-0355.3	2	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0029537756297555143000000
TCGA-02-0003.9	227	2_AXON	10	5	0.0029579791842637461000000
TCGA-02-0069.12	62	2_NON_MEMBRANE_BOUND_ORGANELLE	476	14	0.0029611393313430266000000
TCGA-02-0069.12	62	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	14	0.0029611393313430266000000
TCGA-12-3653.55	255	2_INTRACELLULAR_ORGANELLE_PART	912	49	0.0029665254625537854000000
TCGA-02-0026.1	61	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0029686175010234699000000
TCGA-19-5960.9	134	1_KEGG_BLADDER_CANCER	42	7	0.0029741669226112269000000
TCGA-06-0744.3	12	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	3	0.0029799153778913580000000
TCGA-28-5220.7	15	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	5	0.0029956666150700822000000
TCGA-06-0148.6	69	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0029958298818349529000000
TCGA-19-5951.10	138	2_EXTRACELLULAR_REGION_PART	269	16	0.0029964011924395436000000
TCGA-19-1790.18	201	0_HALLMARK_UV_RESPONSE_DN	122	13	0.0030093961494004457000000
TCGA-41-4097.6	48	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	5	0.0030178699554404484000000
TCGA-02-2470.4	11	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0030193630537621169000000
TCGA-19-2623.11	153	2_REGULATION_OF_CELL_CYCLE	160	13	0.0030208140938602301000000
TCGA-06-0174.37	141	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	6	0.0030218171014939664000000
TCGA-19-1390.12	10	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	228	5	0.0030229436588325624000000
TCGA-06-0137.9	53	2_SYNAPTIC_TRANSMISSION	152	8	0.0030278239711610238000000
TCGA-27-1838.17	131	2_DNA_REPLICATION	82	9	0.0030289093773648856000000
TCGA-87-5896.6	131	2_DNA_REPLICATION	82	9	0.0030289093773648856000000
TCGA-08-0245.4	85	1_KEGG_BLADDER_CANCER	42	6	0.0030346173968994437000000
TCGA-19-4068.6	42	2_EXTRACELLULAR_MATRIX	85	6	0.0030346173968994437000000
TCGA-41-3393.5	88	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0030409185950469294000000
TCGA-19-5950.7	113	1_KEGG_DNA_REPLICATION	32	6	0.0030448266613434839000000
TCGA-14-0789.11	3	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	116	3	0.0030483557188141015000000
TCGA-26-1439.7	3	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	116	3	0.0030483557188141015000000
TCGA-32-2494.8	3	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	116	3	0.0030483557188141015000000
TCGA-14-1825.5	3	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	116	3	0.0030483557188141015000000
TCGA-06-0152.10	19	2_NON_MEMBRANE_BOUND_ORGANELLE	476	8	0.0030569634529834687000000
TCGA-06-0152.10	19	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	8	0.0030569634529834687000000
TCGA-32-4211.14	71	2_SYNAPTIC_TRANSMISSION	152	9	0.0030630809991002597000000
TCGA-27-2526.7	71	2_SYNAPTIC_TRANSMISSION	152	9	0.0030630809991002597000000
TCGA-02-0069.12	62	1_KEGG_DNA_REPLICATION	32	5	0.0030670278491158639000000
TCGA-28-2514.9	62	0_HALLMARK_ANGIOGENESIS	32	5	0.0030670278491158639000000
TCGA-06-0214.9	62	0_HALLMARK_ANGIOGENESIS	32	5	0.0030670278491158639000000
TCGA-06-0211.8	62	1_KEGG_DNA_REPLICATION	32	5	0.0030670278491158639000000
TCGA-19-5955.9	110	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0030704482005904686000000
TCGA-06-0645.9	136	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0030747944143343091000000
TCGA-12-5295.8	66	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0030795847585462204000000
TCGA-06-0154.13	76	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0030803129352408765000000
TCGA-41-2572.8	76	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0030803129352408765000000
TCGA-27-2521.10	94	2_EXTRACELLULAR_MATRIX	85	8	0.0030839608386107483000000
TCGA-02-0023.3	24	1_KEGG_ECM_RECEPTOR_INTERACTION	84	5	0.0030985086644475146000000
TCGA-19-5958.4	35	1_KEGG_PATHWAYS_IN_CANCER	323	9	0.0031051756078943372000000
TCGA-12-0619.11	123	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0031084300894812398000000
TCGA-06-2563.10	123	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0031084300894812398000000
TCGA-06-0189.3	118	0_HALLMARK_COMPLEMENT	176	12	0.0031134973997800864000000
TCGA-32-2634.10	118	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	14	0.0031139995121492242000000
TCGA-19-5950.7	113	2_DNA_METABOLIC_PROCESS	218	13	0.0031144370151801326000000
TCGA-02-0025.5	88	2_COLLAGEN	23	5	0.0031146411139654022000000
TCGA-27-1832.11	88	2_COLLAGEN	23	5	0.0031146411139654022000000
TCGA-41-3393.5	88	2_COLLAGEN	23	5	0.0031146411139654022000000
TCGA-06-0649.13	88	2_COLLAGEN	23	5	0.0031146411139654022000000
TCGA-19-4068.6	42	1_KEGG_FOCAL_ADHESION	195	8	0.0031176499833446619000000
TCGA-06-0169.5	42	1_KEGG_FOCAL_ADHESION	195	8	0.0031176499833446619000000
TCGA-02-0033.5	144	2_CALCIUM_ION_BINDING	75	9	0.0031196423327494232000000
TCGA-06-5415.7	7	2_CELL_CYCLE_PHASE	146	4	0.0031226977150768344000000
TCGA-06-5408.3	99	2_NUCLEUS	1110	29	0.0031246432748258213000000
TCGA-28-5220.7	15	2_REGULATION_OF_CELL_PROLIFERATION	265	6	0.0031464468094106589000000
TCGA-19-2624.29	130	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0031494424550437836000000
TCGA-12-5299.6	38	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0031517696426228191000000
TCGA-06-2557.11	177	2_EXTRACELLULAR_REGION	346	21	0.0031586980181315910000000
TCGA-32-5222.9	70	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0031749640504052270000000
TCGA-02-0024.6	206	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0031816503948952071000000
TCGA-27-1837.5	85	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0031835702176814555000000
TCGA-06-0188.11	66	2_EXTRACELLULAR_MATRIX	85	7	0.0031835702176814555000000
TCGA-76-4926.9	66	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0031859516728824601000000
TCGA-27-2527.6	79	1_KEGG_MELANOMA	71	7	0.0031910042212712339000000
TCGA-41-2575.49	136	2_CHROMOSOME	102	10	0.0032030092900155265000000
TCGA-02-0038.3	199	2_NUCLEOPLASM	233	18	0.0032088590453623620000000
TCGA-28-5214.11	124	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0032109463931236379000000
TCGA-41-3393.5	88	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	6	0.0032153882831560923000000
TCGA-06-0649.13	88	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	6	0.0032153882831560923000000
TCGA-06-2565.10	38	2_DNA_METABOLIC_PROCESS	218	8	0.0032168707664071410000000
TCGA-32-2491.14	244	2_CYTOSKELETON	293	23	0.0032196355969503956000000
TCGA-06-0156.4	80	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0032251882525411312000000
TCGA-32-4209.2	56	2_NEURON_PROJECTION	16	4	0.0032292374053536081000000
TCGA-02-0021.4	170	2_DNA_REPLICATION	82	10	0.0032300916038118413000000
TCGA-41-4097.6	48	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	16	0.0032549764731559768000000
TCGA-08-0358.9	43	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0032653035501609279000000
TCGA-41-5651.5	112	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	8	0.0032653872300726821000000
TCGA-06-0875.7	78	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0032699878535737688000000
TCGA-06-0686.10	26	2_CHROMOSOMAL_PART	78	5	0.0032699878535737688000000
TCGA-28-5215.7	192	2_CYTOSKELETAL_PART	194	16	0.0032850827638620213000000
TCGA-06-0645.9	136	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0032855024603776284000000
TCGA-06-0152.10	19	2_KINESIN_COMPLEX	13	3	0.0032909762802231183000000
TCGA-06-0152.10	19	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0032909762802231183000000
TCGA-02-0069.8	7	1_KEGG_ALZHEIMERS_DISEASE	148	4	0.0032975184704799113000000
TCGA-32-1970.14	94	2_CELL_CYCLE_GO_0007049	265	13	0.0033217745341228111000000
TCGA-41-2571.7	72	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	11	0.0033225927957582107000000
TCGA-02-0114.20	132	2_DNA_METABOLIC_PROCESS	218	14	0.0033369099288806121000000
TCGA-14-4157.7	101	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0033416812694031903000000
TCGA-32-4213.15	198	1_KEGG_MELANOMA	71	10	0.0033429085112069421000000
TCGA-02-0060.19	281	2_CELL_CELL_SIGNALING	353	28	0.0033437026546945122000000
TCGA-28-5220.7	15	2_CELL_PROLIFERATION_GO_0008283	436	7	0.0033475823987346022000000
TCGA-19-1790.18	201	1_KEGG_VIRAL_MYOCARDITIS	70	10	0.0033520800556223617000000
TCGA-06-0185.13	71	1_KEGG_CELL_CYCLE	114	8	0.0033524164570807209000000
TCGA-27-2526.7	71	1_KEGG_CELL_CYCLE	114	8	0.0033524164570807209000000
TCGA-19-4068.7	14	2_NON_MEMBRANE_BOUND_ORGANELLE	476	7	0.0033587995550454800000000
TCGA-19-4068.7	14	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	7	0.0033587995550454800000000
TCGA-06-0185.13	71	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0033619395404748341000000
TCGA-12-3653.55	255	2_ORGANELLE_PART	916	49	0.0033653705087267447000000
TCGA-06-0878.10	115	0_HALLMARK_ANGIOGENESIS	32	6	0.0033748405085906323000000
TCGA-02-0015.16	115	0_HALLMARK_ANGIOGENESIS	32	6	0.0033748405085906323000000
TCGA-06-0750.13	8	2_PLASMA_MEMBRANE	1096	7	0.0033782581802208837000000
TCGA-06-0219.6	6	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0033792218371682236000000
TCGA-08-0244.4	6	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0033792218371682236000000
TCGA-12-5299.5	6	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0033792218371682236000000
TCGA-14-1823.12	6	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0033792218371682236000000
TCGA-14-1829.11	6	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0033792218371682236000000
TCGA-14-2554.9	6	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0033792218371682236000000
TCGA-02-0075.8	128	2_EXTRACELLULAR_MATRIX	85	9	0.0033866030819953647000000
TCGA-26-5135.9	71	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0033868553845205038000000
TCGA-12-0619.11	123	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0033889262985340139000000
TCGA-32-4719.15	123	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0033889262985340139000000
TCGA-41-4097.6	48	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	5	0.0034127002204910402000000
TCGA-76-4928.15	78	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0034200637696945144000000
TCGA-08-0389.4	56	2_CELL_CYCLE_PHASE	146	8	0.0034418846234154847000000
TCGA-06-0132.2	2	2_REGULATION_OF_CYTOKINE_SECRETION	14	2	0.0034460715680489653000000
TCGA-12-3653.55	255	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	44	9	0.0034604880611357734000000
TCGA-14-0789.11	3	2_ION_CHANNEL_ACTIVITY	121	3	0.0034635267099502268000000
TCGA-26-1439.7	3	2_ION_CHANNEL_ACTIVITY	121	3	0.0034635267099502268000000
TCGA-14-1825.5	3	2_ION_CHANNEL_ACTIVITY	121	3	0.0034635267099502268000000
TCGA-32-2632.16	229	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	10	0.0034635901770467882000000
TCGA-28-2513.12	134	2_NEURON_PROJECTION	16	5	0.0034677240097087496000000
TCGA-06-0882.1	11	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	3	0.0034700599604679840000000
TCGA-12-0821.9	81	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0034708566917014366000000
TCGA-28-1747.5	81	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0034708566917014366000000
TCGA-06-0129.11	110	2_NUCLEUS	1110	31	0.0034740455392948304000000
TCGA-32-1979.4	12	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0034740818045436040000000
TCGA-14-1825.8	80	2_MITOSIS	71	7	0.0034762562213337227000000
TCGA-12-0616.1	20	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0034778800985607408000000
TCGA-06-0122.8	90	2_COLLAGEN	23	5	0.0034830230864349707000000
TCGA-02-2485.14	172	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0034876386183283195000000
TCGA-06-1804.7	47	0_HALLMARK_UV_RESPONSE_DN	122	7	0.0034883174277161471000000
TCGA-19-2624.19	5	2_REGULATION_OF_TRANSPORT	57	3	0.0034889794492714487000000
TCGA-19-5954.17	208	2_EXTRACELLULAR_REGION	346	23	0.0035047850859224916000000
TCGA-06-0216.6	67	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0035050767203385108000000
TCGA-14-1829.14	67	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0035050767203385108000000
TCGA-27-1834.10	39	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0035063154891069081000000
TCGA-08-0355.2	7	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	3	0.0035117759023188034000000
TCGA-02-0026.1	61	2_MITOTIC_CELL_CYCLE	134	8	0.0035121919573872784000000
TCGA-19-4068.7	14	2_REPLICATION_FORK	18	3	0.0035257703429298140000000
TCGA-76-6193.13	271	2_RECEPTOR_ACTIVITY	499	34	0.0035359753095028329000000
TCGA-32-1979.10	116	0_HALLMARK_ANGIOGENESIS	32	6	0.0035504844615046635000000
TCGA-02-0071.12	116	0_HALLMARK_ANGIOGENESIS	32	6	0.0035504844615046635000000
TCGA-32-4208.28	140	0_HALLMARK_APOPTOSIS	150	12	0.0035511000326798364000000
TCGA-02-0114.20	132	1_KEGG_COLORECTAL_CANCER	62	8	0.0035577657005868091000000
TCGA-02-0114.20	132	1_KEGG_GLIOMA	62	8	0.0035577657005868091000000
TCGA-28-1747.5	81	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0035580965696647396000000
TCGA-19-4068.2	11	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	4	0.0035611999642700732000000
TCGA-02-0043.10	184	0_HALLMARK_ANGIOGENESIS	32	7	0.0035721699801174104000000
TCGA-08-0359.5	37	2_REGULATION_OF_APOPTOSIS	309	9	0.0035727127209935197000000
TCGA-06-2565.10	38	2_NUCLEUS	1110	16	0.0035736888115039970000000
TCGA-27-1838.17	131	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0035920489652133945000000
TCGA-06-6389.1	18	2_CELL_CELL_SIGNALING	353	7	0.0036082748318470009000000
TCGA-19-5947.4	267	0_HALLMARK_ANGIOGENESIS	32	8	0.0036128389118364897000000
TCGA-14-0787.6	40	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0036153625492205922000000
TCGA-41-3915.10	109	2_REGULATION_OF_CELL_CYCLE	160	11	0.0036160490080125937000000
TCGA-08-0347.7	25	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	5	0.0036236670201800713000000
TCGA-02-0003.9	227	2_STRUCTURAL_MOLECULE_ACTIVITY	206	18	0.0036318777326502659000000
TCGA-06-5411.3	19	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	4	0.0036323005325307593000000
TCGA-81-5910.12	128	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0036463742615592209000000
TCGA-02-0075.8	128	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0036463742615592209000000
TCGA-32-4213.15	198	1_KEGG_ASTHMA	30	7	0.0036498895489181231000000
TCGA-06-0197.1	57	1_KEGG_FOCAL_ADHESION	195	9	0.0036502137702130750000000
TCGA-19-5952.11	193	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	14	0.0036516342247807933000000
TCGA-08-0359.5	37	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	9	0.0036695140327507826000000
TCGA-28-5220.7	15	2_INTERPHASE	62	4	0.0036740508439093945000000
TCGA-06-0122.8	90	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0036784951216367774000000
TCGA-28-5204.5	5	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	3	0.0036787007491090764000000
TCGA-14-0871.20	216	1_KEGG_FOCAL_ADHESION	195	17	0.0036820006029119434000000
TCGA-28-5220.7	15	2_CELL_CYCLE_PHASE	146	5	0.0036863664213598159000000
TCGA-14-0871.20	216	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0036913454923971399000000
TCGA-76-6282.11	185	0_HALLMARK_ANGIOGENESIS	32	7	0.0037039613668007495000000
TCGA-06-0686.10	26	2_CELL_CYCLE_PHASE	146	6	0.0037044124044002783000000
TCGA-26-1439.11	10	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0037047090012235092000000
TCGA-06-0197.1	57	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	15	0.0037118977214439693000000
TCGA-08-0347.4	16	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0037226113501349937000000
TCGA-41-3393.5	88	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	6	0.0037234288997951889000000
TCGA-06-0649.13	88	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	6	0.0037234288997951889000000
TCGA-06-0649.13	88	0_HALLMARK_COAGULATION	125	9	0.0037266195815002746000000
TCGA-06-6390.9	82	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0037316331894781296000000
TCGA-19-5960.9	134	2_NUCLEAR_PART	466	21	0.0037553191521854114000000
TCGA-02-0089.5	91	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0037560353798982318000000
TCGA-41-2571.7	72	2_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0037613884348057800000000
TCGA-41-2571.7	72	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0037613884348057800000000
TCGA-08-0386.4	73	1_KEGG_FOCAL_ADHESION	195	10	0.0037788595906601960000000
TCGA-14-1825.8	80	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0037869098991682015000000
TCGA-06-0156.4	80	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0037869098991682015000000
TCGA-27-1836.8	49	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0037881001779620084000000
TCGA-06-5413.11	142	0_HALLMARK_COMPLEMENT	176	13	0.0037992408578074437000000
TCGA-14-4157.7	101	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0038098893489154173000000
TCGA-14-0789.11	3	2_SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY	125	3	0.0038215695954115052000000
TCGA-26-1439.7	3	2_SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY	125	3	0.0038215695954115052000000
TCGA-14-1825.5	3	2_SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY	125	3	0.0038215695954115052000000
TCGA-19-2625.9	146	1_KEGG_PATHWAYS_IN_CANCER	323	18	0.0038244100286845047000000
TCGA-14-1825.8	80	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0038246024509568850000000
TCGA-19-2631.15	84	0_HALLMARK_E2F_TARGETS	169	10	0.0038314731150189043000000
TCGA-06-0184.11	108	2_CELL_CELL_SIGNALING	353	16	0.0038444684746797224000000
TCGA-28-2502.9	56	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0038474142508611842000000
TCGA-06-0195.8	56	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0038474142508611842000000
TCGA-02-0007.17	217	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0038485946950770891000000
TCGA-19-2624.29	130	2_EXTRACELLULAR_MATRIX	85	9	0.0038547957633737365000000
TCGA-28-2502.9	56	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	12	0.0038571595061968125000000
TCGA-19-2620.8	6	2_NEUROTRANSMITTER_RECEPTOR_ACTIVITY	47	3	0.0038596125764654154000000
TCGA-27-1833.2	41	2_SIGNAL_TRANSDUCTION	1442	19	0.0038818766405293312000000
TCGA-19-5959.13	92	2_COLLAGEN	23	5	0.0038849173616940622000000
TCGA-06-0216.6	67	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0038860049121493740000000
TCGA-08-0375.6	65	1_KEGG_DNA_REPLICATION	32	5	0.0038869453096738019000000
TCGA-06-0189.3	118	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0039011552458732531000000
TCGA-32-2634.10	118	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0039011552458732531000000
TCGA-19-2631.1	6	2_RECEPTOR_ACTIVITY	499	5	0.0039103290804750465000000
TCGA-19-2620.8	6	2_RECEPTOR_ACTIVITY	499	5	0.0039103290804750465000000
TCGA-19-1790.18	201	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0039137166104861688000000
TCGA-06-0686.6	3	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	3	0.0039147786099337388000000
TCGA-19-5958.2	3	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	3	0.0039147786099337388000000
TCGA-28-5220.7	15	2_KINASE_BINDING	63	4	0.0039194730132158153000000
TCGA-28-5215.7	192	2_CORNIFIED_ENVELOPE	12	5	0.0039224081812682604000000
TCGA-06-0241.8	53	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	6	0.0039228341730862945000000
TCGA-32-2634.10	118	0_HALLMARK_ANGIOGENESIS	32	6	0.0039242121525590182000000
TCGA-28-1753.13	174	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0039386901391261706000000
TCGA-28-1747.5	81	2_CELL_CYCLE_GO_0007049	265	12	0.0039473545889106097000000
TCGA-06-0188.11	66	0_HALLMARK_E2F_TARGETS	169	9	0.0039527248376886965000000
TCGA-06-5418.5	13	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	5	0.0039712723700662594000000
TCGA-15-0742.13	74	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0039721298983413002000000
TCGA-12-0821.9	81	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0039809205697153615000000
TCGA-19-5960.9	134	2_INTERPHASE	62	8	0.0039848363366801146000000
TCGA-12-3653.55	255	1_KEGG_VIRAL_MYOCARDITIS	70	11	0.0039881468380622972000000
TCGA-32-4208.28	140	1_KEGG_BLADDER_CANCER	42	7	0.0039905279384881776000000
TCGA-19-1390.12	10	2_CATION_CHANNEL_ACTIVITY	100	4	0.0039938503038238378000000
TCGA-27-1838.17	131	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0040006969709221124000000
TCGA-76-4925.9	83	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0040081130601092073000000
TCGA-08-0355.1	45	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0040081130601092073000000
TCGA-02-0058.1	110	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	7	0.0040105481001939071000000
TCGA-32-1979.4	12	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0040197443054809977000000
TCGA-19-1790.18	201	1_KEGG_ASTHMA	30	7	0.0040354019385111925000000
TCGA-76-6193.13	271	0_HALLMARK_ANGIOGENESIS	32	8	0.0040383127766192382000000
TCGA-12-3650.17	101	2_DNA_REPLICATION	82	8	0.0040459750247761892000000
TCGA-06-0124.6	55	2_SYNAPTIC_TRANSMISSION	152	8	0.0040478144554716251000000
TCGA-19-5960.9	134	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0040561167945449310000000
TCGA-08-0347.7	25	2_EXTRACELLULAR_MATRIX	85	5	0.0040793436696100515000000
TCGA-27-2523.5	3	2_NUCLEOTIDE_KINASE_ACTIVITY	9	2	0.0040878226487615832000000
TCGA-12-0688.10	93	2_COLLAGEN	23	5	0.0040991043526090029000000
TCGA-08-0244.5	39	2_SYNAPTIC_TRANSMISSION	152	7	0.0041004585356004776000000
TCGA-06-0650.2	82	1_KEGG_MELANOMA	71	7	0.0041110456109104904000000
TCGA-02-0034.5	6	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	3	0.0041159363670717529000000
TCGA-19-2624.29	130	2_CYTOSKELETON	293	16	0.0041172128490140096000000
TCGA-02-0007.17	217	2_DNA_REPLICATION	82	11	0.0041211566196956506000000
TCGA-02-0114.20	132	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0041243075396442674000000
TCGA-06-5413.11	142	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	12	0.0041259469159524616000000
TCGA-41-2573.4	31	1_KEGG_ASTHMA	30	4	0.0041382704468604838000000
TCGA-02-0011.1	288	0_HALLMARK_IL2_STAT5_SIGNALING	148	17	0.0041404569232748670000000
TCGA-06-0878.10	115	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0041418133157094354000000
TCGA-02-0015.16	115	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0041418133157094354000000
TCGA-27-1838.17	131	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0041496667316652793000000
TCGA-02-0021.4	170	1_KEGG_P53_SIGNALING_PATHWAY	66	9	0.0041508695225881661000000
TCGA-08-0360.3	144	0_HALLMARK_KRAS_SIGNALING_UP	148	12	0.0041513441359687896000000
TCGA-28-5219.9	47	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	4	0.0041521494657266022000000
TCGA-19-2624.29	130	2_CYTOSKELETAL_PART	194	13	0.0041639790415706566000000
TCGA-14-0871.20	216	2_MICROTUBULE_CYTOSKELETON	117	13	0.0041781441437889867000000
TCGA-41-2575.49	136	1_KEGG_OOCYTE_MEIOSIS	105	10	0.0041821338239841545000000
TCGA-06-0174.37	141	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0041852953531422710000000
TCGA-02-0001.5	117	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0041873959514491200000000
TCGA-06-0188.11	66	0_HALLMARK_ANGIOGENESIS	32	5	0.0041955141030254415000000
TCGA-32-2632.16	229	2_CHROMOSOMAL_PART	78	11	0.0042015286052988505000000
TCGA-12-3650.17	101	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0042068130263485442000000
TCGA-02-0114.20	132	2_MITOTIC_CELL_CYCLE	134	11	0.0042078983619685132000000
TCGA-32-2634.10	118	2_REGULATION_OF_MOLECULAR_FUNCTION	286	15	0.0042110831768217196000000
TCGA-06-0189.3	118	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	11	0.0042161666717708364000000
TCGA-28-5215.7	192	2_CALCIUM_ION_BINDING	75	10	0.0042296114744068483000000
TCGA-08-0380.4	6	2_CYTOSKELETAL_PART	194	4	0.0042315410502875650000000
TCGA-32-2494.10	173	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0042369053084605965000000
TCGA-06-0939.7	58	1_KEGG_FOCAL_ADHESION	195	9	0.0042444034946417571000000
TCGA-14-0786.4	62	0_HALLMARK_APICAL_JUNCTION	182	9	0.0042661201918598058000000
TCGA-32-4719.15	123	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0042679905907194483000000
TCGA-27-1830.7	57	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0042766594835810332000000
TCGA-32-4719.15	123	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0042954122346616549000000
TCGA-12-0616.7	45	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0043011287528099251000000
TCGA-27-1833.2	41	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0043031896897291243000000
TCGA-06-2558.6	74	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0043273429304483448000000
TCGA-06-0192.10	126	0_HALLMARK_INFLAMMATORY_RESPONSE	170	12	0.0043451616775391586000000
TCGA-06-0157.7	89	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0043477225417713960000000
TCGA-32-2634.10	118	1_KEGG_MELANOMA	71	8	0.0043511262017037339000000
TCGA-19-2619.14	100	0_HALLMARK_MYC_TARGETS_V1	178	11	0.0043565868285836643000000
TCGA-06-0155.10	74	2_SYNAPTIC_TRANSMISSION	152	9	0.0043630159551248330000000
TCGA-06-0128.8	74	2_SYNAPTIC_TRANSMISSION	152	9	0.0043630159551248330000000
TCGA-08-0389.4	56	2_NUCLEUS	1110	20	0.0043680087549140441000000
TCGA-28-2513.12	134	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0043800314807460883000000
TCGA-06-0219.6	6	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0043833193080885851000000
TCGA-08-0244.4	6	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0043833193080885851000000
TCGA-14-1823.12	6	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0043833193080885851000000
TCGA-14-1829.11	6	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0043833193080885851000000
TCGA-19-2620.8	6	2_NEUROTRANSMITTER_BINDING	49	3	0.0043833193080885851000000
TCGA-14-2554.9	6	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0043833193080885851000000
TCGA-02-0052.3	116	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0043897766285082651000000
TCGA-76-4925.9	83	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0043909875219722023000000
TCGA-32-1979.4	12	1_KEGG_SMALL_CELL_LUNG_CANCER	83	4	0.0043909875219722023000000
TCGA-16-0861.5	4	1_KEGG_SMALL_CELL_LUNG_CANCER	83	3	0.0043921203623458454000000
TCGA-02-0033.1	4	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	3	0.0043921203623458454000000
TCGA-26-1439.10	84	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0043940708905652040000000
TCGA-02-0048.9	84	1_KEGG_PANCREATIC_CANCER	70	7	0.0043940708905652040000000
TCGA-19-1390.12	10	2_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	246	5	0.0043987531854984274000000
TCGA-06-2570.8	95	2_INTERPHASE	62	7	0.0044020756423379303000000
TCGA-02-0001.5	117	2_SYNAPTIC_TRANSMISSION	152	11	0.0044134774268202066000000
TCGA-06-6391.9	26	2_EXTRACELLULAR_REGION	346	8	0.0044186830097762385000000
TCGA-12-5299.6	38	2_RECEPTOR_ACTIVITY	499	11	0.0044215929376207521000000
TCGA-06-0154.13	76	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0044222405965383283000000
TCGA-41-2572.8	76	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0044222405965383283000000
TCGA-32-2494.10	173	0_HALLMARK_INFLAMMATORY_RESPONSE	170	14	0.0044307764100420125000000
TCGA-06-5415.7	7	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0044333557454556624000000
TCGA-06-2559.11	101	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0044384012970776305000000
TCGA-32-2498.13	133	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0044426426949291491000000
TCGA-06-0174.37	141	2_CHROMOSOME	102	10	0.0044497617144398363000000
TCGA-76-4927.8	93	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	6	0.0044510229060340141000000
TCGA-14-0871.20	216	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	11	0.0044515106040777987000000
TCGA-32-2638.17	159	1_KEGG_MELANOMA	71	9	0.0044538342600315729000000
TCGA-41-2575.49	136	2_INTERPHASE	62	8	0.0044547828845204447000000
TCGA-28-2509.6	59	2_REGULATION_OF_APOPTOSIS	309	11	0.0044616495750088320000000
TCGA-26-5135.9	71	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0044630746443062221000000
TCGA-06-0148.6	69	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0044907461781805531000000
TCGA-06-0649.13	88	2_TRANSMISSION_OF_NERVE_IMPULSE	164	10	0.0044921937913007760000000
TCGA-02-0014.12	5	1_KEGG_MAPK_SIGNALING_PATHWAY	258	4	0.0044942742760957872000000
TCGA-32-2491.14	244	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	10	0.0044968818376066293000000
TCGA-28-5204.5	5	2_INTERPHASE	62	3	0.0045060840600477242000000
TCGA-02-2483.10	100	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0045098206258047582000000
TCGA-26-5132.7	100	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0045098206258047582000000
TCGA-06-0148.6	69	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0045099419795361128000000
TCGA-02-0083.21	135	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0045122286084282879000000
TCGA-06-5858.19	205	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0045355972658731392000000
TCGA-06-0132.2	2	2_CYTOKINE_SECRETION	16	2	0.0045442701996271607000000
TCGA-32-2494.10	173	2_COLLAGEN	23	6	0.0045527441534528668000000
TCGA-28-2509.5	4	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	3	0.0045544274918195449000000
TCGA-02-0016.4	4	1_KEGG_ECM_RECEPTOR_INTERACTION	84	3	0.0045544274918195449000000
TCGA-06-0126.3	4	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	3	0.0045544274918195449000000
TCGA-28-1753.13	174	2_CELL_CYCLE_PHASE	146	13	0.0045709763900873028000000
TCGA-06-0152.10	19	2_MICROTUBULE_CYTOSKELETON	117	5	0.0045725749769081640000000
TCGA-06-0176.8	95	2_SYNAPTIC_TRANSMISSION	152	10	0.0045745987144796179000000
TCGA-81-5910.12	128	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0045772194669806169000000
TCGA-06-0138.2	30	2_NEUROLOGICAL_SYSTEM_PROCESS	296	8	0.0045791719584139315000000
TCGA-06-0645.9	136	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0045882231083211851000000
TCGA-41-3392.31	136	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0045882231083211851000000
TCGA-06-0168.4	22	0_HALLMARK_APICAL_JUNCTION	182	6	0.0045910839431868586000000
TCGA-28-2509.6	59	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	11	0.0046038267147619121000000
TCGA-06-0879.9	84	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0046073976398457945000000
TCGA-02-0048.9	84	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0046073976398457945000000
TCGA-06-0213.9	74	1_KEGG_CELL_CYCLE	114	8	0.0046086206876759083000000
TCGA-06-0155.10	74	1_KEGG_CELL_CYCLE	114	8	0.0046086206876759083000000
TCGA-08-0245.4	85	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0046113921262633927000000
TCGA-08-0355.1	45	2_EXTRACELLULAR_MATRIX	85	6	0.0046113921262633927000000
TCGA-06-2557.11	177	2_EXTRACELLULAR_REGION_PART	269	18	0.0046188292793986471000000
TCGA-14-1825.8	80	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0046207309948493817000000
TCGA-06-0241.8	53	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	6	0.0046346780509381215000000
TCGA-19-4068.6	42	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0046360823620848852000000
TCGA-12-1597.6	51	1_KEGG_BLADDER_CANCER	42	5	0.0046360823620848852000000
TCGA-06-5411.3	19	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	4	0.0046471927244455214000000
TCGA-06-0645.9	136	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0046473721462292027000000
TCGA-27-2523.12	112	2_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0046510217565910433000000
TCGA-27-2523.12	112	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0046510217565910433000000
TCGA-19-5947.4	267	2_PATTERN_BINDING	33	8	0.0046532954773451426000000
TCGA-06-0152.11	56	2_SYNAPTIC_TRANSMISSION	152	8	0.0046586799457619737000000
TCGA-02-2483.10	100	2_CELL_PROLIFERATION_GO_0008283	436	17	0.0046625152641838379000000
TCGA-19-1390.12	10	2_GATED_CHANNEL_ACTIVITY	104	4	0.0046737118686757794000000
TCGA-28-5208.28	220	0_HALLMARK_G2M_CHECKPOINT	174	16	0.0046795388568335360000000
TCGA-02-0007.17	217	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	8	0.0046976319567101858000000
TCGA-02-0024.6	206	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0047035895729663759000000
TCGA-06-5413.11	142	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0047051380420576258000000
TCGA-28-1753.13	174	2_COLLAGEN	23	6	0.0047079925622393716000000
TCGA-02-0115.4	3	2_MITOTIC_CELL_CYCLE	134	3	0.0047155823548296746000000
TCGA-06-0750.9	3	2_MITOTIC_CELL_CYCLE	134	3	0.0047155823548296746000000
TCGA-27-1834.9	3	2_MITOTIC_CELL_CYCLE	134	3	0.0047155823548296746000000
TCGA-06-0882.9	3	2_MITOTIC_CELL_CYCLE	134	3	0.0047155823548296746000000
TCGA-19-1790.1	4	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	85	3	0.0047206755759116341000000
TCGA-02-0033.1	4	2_EXTRACELLULAR_MATRIX	85	3	0.0047206755759116341000000
TCGA-41-2573.4	31	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	6	0.0047272821820474467000000
TCGA-76-4935.7	15	1_KEGG_P53_SIGNALING_PATHWAY	66	4	0.0047290508865539139000000
TCGA-06-2569.5	144	2_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0047378851319515710000000
TCGA-06-2569.5	144	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0047378851319515710000000
TCGA-06-0686.10	26	2_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0047476235309308248000000
TCGA-06-0686.10	26	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0047476235309308248000000
TCGA-19-4068.6	42	2_COLLAGEN	23	4	0.0047484962841786256000000
TCGA-19-4068.6	42	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0047484962841786256000000
TCGA-06-0169.5	42	2_COLLAGEN	23	4	0.0047484962841786256000000
TCGA-32-2491.14	244	0_HALLMARK_COMPLEMENT	176	17	0.0047562094515592604000000
TCGA-76-4931.10	86	0_HALLMARK_E2F_TARGETS	169	10	0.0047648445517171753000000
TCGA-06-0174.35	4	2_MICROVILLUS	7	2	0.0047681166929209075000000
TCGA-06-5415.7	7	1_KEGG_BLADDER_CANCER	42	3	0.0047728629658238689000000
TCGA-28-5220.7	15	2_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	680	8	0.0047739359536855420000000
TCGA-28-5213.9	143	2_NEURON_PROJECTION	16	5	0.0047803310337462476000000
TCGA-02-0033.5	144	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	12	0.0047814923847133940000000
TCGA-02-2483.10	100	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	10	0.0047817429218612127000000
TCGA-06-0645.9	136	2_CELL_CELL_SIGNALING	353	18	0.0047913906497773912000000
TCGA-14-4157.7	101	0_HALLMARK_MYC_TARGETS_V1	178	11	0.0048099738752686669000000
TCGA-12-3650.17	101	0_HALLMARK_MYC_TARGETS_V1	178	11	0.0048099738752686669000000
TCGA-08-0360.3	144	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0048179662226806776000000
TCGA-19-5960.9	134	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0048288356861065657000000
TCGA-27-1837.5	85	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0048316312127058818000000
TCGA-02-0086.2	17	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0048457902290965776000000
TCGA-06-0178.2	17	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0048457902290965776000000
TCGA-12-3653.55	255	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	10	0.0048460325861810830000000
TCGA-02-0014.10	70	2_CELL_CYCLE_PROCESS	163	9	0.0048476689030281525000000
TCGA-06-5415.7	7	2_CELL_CYCLE_PROCESS	163	4	0.0048513261405104769000000
TCGA-06-2559.11	101	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0048627161324567023000000
TCGA-02-0043.10	184	2_ORGAN_DEVELOPMENT	460	25	0.0048646735824842942000000
TCGA-06-5859.9	125	2_REGULATION_OF_APOPTOSIS	309	16	0.0048659105055095173000000
TCGA-32-2634.10	118	2_DNA_BINDING	496	20	0.0048665155712605199000000
TCGA-14-4157.7	101	2_NUCLEAR_CHROMOSOME_PART	22	5	0.0048683588187738392000000
TCGA-19-5958.4	35	1_KEGG_GLIOMA	62	5	0.0048701403006692389000000
TCGA-08-0347.4	16	2_INTERPHASE	62	4	0.0048746976546259852000000
TCGA-14-0787.6	40	2_NON_MEMBRANE_BOUND_ORGANELLE	476	11	0.0048837348344722073000000
TCGA-14-0787.6	40	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	11	0.0048837348344722073000000
TCGA-06-0125.9	75	2_SYNAPTIC_TRANSMISSION	152	9	0.0048906131333344436000000
TCGA-06-0645.9	136	2_SIGNAL_TRANSDUCTION	1442	42	0.0048948819299416083000000
TCGA-12-0688.10	93	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0049028666395659467000000
TCGA-76-4928.15	78	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0049091686793657288000000
TCGA-32-2634.10	118	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0049230622926767307000000
TCGA-02-0074.5	118	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0049230622926767307000000
TCGA-19-5951.10	138	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0049266690503079469000000
TCGA-06-0143.3	3	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	3	0.0049315386212503975000000
TCGA-19-5960.9	134	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0049326010190655859000000
TCGA-02-0033.5	144	2_NEURON_PROJECTION	16	5	0.0049474363245943006000000
TCGA-02-0034.5	6	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	3	0.0049521819021197747000000
TCGA-12-3653.55	255	2_MICROTUBULE_CYTOSKELETON	117	14	0.0049598618807509725000000
TCGA-06-5412.7	153	2_EXTRACELLULAR_REGION	346	19	0.0049686871930290661000000
TCGA-19-2623.11	153	2_EXTRACELLULAR_REGION	346	19	0.0049686871930290661000000
TCGA-06-0128.8	74	2_CELL_CELL_SIGNALING	353	13	0.0049746556152927045000000
TCGA-19-2631.15	84	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0049869117286422673000000
TCGA-32-2494.10	173	0_HALLMARK_KRAS_SIGNALING_UP	148	13	0.0049931421789868730000000
TCGA-28-5218.5	208	0_HALLMARK_ESTROGEN_RESPONSE_LATE	143	14	0.0049992564990670009000000
TCGA-08-0245.4	85	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0050150418597218619000000
TCGA-02-0001.5	117	2_ENZYME_BINDING	154	11	0.0050160172549124056000000
TCGA-12-5295.8	66	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0050315948520159894000000
TCGA-02-0024.6	206	0_HALLMARK_SPERMATOGENESIS	88	11	0.0050484689200208143000000
TCGA-16-1048.13	97	2_COLLAGEN	23	5	0.0050506702624912702000000
TCGA-06-0211.7	10	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	5	0.0050510700319449627000000
TCGA-14-0787.7	14	2_INTEGRAL_TO_PLASMA_MEMBRANE	751	8	0.0050618465537044313000000
TCGA-06-0154.13	76	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0050651524357555183000000
TCGA-41-2572.8	76	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0050651524357555183000000
TCGA-28-2509.5	4	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	3	0.0050651819510828975000000
TCGA-06-0126.3	4	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	3	0.0050651819510828975000000
TCGA-06-0152.11	56	2_RECEPTOR_BINDING	331	11	0.0050652725604750726000000
TCGA-06-0882.6	21	1_KEGG_FOCAL_ADHESION	195	6	0.0050700353235258230000000
TCGA-28-6450.11	139	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0050709084145949624000000
TCGA-06-5859.9	125	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	16	0.0050740385047048780000000
TCGA-02-0083.21	135	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0050748962442150290000000
TCGA-28-5209.15	194	0_HALLMARK_ANGIOGENESIS	32	7	0.0050846164099028063000000
TCGA-02-2470.4	11	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0050846738761110843000000
TCGA-06-0197.1	57	0_HALLMARK_P53_PATHWAY	151	8	0.0050883225028166912000000
TCGA-28-1753.13	174	0_HALLMARK_COAGULATION	125	12	0.0050954488345862281000000
TCGA-32-5222.9	70	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0050991676758414947000000
TCGA-12-3653.55	255	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	207	19	0.0051065103034905459000000
TCGA-06-5410.3	3	2_PHOSPHORUS_OXYGEN_LYASE_ACTIVITY	10	2	0.0051094175018648030000000
TCGA-06-5410.3	3	2_CYCLASE_ACTIVITY	10	2	0.0051094175018648030000000
TCGA-06-0882.5	3	2_CASPASE_REGULATOR_ACTIVITY	10	2	0.0051094175018648030000000
TCGA-06-0241.8	53	2_CELL_CYCLE_PROCESS	163	8	0.0051174957686644026000000
TCGA-32-4210.14	109	2_MITOTIC_CELL_CYCLE	134	10	0.0051474643411293869000000
TCGA-76-6191.6	96	2_NUCLEUS	1110	28	0.0051500329210467941000000
TCGA-76-4927.8	93	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	6	0.0051519605739195149000000
TCGA-06-0143.3	3	2_REGULATION_OF_KINASE_ACTIVITY	138	3	0.0051539894512634384000000
TCGA-76-4934.7	47	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0052104261146729749000000
TCGA-76-4934.7	47	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0052104261146729749000000
TCGA-19-2620.7	47	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0052104261146729749000000
TCGA-19-5954.17	208	1_KEGG_MELANOMA	71	10	0.0052143608285543375000000
TCGA-32-4208.28	140	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0052182661839356836000000
TCGA-19-2623.11	153	1_KEGG_FOCAL_ADHESION	195	14	0.0052226902187012423000000
TCGA-08-0358.9	43	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0052270885250508166000000
TCGA-14-4157.7	101	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	10	0.0052383483491729339000000
TCGA-27-1837.5	85	1_KEGG_MELANOMA	71	7	0.0052430237960443852000000
TCGA-02-0028.9	182	2_TRANSMISSION_OF_NERVE_IMPULSE	164	14	0.0052729854236153130000000
TCGA-32-2494.10	173	2_EXTRACELLULAR_MATRIX	85	10	0.0052815194186933354000000
TCGA-19-2629.15	146	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0052826657763088954000000
TCGA-19-2625.9	146	1_KEGG_BLADDER_CANCER	42	7	0.0052826657763088954000000
TCGA-06-0139.1	179	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0052993483206542624000000
TCGA-41-2571.7	72	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0053229697091663666000000
TCGA-06-0187.10	55	1_KEGG_MELANOMA	71	6	0.0053244568318342681000000
TCGA-14-4157.7	101	2_NUCLEAR_CHROMOSOME	39	6	0.0053257420287318395000000
TCGA-14-3476.17	53	2_CELL_CELL_SIGNALING	353	11	0.0053302423548233085000000
TCGA-06-0137.9	53	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0053569997231422981000000
TCGA-02-0003.9	227	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	42	0.0053643454215695991000000
TCGA-02-0028.9	182	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0053668962006305819000000
TCGA-02-0099.11	141	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0053687860538478962000000
TCGA-06-0174.37	141	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0053687860538478962000000
TCGA-06-0148.6	69	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0053719613699137279000000
TCGA-06-5411.4	23	0_HALLMARK_MYC_TARGETS_V1	178	6	0.0053729079337755158000000
TCGA-08-0389.4	56	2_REPLICATION_FORK	18	4	0.0053817087518303313000000
TCGA-06-0195.8	56	2_REPLICATION_FORK	18	4	0.0053817087518303313000000
TCGA-06-0140.2	25	2_ESTABLISHMENT_OF_LOCALIZATION	659	10	0.0053819707266809808000000
TCGA-06-0143.3	3	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	3	0.0053830310606260909000000
TCGA-28-5220.7	15	2_REGULATION_OF_METABOLIC_PROCESS	691	8	0.0053897781266350414000000
TCGA-02-0003.9	227	1_KEGG_CELL_CYCLE	114	13	0.0054021805602619093000000
TCGA-02-0003.9	227	2_SYSTEM_DEVELOPMENT	694	37	0.0054094279107652849000000
TCGA-14-1825.8	80	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0054348172168900933000000
TCGA-06-0156.4	80	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0054348172168900933000000
TCGA-19-5959.13	92	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0054376597075851936000000
TCGA-06-0649.13	88	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	7	0.0054554249835485034000000
TCGA-06-0154.13	76	2_SYNAPTIC_TRANSMISSION	152	9	0.0054721965423571743000000
TCGA-32-1982.9	89	2_RECEPTOR_ACTIVITY	499	17	0.0054759797030581947000000
TCGA-32-2615.7	77	0_HALLMARK_APOPTOSIS	150	9	0.0054786908404317368000000
TCGA-14-0787.7	14	2_INTRINSIC_TO_PLASMA_MEMBRANE	759	8	0.0054852261310927341000000
TCGA-06-5859.9	125	1_KEGG_DNA_REPLICATION	32	6	0.0054940224591022956000000
TCGA-28-6450.11	139	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0054988160845680159000000
TCGA-06-0173.35	120	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0055094420663948686000000
TCGA-19-2619.10	8	2_SECRETION	142	4	0.0055225119974815001000000
TCGA-06-0644.16	142	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0055225119974815001000000
TCGA-14-0790.9	104	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0055378449701234426000000
TCGA-14-0790.9	104	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0055378449701234426000000
TCGA-28-1753.13	174	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0055426774362915361000000
TCGA-06-0139.1	179	2_COLLAGEN	23	6	0.0055505840715506863000000
TCGA-12-3650.17	101	2_DNA_METABOLIC_PROCESS	218	12	0.0055605985524379920000000
TCGA-12-5299.5	6	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	3	0.0055680366340468178000000
TCGA-14-1823.12	6	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	3	0.0055680366340468178000000
TCGA-41-3393.5	88	2_EXTRACELLULAR_REGION	346	14	0.0055772913965838247000000
TCGA-28-5218.5	208	2_CATION_BINDING	165	15	0.0055854069347676776000000
TCGA-06-0645.9	136	2_EXTRACELLULAR_MATRIX	85	9	0.0056093949566686117000000
TCGA-41-3392.31	136	2_EXTRACELLULAR_MATRIX	85	9	0.0056093949566686117000000
TCGA-06-0241.8	53	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0056266662153300652000000
TCGA-32-1986.8	87	2_GLYCOSAMINOGLYCAN_BINDING	26	5	0.0056283029607611338000000
TCGA-76-4935.7	15	2_CYTOSKELETON	293	6	0.0056465743341773218000000
TCGA-14-0871.20	216	2_EXTRACELLULAR_MATRIX	85	11	0.0056527406785149741000000
TCGA-28-2501.3	51	0_HALLMARK_MYOGENESIS	172	8	0.0056616981855815342000000
TCGA-02-0046.8	148	2_NEURON_PROJECTION	16	5	0.0056624779562852801000000
TCGA-32-2498.13	133	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0056708332872476251000000
TCGA-76-4931.10	86	1_KEGG_MELANOMA	71	7	0.0056737556582245555000000
TCGA-28-5207.12	188	2_MICROTUBULE_CYTOSKELETON	117	12	0.0056783828759944671000000
TCGA-28-5213.9	143	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0056794882650789170000000
TCGA-06-0190.8	143	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0056794882650789170000000
TCGA-76-6193.13	271	2_INTERLEUKIN_BINDING	24	7	0.0056899877219078847000000
TCGA-14-0817.9	85	2_REGULATION_OF_APOPTOSIS	309	13	0.0057120976955065015000000
TCGA-12-0821.9	81	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0057127680464962487000000
TCGA-76-6193.13	271	2_CYTOKINE_BINDING	44	9	0.0057163216226938599000000
TCGA-08-0357.4	36	0_HALLMARK_G2M_CHECKPOINT	174	7	0.0057252697772341935000000
TCGA-32-4211.14	71	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0057534271331020070000000
TCGA-27-2526.7	71	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0057534271331020070000000
TCGA-06-0139.1	179	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0057618638354957410000000
TCGA-28-2501.3	51	2_CONTRACTILE_FIBER_PART	20	4	0.0057858908882498531000000
TCGA-32-1979.10	116	0_HALLMARK_ALLOGRAFT_REJECTION	190	12	0.0057896173153227865000000
TCGA-28-2513.2	2	2_REPLICATION_FORK	18	2	0.0057939445045269719000000
TCGA-02-2486.8	2	2_REPLICATION_FORK	18	2	0.0057939445045269719000000
TCGA-06-0176.8	95	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0057978590792437789000000
TCGA-06-0221.13	45	2_CELL_CYCLE_GO_0007049	265	9	0.0057991150558084443000000
TCGA-32-2494.10	173	0_HALLMARK_APOPTOSIS	150	13	0.0058022962623656225000000
TCGA-12-5295.8	66	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	6	0.0058043889664017804000000
TCGA-12-3649.15	89	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0058104602073195850000000
TCGA-27-1833.2	41	2_SYNAPTIC_TRANSMISSION	152	7	0.0058342128925559901000000
TCGA-06-2570.8	95	1_KEGG_BLADDER_CANCER	42	6	0.0058358300495812481000000
TCGA-06-2570.8	95	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0058358300495812481000000
TCGA-08-0360.3	144	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0058397593834363095000000
TCGA-02-0033.5	144	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0058397593834363095000000
TCGA-06-2569.5	144	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0058397593834363095000000
TCGA-02-2483.10	100	2_COLLAGEN	23	5	0.0058721356183050709000000
TCGA-32-4213.15	198	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0058789299201944109000000
TCGA-12-3652.19	88	0_HALLMARK_E2F_TARGETS	169	10	0.0058898929340652053000000
TCGA-06-2558.6	74	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0059128129095155557000000
TCGA-14-0817.9	85	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	13	0.0059191665236394513000000
TCGA-06-5859.9	125	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	18	0.0059260949436752471000000
TCGA-06-0152.11	56	1_KEGG_MELANOMA	71	6	0.0059282647448506160000000
TCGA-02-0060.19	281	2_IMMUNE_SYSTEM_PROCESS	283	24	0.0059368724055705912000000
TCGA-06-2563.10	123	1_KEGG_MELANOMA	71	8	0.0059458769042862111000000
TCGA-76-6282.11	185	2_RESPONSE_TO_WOUNDING	163	14	0.0059468666175235751000000
TCGA-19-5952.11	193	2_WOUND_HEALING	46	8	0.0059472742757861706000000
TCGA-06-5412.7	153	0_HALLMARK_INFLAMMATORY_RESPONSE	170	13	0.0059583386822418911000000
TCGA-06-5414.13	102	1_KEGG_CELL_CYCLE	114	9	0.0059796627073133999000000
TCGA-19-2625.9	146	2_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0059856066573158997000000
TCGA-19-2625.9	146	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0059856066573158997000000
TCGA-76-4934.7	47	2_EXTRACELLULAR_MATRIX	85	6	0.0059924978891117316000000
TCGA-19-2620.7	47	2_EXTRACELLULAR_MATRIX	85	6	0.0059924978891117316000000
TCGA-28-5220.7	15	1_KEGG_PANCREATIC_CANCER	70	4	0.0059938034552194991000000
TCGA-28-5220.7	15	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0059938034552194991000000
TCGA-06-0126.8	15	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	4	0.0059938034552194991000000
TCGA-06-5418.5	13	2_COLLAGEN	23	3	0.0059956846580133741000000
TCGA-02-0010.18	184	2_TRANSMISSION_OF_NERVE_IMPULSE	164	14	0.0059973705572556766000000
TCGA-32-2495.11	67	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0059979705423889749000000
TCGA-41-3393.5	88	1_KEGG_VIRAL_MYOCARDITIS	70	7	0.0060161692507866155000000
TCGA-06-5859.9	125	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0060201038347266556000000
TCGA-06-5408.3	99	2_CELL_CYCLE_GO_0007049	265	13	0.0060202226483326085000000
TCGA-28-2513.12	134	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0060338455843511789000000
TCGA-32-2491.14	244	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	34	0.0060340155046004294000000
TCGA-32-4211.14	71	0_HALLMARK_ANGIOGENESIS	32	5	0.0060397344765737802000000
TCGA-06-0130.3	155	2_EXTRACELLULAR_REGION	346	19	0.0060416234331016816000000
TCGA-32-2632.16	229	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	15	0.0060624530637489772000000
TCGA-32-2638.17	159	0_HALLMARK_ALLOGRAFT_REJECTION	190	14	0.0060672272929958590000000
TCGA-08-0244.5	39	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0060677526084913606000000
TCGA-06-0122.8	90	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0060765724058251813000000
TCGA-02-0115.4	3	2_CELL_CYCLE_PHASE	146	3	0.0061106627223796008000000
TCGA-06-0750.9	3	2_CELL_CYCLE_PHASE	146	3	0.0061106627223796008000000
TCGA-27-1834.9	3	2_CELL_CYCLE_PHASE	146	3	0.0061106627223796008000000
TCGA-06-0882.9	3	2_CELL_CYCLE_PHASE	146	3	0.0061106627223796008000000
TCGA-19-1390.12	10	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	263	5	0.0061131458746305385000000
TCGA-06-0881.7	203	2_ENDOPEPTIDASE_ACTIVITY	91	11	0.0061177173005154987000000
TCGA-19-5952.11	193	2_PATTERN_BINDING	33	7	0.0061283281621953185000000
TCGA-06-0650.2	82	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0061503453774747448000000
TCGA-06-5413.11	142	2_INTERPHASE	62	8	0.0061576045748514925000000
TCGA-41-2571.7	72	2_CELL_CYCLE_PROCESS	163	9	0.0061602196820058058000000
TCGA-14-4157.7	101	1_KEGG_MISMATCH_REPAIR	23	5	0.0061681210848327462000000
TCGA-19-2629.15	146	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0061703656591487631000000
TCGA-87-5896.6	131	2_CELL_CYCLE_GO_0007049	265	15	0.0061704527904440235000000
TCGA-28-1753.13	174	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0061716641968583823000000
TCGA-28-1753.13	174	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0061716641968583823000000
TCGA-08-0245.4	85	2_DNA_METABOLIC_PROCESS	218	11	0.0061804393775475985000000
TCGA-28-1753.13	174	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	13	0.0061860274536289410000000
TCGA-06-0174.37	141	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0061888000015119004000000
TCGA-76-4931.10	86	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0061957850804794873000000
TCGA-08-0354.5	18	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0062018411092972878000000
TCGA-76-6191.6	96	1_KEGG_BLADDER_CANCER	42	6	0.0062045027515965304000000
TCGA-12-5299.5	6	2_GROWTH	55	3	0.0062327161878431396000000
TCGA-02-0011.1	288	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	9	0.0062403209908602391000000
TCGA-02-0115.4	3	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0062444026245060662000000
TCGA-06-0143.3	3	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0062444026245060662000000
TCGA-06-0750.9	3	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0062444026245060662000000
TCGA-27-1834.9	3	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0062444026245060662000000
TCGA-06-0882.9	3	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0062444026245060662000000
TCGA-27-1831.4	3	2_POTASSIUM_CHANNEL_REGULATOR_ACTIVITY	11	2	0.0062444026245060662000000
TCGA-32-1970.14	94	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0062840796144341118000000
TCGA-12-0616.7	45	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0062904391397632575000000
TCGA-08-0355.1	45	2_COLLAGEN	23	4	0.0062904391397632575000000
TCGA-08-0355.1	45	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0062904391397632575000000
TCGA-06-0173.35	120	1_KEGG_ENDOMETRIAL_CANCER	52	7	0.0063000321087170151000000
TCGA-76-4925.9	83	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0063001587846461277000000
TCGA-81-5910.12	128	0_HALLMARK_ANGIOGENESIS	32	6	0.0063074533063609464000000
TCGA-81-5910.12	128	1_KEGG_DNA_REPLICATION	32	6	0.0063074533063609464000000
TCGA-06-0686.10	26	2_REGULATION_OF_CELL_CYCLE	160	6	0.0063122850907889189000000
TCGA-76-6282.11	185	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	18	0.0063225415073250744000000
TCGA-06-2561.5	42	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	7	0.0063250269847175897000000
TCGA-32-1970.14	94	2_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0063278221857236685000000
TCGA-32-1970.14	94	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0063278221857236685000000
TCGA-08-0345.2	77	2_EXTRACELLULAR_REGION	346	13	0.0063344047628759526000000
TCGA-02-0086.2	17	2_INTERPHASE	62	4	0.0063433298988568648000000
TCGA-06-0178.2	17	2_INTERPHASE	62	4	0.0063433298988568648000000
TCGA-28-5220.7	15	2_CELL_CYCLE_PROCESS	163	5	0.0063438719350543144000000
TCGA-14-0786.2	10	2_CELL_CYCLE_GO_0007049	265	5	0.0063452718359879399000000
TCGA-76-4929.8	91	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0063516255474517216000000
TCGA-41-2575.46	4	2_GABA_RECEPTOR_ACTIVITY	8	2	0.0063565912667072795000000
TCGA-27-2527.6	79	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0063614548328831313000000
TCGA-06-0214.9	62	2_CELL_PROLIFERATION_GO_0008283	436	13	0.0063792261784731026000000
TCGA-06-0238.4	24	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	6	0.0063908935970692672000000
TCGA-08-0347.4	16	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	3	0.0064193398588437102000000
TCGA-32-2634.10	118	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	7	0.0064208719851089457000000
TCGA-14-0781.7	155	2_CELL_PROJECTION	76	9	0.0064304550359542871000000
TCGA-02-0009.6	188	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	36	0.0064512875925326419000000
TCGA-41-2571.7	72	1_KEGG_DNA_REPLICATION	32	5	0.0064749746747463158000000
TCGA-06-0132.2	2	2_REGULATION_OF_PROTEIN_SECRETION	19	2	0.0064755850344723719000000
TCGA-27-2524.5	75	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0064756248288592930000000
TCGA-76-6193.13	271	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	12	0.0064853622615816614000000
TCGA-06-0881.7	203	2_SIGNAL_TRANSDUCTION	1442	56	0.0064874115766601183000000
TCGA-06-2563.10	123	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0064976720087558315000000
TCGA-06-2563.10	123	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0064976720087558315000000
TCGA-02-0079.1	5	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	3	0.0065137062581790434000000
TCGA-76-4935.4	5	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	3	0.0065137062581790434000000
TCGA-02-0046.8	148	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0065146925495882455000000
TCGA-02-0007.17	217	2_NUCLEUS	1110	49	0.0065293835784537135000000
TCGA-32-5222.9	70	0_HALLMARK_E2F_TARGETS	169	9	0.0065324384016176001000000
TCGA-12-3649.15	89	0_HALLMARK_E2F_TARGETS	169	10	0.0065341931585799996000000
TCGA-28-2509.6	59	2_APOPTOSIS_GO	389	12	0.0065536995200842210000000
TCGA-06-5413.11	142	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0065608599851161862000000
TCGA-06-0219.6	6	2_PROTEIN_KINASE_BINDING	56	3	0.0065839370053872494000000
TCGA-08-0244.4	6	2_PROTEIN_KINASE_BINDING	56	3	0.0065839370053872494000000
TCGA-12-5299.5	6	2_PROTEIN_KINASE_BINDING	56	3	0.0065839370053872494000000
TCGA-14-1823.12	6	2_PROTEIN_KINASE_BINDING	56	3	0.0065839370053872494000000
TCGA-14-1829.11	6	2_PROTEIN_KINASE_BINDING	56	3	0.0065839370053872494000000
TCGA-14-2554.9	6	2_PROTEIN_KINASE_BINDING	56	3	0.0065839370053872494000000
TCGA-06-2557.11	177	2_DEFENSE_RESPONSE	222	16	0.0065842559322711021000000
TCGA-19-5947.4	267	2_AXON	10	5	0.0065843067269674340000000
TCGA-12-0619.11	123	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0065991785813808313000000
TCGA-06-5418.5	13	1_KEGG_ECM_RECEPTOR_INTERACTION	84	4	0.0066101009660876368000000
TCGA-06-0879.9	84	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0066101009660876368000000
TCGA-02-0048.9	84	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0066101009660876368000000
TCGA-06-0686.6	3	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	3	0.0066304683491728959000000
TCGA-28-5215.7	192	1_KEGG_GLIOMA	62	9	0.0066306418259072103000000
TCGA-06-2562.7	57	2_EXTRACELLULAR_REGION_PART	269	10	0.0066335410357216285000000
TCGA-27-1830.7	57	2_EXTRACELLULAR_REGION_PART	269	10	0.0066335410357216285000000
TCGA-14-0790.9	104	2_EXTRACELLULAR_MATRIX	85	8	0.0066353437781802842000000
TCGA-06-2564.7	92	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0066358123202578728000000
TCGA-14-4157.7	101	1_KEGG_GLIOMA	62	7	0.0066448288216114093000000
TCGA-12-3650.17	101	2_INTERPHASE	62	7	0.0066448288216114093000000
TCGA-06-2559.11	101	2_INTERPHASE	62	7	0.0066448288216114093000000
TCGA-08-0354.5	18	2_MITOTIC_CELL_CYCLE	134	5	0.0066485128454544231000000
TCGA-06-5412.7	153	2_NEURON_PROJECTION	16	5	0.0066681511989227019000000
TCGA-28-5219.9	47	2_RECEPTOR_ACTIVITY	499	12	0.0066860028761547398000000
TCGA-02-0071.12	116	2_REGULATION_OF_CELL_CYCLE	160	11	0.0066903712715342799000000
TCGA-27-1836.8	49	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0066913698637615232000000
TCGA-32-2494.10	173	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0066914618610552489000000
TCGA-41-2575.49	136	2_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0067044719390088022000000
TCGA-41-2575.49	136	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0067044719390088022000000
TCGA-41-4097.6	48	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	5	0.0067145980441084179000000
TCGA-02-0014.10	70	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0067179132662297664000000
TCGA-28-2509.6	59	2_PROGRAMMED_CELL_DEATH	390	12	0.0067298678089686044000000
TCGA-32-1991.4	7	2_ENDOPLASMIC_RETICULUM	177	4	0.0067409297594131709000000
TCGA-06-0176.8	95	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0067468476012506962000000
TCGA-08-0353.8	100	2_CELL_CYCLE_GO_0007049	265	13	0.0067489534706844734000000
TCGA-06-0644.16	142	2_EXTRACELLULAR_REGION	346	18	0.0067584420048445995000000
TCGA-32-1979.4	12	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0067671869470517275000000
TCGA-06-0187.10	55	1_KEGG_BLADDER_CANCER	42	5	0.0067764377094779631000000
TCGA-06-0174.37	141	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0067819966797365147000000
TCGA-06-0154.13	76	2_CELL_CELL_SIGNALING	353	13	0.0067848263145566376000000
TCGA-06-0210.6	103	2_COLLAGEN	23	5	0.0067952545934942292000000
TCGA-27-1837.5	85	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	6	0.0067995810739785237000000
TCGA-02-0014.12	5	1_KEGG_MELANOMA	71	3	0.0067999901568567391000000
TCGA-08-0244.5	39	2_TRANSMISSION_OF_NERVE_IMPULSE	164	7	0.0068040255318655846000000
TCGA-06-0877.7	4	2_ENZYME_INHIBITOR_ACTIVITY	96	3	0.0068228927066983445000000
TCGA-08-0348.3	4	2_ENZYME_INHIBITOR_ACTIVITY	96	3	0.0068228927066983445000000
TCGA-28-5207.12	188	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0068343289086680824000000
TCGA-06-5414.13	102	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	8	0.0068374640461581941000000
TCGA-02-0007.17	217	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	20	6	0.0068557986297837640000000
TCGA-02-0007.17	217	2_INTERMEDIATE_FILAMENT	20	6	0.0068557986297837640000000
TCGA-08-0350.2	46	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0068784307511947753000000
TCGA-02-0113.3	46	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0068784307511947753000000
TCGA-12-5301.7	46	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0068784307511947753000000
TCGA-14-0789.11	3	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	152	3	0.0069010751655275062000000
TCGA-26-1439.7	3	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	152	3	0.0069010751655275062000000
TCGA-32-2494.8	3	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	152	3	0.0069010751655275062000000
TCGA-14-1825.5	3	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	152	3	0.0069010751655275062000000
TCGA-19-2624.29	130	0_HALLMARK_ANGIOGENESIS	32	6	0.0069023554944424598000000
TCGA-06-5856.13	152	1_KEGG_BLADDER_CANCER	42	7	0.0069073937452836312000000
TCGA-12-0688.10	93	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0069293272329998441000000
TCGA-27-1837.5	85	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0069312135604472774000000
TCGA-28-5216.8	162	2_TISSUE_DEVELOPMENT	115	11	0.0069331750959450364000000
TCGA-06-2558.6	74	2_EXTRACELLULAR_MATRIX	85	7	0.0069422618489320426000000
TCGA-16-0861.4	6	2_REGULATION_OF_TRANSPORT	57	3	0.0069480496590473501000000
TCGA-06-0750.13	8	2_MEMBRANE_PART	1217	7	0.0069571652250359920000000
TCGA-06-0158.4	65	2_CELL_CELL_SIGNALING	353	12	0.0069945985160826066000000
TCGA-02-0071.12	116	2_REGULATION_OF_CELL_PROLIFERATION	265	14	0.0070140299116236201000000
TCGA-32-4210.14	109	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0070164762810079025000000
TCGA-19-5950.7	113	2_PROTEIN_KINASE_BINDING	56	7	0.0070194761785489605000000
TCGA-06-0125.9	75	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0070198377812869996000000
TCGA-02-0021.4	170	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0070223525926939347000000
TCGA-02-0021.4	170	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0070223525926939347000000
TCGA-06-0686.10	26	2_CELL_CYCLE_PROCESS	163	6	0.0070302667639042249000000
TCGA-02-0034.4	88	2_CELL_CELL_SIGNALING	353	14	0.0070426045731627508000000
TCGA-19-1390.12	10	2_CALCIUM_CHANNEL_ACTIVITY	32	3	0.0070438784722486065000000
TCGA-12-5295.8	66	2_INTERPHASE	62	6	0.0070500150028320087000000
TCGA-06-0188.11	66	2_INTERPHASE	62	6	0.0070500150028320087000000
TCGA-06-5412.7	153	1_KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	99	10	0.0070813134396581308000000
TCGA-41-2572.8	76	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0070824165866531646000000
TCGA-41-2572.8	76	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0070824165866531646000000
TCGA-28-5204.5	5	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	3	0.0070945093088014815000000
TCGA-02-0069.12	62	2_CHROMOSOME	102	7	0.0070980525046966921000000
TCGA-14-0817.9	85	2_NON_MEMBRANE_BOUND_ORGANELLE	476	16	0.0070983864756867538000000
TCGA-14-0817.9	85	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	16	0.0070983864756867538000000
TCGA-14-0781.7	155	2_NEURON_PROJECTION	16	5	0.0071076964780853267000000
TCGA-06-0130.3	155	2_NEURON_PROJECTION	16	5	0.0071076964780853267000000
TCGA-06-5413.11	142	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0071084145896961283000000
TCGA-06-0219.6	6	2_NEGATIVE_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	221	4	0.0071203352902455474000000
TCGA-08-0244.4	6	2_NEGATIVE_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	221	4	0.0071203352902455474000000
TCGA-14-1829.11	6	2_NEGATIVE_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	221	4	0.0071203352902455474000000
TCGA-14-2554.9	6	2_NEGATIVE_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	221	4	0.0071203352902455474000000
TCGA-14-0790.9	104	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	5	0.0071270607460476101000000
TCGA-06-0124.6	55	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0071454515202953647000000
TCGA-28-5220.7	15	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0071542709217346382000000
TCGA-02-2486.9	141	2_RECEPTOR_ACTIVITY	499	22	0.0071553575904707671000000
TCGA-02-0054.3	93	1_KEGG_LONG_TERM_POTENTIATION	68	7	0.0071644567549591113000000
TCGA-06-0139.1	179	2_EXTRACELLULAR_MATRIX	85	10	0.0071741621305347674000000
TCGA-27-1836.8	49	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0071779446403170298000000
TCGA-06-2570.8	95	2_M_PHASE	94	8	0.0071817291019810239000000
TCGA-02-0075.8	128	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0071900957439840129000000
TCGA-06-0750.4	2	1_KEGG_PROTEIN_EXPORT	20	2	0.0071950944827481704000000
TCGA-76-6191.6	96	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0072102532769370989000000
TCGA-41-2575.49	136	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0072104979051582684000000
TCGA-27-1838.17	131	1_KEGG_DNA_REPLICATION	32	6	0.0072165072338677650000000
TCGA-87-5896.6	131	0_HALLMARK_ANGIOGENESIS	32	6	0.0072165072338677650000000
TCGA-32-2498.13	133	0_HALLMARK_E2F_TARGETS	169	12	0.0072210407019714529000000
TCGA-06-0122.8	90	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	10	0.0072387997188864068000000
TCGA-06-0176.8	95	2_REGULATION_OF_CELL_CYCLE	160	10	0.0072639129841149111000000
TCGA-14-0790.9	104	2_CELL_CYCLE_PHASE	146	10	0.0072796345459139843000000
TCGA-32-5222.9	70	2_SYSTEM_PROCESS	451	14	0.0072824451882001042000000
TCGA-06-2564.7	92	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0073338906012192914000000
TCGA-06-0185.13	71	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0073375545082903894000000
TCGA-08-0347.7	25	2_EXTRACELLULAR_REGION_PART	269	7	0.0073414542108466933000000
TCGA-16-1045.10	81	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0073668519685313096000000
TCGA-02-0009.6	188	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	6	0.0073764076179759558000000
TCGA-28-2509.6	59	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	14	0.0073871615825506186000000
TCGA-08-0389.4	56	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0074165048240072062000000
TCGA-02-0080.3	20	0_HALLMARK_UV_RESPONSE_DN	122	5	0.0074188184080439682000000
TCGA-06-2558.6	74	0_HALLMARK_ANGIOGENESIS	32	5	0.0074192440849760169000000
TCGA-06-2558.6	74	1_KEGG_DNA_REPLICATION	32	5	0.0074192440849760169000000
TCGA-06-0648.6	17	2_REGULATION_OF_CELL_PROLIFERATION	265	6	0.0074201706117182379000000
TCGA-27-2528.10	99	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0074259927828950511000000
TCGA-76-4928.15	78	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	6	0.0074262745482779344000000
TCGA-76-4928.15	78	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	6	0.0074262745482779344000000
TCGA-06-5412.7	153	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0074379508553660571000000
TCGA-19-2623.11	153	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0074379508553660571000000
TCGA-26-5133.10	75	2_REGULATION_OF_CELL_CYCLE	160	9	0.0074674206175658099000000
TCGA-02-0115.4	3	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0074927539627462954000000
TCGA-06-0143.3	3	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0074927539627462954000000
TCGA-06-0750.9	3	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0074927539627462954000000
TCGA-27-1834.9	3	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0074927539627462954000000
TCGA-06-0882.9	3	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0074927539627462954000000
TCGA-19-2620.6	3	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0074927539627462954000000
TCGA-27-2523.5	3	2_PHOSPHOTRANSFERASE_ACTIVITY_PHOSPHATE_GROUP_AS_ACCEPTOR	12	2	0.0074927539627462954000000
TCGA-06-0208.3	3	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0074927539627462954000000
TCGA-08-0354.7	47	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0075061738918002548000000
TCGA-08-0380.5	47	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0075061738918002548000000
TCGA-28-5219.9	47	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0075061738918002548000000
TCGA-15-1444.3	107	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0075120901501736850000000
TCGA-19-5954.17	208	0_HALLMARK_KRAS_SIGNALING_UP	148	14	0.0075121728253067996000000
TCGA-06-0219.6	6	2_NEGATIVE_REGULATION_OF_METABOLIC_PROCESS	224	4	0.0075137767036245542000000
TCGA-08-0244.4	6	2_NEGATIVE_REGULATION_OF_METABOLIC_PROCESS	224	4	0.0075137767036245542000000
TCGA-14-1829.11	6	2_NEGATIVE_REGULATION_OF_METABOLIC_PROCESS	224	4	0.0075137767036245542000000
TCGA-14-2554.9	6	2_NEGATIVE_REGULATION_OF_METABOLIC_PROCESS	224	4	0.0075137767036245542000000
TCGA-02-0046.8	148	2_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0075255977744844950000000
TCGA-02-0046.8	148	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	22	0.0075255977744844950000000
TCGA-08-0246.6	62	1_KEGG_FOCAL_ADHESION	195	9	0.0075300349659340408000000
TCGA-06-0211.8	62	1_KEGG_FOCAL_ADHESION	195	9	0.0075300349659340408000000
TCGA-06-0169.5	42	0_HALLMARK_HYPOXIA	154	7	0.0075338636662901862000000
TCGA-19-5947.4	267	2_DEFENSE_RESPONSE	222	20	0.0075369082896823729000000
TCGA-02-0089.5	91	1_KEGG_PANCREATIC_CANCER	70	7	0.0075369523533362652000000
TCGA-76-6282.11	185	0_HALLMARK_ALLOGRAFT_REJECTION	190	15	0.0075468928535924818000000
TCGA-06-0877.7	4	2_CELL_PROLIFERATION_GO_0008283	436	4	0.0075640845251909242000000
TCGA-08-0348.3	4	2_CELL_PROLIFERATION_GO_0008283	436	4	0.0075640845251909242000000
TCGA-02-0024.6	206	1_KEGG_DNA_REPLICATION	32	7	0.0075735092173445512000000
TCGA-32-2634.10	118	2_NUCLEAR_PART	466	19	0.0075870914294926366000000
TCGA-06-0686.5	14	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	3	0.0076187551043794526000000
TCGA-26-5134.2	14	2_COLLAGEN	23	3	0.0076187551043794526000000
TCGA-06-0139.1	179	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0076202867759166361000000
TCGA-06-0192.10	126	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0076296635399795767000000
TCGA-02-2485.14	172	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	8	0.0076402961732830168000000
TCGA-06-5415.7	7	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0076428028808501313000000
TCGA-14-0871.20	216	2_CELL_CYCLE_PROCESS	163	15	0.0076459994884958806000000
TCGA-08-0357.4	36	1_KEGG_P53_SIGNALING_PATHWAY	66	5	0.0076868921762575267000000
TCGA-02-0060.19	281	2_HEMOSTASIS	44	9	0.0076930090576564827000000
TCGA-28-5204.3	4	2_CATION_CHANNEL_ACTIVITY	100	3	0.0077191259541365305000000
TCGA-32-4211.14	71	2_EXTRACELLULAR_REGION_PART	269	11	0.0077243034372653950000000
TCGA-02-0052.3	116	2_EXTRACELLULAR_REGION	346	16	0.0077376754833268753000000
TCGA-76-6285.5	106	0_HALLMARK_MYC_TARGETS_V1	178	11	0.0077542097417957626000000
TCGA-02-0086.2	17	2_MITOTIC_CELL_CYCLE_CHECKPOINT	19	3	0.0077850091961085780000000
TCGA-02-0033.5	144	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	7	0.0078006871482933704000000
TCGA-12-0688.10	93	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0078118832063597413000000
TCGA-06-0152.10	19	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	4	0.0078197838095434048000000
TCGA-06-0124.6	55	2_CELL_CELL_SIGNALING	353	11	0.0078244203426148830000000
TCGA-14-0789.10	106	2_COLLAGEN	23	5	0.0078288383727949159000000
TCGA-06-0130.3	155	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0078332117131652695000000
TCGA-06-5412.7	153	0_HALLMARK_KRAS_SIGNALING_UP	148	12	0.0078359896203637220000000
TCGA-08-0389.4	56	2_CELL_CYCLE_PROCESS	163	8	0.0078494604573394449000000
TCGA-06-0195.8	56	2_DNA_BINDING	496	13	0.0078508389496138743000000
TCGA-76-6191.6	96	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0078678130575316352000000
TCGA-08-0353.8	100	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0078741228126796396000000
TCGA-26-5132.7	100	1_KEGG_BLADDER_CANCER	42	6	0.0078741228126796396000000
TCGA-26-5132.7	100	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0078741228126796396000000
TCGA-76-4925.9	83	1_KEGG_THYROID_CANCER	29	5	0.0078793441563003823000000
TCGA-06-6390.9	82	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0079159663397147563000000
TCGA-12-1597.6	51	2_DNA_REPLICATION	82	6	0.0079159663397148569000000
TCGA-41-2571.7	72	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0079297719277020041000000
TCGA-06-0881.7	203	2_INFLAMMATORY_RESPONSE	112	12	0.0079414018228534181000000
TCGA-41-2575.44	7	2_PHOTORECEPTOR_CELL_MAINTENANCE	5	2	0.0079440566444479183000000
TCGA-12-0620.1	2	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0079524728493541291000000
TCGA-06-0133.2	2	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0079524728493541291000000
TCGA-02-0023.1	2	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0079524728493541291000000
TCGA-06-0127.4	2	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0079524728493541291000000
TCGA-08-0355.3	2	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0079524728493541291000000
TCGA-19-2619.14	100	2_EXTRACELLULAR_REGION_PART	269	13	0.0079554502083333551000000
TCGA-02-0052.3	116	2_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0079674112441984624000000
TCGA-02-0052.3	116	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	19	0.0079674112441984624000000
TCGA-12-5299.5	6	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	5	0.0079780434362921697000000
TCGA-14-1823.12	6	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	5	0.0079780434362921697000000
TCGA-19-5955.9	110	2_IMMUNE_SYSTEM_PROCESS	283	14	0.0079793875403007704000000
TCGA-06-0139.1	179	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	86	10	0.0079865332466466793000000
TCGA-06-0139.1	179	2_LOCOMOTORY_BEHAVIOR	86	10	0.0079865332466466793000000
TCGA-06-5413.11	142	2_EXTRACELLULAR_MATRIX	85	9	0.0080119150338045734000000
TCGA-06-0192.10	126	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	11	0.0080307883393402821000000
TCGA-02-0043.10	184	2_EXTRACELLULAR_SPACE	192	15	0.0080310713977174257000000
TCGA-27-1836.8	49	1_KEGG_PATHWAYS_IN_CANCER	323	10	0.0080447335309931211000000
TCGA-19-1790.18	201	0_HALLMARK_HYPOXIA	154	14	0.0080450487702313292000000
TCGA-06-0686.1	7	2_PLASMA_MEMBRANE_PART	901	6	0.0080526197162500354000000
TCGA-06-0130.3	155	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0080554389020561865000000
TCGA-06-0143.3	3	2_REGULATION_OF_CELL_CYCLE	160	3	0.0080571074849944257000000
TCGA-19-2620.6	3	2_REGULATION_OF_CELL_CYCLE	160	3	0.0080571074849944257000000
TCGA-06-0208.3	3	2_REGULATION_OF_CELL_CYCLE	160	3	0.0080571074849944257000000
TCGA-19-5954.17	208	1_KEGG_DNA_REPLICATION	32	7	0.0080736059771261796000000
TCGA-28-5218.5	208	1_KEGG_DNA_REPLICATION	32	7	0.0080736059771261796000000
TCGA-19-2631.15	84	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0081125013684716606000000
TCGA-08-0354.5	18	2_INTERPHASE	62	4	0.0081157016396813959000000
TCGA-08-0360.3	144	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0081408022736204552000000
TCGA-08-0360.3	144	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	9	0.0081408022736204552000000
TCGA-27-1833.7	17	1_KEGG_P53_SIGNALING_PATHWAY	66	4	0.0081592732620871435000000
TCGA-06-0178.2	17	1_KEGG_P53_SIGNALING_PATHWAY	66	4	0.0081592732620871435000000
TCGA-06-0155.10	74	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0081670464883385023000000
TCGA-06-0128.8	74	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0081670464883385023000000
TCGA-16-1048.13	97	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0081702555566141380000000
TCGA-41-4097.6	48	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	4	0.0081753624907465131000000
TCGA-76-4934.7	47	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0081917370729915426000000
TCGA-19-5960.9	134	2_REGULATION_OF_CELL_PROLIFERATION	265	15	0.0081946943714236130000000
TCGA-16-1048.13	97	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0082006217794408677000000
TCGA-12-0618.5	41	2_REGULATION_OF_CELL_CYCLE	160	7	0.0082029578831965873000000
TCGA-06-2567.9	156	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	7	0.0082070569351734065000000
TCGA-06-0152.11	56	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0082145021283997199000000
TCGA-19-2619.14	100	0_HALLMARK_HYPOXIA	154	10	0.0082268493989360644000000
TCGA-19-5960.9	134	1_KEGG_DNA_REPLICATION	32	6	0.0082295915140679615000000
TCGA-19-2625.9	146	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0082480687939355899000000
TCGA-19-2625.9	146	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0082480687939355899000000
TCGA-27-2521.10	94	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0082529524903975846000000
TCGA-28-5220.7	15	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0082759960815100321000000
TCGA-32-1986.8	87	2_POLYSACCHARIDE_BINDING	28	5	0.0082881383041541312000000
TCGA-06-5412.7	153	2_RECEPTOR_ACTIVITY	499	23	0.0082949684558209519000000
TCGA-02-0001.5	117	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	12	0.0082967523573289174000000
TCGA-28-1753.13	174	1_KEGG_LEISHMANIA_INFECTION	70	9	0.0082995822540614002000000
TCGA-26-5136.6	160	2_NEURON_PROJECTION	16	5	0.0083068014340530634000000
TCGA-41-2572.8	76	2_EXTRACELLULAR_MATRIX	85	7	0.0083124269309579873000000
TCGA-27-2521.10	94	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0083149285603055928000000
TCGA-06-0145.19	81	1_KEGG_ASTHMA	30	5	0.0083232937350913288000000
TCGA-41-3393.5	88	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	6	0.0083293814197913790000000
TCGA-06-0649.13	88	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	6	0.0083293814197913790000000
TCGA-12-3649.15	89	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0083325598453574783000000
TCGA-14-4157.7	101	1_KEGG_BLADDER_CANCER	42	6	0.0083440220128860407000000
TCGA-12-3650.17	101	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0083440220128860407000000
TCGA-06-2559.11	101	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0083440220128860407000000
TCGA-19-4068.7	14	2_DNA_REPLICATION	82	4	0.0083461678231836010000000
TCGA-32-1979.10	116	2_EXTRACELLULAR_REGION_PART	269	14	0.0083470292374649199000000
TCGA-06-0184.11	108	0_HALLMARK_COMPLEMENT	176	11	0.0083526767616148006000000
TCGA-76-6193.13	271	2_EXTRACELLULAR_MATRIX	85	12	0.0083716854804114522000000
TCGA-08-0345.2	77	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0083844523645019223000000
TCGA-06-0139.1	179	2_PLASMA_MEMBRANE	1096	42	0.0084336914977232048000000
TCGA-02-0060.19	281	2_AXON	10	5	0.0084637738256851114000000
TCGA-06-0154.13	76	0_HALLMARK_ANGIOGENESIS	32	5	0.0084684329921983163000000
TCGA-02-0075.8	128	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0084721258161701198000000
TCGA-06-0649.13	88	0_HALLMARK_COMPLEMENT	176	10	0.0084745453112666479000000
TCGA-12-3649.15	89	0_HALLMARK_G2M_CHECKPOINT	174	10	0.0084842322736516720000000
TCGA-02-0024.6	206	0_HALLMARK_P53_PATHWAY	151	14	0.0085002666574023871000000
TCGA-02-0115.4	3	2_CELL_CYCLE_PROCESS	163	3	0.0085218416179170982000000
TCGA-06-0750.9	3	2_CELL_CYCLE_PROCESS	163	3	0.0085218416179170982000000
TCGA-27-1834.9	3	2_CELL_CYCLE_PROCESS	163	3	0.0085218416179170982000000
TCGA-06-0882.9	3	2_CELL_CYCLE_PROCESS	163	3	0.0085218416179170982000000
TCGA-76-6191.6	96	2_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0085295073156021386000000
TCGA-76-6191.6	96	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0085295073156021386000000
TCGA-19-1390.12	10	2_ION_CHANNEL_ACTIVITY	121	4	0.0085602155677569208000000
TCGA-19-5952.11	193	2_COLLAGEN	23	6	0.0085855168857268266000000
TCGA-06-0743.14	63	1_KEGG_FOCAL_ADHESION	195	9	0.0086300800959227784000000
TCGA-02-2485.14	172	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0086398731478270277000000
TCGA-02-2485.14	172	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0086398731478270277000000
TCGA-76-6282.11	185	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0086423283480129183000000
TCGA-76-6285.5	106	2_CELL_CYCLE_PHASE	146	10	0.0086533590408670695000000
TCGA-06-5411.4	23	2_CELL_PROLIFERATION_GO_0008283	436	8	0.0086625998389592770000000
TCGA-28-2501.3	51	2_CONTRACTILE_FIBER	22	4	0.0086662317487616984000000
TCGA-32-2638.17	159	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0086703264710030481000000
TCGA-28-5218.5	208	2_CALCIUM_ION_BINDING	75	10	0.0086705248713155342000000
TCGA-28-5204.3	4	2_GATED_CHANNEL_ACTIVITY	104	3	0.0086903757698100284000000
TCGA-06-2570.8	95	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0086952532490252813000000
TCGA-06-0176.8	95	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0086952532490252813000000
TCGA-32-5222.9	70	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0086984060238111706000000
TCGA-27-1836.8	49	2_NUCLEUS	1110	18	0.0087057955408567332000000
TCGA-06-0122.8	90	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0087134408416410306000000
TCGA-06-2565.10	38	0_HALLMARK_MITOTIC_SPINDLE	175	7	0.0087153803095331196000000
TCGA-02-0054.3	93	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	7	0.0087189595222544707000000
TCGA-19-5954.17	208	2_REGULATION_OF_PHOSPHORYLATION	45	8	0.0087236125951008475000000
TCGA-02-0003.9	227	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	10	0.0087344799760633637000000
TCGA-28-5220.7	15	0_HALLMARK_G2M_CHECKPOINT	174	5	0.0087420814262025495000000
TCGA-12-0620.1	2	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0087477201342904508000000
TCGA-12-0620.3	2	2_PHOSPHOINOSITIDE_METABOLIC_PROCESS	22	2	0.0087477201342904508000000
TCGA-12-0620.2	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-06-0644.1	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-26-1439.2	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-19-2629.3	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-28-2502.1	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-16-1045.2	2	2_PHOSPHOINOSITIDE_METABOLIC_PROCESS	22	2	0.0087477201342904508000000
TCGA-76-4928.2	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-06-0169.1	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-06-0877.5	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-27-2524.3	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-08-0380.1	2	2_PHOSPHOINOSITIDE_METABOLIC_PROCESS	22	2	0.0087477201342904508000000
TCGA-02-0009.3	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-06-0133.2	2	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0087477201342904508000000
TCGA-06-0750.3	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-12-0692.1	2	2_PHOSPHOINOSITIDE_METABOLIC_PROCESS	22	2	0.0087477201342904508000000
TCGA-32-1986.6	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-02-0023.2	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-02-0023.1	2	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0087477201342904508000000
TCGA-28-5208.1	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-14-0787.1	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-06-2563.1	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-19-5952.1	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-27-1834.1	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-02-0083.2	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-02-0064.1	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-06-5415.1	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-02-0071.3	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-06-0214.2	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-06-0211.2	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-06-0882.3	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-06-0743.6	2	2_PHOSPHOINOSITIDE_METABOLIC_PROCESS	22	2	0.0087477201342904508000000
TCGA-06-0743.1	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-06-0127.4	2	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0087477201342904508000000
TCGA-06-0127.1	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-08-0355.3	2	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0087477201342904508000000
TCGA-14-2554.2	2	2_MRNA_BINDING	22	2	0.0087477201342904508000000
TCGA-19-1390.13	110	2_NUCLEAR_CHROMOSOME	39	6	0.0087602700760903221000000
TCGA-26-5134.2	14	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	4	0.0087613000918710209000000
TCGA-27-2519.7	113	0_HALLMARK_E2F_TARGETS	169	11	0.0087926361073973145000000
TCGA-08-0347.4	16	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0087926725929789139000000
TCGA-32-2491.14	244	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	9	0.0087956428895505281000000
TCGA-32-2491.14	244	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0087956428895505281000000
TCGA-02-0009.6	188	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0088190778596288280000000
TCGA-06-2563.10	123	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	10	0.0088299348377520823000000
TCGA-06-0156.4	80	1_KEGG_FOCAL_ADHESION	195	10	0.0088347503861285342000000
TCGA-08-0386.4	73	2_CELL_CYCLE_GO_0007049	265	11	0.0088423858465420634000000
TCGA-06-6390.9	82	1_KEGG_ASTHMA	30	5	0.0088441733274838893000000
TCGA-06-2564.7	92	0_HALLMARK_E2F_TARGETS	169	10	0.0088479428915820488000000
TCGA-06-5856.13	152	2_CELL_CYCLE_GO_0007049	265	16	0.0088529145078917876000000
TCGA-02-0115.4	3	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0088544474626462560000000
TCGA-15-0742.12	3	2_REGULATION_OF_ACTION_POTENTIAL	13	2	0.0088544474626462560000000
TCGA-06-0143.3	3	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0088544474626462560000000
TCGA-06-0750.9	3	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0088544474626462560000000
TCGA-27-1834.9	3	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0088544474626462560000000
TCGA-06-0882.9	3	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0088544474626462560000000
TCGA-19-2620.6	3	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0088544474626462560000000
TCGA-06-0208.3	3	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0088544474626462560000000
TCGA-02-0024.6	206	2_KINESIN_COMPLEX	13	5	0.0088559937564590026000000
TCGA-06-0139.1	179	1_KEGG_HEMATOPOIETIC_CELL_LINEAGE	87	10	0.0088774780992224092000000
TCGA-26-5136.6	160	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0088895944299730890000000
TCGA-27-2528.10	99	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0088974277321398412000000
TCGA-06-0166.5	35	0_HALLMARK_ANGIOGENESIS	32	4	0.0089098079952415112000000
TCGA-19-5958.4	35	0_HALLMARK_ANGIOGENESIS	32	4	0.0089098079952415112000000
TCGA-08-0357.4	36	2_CELL_CYCLE_GO_0007049	265	8	0.0089125324161032013000000
TCGA-06-0744.10	36	2_CELL_CYCLE_GO_0007049	265	8	0.0089125324161032013000000
TCGA-08-0350.2	46	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	5	0.0089142728339331873000000
TCGA-06-0152.10	19	2_MITOTIC_CELL_CYCLE	134	5	0.0089205888825599575000000
TCGA-06-2564.7	92	1_KEGG_MELANOMA	71	7	0.0089263598583066688000000
TCGA-12-5299.5	6	1_KEGG_GLIOMA	62	3	0.0089699653212804119000000
TCGA-14-1823.12	6	1_KEGG_GLIOMA	62	3	0.0089699653212804119000000
TCGA-27-1838.17	131	2_CELL_CYCLE_PHASE	146	11	0.0090264580370034188000000
TCGA-08-0345.2	77	0_HALLMARK_ANGIOGENESIS	32	5	0.0090349076817780039000000
TCGA-06-0189.3	118	1_KEGG_FOCAL_ADHESION	195	12	0.0090711293610277136000000
TCGA-41-4097.6	48	2_SYSTEM_DEVELOPMENT	694	14	0.0090878949475252380000000
TCGA-76-4929.8	91	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0091070767240048530000000
TCGA-41-4097.6	48	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	5	0.0091071884969651327000000
TCGA-06-0127.2	23	1_KEGG_FOCAL_ADHESION	195	6	0.0091122709883949254000000
TCGA-19-2625.9	146	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0091176095416351383000000
TCGA-06-0137.9	53	2_SYSTEM_PROCESS	451	12	0.0091302442939852537000000
TCGA-06-0125.9	75	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0091441886533667003000000
TCGA-76-4928.15	78	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0091454763422796140000000
TCGA-76-4928.15	78	2_CELL_CELL_SIGNALING	353	13	0.0091552892993127816000000
TCGA-76-6191.6	96	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0091559590630540949000000
TCGA-02-0115.1	36	2_SYSTEM_DEVELOPMENT	694	12	0.0091729754217751997000000
TCGA-02-0071.12	116	2_CELL_PROLIFERATION_GO_0008283	436	18	0.0091785093712186665000000
TCGA-12-5301.1	14	1_KEGG_ECM_RECEPTOR_INTERACTION	84	4	0.0091915399170264013000000
TCGA-06-5417.5	79	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0091941470331722390000000
TCGA-32-2632.16	229	2_DNA_METABOLIC_PROCESS	218	18	0.0092030165387292275000000
TCGA-19-1390.13	110	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0092411603183712113000000
TCGA-06-0122.8	90	2_CELL_CELL_SIGNALING	353	14	0.0092479908924552098000000
TCGA-08-0353.8	100	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0092618372974614671000000
TCGA-19-2619.14	100	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0092618372974614671000000
TCGA-02-2483.10	100	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0092618372974614671000000
TCGA-28-2514.9	62	0_HALLMARK_APOPTOSIS	150	8	0.0092638003752820962000000
TCGA-26-1439.11	10	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0092792822898188909000000
TCGA-02-0115.1	36	2_ORGAN_DEVELOPMENT	460	10	0.0092913324823767265000000
TCGA-28-2509.6	59	2_NON_MEMBRANE_BOUND_ORGANELLE	476	13	0.0092948492853432048000000
TCGA-28-2509.6	59	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	13	0.0092948492853432048000000
TCGA-06-0650.2	82	0_HALLMARK_APOPTOSIS	150	9	0.0093034927303562911000000
TCGA-06-0650.2	82	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	9	0.0093034927303562911000000
TCGA-06-2558.6	74	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0093137468498041137000000
TCGA-27-1830.7	57	2_EXTRACELLULAR_REGION	346	11	0.0093164224376065183000000
TCGA-28-5218.5	208	2_CYTOSKELETAL_PART	194	16	0.0093262298491462847000000
TCGA-06-0178.2	17	2_CELL_PROLIFERATION_GO_0008283	436	7	0.0093324412426659849000000
TCGA-06-0648.6	17	2_CELL_PROLIFERATION_GO_0008283	436	7	0.0093324412426659849000000
TCGA-28-5216.8	162	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0093404605566380534000000
TCGA-06-0145.19	81	2_SYNAPTIC_TRANSMISSION	152	9	0.0093585024537628826000000
TCGA-19-2624.29	130	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0093907505120831604000000
TCGA-19-5955.9	110	2_COLLAGEN	23	5	0.0093948489574754539000000
TCGA-06-2569.5	144	2_DNA_METABOLIC_PROCESS	218	14	0.0093965132429991161000000
TCGA-06-0219.6	6	2_KINASE_BINDING	63	3	0.0094162107706102678000000
TCGA-08-0244.4	6	2_KINASE_BINDING	63	3	0.0094162107706102678000000
TCGA-12-5299.5	6	2_KINASE_BINDING	63	3	0.0094162107706102678000000
TCGA-14-1823.12	6	2_KINASE_BINDING	63	3	0.0094162107706102678000000
TCGA-14-1829.11	6	2_KINASE_BINDING	63	3	0.0094162107706102678000000
TCGA-14-2554.9	6	2_KINASE_BINDING	63	3	0.0094162107706102678000000
TCGA-32-2632.16	229	2_REGULATION_OF_APOPTOSIS	309	22	0.0094330849005256415000000
TCGA-02-0099.11	141	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0094356576622242581000000
TCGA-19-1390.13	110	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0094618236810910215000000
TCGA-32-2632.16	229	2_CELL_DEVELOPMENT	511	30	0.0094710528510178107000000
TCGA-32-1979.4	12	2_NEGATIVE_REGULATION_OF_GROWTH	29	3	0.0094901065475660705000000
TCGA-28-5218.5	208	0_HALLMARK_P53_PATHWAY	151	14	0.0095103156825723737000000
TCGA-06-2564.7	92	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0095137404866459437000000
TCGA-32-2498.13	133	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	50	7	0.0095348843934858173000000
TCGA-76-4925.9	83	1_KEGG_ENDOMETRIAL_CANCER	52	6	0.0095393846367414978000000
TCGA-02-0011.1	288	2_AXON	10	5	0.0095499933694856397000000
TCGA-32-2634.10	118	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0095676196102444933000000
TCGA-19-5958.4	35	1_KEGG_MELANOMA	71	5	0.0095677075194255425000000
TCGA-26-5139.10	163	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0095721578168251956000000
TCGA-14-4157.7	101	2_CHROMATIN	25	5	0.0095752983258878474000000
TCGA-02-2485.14	172	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	9	0.0095763483582631606000000
TCGA-27-1833.5	2	2_REGULATION_OF_HEART_CONTRACTION	23	2	0.0095808363375570280000000
TCGA-02-0115.3	2	2_REGULATION_OF_HEART_CONTRACTION	23	2	0.0095808363375570280000000
TCGA-27-2524.7	2	2_REGULATION_OF_HEART_CONTRACTION	23	2	0.0095808363375570280000000
TCGA-12-3653.7	2	2_REGULATION_OF_HEART_CONTRACTION	23	2	0.0095808363375570280000000
TCGA-28-5207.12	188	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	123	12	0.0096046457138111892000000
TCGA-02-0048.9	84	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0096172220664347829000000
TCGA-28-2509.6	59	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0096254530909664800000000
TCGA-28-2514.9	62	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0096261103544653115000000
TCGA-12-3650.17	101	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0096371957555366362000000
TCGA-26-5134.2	14	2_EXTRACELLULAR_MATRIX	85	4	0.0096372380718436016000000
TCGA-19-2623.11	153	2_CELL_CYCLE_GO_0007049	265	16	0.0096414806456089821000000
TCGA-06-0130.3	155	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	20	0.0096419946554536333000000
TCGA-06-2559.11	101	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0096574377379735569000000
TCGA-27-1833.2	41	2_TRANSMISSION_OF_NERVE_IMPULSE	164	7	0.0096593645273012844000000
TCGA-41-5651.5	112	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0096595309034312651000000
TCGA-12-0692.6	11	1_KEGG_DNA_REPLICATION	32	3	0.0096630403283965785000000
TCGA-08-0350.2	46	2_CELL_CELL_SIGNALING	353	10	0.0096685105126759034000000
TCGA-12-5301.7	46	2_CELL_CELL_SIGNALING	353	10	0.0096685105126759034000000
TCGA-06-0645.9	136	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	299	16	0.0097095973019493166000000
TCGA-14-0786.4	62	2_SIGNAL_TRANSDUCTION	1442	24	0.0097096029895490880000000
TCGA-02-0024.6	206	2_M_PHASE	94	11	0.0097147276481301531000000
TCGA-06-0145.4	7	2_CYTOSKELETAL_PART	194	4	0.0097148706133272922000000
TCGA-19-1390.12	10	2_SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY	125	4	0.0097453076076368210000000
TCGA-19-5951.10	138	1_KEGG_DNA_REPLICATION	32	6	0.0097576494113625813000000
TCGA-76-4927.8	93	0_HALLMARK_E2F_TARGETS	169	10	0.0097627125999757026000000
TCGA-27-1837.5	85	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0097663667823339097000000
TCGA-02-0011.1	288	2_CELL_CYCLE_GO_0007049	265	23	0.0097807961634290130000000
TCGA-02-0021.4	170	2_REGULATION_OF_CELL_CYCLE	160	13	0.0097850300135169654000000
TCGA-02-0001.5	117	2_CATION_BINDING	165	11	0.0097998238291811725000000
TCGA-06-6391.9	26	2_EXTRACELLULAR_REGION_PART	269	7	0.0098036487679113715000000
TCGA-14-0789.11	3	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0098477428562370722000000
TCGA-26-1439.7	3	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0098477428562370722000000
TCGA-19-5959.2	3	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0098477428562370722000000
TCGA-19-2623.13	3	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0098477428562370722000000
TCGA-32-2494.8	3	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0098477428562370722000000
TCGA-06-5410.3	3	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0098477428562370722000000
TCGA-06-1804.4	3	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0098477428562370722000000
TCGA-14-1825.5	3	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0098477428562370722000000
TCGA-06-0649.14	3	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0098477428562370722000000
TCGA-02-0033.5	144	2_SIGNAL_TRANSDUCTION	1442	43	0.0098745452465089697000000
TCGA-27-1838.17	131	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0098802913148401377000000
TCGA-87-5896.6	131	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0098802913148401377000000
TCGA-02-0009.6	188	2_SYSTEM_DEVELOPMENT	694	32	0.0098932400936978925000000
TCGA-28-5216.8	162	0_HALLMARK_ESTROGEN_RESPONSE_LATE	143	12	0.0099163520365787555000000
TCGA-28-5220.7	15	1_KEGG_PATHWAYS_IN_CANCER	323	6	0.0099309175049431785000000
TCGA-12-0688.10	93	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0099337076403622233000000
TCGA-32-2632.16	229	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	22	0.0099375127850643563000000
TCGA-08-0350.2	46	2_CELL_CYCLE_PHASE	146	7	0.0099533518103560835000000
TCGA-12-0692.6	11	2_NON_MEMBRANE_BOUND_ORGANELLE	476	6	0.0099669365764700601000000
TCGA-12-0692.6	11	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	6	0.0099669365764700601000000
TCGA-02-0014.10	70	2_INTERPHASE	62	6	0.0099686179571164754000000
TCGA-28-5207.12	188	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	10	0.0099739608869460015000000
TCGA-06-0156.4	80	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0100049344612411910000000
TCGA-08-0350.2	46	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0100505763044780440000000
TCGA-19-5954.17	208	2_DNA_METABOLIC_PROCESS	218	17	0.0100537313624524910000000
TCGA-19-2625.9	146	2_EXTRACELLULAR_MATRIX	85	9	0.0100646199401350330000000
TCGA-14-0817.9	85	2_CELL_CYCLE_PHASE	146	9	0.0100646199401350340000000
TCGA-02-0014.10	70	2_MITOTIC_CELL_CYCLE	134	8	0.0101164814957373660000000
TCGA-14-1825.8	80	2_MICROTUBULE_CYTOSKELETON	117	8	0.0101344471809773260000000
TCGA-27-2519.7	113	2_IMMUNE_RESPONSE	206	12	0.0101407506303058830000000
TCGA-12-3650.17	101	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0101616418288940480000000
TCGA-08-0347.4	16	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0101704766235597020000000
TCGA-28-6450.11	139	1_KEGG_DNA_REPLICATION	32	6	0.0101736429274410040000000
TCGA-02-0060.19	281	1_KEGG_LEISHMANIA_INFECTION	70	11	0.0101794681003488570000000
TCGA-06-5415.3	8	2_INTEGRAL_TO_PLASMA_MEMBRANE	751	6	0.0101873100976081770000000
TCGA-06-0221.4	8	2_INTEGRAL_TO_PLASMA_MEMBRANE	751	6	0.0101873100976081770000000
TCGA-06-5418.4	24	2_NEUROLOGICAL_SYSTEM_PROCESS	296	7	0.0102049239410744090000000
TCGA-06-0129.11	110	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0102092613498143500000000
TCGA-06-0168.3	4	2_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY	10	2	0.0102130652672037990000000
TCGA-32-2632.1	4	2_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY	10	2	0.0102130652672037990000000
TCGA-32-2491.13	4	2_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY	10	2	0.0102130652672037990000000
TCGA-06-0154.13	76	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0102199162287495180000000
TCGA-14-0786.4	62	2_SYNAPTIC_TRANSMISSION	152	8	0.0102203728598241650000000
TCGA-08-0246.6	62	2_SYNAPTIC_TRANSMISSION	152	8	0.0102203728598241650000000
TCGA-06-0152.10	19	2_INTERPHASE	62	4	0.0102294663847523940000000
TCGA-12-3653.55	255	2_CELL_PROLIFERATION_GO_0008283	436	29	0.0102391470517260960000000
TCGA-08-0347.4	16	2_NON_MEMBRANE_BOUND_ORGANELLE	476	7	0.0102483534745600130000000
TCGA-08-0347.4	16	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	7	0.0102483534745600130000000
TCGA-06-5856.13	152	2_CELL_PROLIFERATION_GO_0008283	436	21	0.0102881641667085730000000
TCGA-06-0744.10	36	1_KEGG_PANCREATIC_CANCER	70	5	0.0102966049453401990000000
TCGA-14-0781.7	155	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	12	0.0103067102966555340000000
TCGA-06-0124.6	55	0_HALLMARK_UV_RESPONSE_DN	122	7	0.0103341585408147730000000
TCGA-02-0086.2	17	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0103344018098571330000000
TCGA-32-1986.12	17	1_KEGG_LEISHMANIA_INFECTION	70	4	0.0103344018098571330000000
TCGA-32-1986.12	17	1_KEGG_VIRAL_MYOCARDITIS	70	4	0.0103344018098571330000000
TCGA-06-0648.6	17	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0103344018098571330000000
TCGA-12-0616.4	7	2_NON_MEMBRANE_BOUND_ORGANELLE	476	5	0.0103727800439277800000000
TCGA-12-0616.4	7	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	5	0.0103727800439277800000000
TCGA-26-5136.6	160	2_CHROMOSOMAL_PART	78	9	0.0103830373013022310000000
TCGA-06-0157.7	89	0_HALLMARK_MYC_TARGETS_V1	178	10	0.0103899386078080270000000
TCGA-12-5299.5	6	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	4	0.0103940670992407800000000
TCGA-08-0354.5	18	1_KEGG_P53_SIGNALING_PATHWAY	66	4	0.0104354938722547760000000
TCGA-06-0213.9	74	0_HALLMARK_E2F_TARGETS	169	9	0.0104427207476537900000000
TCGA-08-0244.5	39	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	7	0.0104573513756062770000000
TCGA-27-1834.10	39	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	7	0.0104573513756062770000000
TCGA-02-0011.1	288	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	15	0.0104866679176576440000000
TCGA-06-0173.35	120	2_CELL_CYCLE_GO_0007049	265	14	0.0104925170110445920000000
TCGA-19-5960.9	134	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	11	0.0105200572131891840000000
TCGA-02-2483.10	100	1_KEGG_FOCAL_ADHESION	195	11	0.0105351286966172650000000
TCGA-26-5132.7	100	1_KEGG_FOCAL_ADHESION	195	11	0.0105351286966172650000000
TCGA-02-0074.5	118	2_MITOTIC_CELL_CYCLE	134	10	0.0105620164265343240000000
TCGA-27-2528.10	99	2_REGULATION_OF_CELL_CYCLE	160	10	0.0105678769396133280000000
TCGA-26-5136.6	160	2_PROTEIN_HOMODIMERIZATION_ACTIVITY	99	10	0.0105678769396133460000000
TCGA-41-5651.5	112	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0105720685404434840000000
TCGA-28-5215.7	192	2_CATION_BINDING	165	14	0.0105876938491645270000000
TCGA-14-0813.5	5	2_GABA_RECEPTOR_ACTIVITY	8	2	0.0105898322740181450000000
TCGA-28-1753.13	174	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0105902915458147680000000
TCGA-28-1753.13	174	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0105902915458147680000000
TCGA-32-1970.14	94	2_NUCLEUS	1110	27	0.0105932259035110900000000
TCGA-02-0099.11	141	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0106007808136843240000000
TCGA-06-1804.6	30	2_NUCLEAR_CHROMOSOME	39	4	0.0106285222911852390000000
TCGA-02-0011.1	288	2_DNA_REPLICATION	82	12	0.0106480358681166500000000
TCGA-27-1833.7	17	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0106615582506913820000000
TCGA-02-0086.2	17	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0106615582506913820000000
TCGA-06-0648.6	17	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0106615582506913820000000
TCGA-14-0813.10	53	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0106821919930231660000000
TCGA-02-0060.19	281	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	12	0.0107007362841338560000000
TCGA-06-5858.19	205	2_MITOTIC_CELL_CYCLE	134	13	0.0107491244941758360000000
TCGA-06-2557.11	177	1_KEGG_MELANOMA	71	9	0.0107571205508150850000000
TCGA-28-5218.5	208	0_HALLMARK_G2M_CHECKPOINT	174	15	0.0107751240568154640000000
TCGA-32-2632.16	229	2_CELL_CYCLE_GO_0007049	265	20	0.0107804732565718290000000
TCGA-26-5135.9	71	1_KEGG_GLIOMA	62	6	0.0108335077467000530000000
TCGA-08-0246.6	62	1_KEGG_MELANOMA	71	6	0.0108335077467000530000000
TCGA-06-5415.3	8	2_INTRINSIC_TO_PLASMA_MEMBRANE	759	6	0.0108414328219537390000000
TCGA-06-0221.4	8	2_INTRINSIC_TO_PLASMA_MEMBRANE	759	6	0.0108414328219537390000000
TCGA-12-5299.5	6	1_KEGG_P53_SIGNALING_PATHWAY	66	3	0.0108427549916041160000000
TCGA-14-1823.12	6	1_KEGG_P53_SIGNALING_PATHWAY	66	3	0.0108427549916041160000000
TCGA-28-5220.7	15	2_POSITIVE_REGULATION_OF_PHOSPHORYLATION	24	3	0.0108562957661053060000000
TCGA-12-5299.5	6	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	5	0.0108654540117802180000000
TCGA-14-1823.12	6	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	5	0.0108654540117802180000000
TCGA-02-0027.3	81	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0108743503891396870000000
TCGA-16-1045.10	81	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0108743503891396870000000
TCGA-02-0107.3	71	2_ORGAN_DEVELOPMENT	460	14	0.0109071138993987510000000
TCGA-28-5204.5	5	1_KEGG_SMALL_CELL_LUNG_CANCER	83	3	0.0109105716366615940000000
TCGA-06-0126.7	5	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	3	0.0109105716366615940000000
TCGA-26-5136.6	160	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0109452057422240270000000
TCGA-28-5207.12	188	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0109592933098945810000000
TCGA-06-0192.10	126	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	10	0.0109641093616896880000000
TCGA-06-0169.5	42	2_RESPONSE_TO_WOUNDING	163	7	0.0109716702829699630000000
TCGA-02-0115.1	36	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	13	0.0109906336181896240000000
TCGA-06-2567.9	156	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	12	0.0110147887576338730000000
TCGA-14-0789.10	106	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	10	0.0110189024521298880000000
TCGA-14-4157.7	101	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	44	6	0.0110360654423391140000000
TCGA-06-0744.10	36	1_KEGG_MELANOMA	71	5	0.0110463280119942020000000
TCGA-06-0876.9	106	1_KEGG_BLADDER_CANCER	42	6	0.0110487755575225230000000
TCGA-02-0099.11	141	0_HALLMARK_ANGIOGENESIS	32	6	0.0110489547300975590000000
TCGA-32-4210.14	109	1_KEGG_GLIOMA	62	7	0.0110500668345317640000000
TCGA-32-4210.14	109	2_INTERPHASE	62	7	0.0110500668345317640000000
TCGA-06-2570.8	95	2_MITOSIS	71	7	0.0110601615958817280000000
TCGA-06-2570.8	95	2_PROTEIN_HETERODIMERIZATION_ACTIVITY	71	7	0.0110601615958817280000000
TCGA-06-5417.5	79	1_KEGG_ACUTE_MYELOID_LEUKEMIA	56	6	0.0110946659215119940000000
TCGA-06-5413.11	142	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0111079106938184510000000
TCGA-41-2573.4	31	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	5	0.0111192781731287470000000
TCGA-02-2485.14	172	2_REGULATION_OF_CELL_CYCLE	160	13	0.0111264002227892920000000
TCGA-14-0787.7	14	2_TRANSMEMBRANE_RECEPTOR_ACTIVITY	358	6	0.0111303495343254830000000
TCGA-12-0692.7	23	2_SYSTEM_PROCESS	451	8	0.0111322792769760520000000
TCGA-06-0216.6	67	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0111369122484125710000000
TCGA-06-0129.11	110	0_HALLMARK_MYC_TARGETS_V1	178	11	0.0111414168151066270000000
TCGA-41-2575.49	136	2_MICROTUBULE_CYTOSKELETON	117	10	0.0111709990343902030000000
TCGA-02-2483.10	100	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0111938992689870980000000
TCGA-19-5960.9	134	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	12	0.0111988488229478410000000
TCGA-02-0114.20	132	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	8	0.0112036380101955270000000
TCGA-28-5216.8	162	2_EPIDERMIS_DEVELOPMENT	59	8	0.0112058367434247800000000
TCGA-19-1790.18	201	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0112153819435333750000000
TCGA-41-3393.5	88	2_EXTRACELLULAR_REGION_PART	269	12	0.0112231732931209580000000
TCGA-19-2629.15	146	2_MITOTIC_CELL_CYCLE	134	11	0.0112412934397642000000000
TCGA-26-5139.10	163	0_HALLMARK_E2F_TARGETS	169	13	0.0112504332465372650000000
TCGA-76-6191.6	96	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0112762220651054030000000
TCGA-06-0881.7	203	2_CELL_CELL_SIGNALING	353	22	0.0112843261435381670000000
TCGA-06-0750.12	52	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0113015078170798770000000
TCGA-06-5411.4	23	1_KEGG_ENDOMETRIAL_CANCER	52	4	0.0113015078170798770000000
TCGA-02-0021.4	170	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0113156627582956610000000
TCGA-02-0024.6	206	2_MITOTIC_CELL_CYCLE	134	13	0.0113358570624509350000000
TCGA-16-1045.10	81	2_EXTRACELLULAR_REGION	346	13	0.0113362759374781610000000
TCGA-02-0060.19	281	2_WOUND_HEALING	46	9	0.0113474417918608800000000
TCGA-02-0052.3	116	0_HALLMARK_E2F_TARGETS	169	11	0.0113507259063556740000000
TCGA-06-0210.6	103	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0113579676384684100000000
TCGA-02-2470.4	11	2_CELL_CYCLE_GO_0007049	265	5	0.0113668669512342990000000
TCGA-02-2470.4	11	2_REGULATION_OF_CELL_PROLIFERATION	265	5	0.0113668669512342990000000
TCGA-06-0213.9	74	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	6	0.0113786703670147750000000
TCGA-06-0686.1	7	2_INTEGRAL_TO_MEMBRANE	956	6	0.0114389677644259210000000
TCGA-32-2494.10	173	2_REGULATION_OF_CELL_PROLIFERATION	265	17	0.0114497544595600010000000
TCGA-06-0879.9	84	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	6	0.0114548178149316580000000
TCGA-02-0048.9	84	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	6	0.0114548178149316580000000
TCGA-15-0742.13	74	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0114707912746657910000000
TCGA-06-5415.7	7	2_PROTEIN_KINASE_BINDING	56	3	0.0114734277470675060000000
TCGA-06-0211.7	10	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	299	5	0.0114762596630372160000000
TCGA-76-4927.8	93	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	6	0.0114937482901718640000000
TCGA-02-0089.5	91	0_HALLMARK_COMPLEMENT	176	10	0.0114994515886000450000000
TCGA-27-2521.10	94	2_MITOTIC_CELL_CYCLE	134	9	0.0115084260449343520000000
TCGA-06-5413.11	142	1_KEGG_DNA_REPLICATION	32	6	0.0115090275779559310000000
TCGA-19-5947.4	267	0_HALLMARK_HYPOXIA	154	16	0.0115474743146233350000000
TCGA-41-5651.5	112	2_EXTRACELLULAR_MATRIX	85	8	0.0115565078071204700000000
TCGA-19-5952.11	193	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	21	0.0115649504332079360000000
TCGA-06-0184.11	108	0_HALLMARK_KRAS_SIGNALING_UP	148	10	0.0115691781268759590000000
TCGA-19-5952.6	8	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	4	0.0115827217990933740000000
TCGA-02-0009.6	188	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0115964795799838610000000
TCGA-16-1045.10	81	0_HALLMARK_ANGIOGENESIS	32	5	0.0116048766406199270000000
TCGA-28-1747.5	81	1_KEGG_DNA_REPLICATION	32	5	0.0116048766406199270000000
TCGA-06-0648.6	17	2_REGULATION_OF_CELL_CYCLE	160	5	0.0116075524286710540000000
TCGA-02-0060.19	281	2_SYSTEM_DEVELOPMENT	694	42	0.0116295889826141650000000
TCGA-02-0038.3	199	1_KEGG_PYRIMIDINE_METABOLISM	64	9	0.0116394102600277760000000
TCGA-32-1979.4	12	2_REGULATION_OF_CELL_GROWTH	31	3	0.0116576406469521160000000
TCGA-02-0069.13	16	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	3	0.0116839708176868470000000
TCGA-76-6285.5	106	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0116856525399557980000000
TCGA-06-0878.10	115	2_COLLAGEN	23	5	0.0116872121772456680000000
TCGA-02-0015.16	115	2_COLLAGEN	23	5	0.0116872121772456680000000
TCGA-02-2485.14	172	1_KEGG_ACUTE_MYELOID_LEUKEMIA	56	8	0.0116892992252349160000000
TCGA-02-0060.19	281	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	47	0.0116957121316466890000000
TCGA-32-4213.12	5	1_KEGG_GAP_JUNCTION	85	3	0.0117248707198181530000000
TCGA-06-0126.7	5	2_EXTRACELLULAR_MATRIX	85	3	0.0117248707198181530000000
TCGA-19-5947.4	267	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0117300176422175700000000
TCGA-06-0156.4	80	2_EXTRACELLULAR_MATRIX	85	7	0.0117338309969815990000000
TCGA-06-0129.11	110	2_INTERPHASE	62	7	0.0117408397163829180000000
TCGA-28-5208.28	220	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	13	0.0117472078737870470000000
TCGA-16-1048.13	97	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0117522078236000830000000
TCGA-81-5910.12	128	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0117526062266667830000000
TCGA-14-4157.7	101	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0117550142625936350000000
TCGA-12-3650.17	101	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0117550142625936350000000
TCGA-06-2559.11	101	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0117550142625936350000000
TCGA-41-2571.7	72	1_KEGG_GLIOMA	62	6	0.0117583630159406520000000
TCGA-41-2571.7	72	2_INTERPHASE	62	6	0.0117583630159406520000000
TCGA-06-0197.1	57	0_HALLMARK_E2F_TARGETS	169	8	0.0117591548777075010000000
TCGA-12-0616.1	20	2_MITOTIC_CELL_CYCLE	134	5	0.0117591778863900420000000
TCGA-08-0349.1	31	1_KEGG_ECM_RECEPTOR_INTERACTION	84	5	0.0117958531659095260000000
TCGA-12-3653.55	255	2_CHROMOSOMAL_PART	78	11	0.0118468376161047630000000
TCGA-02-2485.14	172	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0118544325462235190000000
TCGA-76-6191.6	96	1_KEGG_MELANOMA	71	7	0.0118593379854811070000000
TCGA-02-0114.20	132	1_KEGG_ENDOMETRIAL_CANCER	52	7	0.0118687898935566010000000
TCGA-28-2513.12	134	0_HALLMARK_COMPLEMENT	176	12	0.0118745009638758690000000
TCGA-08-0354.7	47	2_CELL_CELL_SIGNALING	353	10	0.0118790046673800610000000
TCGA-02-0033.5	144	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	19	0.0118904427249128880000000
TCGA-32-2634.10	118	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0118959053307203920000000
TCGA-02-0083.21	135	1_KEGG_MELANOMA	71	8	0.0119049200221402540000000
TCGA-32-1991.4	7	2_OLIGOSACCHARYL_TRANSFERASE_COMPLEX	6	2	0.0119118795373995240000000
TCGA-12-5299.5	6	2_CELLULAR_RESPONSE_TO_NUTRIENT_LEVELS	7	2	0.0119118795373995240000000
TCGA-26-1439.7	3	2_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX	15	2	0.0119177647316685340000000
TCGA-06-5415.5	3	2_NITROGEN_COMPOUND_BIOSYNTHETIC_PROCESS	15	2	0.0119177647316685340000000
TCGA-06-5858.19	205	0_HALLMARK_MYC_TARGETS_V1	178	15	0.0119232620935520570000000
TCGA-02-0025.5	88	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0119539038494113920000000
TCGA-41-3393.5	88	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	6	0.0119539038494113920000000
TCGA-06-0649.13	88	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	6	0.0119539038494113920000000
TCGA-06-0649.13	88	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0119539038494113920000000
TCGA-76-4935.8	21	2_CELL_CELL_SIGNALING	353	7	0.0119623975858476460000000
TCGA-12-3653.55	255	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	14	0.0119707941232832860000000
TCGA-28-5214.11	124	2_CHROMOSOME	102	9	0.0119750005957489690000000
TCGA-06-0190.8	143	0_HALLMARK_ANGIOGENESIS	32	6	0.0119845590975264940000000
TCGA-02-0099.11	141	2_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0120231359247492760000000
TCGA-02-0099.11	141	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	21	0.0120231359247492760000000
TCGA-28-5204.3	4	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	116	3	0.0120840112724314220000000
TCGA-02-0024.6	206	1_KEGG_PATHWAYS_IN_CANCER	323	21	0.0121433411314324570000000
TCGA-06-2570.8	95	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	7	0.0121516177983755640000000
TCGA-06-0176.8	95	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	7	0.0121516177983755640000000
TCGA-06-5858.19	205	2_COLLAGEN	23	6	0.0121567465853696430000000
TCGA-12-0619.11	123	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0121651096461907230000000
TCGA-06-0686.1	7	2_INTRINSIC_TO_MEMBRANE	966	6	0.0121658197161422340000000
TCGA-08-0360.3	144	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0121829146686858720000000
TCGA-28-5209.15	194	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0121830163527340150000000
TCGA-02-0052.3	116	2_COLLAGEN	23	5	0.0121941677167503770000000
TCGA-02-0071.12	116	2_COLLAGEN	23	5	0.0121941677167503770000000
TCGA-14-3476.17	53	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0122043863550215790000000
TCGA-19-2629.15	146	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0122138609016603110000000
TCGA-06-0188.11	66	2_CELL_CYCLE_PHASE	146	8	0.0122173529174427980000000
TCGA-02-0113.4	9	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	4	0.0122188506942084840000000
TCGA-02-0054.2	9	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	4	0.0122188506942084840000000
TCGA-76-6193.13	271	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0122299063460164100000000
TCGA-27-2521.10	94	2_CHROMOSOME	102	8	0.0122409195186377570000000
TCGA-06-0241.8	53	2_CELL_CYCLE_ARREST_GO_0007050	49	5	0.0122441289549941830000000
TCGA-06-2558.6	74	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	16	0.0122578565584233810000000
TCGA-76-4928.15	78	2_NEURON_PROJECTION	16	4	0.0122629501418323530000000
TCGA-12-0620.1	2	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0123073984573378050000000
TCGA-06-0133.2	2	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0123073984573378050000000
TCGA-02-0023.1	2	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0123073984573378050000000
TCGA-06-0127.4	2	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0123073984573378050000000
TCGA-08-0355.3	2	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0123073984573378050000000
TCGA-02-2483.10	100	2_NUCLEUS	1110	28	0.0123094074703200010000000
TCGA-02-0085.1	45	2_ORGAN_DEVELOPMENT	460	11	0.0123148208458459060000000
TCGA-28-2514.9	62	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0123199372044629890000000
TCGA-32-1991.11	82	0_HALLMARK_ANGIOGENESIS	32	5	0.0123289472080292760000000
TCGA-06-0650.2	82	0_HALLMARK_ANGIOGENESIS	32	5	0.0123289472080292760000000
TCGA-02-0102.8	82	1_KEGG_DNA_REPLICATION	32	5	0.0123289472080292760000000
TCGA-27-1833.7	17	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0123312357829346000000000
TCGA-02-0086.2	17	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0123312357829346000000000
TCGA-06-0648.6	17	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0123312357829346000000000
TCGA-06-0686.10	26	2_CHROMOSOME	102	5	0.0123379553699647750000000
TCGA-06-6389.1	18	2_SYNAPTIC_TRANSMISSION	152	5	0.0123394241540986940000000
TCGA-06-0168.4	22	0_HALLMARK_UV_RESPONSE_DN	122	5	0.0123430596687741990000000
TCGA-14-0790.9	104	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0123459106183262890000000
TCGA-08-0390.3	6	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	3	0.0124057607347347330000000
TCGA-32-1979.4	12	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	5	0.0124736079554504590000000
TCGA-06-0877.7	4	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0124808724916065940000000
TCGA-16-0861.5	4	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0124808724916065940000000
TCGA-06-2561.7	4	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0124808724916065940000000
TCGA-08-0348.3	4	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0124808724916065940000000
TCGA-19-1790.1	4	2_REGULATION_OF_TRANSCRIPTION	494	4	0.0124860038424335470000000
TCGA-02-0007.17	217	2_NERVOUS_SYSTEM_DEVELOPMENT	307	21	0.0124868491854915560000000
TCGA-41-2573.4	31	2_EXTRACELLULAR_MATRIX	85	5	0.0125042844075492230000000
TCGA-06-0877.8	61	2_EXTRACELLULAR_REGION_PART	269	10	0.0125296424509980690000000
TCGA-02-0052.3	116	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0125453214883116460000000
TCGA-06-5417.5	79	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0125827108627064360000000
TCGA-19-5952.11	193	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0125901550476272520000000
TCGA-12-3653.55	255	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	9	0.0125904178331143110000000
TCGA-27-2524.5	75	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	16	0.0126037024844515060000000
TCGA-06-2559.11	101	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0126245021953671520000000
TCGA-06-0645.9	136	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0126586521179066960000000
TCGA-06-0645.9	136	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0126586521179066960000000
TCGA-12-3650.17	101	2_REGULATION_OF_CELL_CYCLE	160	10	0.0126598608578467640000000
TCGA-06-0875.7	78	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0126716373420057890000000
TCGA-06-5856.13	152	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0126750380798038070000000
TCGA-06-5856.13	152	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	9	0.0126750380798038070000000
TCGA-14-1034.7	97	1_KEGG_MELANOMA	71	7	0.0127059590640778080000000
TCGA-06-5411.4	23	2_MICROTUBULE_CYTOSKELETON	117	5	0.0127182160487322760000000
TCGA-12-0616.1	20	1_KEGG_GLIOMA	62	4	0.0127241218300225020000000
TCGA-02-2470.4	11	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0127266115908144220000000
TCGA-28-5207.12	188	1_KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	52	8	0.0127336472293018230000000
TCGA-27-2528.10	99	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0127486245965757820000000
TCGA-16-1045.10	81	2_EXTRACELLULAR_MATRIX	85	7	0.0127511319785767190000000
TCGA-12-3649.15	89	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0127656640435073100000000
TCGA-32-1982.9	89	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0127656640435073100000000
TCGA-02-0069.12	62	2_CELL_CYCLE_GO_0007049	265	10	0.0127668038344390010000000
TCGA-06-0211.8	62	2_CELL_CYCLE_GO_0007049	265	10	0.0127668038344390010000000
TCGA-08-0354.5	18	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0127755861150595350000000
TCGA-28-5214.11	124	2_REGULATION_OF_CELL_CYCLE	160	11	0.0128120521332625410000000
TCGA-26-1439.11	10	2_MITOTIC_CELL_CYCLE	134	4	0.0128527702707583020000000
TCGA-41-3393.4	12	1_KEGG_DNA_REPLICATION	32	3	0.0128544008380830320000000
TCGA-28-5214.11	124	2_CHROMOSOMAL_PART	78	8	0.0128973070385776500000000
TCGA-02-0034.5	6	1_KEGG_LEISHMANIA_INFECTION	70	3	0.0129581408419112330000000
TCGA-02-0034.5	6	1_KEGG_VIRAL_MYOCARDITIS	70	3	0.0129581408419112330000000
TCGA-12-5299.5	6	1_KEGG_PANCREATIC_CANCER	70	3	0.0129581408419112330000000
TCGA-14-1823.12	6	1_KEGG_PANCREATIC_CANCER	70	3	0.0129581408419112330000000
TCGA-14-1823.12	6	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	3	0.0129581408419112330000000
TCGA-19-1790.18	201	2_IMMUNE_RESPONSE	206	16	0.0129854370865293940000000
TCGA-41-3915.10	109	1_KEGG_BLADDER_CANCER	42	6	0.0129871940244149120000000
TCGA-41-3915.10	109	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0129871940244149120000000
TCGA-06-0184.11	108	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	10	0.0130373753185188570000000
TCGA-76-6282.11	185	2_ENZYME_REGULATOR_ACTIVITY	277	18	0.0130542107861009760000000
TCGA-41-2572.8	76	0_HALLMARK_E2F_TARGETS	169	9	0.0130551737697593080000000
TCGA-19-5960.9	134	1_KEGG_ENDOMETRIAL_CANCER	52	7	0.0131083423946202070000000
TCGA-02-0011.1	288	2_NON_MEMBRANE_BOUND_ORGANELLE	476	33	0.0131168651578276560000000
TCGA-02-0011.1	288	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	33	0.0131168651578276560000000
TCGA-32-2634.10	118	2_NUCLEAR_CHROMOSOME	39	6	0.0131567328757690830000000
TCGA-06-0184.11	108	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	15	0.0131630556653888520000000
TCGA-06-2562.7	57	0_HALLMARK_UV_RESPONSE_DN	122	7	0.0131796475260502910000000
TCGA-06-0197.1	57	0_HALLMARK_UV_RESPONSE_DN	122	7	0.0131796475260502910000000
TCGA-08-0354.5	18	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0132129452020004960000000
TCGA-02-0014.10	70	2_REPLICATION_FORK	18	4	0.0132129452020004960000000
TCGA-06-0157.7	89	2_NON_MEMBRANE_BOUND_ORGANELLE	476	16	0.0132134532919343400000000
TCGA-06-0157.7	89	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	16	0.0132134532919343400000000
TCGA-28-5218.5	208	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	6	0.0132161391463665540000000
TCGA-02-0060.19	281	0_HALLMARK_KRAS_SIGNALING_UP	148	16	0.0132230318860317370000000
TCGA-02-2486.9	141	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	8	0.0132289485669529590000000
TCGA-08-0352.2	59	2_EXTRACELLULAR_REGION	346	11	0.0132336952413826380000000
TCGA-14-4157.7	101	1_KEGG_PATHWAYS_IN_CANCER	323	14	0.0132459048257064090000000
TCGA-02-0010.18	184	2_SYNAPTIC_TRANSMISSION	152	13	0.0132459751725166310000000
TCGA-87-5896.6	131	0_HALLMARK_APICAL_JUNCTION	182	12	0.0132484520549962250000000
TCGA-08-0353.8	100	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0132696387906946990000000
TCGA-19-2619.14	100	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0132696387906946990000000
TCGA-02-2483.10	100	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0132696387906946990000000
TCGA-19-5954.6	8	2_ENDOPLASMIC_RETICULUM	177	4	0.0132846019857911500000000
TCGA-06-2567.9	156	1_KEGG_ASTHMA	30	6	0.0133068606537230030000000
TCGA-02-0071.12	116	2_STRUCTURAL_MOLECULE_ACTIVITY	206	12	0.0133286460058815430000000
TCGA-27-2524.5	75	2_EXTRACELLULAR_REGION_PART	269	11	0.0133586640328760520000000
TCGA-06-0221.13	45	2_CHROMOSOME	102	6	0.0133659751929123670000000
TCGA-02-0052.3	116	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	7	0.0133692453589346320000000
TCGA-32-2638.17	159	0_HALLMARK_APOPTOSIS	150	12	0.0134021430785017880000000
TCGA-28-5219.9	47	2_TRANSMEMBRANE_RECEPTOR_ACTIVITY	358	10	0.0134500672244899420000000
TCGA-19-2625.9	146	0_HALLMARK_ANGIOGENESIS	32	6	0.0135078779774455530000000
TCGA-02-0114.20	132	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	7	0.0135172143191406150000000
TCGA-14-0781.7	155	0_HALLMARK_HYPOXIA	154	12	0.0135216342423850590000000
TCGA-12-5299.5	6	1_KEGG_MELANOMA	71	3	0.0135265855205309450000000
TCGA-14-1823.12	6	1_KEGG_MELANOMA	71	3	0.0135265855205309450000000
TCGA-32-2498.13	133	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	11	0.0135622583159006150000000
TCGA-14-0790.9	104	2_GLYCOSAMINOGLYCAN_BINDING	26	5	0.0135717421056793500000000
TCGA-06-0122.8	90	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0136216078585455670000000
TCGA-26-1439.11	10	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	4	0.0136326013403722230000000
TCGA-02-0060.19	281	2_LOCOMOTORY_BEHAVIOR	86	12	0.0137328608362835870000000
TCGA-32-2494.10	173	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0137377757387137370000000
TCGA-06-0142.3	8	2_EXTRACELLULAR_MATRIX_PART	51	3	0.0137606712705851780000000
TCGA-06-0213.9	74	1_KEGG_GLIOMA	62	6	0.0138005467487041130000000
TCGA-06-2558.6	74	1_KEGG_GLIOMA	62	6	0.0138005467487041130000000
TCGA-06-2558.6	74	2_INTERPHASE	62	6	0.0138005467487041130000000
TCGA-12-3650.17	101	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0138062496936144950000000
TCGA-26-5136.6	160	2_CHROMOSOME	102	10	0.0138338691260273280000000
TCGA-19-1390.13	110	2_MICROTUBULE_CYTOSKELETON	117	9	0.0138459323307141250000000
TCGA-02-2486.9	141	2_PLASMA_MEMBRANE	1096	35	0.0138461364205829020000000
TCGA-19-2625.9	146	2_REGULATION_OF_MOLECULAR_FUNCTION	286	16	0.0138695100654243690000000
TCGA-02-0071.12	116	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0138827550754979950000000
TCGA-26-1439.10	84	0_HALLMARK_ANGIOGENESIS	32	5	0.0138830949616285250000000
TCGA-06-0879.9	84	0_HALLMARK_ANGIOGENESIS	32	5	0.0138830949616285250000000
TCGA-06-0143.6	63	2_ENZYME_ACTIVATOR_ACTIVITY	111	7	0.0138908831570620890000000
TCGA-06-0139.1	179	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0138910827196969100000000
TCGA-28-5220.7	15	2_POSITIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	26	3	0.0139192576946834770000000
TCGA-28-5220.7	15	2_REGULATION_OF_PROTEIN_AMINO_ACID_PHOSPHORYLATION	26	3	0.0139192576946834770000000
TCGA-28-5220.7	15	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0139192576946834770000000
TCGA-06-0169.5	42	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	7	0.0139215344429568110000000
TCGA-19-5951.10	138	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0139383595738483920000000
TCGA-76-6193.13	271	2_PROTEOLYSIS	154	16	0.0139470175012972020000000
TCGA-27-2519.7	113	1_KEGG_CELL_CYCLE	114	9	0.0139555370281807240000000
TCGA-14-0786.2	10	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0139685839176205420000000
TCGA-41-2571.7	72	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	8	0.0139757772234321040000000
TCGA-41-2575.49	136	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	8	0.0139757772234321040000000
TCGA-06-2563.10	123	1_KEGG_FOCAL_ADHESION	195	12	0.0139759434409178540000000
TCGA-28-5207.12	188	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	7	0.0139779419124459390000000
TCGA-06-0192.10	126	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0139805028303789620000000
TCGA-27-1831.9	85	2_SYNAPTIC_TRANSMISSION	152	9	0.0139835671129845010000000
TCGA-08-0347.4	16	0_HALLMARK_MYC_TARGETS_V1	178	5	0.0139977545154224020000000
TCGA-27-2519.7	113	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	7	0.0140322221884025060000000
TCGA-27-2518.5	20	0_HALLMARK_GLYCOLYSIS	139	5	0.0140676991826821570000000
TCGA-16-1045.10	81	2_CELL_CELL_SIGNALING	353	13	0.0140839436676646990000000
TCGA-28-5215.7	192	0_HALLMARK_COAGULATION	125	12	0.0140967593671923360000000
TCGA-12-5299.5	6	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	3	0.0141113197215965750000000
TCGA-14-1823.12	6	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	3	0.0141113197215965750000000
TCGA-76-6192.6	43	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	14	0.0141320144287861680000000
TCGA-06-2563.10	123	2_CELL_CYCLE_PROCESS	163	11	0.0141558897707829610000000
TCGA-06-0124.6	55	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0141687557249057970000000
TCGA-06-0187.10	55	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0141687557249057970000000
TCGA-06-0745.4	55	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0141687557249057970000000
TCGA-28-2513.12	134	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0142371440444068310000000
TCGA-32-2634.10	118	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0142421419207483990000000
TCGA-02-0074.5	118	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0142421419207483990000000
TCGA-12-0616.7	45	2_NEUROLOGICAL_SYSTEM_PROCESS	296	9	0.0142906174811477040000000
TCGA-26-5136.6	160	0_HALLMARK_COMPLEMENT	176	13	0.0143053043621782210000000
TCGA-02-0024.6	206	2_SPINDLE	35	7	0.0143135670445891390000000
TCGA-12-0620.3	2	2_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS	28	2	0.0143144511288428170000000
TCGA-16-1045.2	2	2_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS	28	2	0.0143144511288428170000000
TCGA-08-0380.1	2	2_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS	28	2	0.0143144511288428170000000
TCGA-12-0692.1	2	2_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS	28	2	0.0143144511288428170000000
TCGA-06-0132.2	2	2_PROTEIN_SECRETION	28	2	0.0143144511288428170000000
TCGA-06-0743.6	2	2_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS	28	2	0.0143144511288428170000000
TCGA-19-5960.9	134	2_INTRACELLULAR_ORGANELLE_PART	912	30	0.0143570601570135420000000
TCGA-32-2491.14	244	1_KEGG_SMALL_CELL_LUNG_CANCER	83	11	0.0143803028490765240000000
TCGA-19-2624.29	130	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0143803397850755040000000
TCGA-14-0789.10	106	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0143873903956656250000000
TCGA-14-4157.7	101	2_DNA_DEPENDENT_DNA_REPLICATION	46	6	0.0143934392855863730000000
TCGA-32-5222.9	70	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0143947579541317610000000
TCGA-06-0173.35	120	2_COLLAGEN	23	5	0.0143970557082784020000000
TCGA-28-5219.9	47	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	7	0.0144145842686621960000000
TCGA-06-0744.10	36	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	4	0.0144422903345281780000000
TCGA-26-1439.11	10	2_REGULATION_OF_KINASE_ACTIVITY	138	4	0.0144469586254390750000000
TCGA-06-0168.4	22	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	5	0.0144547970566450200000000
TCGA-06-0195.8	56	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	7	0.0144625354779255800000000
TCGA-02-0009.6	188	0_HALLMARK_APOPTOSIS	150	13	0.0144798939383516490000000
TCGA-02-0089.5	91	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0145235431984878180000000
TCGA-19-1390.13	110	1_KEGG_PYRIMIDINE_METABOLISM	64	7	0.0145497932215095520000000
TCGA-27-2523.12	112	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0145502309947192770000000
TCGA-19-1390.13	110	2_CHROMATIN	25	5	0.0145612559931603720000000
TCGA-14-1829.3	8	1_KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	52	3	0.0145973471639897450000000
TCGA-02-0046.8	148	0_HALLMARK_ANGIOGENESIS	32	6	0.0146081184314188920000000
TCGA-12-1597.3	3	1_KEGG_FOCAL_ADHESION	195	3	0.0146351983814863450000000
TCGA-02-0107.3	71	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	19	0.0146379708132280860000000
TCGA-08-0375.6	65	2_SYNAPTIC_TRANSMISSION	152	8	0.0146479204895051930000000
TCGA-06-0219.6	6	2_REGULATION_OF_CELL_PROLIFERATION	265	4	0.0146754065904296600000000
TCGA-08-0244.4	6	2_REGULATION_OF_CELL_PROLIFERATION	265	4	0.0146754065904296600000000
TCGA-12-5299.5	6	2_REGULATION_OF_CELL_PROLIFERATION	265	4	0.0146754065904296600000000
TCGA-14-1829.11	6	2_REGULATION_OF_CELL_PROLIFERATION	265	4	0.0146754065904296600000000
TCGA-14-2554.9	6	2_REGULATION_OF_CELL_PROLIFERATION	265	4	0.0146754065904296600000000
TCGA-14-1825.8	80	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0146854908545549520000000
TCGA-08-0245.4	85	1_KEGG_DNA_REPLICATION	32	5	0.0147155843527695570000000
TCGA-27-1837.5	85	1_KEGG_DNA_REPLICATION	32	5	0.0147155843527695570000000
TCGA-27-1831.9	85	0_HALLMARK_ANGIOGENESIS	32	5	0.0147155843527695570000000
TCGA-08-0359.5	37	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	7	0.0147471189085540500000000
TCGA-02-0099.11	141	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0147497206777054400000000
TCGA-08-0354.5	18	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0147751626096169830000000
TCGA-02-0089.5	91	1_KEGG_ASTHMA	30	5	0.0147764990553585740000000
TCGA-28-2502.9	56	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0147939711572063460000000
TCGA-06-0646.4	63	2_CELL_CYCLE_GO_0007049	265	10	0.0148055180314029720000000
TCGA-08-0347.7	25	2_EXTRACELLULAR_MATRIX_PART	51	4	0.0148086962635740320000000
TCGA-02-0028.9	182	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0148390215789217480000000
TCGA-28-6450.11	139	2_AXON	10	4	0.0148673880982080410000000
TCGA-19-5960.9	134	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	7	0.0149261649656223390000000
TCGA-06-0137.9	53	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0149560262894650520000000
TCGA-19-1790.1	4	2_NEGATIVE_REGULATION_OF_TRANSCRIPTION_FACTOR_ACTIVITY	12	2	0.0149749317560417970000000
TCGA-16-0861.5	4	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0149749317560417970000000
TCGA-06-2561.7	4	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0149749317560417970000000
TCGA-02-0052.3	116	2_EXTRACELLULAR_MATRIX	85	8	0.0149977671130435350000000
TCGA-27-1837.5	85	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0150064303878541800000000
TCGA-27-1837.5	85	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0150064303878541800000000
TCGA-19-2624.29	130	2_DNA_METABOLIC_PROCESS	218	13	0.0150203261979982660000000
TCGA-26-1439.11	10	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0150629747150833660000000
TCGA-19-5950.7	113	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0150738960406858950000000
TCGA-14-4157.7	101	1_KEGG_PANCREATIC_CANCER	70	7	0.0151053338893358430000000
TCGA-06-0152.10	19	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	3	0.0151493277950033280000000
TCGA-12-3650.17	101	2_NUCLEUS	1110	28	0.0151562884655821290000000
TCGA-06-2559.11	101	2_NUCLEUS	1110	28	0.0151562884655821290000000
TCGA-02-0054.3	93	2_CELL_PROJECTION	76	7	0.0151571812051563800000000
TCGA-12-5301.9	11	0_HALLMARK_COAGULATION	125	4	0.0151574135424941920000000
TCGA-41-5651.5	112	1_KEGG_BLADDER_CANCER	42	6	0.0151930930294407340000000
TCGA-06-2562.7	57	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	8	0.0152059351406819490000000
TCGA-32-2632.16	229	2_HEMATOPOIETIN_INTERFERON_CLASSD200_DOMAIN_CYTOKINE_RECEPTOR_ACTIVITY	32	7	0.0152114716097576040000000
TCGA-28-2502.9	56	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	4	0.0152340762295701360000000
TCGA-06-0152.11	56	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0152340762295701360000000
TCGA-19-5954.17	208	2_SPINDLE	35	7	0.0152502081390854300000000
TCGA-06-0154.13	76	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0152513909609012460000000
TCGA-41-2572.8	76	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0152513909609012460000000
TCGA-14-0871.20	216	2_M_PHASE	94	11	0.0152774083668110040000000
TCGA-14-0789.10	106	2_EXTRACELLULAR_REGION_PART	269	13	0.0152887458514075930000000
TCGA-26-1439.11	10	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	4	0.0152968147903862190000000
TCGA-14-0789.11	3	2_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	198	3	0.0153247165765272380000000
TCGA-26-1439.7	3	2_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	198	3	0.0153247165765272380000000
TCGA-32-2494.8	3	2_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	198	3	0.0153247165765272380000000
TCGA-14-1825.5	3	2_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	198	3	0.0153247165765272380000000
TCGA-08-0245.4	85	1_KEGG_FOCAL_ADHESION	195	10	0.0153539903352426440000000
TCGA-19-5955.9	110	0_HALLMARK_APOPTOSIS	150	10	0.0153679998451983250000000
TCGA-12-0620.1	2	2_NEGATIVE_REGULATION_OF_GROWTH	29	2	0.0153747808420905490000000
TCGA-06-0133.2	2	2_NEGATIVE_REGULATION_OF_GROWTH	29	2	0.0153747808420905490000000
TCGA-02-0023.1	2	2_NEGATIVE_REGULATION_OF_GROWTH	29	2	0.0153747808420905490000000
TCGA-06-0127.4	2	2_NEGATIVE_REGULATION_OF_GROWTH	29	2	0.0153747808420905490000000
TCGA-08-0355.3	2	2_NEGATIVE_REGULATION_OF_GROWTH	29	2	0.0153747808420905490000000
TCGA-02-0099.11	141	2_CELL_CYCLE_GO_0007049	265	15	0.0153869192745621250000000
TCGA-76-4931.10	86	2_SYNAPTIC_TRANSMISSION	152	9	0.0154059858395051050000000
TCGA-27-2523.5	3	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_KINASE_ACTIVITY	17	2	0.0154341620000586180000000
TCGA-02-0043.10	184	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0154970967945581830000000
TCGA-02-0010.18	184	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0154970967945581830000000
TCGA-28-2509.5	4	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	3	0.0155061707333225990000000
TCGA-06-0126.3	4	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	3	0.0155061707333225990000000
TCGA-06-5413.11	142	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0155388616320136580000000
TCGA-06-2557.11	177	2_CELL_CYCLE_GO_0007049	265	17	0.0155633250366736670000000
TCGA-41-2571.7	72	2_REGULATION_OF_KINASE_ACTIVITY	138	8	0.0155662312854340550000000
TCGA-06-0189.3	118	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0155788329433229730000000
TCGA-27-1835.6	86	0_HALLMARK_ANGIOGENESIS	32	5	0.0155866651386228900000000
TCGA-28-5207.12	188	1_KEGG_VIRAL_MYOCARDITIS	70	9	0.0155878213138063750000000
TCGA-02-2485.14	172	1_KEGG_BLADDER_CANCER	42	7	0.0156273336127960020000000
TCGA-19-5950.7	113	2_KINASE_BINDING	63	7	0.0156317836106510820000000
TCGA-76-4926.9	66	1_KEGG_MELANOMA	71	6	0.0156380076749006860000000
TCGA-06-0237.4	66	1_KEGG_MELANOMA	71	6	0.0156380076749006860000000
TCGA-19-5960.9	134	2_ORGANELLE_PART	916	30	0.0156609470924296350000000
TCGA-02-0083.21	135	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	7	0.0156751397265389590000000
TCGA-02-0099.11	141	2_AXON	10	4	0.0157353621138483570000000
TCGA-02-0047.8	185	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0158341346502044320000000
TCGA-76-6282.11	185	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0158341346502044320000000
TCGA-06-0241.8	53	2_NON_MEMBRANE_BOUND_ORGANELLE	476	12	0.0158482303093580510000000
TCGA-06-0241.8	53	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	12	0.0158482303093580510000000
TCGA-08-0354.5	18	2_REGULATION_OF_CELL_CYCLE	160	5	0.0158529789340873390000000
TCGA-06-0184.11	108	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0158531940386251210000000
TCGA-06-0197.1	57	0_HALLMARK_COMPLEMENT	176	8	0.0158561293881384940000000
TCGA-32-2615.7	77	2_CELL_PROLIFERATION_GO_0008283	436	14	0.0158615632478320940000000
TCGA-19-5954.6	8	2_OLIGOSACCHARYL_TRANSFERASE_COMPLEX	6	2	0.0158780213275490290000000
TCGA-19-5955.8	6	1_KEGG_ONE_CARBON_POOL_BY_FOLATE	8	2	0.0158780213275490290000000
TCGA-02-0071.9	6	2_PROTEIN_TARGETING_TO_MEMBRANE	8	2	0.0158780213275490290000000
TCGA-19-2620.8	6	2_GABA_RECEPTOR_ACTIVITY	8	2	0.0158780213275490290000000
TCGA-15-1444.3	107	0_HALLMARK_ALLOGRAFT_REJECTION	190	11	0.0158868034979970860000000
TCGA-41-2571.7	72	2_REGULATION_OF_MOLECULAR_FUNCTION	286	11	0.0159444314602157600000000
TCGA-06-5418.4	24	2_SYSTEM_PROCESS	451	8	0.0160068636672056620000000
TCGA-06-0152.11	56	2_GROWTH_FACTOR_ACTIVITY	49	5	0.0161091686650098040000000
TCGA-06-5414.13	102	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0161237073494411610000000
TCGA-02-0014.10	70	2_CHROMOSOME	102	7	0.0161237073494411610000000
TCGA-06-0878.10	115	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0161629211743262900000000
TCGA-02-0015.16	115	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0161629211743262900000000
TCGA-19-1790.18	201	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0161645199981335190000000
TCGA-32-2491.14	244	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	11	0.0161750152656438170000000
TCGA-06-0650.2	82	2_CELL_CELL_SIGNALING	353	13	0.0161815168337561270000000
TCGA-26-1439.11	10	1_KEGG_BLADDER_CANCER	42	3	0.0162126319897864180000000
TCGA-27-1835.6	86	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0162212768641039860000000
TCGA-32-2494.10	173	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0162331460609749160000000
TCGA-32-2494.10	173	1_KEGG_BLADDER_CANCER	42	7	0.0162331460609749160000000
TCGA-41-3392.31	136	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0162405183305037830000000
TCGA-12-0619.11	123	2_COLLAGEN	23	5	0.0162448714696858020000000
TCGA-06-2563.10	123	2_COLLAGEN	23	5	0.0162448714696858020000000
TCGA-08-0245.4	85	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0162525651352391190000000
TCGA-27-1831.9	85	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0162525651352391190000000
TCGA-06-5415.7	7	2_NEGATIVE_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	221	4	0.0163091383022820200000000
TCGA-02-0003.9	227	2_NON_MEMBRANE_BOUND_ORGANELLE	476	28	0.0163240313250915680000000
TCGA-02-0003.9	227	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	28	0.0163240313250915680000000
TCGA-87-5896.6	131	2_DNA_METABOLIC_PROCESS	218	13	0.0163397106020314290000000
TCGA-06-2562.7	57	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0163574207641641840000000
TCGA-06-0171.7	57	2_COLLAGEN	23	4	0.0163574207641641840000000
TCGA-06-0171.7	57	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0163574207641641840000000
TCGA-02-0048.9	84	2_CYTOSKELETON	293	12	0.0163796218213093060000000
TCGA-06-5415.7	7	2_KINASE_BINDING	63	3	0.0163999142432300630000000
TCGA-14-0871.20	216	2_COLLAGEN	23	6	0.0164132973245232280000000
TCGA-06-2562.7	57	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0164192102852993990000000
TCGA-06-0197.1	57	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0164192102852993990000000
TCGA-14-3476.17	53	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	9	0.0164192836805759600000000
TCGA-06-0237.4	66	2_SYNAPTIC_TRANSMISSION	152	8	0.0164434695822824950000000
TCGA-19-5955.9	110	2_DEFENSE_RESPONSE	222	12	0.0164496320412370610000000
TCGA-32-2491.14	244	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	8	0.0164624251828067590000000
TCGA-76-4927.8	93	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	6	0.0164728649761770600000000
TCGA-27-2523.12	112	2_DNA_METABOLIC_PROCESS	218	12	0.0164848927722901460000000
TCGA-28-5216.8	162	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION	30	6	0.0165302214188399810000000
TCGA-02-2485.14	172	2_DNA_METABOLIC_PROCESS	218	15	0.0165400920762469250000000
TCGA-12-0618.5	41	0_HALLMARK_MYC_TARGETS_V1	178	7	0.0165634833392322640000000
TCGA-12-3650.17	101	2_PROTEIN_HETERODIMERIZATION_ACTIVITY	71	7	0.0166119850767925990000000
TCGA-06-2559.11	101	2_PROTEIN_HETERODIMERIZATION_ACTIVITY	71	7	0.0166119850767925990000000
TCGA-19-5952.11	193	0_HALLMARK_KRAS_SIGNALING_UP	148	13	0.0166251943471498360000000
TCGA-06-0152.10	19	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	4	0.0166430211711257950000000
TCGA-06-5411.3	19	1_KEGG_LEISHMANIA_INFECTION	70	4	0.0166430211711257950000000
TCGA-06-5411.3	19	1_KEGG_VIRAL_MYOCARDITIS	70	4	0.0166430211711257950000000
TCGA-32-1991.11	82	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0166443464947431050000000
TCGA-06-0648.6	17	2_NON_MEMBRANE_BOUND_ORGANELLE	476	7	0.0166693479961515130000000
TCGA-06-0648.6	17	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	7	0.0166693479961515130000000
TCGA-41-2575.44	7	2_MICROVILLUS	7	2	0.0166707456218041850000000
TCGA-06-5418.5	13	0_HALLMARK_ANGIOGENESIS	32	3	0.0166722637013269510000000
TCGA-06-0749.1	13	0_HALLMARK_ANGIOGENESIS	32	3	0.0166722637013269510000000
TCGA-27-2521.10	94	2_DNA_METABOLIC_PROCESS	218	11	0.0166743980123802460000000
TCGA-76-6285.5	106	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0166940993470733460000000
TCGA-02-0071.12	116	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0167287484496176640000000
TCGA-76-6285.5	106	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0167337564376920310000000
TCGA-28-5207.12	188	2_SYNAPTIC_TRANSMISSION	152	13	0.0167347209993693180000000
TCGA-26-1439.11	10	1_KEGG_PATHWAYS_IN_CANCER	323	5	0.0167430562680257020000000
TCGA-06-5413.11	142	2_CELL_CYCLE_GO_0007049	265	15	0.0167780339911606100000000
TCGA-12-5295.8	66	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0167936665593672150000000
TCGA-06-0188.11	66	1_KEGG_BLADDER_CANCER	42	5	0.0167936665593672150000000
TCGA-28-5208.28	220	0_HALLMARK_APOPTOSIS	150	14	0.0167972755664642680000000
TCGA-06-5413.11	142	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0168219280058152340000000
TCGA-14-1034.7	97	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	9	0.0168302003268659540000000
TCGA-06-0646.4	63	2_REGULATION_OF_CELL_CYCLE	160	8	0.0168570897728082920000000
TCGA-28-5207.12	188	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0168779179003365440000000
TCGA-02-0009.6	188	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0168779179003365440000000
TCGA-28-5209.15	194	2_EXTRACELLULAR_REGION_PART	269	18	0.0168936228164458350000000
TCGA-28-5214.11	124	2_COLLAGEN	23	5	0.0169004002772633890000000
TCGA-02-0001.5	117	2_KINASE_REGULATOR_ACTIVITY	41	6	0.0169172168233109740000000
TCGA-32-1979.4	12	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0169257268091008470000000
TCGA-06-5856.13	152	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0169503385263376940000000
TCGA-14-4157.7	101	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	12	0.0169507443504863280000000
TCGA-08-0344.1	18	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	3	0.0169711965401612330000000
TCGA-06-0132.1	18	2_COLLAGEN	23	3	0.0169711965401612330000000
TCGA-02-0079.1	5	2_FOCAL_ADHESION_FORMATION	10	2	0.0170121645632280130000000
TCGA-28-5204.5	5	2_NF_KAPPAB_BINDING	10	2	0.0170121645632280130000000
TCGA-32-2634.10	118	2_EXTRACELLULAR_MATRIX	85	8	0.0170199115875969450000000
TCGA-02-0074.5	118	2_EXTRACELLULAR_MATRIX	85	8	0.0170199115875969450000000
TCGA-06-5856.13	152	0_HALLMARK_ANGIOGENESIS	32	6	0.0170272140073565970000000
TCGA-06-5856.13	152	1_KEGG_DNA_REPLICATION	32	6	0.0170272140073565970000000
TCGA-02-0046.8	148	2_CATION_BINDING	165	12	0.0170637009869020130000000
TCGA-02-2483.10	100	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	7	0.0170797835164081850000000
TCGA-32-4210.14	109	2_CONDENSED_CHROMOSOME	26	5	0.0170816558754624190000000
TCGA-32-4210.14	109	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0170816558754624190000000
TCGA-27-1832.11	88	1_KEGG_CELL_CYCLE	114	8	0.0170866731826100730000000
TCGA-08-0347.4	16	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0171001201303383370000000
TCGA-19-1790.1	4	2_REGULATION_OF_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	535	4	0.0171924148287936650000000
TCGA-06-5415.7	7	2_NEGATIVE_REGULATION_OF_METABOLIC_PROCESS	224	4	0.0172058743950531110000000
TCGA-08-0360.3	144	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0172245823789416090000000
TCGA-02-0033.5	144	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	8	0.0172245823789416090000000
TCGA-12-0688.10	93	2_CELL_CYCLE_GO_0007049	265	12	0.0172410973904572990000000
TCGA-14-1825.8	80	2_SPINDLE	35	5	0.0172489904490644510000000
TCGA-02-0058.1	110	2_SYNAPTIC_TRANSMISSION	152	10	0.0172789269501162460000000
TCGA-06-0644.16	142	1_KEGG_MELANOMA	71	8	0.0172921448910258010000000
TCGA-41-2571.7	72	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	8	0.0173070060188168060000000
TCGA-06-0124.6	55	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0173078782183631250000000
TCGA-08-0345.2	77	2_EXTRACELLULAR_REGION_PART	269	11	0.0173267668298989000000000
TCGA-02-0043.10	184	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0173460373825498200000000
TCGA-02-0010.18	184	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0173460373825498200000000
TCGA-26-1439.7	3	2_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY	18	2	0.0173622054991678510000000
TCGA-06-5410.3	3	2_ADENYLATE_CYCLASE_ACTIVATION	18	2	0.0173622054991678510000000
TCGA-32-2495.11	67	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	4	0.0173645895064731270000000
TCGA-06-0145.19	81	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0173785299007921360000000
TCGA-06-5859.9	125	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0174042918840973180000000
TCGA-76-4925.9	83	2_REGULATION_OF_CELL_CYCLE	160	9	0.0174113047375804710000000
TCGA-28-5216.8	162	2_DNA_REPLICATION	82	9	0.0174170729904054960000000
TCGA-06-0744.3	12	2_PLASMA_MEMBRANE	1096	8	0.0174206272083010440000000
TCGA-06-0214.9	62	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0174292241576172770000000
TCGA-06-0221.13	45	1_KEGG_GLIOMA	62	5	0.0174292241576172770000000
TCGA-02-0085.1	45	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	5	0.0174292241576172770000000
TCGA-12-1597.6	51	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0174316255893899420000000
TCGA-08-0360.3	144	0_HALLMARK_INFLAMMATORY_RESPONSE	170	12	0.0174765336258578780000000
TCGA-06-0152.10	19	2_KINASE_INHIBITOR_ACTIVITY	22	3	0.0175190406357734920000000
TCGA-32-2615.7	77	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0175214771358337960000000
TCGA-02-0009.6	188	0_HALLMARK_COMPLEMENT	176	14	0.0175234550766685050000000
TCGA-27-2521.10	94	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0175241138332306660000000
TCGA-76-6282.11	185	2_IMMUNE_SYSTEM_PROCESS	283	18	0.0175400244408230460000000
TCGA-06-0939.7	58	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0175407742976069450000000
TCGA-14-0787.6	40	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	5	0.0175640683866673290000000
TCGA-19-5958.4	35	0_HALLMARK_GLYCOLYSIS	139	6	0.0175737656530403530000000
TCGA-02-0046.8	148	2_CYTOSKELETAL_PART	194	13	0.0175818149098243730000000
TCGA-27-1837.5	85	2_EXTRACELLULAR_MATRIX	85	7	0.0175833779182293650000000
TCGA-12-0620.1	2	2_REGULATION_OF_CELL_GROWTH	31	2	0.0176090470235762200000000
TCGA-08-0356.3	2	1_KEGG_BASE_EXCISION_REPAIR	31	2	0.0176090470235762200000000
TCGA-06-0133.2	2	2_REGULATION_OF_CELL_GROWTH	31	2	0.0176090470235762200000000
TCGA-02-0023.1	2	2_REGULATION_OF_CELL_GROWTH	31	2	0.0176090470235762200000000
TCGA-06-0127.4	2	2_REGULATION_OF_CELL_GROWTH	31	2	0.0176090470235762200000000
TCGA-08-0355.3	2	2_REGULATION_OF_CELL_GROWTH	31	2	0.0176090470235762200000000
TCGA-76-6193.13	271	2_INTERLEUKIN_RECEPTOR_ACTIVITY	19	6	0.0176405244454919950000000
TCGA-19-5960.9	134	2_CHROMOSOME_ORGANIZATION_AND_BIOGENESIS	99	9	0.0176425255493342890000000
TCGA-02-0107.3	71	2_SYSTEM_DEVELOPMENT	694	17	0.0176466159251904740000000
TCGA-06-0176.8	95	2_CELL_CELL_SIGNALING	353	14	0.0176540993923547350000000
TCGA-06-5412.7	153	0_HALLMARK_ANGIOGENESIS	32	6	0.0176801217077181970000000
TCGA-19-2623.11	153	2_BASEMENT_MEMBRANE	32	6	0.0176801217077181970000000
TCGA-16-0861.5	4	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0176951469975573480000000
TCGA-06-2561.7	4	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0176951469975573480000000
TCGA-02-0010.5	4	2_REGULATION_OF_ACTION_POTENTIAL	13	2	0.0176951469975573480000000
TCGA-12-5301.9	11	2_BLOOD_COAGULATION	39	3	0.0177254125432762320000000
TCGA-12-5301.9	11	2_COAGULATION	39	3	0.0177254125432762320000000
TCGA-19-5955.9	110	2_EXTRACELLULAR_REGION	346	15	0.0177330374519067340000000
TCGA-76-6282.11	185	2_SIGNAL_TRANSDUCTION	1442	51	0.0177524580272546140000000
TCGA-32-2634.10	118	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	6	0.0177667207315344200000000
TCGA-19-1390.13	110	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0178617796485543050000000
TCGA-06-5412.7	153	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0178755560234462390000000
TCGA-19-5950.7	113	0_HALLMARK_APICAL_JUNCTION	182	11	0.0178767648458831480000000
TCGA-12-0616.1	20	2_CELL_CYCLE_PHASE	146	5	0.0178808449058183990000000
TCGA-06-6389.1	18	2_TRANSMISSION_OF_NERVE_IMPULSE	164	5	0.0178810387577265330000000
TCGA-14-0786.4	62	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0178996457960845650000000
TCGA-08-0246.6	62	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0178996457960845650000000
TCGA-19-1790.18	201	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	8	0.0179186077542005180000000
TCGA-19-1790.18	201	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0179186077542005180000000
TCGA-02-0024.6	206	2_DNA_REPLICATION	82	10	0.0179791980349303900000000
TCGA-06-2565.10	38	2_SPINDLE	35	4	0.0180030599398880200000000
TCGA-06-5408.3	99	2_CHROMOSOME	102	8	0.0180095947411113050000000
TCGA-27-2527.6	79	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	9	0.0180141163368691060000000
TCGA-02-0007.17	217	2_CHROMOSOMAL_PART	78	10	0.0180500827610885520000000
TCGA-06-0241.8	53	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	5	0.0181165336538592100000000
TCGA-02-0058.1	110	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	16	0.0181463979456051030000000
TCGA-32-4211.14	71	2_CELL_CELL_SIGNALING	353	12	0.0181664522237529880000000
TCGA-06-0185.13	71	2_CELL_CELL_SIGNALING	353	12	0.0181664522237529880000000
TCGA-02-0021.4	170	2_CELL_PROLIFERATION_GO_0008283	436	22	0.0181750433858974820000000
TCGA-06-0939.7	58	2_NEUROLOGICAL_SYSTEM_PROCESS	296	10	0.0181997061510350800000000
TCGA-02-0089.5	91	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	6	0.0182301926008573870000000
TCGA-06-0158.4	65	1_KEGG_PATHWAYS_IN_CANCER	323	11	0.0182377259256038190000000
TCGA-06-0877.7	4	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	3	0.0182496833801096720000000
TCGA-08-0348.3	4	2_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION	133	3	0.0182496833801096720000000
TCGA-19-5947.4	267	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0182562578311947880000000
TCGA-28-5207.12	188	2_NEURON_PROJECTION	16	5	0.0182726756733657650000000
TCGA-06-0192.10	126	2_COLLAGEN	23	5	0.0182735454886129090000000
TCGA-32-4209.2	56	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0182802866302445130000000
TCGA-28-5215.7	192	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0183479621647857080000000
TCGA-32-1982.9	89	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	9	0.0183623396156020610000000
TCGA-02-0064.3	26	2_NEUROLOGICAL_SYSTEM_PROCESS	296	7	0.0183766500350056040000000
TCGA-32-2495.11	67	2_SYNAPTIC_TRANSMISSION	152	8	0.0184212211481347070000000
TCGA-26-5139.10	163	1_KEGG_PATHWAYS_IN_CANCER	323	18	0.0184316358843330700000000
TCGA-08-0360.3	144	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0184396886799191510000000
TCGA-32-1982.9	89	2_HEMATOPOIETIN_INTERFERON_CLASSD200_DOMAIN_CYTOKINE_RECEPTOR_ACTIVITY	32	5	0.0184442318163669100000000
TCGA-06-2570.8	95	2_DNA_METABOLIC_PROCESS	218	11	0.0184808487322103700000000
TCGA-06-0176.8	95	2_DNA_METABOLIC_PROCESS	218	11	0.0184808487322103700000000
TCGA-32-2634.10	118	2_DNA_REPAIR	113	9	0.0184989387047033960000000
TCGA-26-5139.10	163	0_HALLMARK_P53_PATHWAY	151	12	0.0185007231944983520000000
TCGA-32-1980.1	24	2_ORGAN_DEVELOPMENT	460	8	0.0185094432162501090000000
TCGA-06-0877.8	61	2_EXTRACELLULAR_REGION	346	11	0.0185139373972204420000000
TCGA-02-0001.5	117	1_KEGG_CELL_CYCLE	114	9	0.0185456283287772530000000
TCGA-06-2569.5	144	2_MICROTUBULE_CYTOSKELETON	117	10	0.0185652511863848050000000
TCGA-02-0071.12	116	1_KEGG_BLADDER_CANCER	42	6	0.0185976968311803020000000
TCGA-02-0071.12	116	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0185976968311803020000000
TCGA-06-2557.11	177	2_CELL_CYCLE_PROCESS	163	13	0.0186243260588137800000000
TCGA-02-0025.5	88	2_SYNAPTIC_TRANSMISSION	152	9	0.0186251005633489420000000
TCGA-27-1832.11	88	2_SYNAPTIC_TRANSMISSION	152	9	0.0186251005633489420000000
TCGA-16-0861.5	4	2_MITOTIC_CELL_CYCLE	134	3	0.0186661172578103770000000
TCGA-06-2561.7	4	2_MITOTIC_CELL_CYCLE	134	3	0.0186661172578103770000000
TCGA-32-2634.10	118	1_KEGG_COLORECTAL_CANCER	62	7	0.0186723570968449770000000
TCGA-76-6285.5	106	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	9	0.0187161335618737410000000
TCGA-19-5952.11	193	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0187298408090708250000000
TCGA-06-0169.5	42	0_HALLMARK_ANGIOGENESIS	32	4	0.0187326402743685850000000
TCGA-06-2561.5	42	0_HALLMARK_ANGIOGENESIS	32	4	0.0187326402743685850000000
TCGA-06-0875.7	78	1_KEGG_GLIOMA	62	6	0.0187489199431840230000000
TCGA-06-0875.7	78	2_INTERPHASE	62	6	0.0187489199431840230000000
TCGA-02-0069.12	62	2_CHROMOSOMAL_PART	78	6	0.0187489199431842730000000
TCGA-28-5214.11	124	2_DNA_REPLICATION	82	8	0.0187656784021487770000000
TCGA-06-0210.6	103	2_TRANSMISSION_OF_NERVE_IMPULSE	164	10	0.0187793309070535230000000
TCGA-27-1833.5	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144980000000
TCGA-28-2513.2	2	1_KEGG_DNA_REPLICATION	32	2	0.0187829834918144980000000
TCGA-28-2502.3	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144980000000
TCGA-02-0115.3	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144980000000
TCGA-16-1045.3	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144980000000
TCGA-32-1991.7	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144980000000
TCGA-27-2524.7	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144980000000
TCGA-06-0747.3	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144980000000
TCGA-06-2565.8	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144980000000
TCGA-76-4926.6	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144980000000
TCGA-41-2572.4	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144980000000
TCGA-27-1834.8	2	2_CALCIUM_CHANNEL_ACTIVITY	32	2	0.0187829834918144980000000
TCGA-02-2486.8	2	1_KEGG_DNA_REPLICATION	32	2	0.0187829834918144980000000
TCGA-08-0352.2	59	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0187861493499641740000000
TCGA-14-2554.5	59	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0187861493499641740000000
TCGA-27-2526.7	71	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0188363211110329500000000
TCGA-32-2491.14	244	1_KEGG_LEISHMANIA_INFECTION	70	10	0.0188653231162056770000000
TCGA-06-5415.7	7	1_KEGG_P53_SIGNALING_PATHWAY	66	3	0.0188799684167058960000000
TCGA-27-1832.11	88	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0188966501261906870000000
TCGA-06-0174.37	141	0_HALLMARK_MITOTIC_SPINDLE	175	12	0.0189242057766142340000000
TCGA-26-5139.10	163	2_INTRACELLULAR_ORGANELLE_PART	912	34	0.0189399147712370730000000
TCGA-32-1977.11	107	0_HALLMARK_COAGULATION	125	9	0.0189410451965114530000000
TCGA-14-1034.7	97	2_REGULATION_OF_KINASE_ACTIVITY	138	9	0.0189482459097450870000000
TCGA-06-2565.3	60	2_CELL_CELL_SIGNALING	353	11	0.0189525778409363360000000
TCGA-26-1439.10	84	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	7	0.0189677191610978790000000
TCGA-41-3393.4	12	2_CELL_CYCLE_GO_0007049	265	5	0.0190405368841608390000000
TCGA-14-0781.7	155	0_HALLMARK_ANGIOGENESIS	32	6	0.0190469168303320090000000
TCGA-02-0046.8	148	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	20	5	0.0191066120532056330000000
TCGA-02-0046.8	148	2_INTERMEDIATE_FILAMENT	20	5	0.0191066120532056330000000
TCGA-28-5209.15	194	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0191175814626509610000000
TCGA-14-1829.3	8	2_CYTOSKELETAL_PART	194	4	0.0191175814626509610000000
TCGA-02-2470.4	11	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	3	0.0191504165047285990000000
TCGA-28-2502.9	56	2_REGULATION_OF_APOPTOSIS	309	10	0.0191513846891487660000000
TCGA-16-1045.10	81	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	8	0.0192643210367407090000000
TCGA-06-0145.19	81	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	8	0.0192643210367407090000000
TCGA-06-0241.8	53	1_KEGG_FOCAL_ADHESION	195	8	0.0192769127991912200000000
TCGA-02-0046.8	148	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	50	7	0.0192864829471013670000000
TCGA-06-2562.7	57	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0192881733160967760000000
TCGA-19-2619.10	8	2_REGULATION_OF_TRANSPORT	57	3	0.0192881733160967760000000
TCGA-32-1986.8	87	2_PATTERN_BINDING	33	5	0.0193033678838259210000000
TCGA-06-2564.7	92	2_CELL_CYCLE_PHASE	146	9	0.0193761682535164050000000
TCGA-28-2501.3	51	2_EXTRACELLULAR_REGION_PART	269	9	0.0193862462491928460000000
TCGA-14-0790.9	104	2_CELL_CYCLE_PROCESS	163	10	0.0193979406043595750000000
TCGA-27-1831.4	3	2_CHANNEL_REGULATOR_ACTIVITY	19	2	0.0194034468363017550000000
TCGA-08-0350.2	46	1_KEGG_GLIOMA	62	5	0.0194566024002891800000000
TCGA-41-2571.7	72	2_CHROMOSOME	102	7	0.0194674114300783520000000
TCGA-19-5955.9	110	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0194829418878909520000000
TCGA-76-4935.7	15	2_M_PHASE	94	4	0.0194920685472198750000000
TCGA-06-0939.7	58	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0194926722605409520000000
TCGA-19-5960.9	134	2_CELL_PROLIFERATION_GO_0008283	436	19	0.0194987086039137730000000
TCGA-41-5651.5	112	2_CONDENSED_CHROMOSOME	26	5	0.0195055745860195600000000
TCGA-41-5651.5	112	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0195055745860195600000000
TCGA-27-2523.12	112	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0195055745860195600000000
TCGA-32-1980.1	24	0_HALLMARK_UV_RESPONSE_DN	122	5	0.0195143817477960690000000
TCGA-06-0877.7	4	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	3	0.0195178237375286910000000
TCGA-16-0861.5	4	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	3	0.0195178237375286910000000
TCGA-08-0348.3	4	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	3	0.0195178237375286910000000
TCGA-27-1833.7	17	0_HALLMARK_MYC_TARGETS_V1	178	5	0.0195286045526082590000000
TCGA-02-0086.2	17	0_HALLMARK_MYC_TARGETS_V1	178	5	0.0195286045526082590000000
TCGA-28-5215.7	192	0_HALLMARK_G2M_CHECKPOINT	174	14	0.0195583289310519400000000
TCGA-02-0038.3	199	2_REGULATION_OF_CELL_PROLIFERATION	265	18	0.0195614263121210130000000
TCGA-32-2491.14	244	2_CHROMOSOME	102	12	0.0195750899099495880000000
TCGA-06-5413.11	142	2_CELL_CYCLE_PHASE	146	11	0.0196158974418621510000000
TCGA-19-2624.29	130	2_NUCLEUS	1110	33	0.0196538898352524690000000
TCGA-28-2502.9	56	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	10	0.0197006183989647010000000
TCGA-81-5910.12	128	2_COLLAGEN	23	5	0.0197325555887298070000000
TCGA-02-0075.8	128	2_COLLAGEN	23	5	0.0197325555887298070000000
TCGA-12-3652.19	88	2_NEURON_PROJECTION	16	4	0.0198436439680074430000000
TCGA-12-5299.5	6	2_REGULATION_OF_MOLECULAR_FUNCTION	286	4	0.0198709657738589330000000
TCGA-19-5952.11	193	2_BLOOD_COAGULATION	39	7	0.0198900225268963500000000
TCGA-19-5952.11	193	2_COAGULATION	39	7	0.0198900225268963500000000
TCGA-32-4213.15	198	0_HALLMARK_E2F_TARGETS	169	14	0.0198982832994363080000000
TCGA-14-0790.9	104	2_POLYSACCHARIDE_BINDING	28	5	0.0199256482332760030000000
TCGA-14-0787.7	14	2_PLASMA_MEMBRANE_PART	901	8	0.0199546799302311730000000
TCGA-02-0011.1	288	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	9	0.0199890635939753250000000
TCGA-06-0747.12	80	0_HALLMARK_E2F_TARGETS	169	9	0.0199895871156260120000000
TCGA-06-0132.2	2	2_REGULATION_OF_SECRETION	33	2	0.0199947888783829700000000
TCGA-19-1790.18	201	2_EXTRACELLULAR_MATRIX	85	10	0.0200416020895273530000000
TCGA-28-2509.6	59	2_CELL_DEVELOPMENT	511	13	0.0200623321855538630000000
TCGA-08-0359.5	37	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0200648991211045650000000
TCGA-06-0154.13	76	2_ENZYME_REGULATOR_ACTIVITY	277	11	0.0200943687603297870000000
TCGA-06-2565.3	60	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0200955857158376110000000
TCGA-06-2565.3	60	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	4	0.0200955857158376110000000
TCGA-02-0043.10	184	0_HALLMARK_APICAL_JUNCTION	182	14	0.0201163728336517180000000
TCGA-02-0007.17	217	2_SPINDLE	35	7	0.0201208165405898470000000
TCGA-06-0648.3	19	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	3	0.0201213000899234450000000
TCGA-02-0021.4	170	2_CELL_CYCLE_PHASE	146	12	0.0201237867006313110000000
TCGA-06-0122.8	90	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	9	0.0201295233446175570000000
TCGA-06-0645.9	136	0_HALLMARK_COAGULATION	125	10	0.0201502047054821710000000
TCGA-27-2523.12	112	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0201507264885397820000000
TCGA-14-0790.9	104	1_KEGG_MELANOMA	71	7	0.0201548538252366260000000
TCGA-19-2625.9	146	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0201845547676319860000000
TCGA-76-6282.11	185	2_IMMUNE_RESPONSE	206	15	0.0201977440030341980000000
TCGA-16-1048.13	97	1_KEGG_ASTHMA	30	5	0.0202071348643853390000000
TCGA-19-5947.4	267	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	14	0.0202445105620655020000000
TCGA-06-0241.8	53	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0203497391688481740000000
TCGA-06-0157.7	89	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0203656166692943380000000
TCGA-06-0877.7	4	2_REGULATION_OF_KINASE_ACTIVITY	138	3	0.0203949556104787290000000
TCGA-16-0861.5	4	2_REGULATION_OF_KINASE_ACTIVITY	138	3	0.0203949556104787290000000
TCGA-08-0348.3	4	2_REGULATION_OF_KINASE_ACTIVITY	138	3	0.0203949556104787290000000
TCGA-76-6282.2	9	2_OLIGOSACCHARYL_TRANSFERASE_COMPLEX	6	2	0.0204088341522304100000000
TCGA-12-5299.5	6	2_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS	9	2	0.0204088341522304100000000
TCGA-06-0129.11	110	2_INTRACELLULAR_ORGANELLE_PART	912	26	0.0204195781156397000000000
TCGA-02-0011.1	288	1_KEGG_ALLOGRAFT_REJECTION	37	8	0.0204360424129145300000000
TCGA-02-2485.14	172	1_KEGG_FOCAL_ADHESION	195	14	0.0204505657257448290000000
TCGA-06-5858.19	205	1_KEGG_ALLOGRAFT_REJECTION	37	7	0.0204584200928362400000000
TCGA-06-0649.13	88	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	7	0.0204601688941410880000000
TCGA-26-1439.9	3	2_DNA_METABOLIC_PROCESS	218	3	0.0204821216871570140000000
TCGA-32-1986.3	3	2_DNA_METABOLIC_PROCESS	218	3	0.0204821216871570140000000
TCGA-06-0649.4	3	2_DNA_METABOLIC_PROCESS	218	3	0.0204821216871570140000000
TCGA-32-2634.10	118	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	6	0.0205180536088799790000000
TCGA-02-0074.5	118	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0205180536088799790000000
TCGA-32-2634.10	118	2_CHROMATIN	25	5	0.0205225515604783300000000
TCGA-08-0350.2	46	2_CELL_CYCLE_PROCESS	163	7	0.0205424818704322660000000
TCGA-06-0190.8	143	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0206181827666706110000000
TCGA-19-1790.1	4	2_NEGATIVE_REGULATION_OF_DNA_BINDING	14	2	0.0206414221684808470000000
TCGA-02-2470.4	11	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0206491451609283550000000
TCGA-14-0786.2	10	0_HALLMARK_P53_PATHWAY	151	4	0.0206501377708134880000000
TCGA-02-0069.8	7	1_KEGG_LONG_TERM_POTENTIATION	68	3	0.0206640098570438150000000
TCGA-19-1390.13	110	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0206645968498414340000000
TCGA-06-0166.5	35	1_KEGG_SMALL_CELL_LUNG_CANCER	83	5	0.0206673362169661060000000
TCGA-19-5952.11	193	0_HALLMARK_P53_PATHWAY	151	13	0.0206838386407869920000000
TCGA-06-5858.19	205	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0206954050134174440000000
TCGA-12-3652.19	88	2_MICROTUBULE_CYTOSKELETON	117	8	0.0206976864958645890000000
TCGA-02-0086.2	17	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0207265268499660650000000
TCGA-06-0178.2	17	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0207265268499660650000000
TCGA-32-4213.15	198	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0207283264323933000000000
TCGA-19-5947.4	267	2_PEPTIDE_BINDING	79	11	0.0207709557066902970000000
TCGA-06-0241.8	53	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	13	0.0207812275282292790000000
TCGA-06-2559.11	101	2_MITOTIC_CELL_CYCLE	134	9	0.0207813977386886620000000
TCGA-76-6285.5	106	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0207854170887802540000000
TCGA-19-2624.19	5	2_REGULATION_OF_HORMONE_SECRETION	11	2	0.0207882412895869400000000
TCGA-28-5204.5	5	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0207882412895869400000000
TCGA-26-5139.10	163	2_ORGANELLE_PART	916	34	0.0207979767017065220000000
TCGA-02-0011.1	288	2_CHROMOSOME	102	13	0.0208007512359323280000000
TCGA-27-2523.12	112	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0208251841144279390000000
TCGA-06-0877.8	61	0_HALLMARK_UV_RESPONSE_DN	122	7	0.0208396755527208220000000
TCGA-06-0173.35	120	1_KEGG_GLIOMA	62	7	0.0208539533094387920000000
TCGA-02-2486.9	141	0_HALLMARK_KRAS_SIGNALING_UP	148	11	0.0208740352304294870000000
TCGA-08-0245.4	85	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0208742080619576070000000
TCGA-14-0817.9	85	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0208742080619576070000000
TCGA-28-5218.5	208	2_KERATINOCYTE_DIFFERENTIATION	15	5	0.0208994970993100280000000
TCGA-06-0148.6	69	1_KEGG_BLADDER_CANCER	42	5	0.0209125250578680380000000
TCGA-32-4213.15	198	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0209238762564734750000000
TCGA-19-5950.7	113	2_NON_MEMBRANE_BOUND_ORGANELLE	476	18	0.0211034005652434020000000
TCGA-19-5950.7	113	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	18	0.0211034005652434020000000
TCGA-14-0781.7	155	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	31	0.0211045830551618260000000
TCGA-06-2563.10	123	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0211096384995801130000000
TCGA-32-4719.15	123	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0211096384995801130000000
TCGA-02-0038.3	199	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0211462510037583770000000
TCGA-12-0619.11	123	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0211592575277165760000000
TCGA-06-2563.10	123	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0211592575277165760000000
TCGA-06-2563.10	123	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0211592575277165760000000
TCGA-06-0686.5	14	0_HALLMARK_ANGIOGENESIS	32	3	0.0211704150256216690000000
TCGA-26-5134.2	14	0_HALLMARK_ANGIOGENESIS	32	3	0.0211704150256216690000000
TCGA-12-0688.10	93	2_CELL_CYCLE_PHASE	146	9	0.0211731565491731080000000
TCGA-06-0145.17	11	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	4	0.0211836729723278990000000
TCGA-14-0817.9	85	2_REGULATION_OF_CELL_CYCLE	160	9	0.0211895062069178200000000
TCGA-27-1834.10	39	1_KEGG_FOCAL_ADHESION	195	7	0.0212750775001594310000000
TCGA-14-1034.7	97	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	9	0.0212900697187628980000000
TCGA-06-0877.7	4	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	3	0.0212978811757053510000000
TCGA-16-0861.5	4	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	3	0.0212978811757053510000000
TCGA-08-0348.3	4	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	3	0.0212978811757053510000000
TCGA-02-0028.9	182	2_CALCIUM_ION_BINDING	75	9	0.0213003391903642540000000
TCGA-27-1833.2	41	1_KEGG_MELANOMA	71	5	0.0213278836450542380000000
TCGA-06-5859.9	125	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0213423103822848560000000
TCGA-19-2620.6	3	2_NEGATIVE_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	221	3	0.0213434210892201360000000
TCGA-06-0208.3	3	2_NEGATIVE_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	221	3	0.0213434210892201360000000
TCGA-06-5858.19	205	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0213561773332203750000000
TCGA-19-1390.12	10	1_KEGG_TYPE_II_DIABETES_MELLITUS	46	3	0.0213902406713405160000000
TCGA-08-0350.2	46	2_NON_MEMBRANE_BOUND_ORGANELLE	476	11	0.0214087631476059040000000
TCGA-08-0350.2	46	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	11	0.0214087631476059040000000
TCGA-08-0352.2	59	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0214128445438139840000000
TCGA-32-1986.12	17	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	4	0.0214136738088639210000000
TCGA-06-0877.8	61	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0214711501891702750000000
TCGA-06-0875.7	78	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0214835446327001950000000
TCGA-32-2494.10	173	0_HALLMARK_E2F_TARGETS	169	13	0.0215149649164531680000000
TCGA-14-2554.5	59	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0215462406860290850000000
TCGA-06-0645.5	3	1_KEGG_PROTEIN_EXPORT	20	2	0.0215578619575202970000000
TCGA-12-0619.3	3	1_KEGG_PROTEIN_EXPORT	20	2	0.0215578619575202970000000
TCGA-12-0688.1	3	1_KEGG_PROTEIN_EXPORT	20	2	0.0215578619575202970000000
TCGA-08-0375.1	3	1_KEGG_PROTEIN_EXPORT	20	2	0.0215578619575202970000000
TCGA-16-0861.1	3	1_KEGG_PROTEIN_EXPORT	20	2	0.0215578619575202970000000
TCGA-06-0747.2	3	1_KEGG_PROTEIN_EXPORT	20	2	0.0215578619575202970000000
TCGA-14-0817.5	3	1_KEGG_PROTEIN_EXPORT	20	2	0.0215578619575202970000000
TCGA-06-0137.6	3	1_KEGG_PROTEIN_EXPORT	20	2	0.0215578619575202970000000
TCGA-02-0048.3	3	1_KEGG_PROTEIN_EXPORT	20	2	0.0215578619575202970000000
TCGA-27-1831.4	3	2_AUXILIARY_TRANSPORT_PROTEIN_ACTIVITY	20	2	0.0215578619575202970000000
TCGA-02-0047.8	185	2_CYTOPLASMIC_PART	912	37	0.0215723835332547640000000
TCGA-19-5950.7	113	2_CELL_MATRIX_JUNCTION	13	4	0.0215728515640125630000000
TCGA-19-5950.7	113	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0215728515640125630000000
TCGA-02-2483.10	100	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	9	0.0216003580211093890000000
TCGA-28-5219.9	47	1_KEGG_GLIOMA	62	5	0.0216636026463798910000000
TCGA-08-0389.4	56	2_MITOTIC_CELL_CYCLE	134	7	0.0216774629941044390000000
TCGA-12-5299.5	6	1_KEGG_SMALL_CELL_LUNG_CANCER	83	3	0.0216826178227995480000000
TCGA-14-1823.12	6	1_KEGG_SMALL_CELL_LUNG_CANCER	83	3	0.0216826178227995480000000
TCGA-19-5959.13	92	0_HALLMARK_ANGIOGENESIS	32	5	0.0216961246269063990000000
TCGA-19-5959.13	92	1_KEGG_DNA_REPLICATION	32	5	0.0216961246269063990000000
TCGA-14-1825.8	80	2_INTERPHASE	62	6	0.0217129058288024580000000
TCGA-02-0003.9	227	0_HALLMARK_E2F_TARGETS	169	15	0.0217318886575778340000000
TCGA-08-0347.7	25	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	207	6	0.0217414312633437900000000
TCGA-06-2565.10	38	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0217691593672661690000000
TCGA-12-3653.55	255	1_KEGG_SMALL_CELL_LUNG_CANCER	83	11	0.0218227445339688600000000
TCGA-19-5954.17	208	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	10	0.0218290281626699130000000
TCGA-08-0380.4	6	2_CYTOSKELETON	293	4	0.0218734601326029680000000
TCGA-32-4211.14	71	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	4	0.0218930395767810360000000
TCGA-12-0616.1	20	1_KEGG_MELANOMA	71	4	0.0218930395767810360000000
TCGA-02-0089.5	91	1_KEGG_CELL_CYCLE	114	8	0.0219244590093409350000000
TCGA-02-0074.5	118	0_HALLMARK_MYC_TARGETS_V1	178	11	0.0219480471442861060000000
TCGA-08-0349.1	31	2_CELL_CELL_SIGNALING	353	8	0.0219961047227496090000000
TCGA-19-1790.18	201	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0220007994434615640000000
TCGA-02-0060.19	281	0_HALLMARK_HYPOXIA	154	16	0.0220063385855382120000000
TCGA-08-0375.6	65	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0220128889522128860000000
TCGA-28-1753.13	174	2_MITOTIC_SPINDLE_ORGANIZATION_AND_BIOGENESIS	9	4	0.0220205734527530280000000
TCGA-06-5859.9	125	2_NUCLEUS	1110	32	0.0220395144107605850000000
TCGA-32-5222.9	70	1_KEGG_MELANOMA	71	6	0.0220400501942334720000000
TCGA-26-5135.9	71	1_KEGG_PANCREATIC_CANCER	70	6	0.0220400501942334720000000
TCGA-12-3649.15	89	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0220486462715680720000000
TCGA-32-2494.10	173	2_DEFENSE_RESPONSE	222	15	0.0220721490629105300000000
TCGA-06-0129.11	110	2_ORGANELLE_PART	916	26	0.0220778394454666130000000
TCGA-27-1838.17	131	2_COLLAGEN	23	5	0.0220903643986992900000000
TCGA-06-0141.1	45	2_SYSTEM_DEVELOPMENT	694	13	0.0221094309573351240000000
TCGA-32-1977.11	107	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0221106080020623260000000
TCGA-27-1832.11	88	2_EXTRACELLULAR_MATRIX	85	7	0.0221293933061317280000000
TCGA-02-0003.9	227	2_CELL_DEVELOPMENT	511	29	0.0221964846054518610000000
TCGA-02-0052.3	116	2_CYTOSKELETON	293	14	0.0222130151996393910000000
TCGA-02-0071.12	116	2_CYTOSKELETON	293	14	0.0222130151996393910000000
TCGA-06-0145.17	11	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	3	0.0222233917700391490000000
TCGA-02-2470.4	11	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	3	0.0222233917700391490000000
TCGA-19-2620.6	3	2_NEGATIVE_REGULATION_OF_METABOLIC_PROCESS	224	3	0.0222285338911221570000000
TCGA-06-0208.3	3	2_NEGATIVE_REGULATION_OF_METABOLIC_PROCESS	224	3	0.0222285338911221570000000
TCGA-28-5208.28	220	2_CENTRAL_NERVOUS_SYSTEM_DEVELOPMENT	96	11	0.0222952626096726380000000
TCGA-06-0152.10	19	2_CELL_PROLIFERATION_GO_0008283	436	7	0.0223063686335892230000000
TCGA-06-0750.13	8	2_SIGNAL_TRANSDUCTION	1442	7	0.0223360425544987560000000
TCGA-02-0099.11	141	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0223463805211003290000000
TCGA-06-0750.13	8	2_MEMBRANE	1443	7	0.0224425236679955640000000
TCGA-06-0145.17	11	2_REGULATION_OF_KINASE_ACTIVITY	138	4	0.0224452752005350890000000
TCGA-76-6193.13	271	2_RESPONSE_TO_STRESS	427	29	0.0224503015922660270000000
TCGA-02-0034.5	6	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	3	0.0224802915598785940000000
TCGA-06-5859.9	125	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0225036433795830740000000
TCGA-19-2624.29	130	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0225159404160429590000000
TCGA-12-0620.1	2	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	2	0.0225320064065098430000000
TCGA-06-0133.2	2	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	2	0.0225320064065098430000000
TCGA-02-0023.1	2	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	2	0.0225320064065098430000000
TCGA-06-0127.4	2	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	2	0.0225320064065098430000000
TCGA-08-0355.3	2	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	2	0.0225320064065098430000000
TCGA-12-0619.11	123	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	6	0.0225492592629507500000000
TCGA-06-5859.9	125	2_APOPTOSIS_GO	389	17	0.0225544742562787180000000
TCGA-02-0069.8	7	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	3	0.0225561985980800500000000
TCGA-14-1823.15	87	2_SYSTEM_PROCESS	451	15	0.0225594154494795120000000
TCGA-41-5651.5	112	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0225617842266679180000000
TCGA-06-0140.2	25	2_SYSTEM_PROCESS	451	8	0.0225651342767130280000000
TCGA-28-5209.15	194	1_KEGG_MELANOMA	71	9	0.0226012664402746970000000
TCGA-02-0074.5	118	2_CELL_CYCLE_PHASE	146	10	0.0226099950400385980000000
TCGA-06-2561.5	42	0_HALLMARK_APICAL_JUNCTION	182	7	0.0226187195605660300000000
TCGA-02-2485.14	172	2_CELL_CYCLE_PHASE	146	12	0.0226592831629543330000000
TCGA-76-4935.8	21	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	253	6	0.0227256021587186640000000
TCGA-06-0878.10	115	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	10	0.0228281597181830870000000
TCGA-06-0875.7	78	2_MITOTIC_CELL_CYCLE	134	8	0.0228476263508339060000000
TCGA-14-0789.10	106	1_KEGG_MELANOMA	71	7	0.0228480792888553810000000
TCGA-28-5213.9	143	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	7	0.0228687732500854060000000
TCGA-32-2638.17	159	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0228750777179924580000000
TCGA-06-0881.7	203	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0228806775986438870000000
TCGA-06-0173.35	120	1_KEGG_PROSTATE_CANCER	87	8	0.0229059934634840740000000
TCGA-08-0356.2	23	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	4	0.0229149362894579200000000
TCGA-02-0069.12	62	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0229149362894579200000000
TCGA-14-0786.4	62	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0229149362894579200000000
TCGA-08-0246.6	62	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0229149362894579200000000
TCGA-06-0214.9	62	2_COLLAGEN	23	4	0.0229149362894579200000000
TCGA-06-0211.8	62	2_COLLAGEN	23	4	0.0229149362894579200000000
TCGA-76-6285.5	106	2_CELL_CYCLE_PROCESS	163	10	0.0229833491140999930000000
TCGA-19-5954.17	208	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0230090437345700990000000
TCGA-02-0024.6	206	0_HALLMARK_ESTROGEN_RESPONSE_LATE	143	13	0.0231005089208397050000000
TCGA-06-0192.10	126	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0231040736942074960000000
TCGA-06-0192.10	126	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0231040736942074960000000
TCGA-32-2634.10	118	1_KEGG_PYRIMIDINE_METABOLISM	64	7	0.0231055080017864670000000
TCGA-06-0877.7	4	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	4	0.0231185101856021640000000
TCGA-16-0861.5	4	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	4	0.0231185101856021640000000
TCGA-08-0348.3	4	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	4	0.0231185101856021640000000
TCGA-06-0878.10	115	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0231274657972220100000000
TCGA-02-0015.16	115	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0231274657972220100000000
TCGA-12-0616.1	20	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	4	0.0231493822501545180000000
TCGA-06-0190.8	143	0_HALLMARK_COMPLEMENT	176	12	0.0231501142782447250000000
TCGA-12-3649.15	89	1_KEGG_FOCAL_ADHESION	195	10	0.0232287255474499450000000
TCGA-32-1977.11	107	2_ENZYME_REGULATOR_ACTIVITY	277	13	0.0232365774482345200000000
TCGA-12-3650.17	101	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0232968464487418490000000
TCGA-06-2559.11	101	2_CELL_PROLIFERATION_GO_0008283	436	16	0.0232968464487418490000000
TCGA-06-5859.9	125	2_PROGRAMMED_CELL_DEATH	390	17	0.0233219032605714370000000
TCGA-06-5412.7	153	2_DEFENSE_RESPONSE	222	14	0.0233875129560040010000000
TCGA-14-0789.11	3	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	228	3	0.0234462886186571140000000
TCGA-26-1439.7	3	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	228	3	0.0234462886186571140000000
TCGA-32-2494.8	3	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	228	3	0.0234462886186571140000000
TCGA-14-1825.5	3	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	228	3	0.0234462886186571140000000
TCGA-02-2483.10	100	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION	30	5	0.0234502307200747210000000
TCGA-06-0214.9	62	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	14	0.0234763129586008710000000
TCGA-28-5209.15	194	2_SYNAPTIC_TRANSMISSION	152	13	0.0234874713739763740000000
TCGA-06-0184.11	108	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0235050544787332730000000
TCGA-19-1390.13	110	2_DNA_DEPENDENT_DNA_REPLICATION	46	6	0.0235409268104924720000000
TCGA-76-6282.2	9	2_ENDOPLASMIC_RETICULUM	177	4	0.0235626037691598070000000
TCGA-02-0089.5	91	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0235883508981111980000000
TCGA-02-0089.5	91	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0235883508981111980000000
TCGA-06-0124.6	55	2_GLYCOSAMINOGLYCAN_BINDING	26	4	0.0236131623029517780000000
TCGA-06-5408.3	99	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0236280556535006100000000
TCGA-12-0692.7	23	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	3	0.0236345362368201440000000
TCGA-02-0080.3	20	2_COLLAGEN	23	3	0.0236345362368201440000000
TCGA-28-2502.9	56	2_APOPTOSIS_GO	389	11	0.0236654795454591430000000
TCGA-32-4213.15	198	1_KEGG_LEISHMANIA_INFECTION	70	9	0.0236702416256536450000000
TCGA-02-0009.6	188	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0236757369464228800000000
TCGA-02-0007.17	217	0_HALLMARK_MYC_TARGETS_V1	178	15	0.0236824666621256760000000
TCGA-28-2501.3	51	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	4	0.0236843696692201140000000
TCGA-06-0877.8	61	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0236868077699547260000000
TCGA-06-0686.1	7	2_CELL_SURFACE_RECEPTOR_LINKED_SIGNAL_TRANSDUCTION_GO_0007166	563	5	0.0237052320503579670000000
TCGA-19-1390.13	110	0_HALLMARK_DNA_REPAIR	125	9	0.0237269115778676980000000
TCGA-12-5295.8	66	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0237332191223759220000000
TCGA-76-4931.10	86	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0237359435808351460000000
TCGA-28-5208.28	220	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	18	0.0237487257168413970000000
TCGA-06-0145.17	11	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	4	0.0237615892990717460000000
TCGA-06-5415.7	7	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	4	0.0237625702072300040000000
TCGA-02-0028.9	182	2_CELL_PROJECTION	76	9	0.0237654040832181340000000
TCGA-32-4209.2	56	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	5	0.0238101426220167260000000
TCGA-19-1790.1	4	2_NEGATIVE_REGULATION_OF_BINDING	15	2	0.0238136612364194500000000
TCGA-02-0115.4	3	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0238254268088847370000000
TCGA-06-0143.3	3	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0238254268088847370000000
TCGA-06-0750.9	3	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0238254268088847370000000
TCGA-27-1834.9	3	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0238254268088847370000000
TCGA-06-0882.9	3	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0238254268088847370000000
TCGA-19-2620.6	3	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0238254268088847370000000
TCGA-06-0208.3	3	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0238254268088847370000000
TCGA-08-0357.4	36	1_KEGG_SMALL_CELL_LUNG_CANCER	83	5	0.0238361283315568390000000
TCGA-06-0157.7	89	2_EXTRACELLULAR_MATRIX	85	7	0.0238452677906111110000000
TCGA-28-2502.3	2	2_LIGAND_GATED_CHANNEL_ACTIVITY	36	2	0.0238574185480684330000000
TCGA-32-1991.7	2	2_LIGAND_GATED_CHANNEL_ACTIVITY	36	2	0.0238574185480684330000000
TCGA-08-0386.2	2	2_LIGAND_GATED_CHANNEL_ACTIVITY	36	2	0.0238574185480684330000000
TCGA-41-2572.4	2	2_LIGAND_GATED_CHANNEL_ACTIVITY	36	2	0.0238574185480684330000000
TCGA-26-5135.9	71	1_KEGG_MELANOMA	71	6	0.0239327958783594720000000
TCGA-02-0033.5	144	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	7	0.0239344747408219950000000
TCGA-02-0071.12	116	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0239350708993448100000000
TCGA-12-5295.8	66	2_REGULATION_OF_CELL_CYCLE	160	8	0.0239471204231384470000000
TCGA-02-0015.16	115	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0239725326462920490000000
TCGA-06-2561.5	42	1_KEGG_MELANOMA	71	5	0.0240694335283841610000000
TCGA-08-0347.7	25	0_HALLMARK_UV_RESPONSE_DN	122	5	0.0241421425091404050000000
TCGA-14-0781.7	155	2_RESPONSE_TO_WOUNDING	163	12	0.0241421539564717730000000
TCGA-16-0861.5	4	2_CELL_CYCLE_PHASE	146	3	0.0241650993481844520000000
TCGA-06-2561.7	4	2_CELL_CYCLE_PHASE	146	3	0.0241650993481844520000000
TCGA-28-5215.7	192	0_HALLMARK_HYPOXIA	154	13	0.0242032136013602270000000
TCGA-27-1831.9	85	2_CELL_CELL_SIGNALING	353	13	0.0242164377577070780000000
TCGA-41-3392.31	136	2_CELL_PROLIFERATION_GO_0008283	436	19	0.0242180286723335070000000
TCGA-28-2502.9	56	2_PROGRAMMED_CELL_DEATH	390	11	0.0242433453592336560000000
TCGA-02-0024.6	206	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0242490395979626480000000
TCGA-02-0010.18	184	1_KEGG_BLADDER_CANCER	42	7	0.0242889947100729700000000
TCGA-16-1045.10	81	1_KEGG_ALLOGRAFT_REJECTION	37	5	0.0242912177991100290000000
TCGA-32-1977.11	107	1_KEGG_MELANOMA	71	7	0.0243025365489216850000000
TCGA-02-2483.10	100	2_REGULATION_OF_KINASE_ACTIVITY	138	9	0.0243048815101076230000000
TCGA-19-1790.18	201	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0243554288555431830000000
TCGA-32-2638.17	159	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0243851971178853650000000
TCGA-08-0347.7	25	1_KEGG_PATHWAYS_IN_CANCER	323	7	0.0244215448168875230000000
TCGA-28-6450.11	139	0_HALLMARK_COAGULATION	125	10	0.0244227112069266350000000
TCGA-06-0143.6	63	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0244290639893613260000000
TCGA-06-0646.4	63	2_COLLAGEN	23	4	0.0244290639893613260000000
TCGA-06-0646.4	63	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0244290639893613260000000
TCGA-06-0743.14	63	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0244290639893613260000000
TCGA-02-0026.1	61	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0244304248197188610000000
TCGA-14-0789.10	106	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	6	0.0244757491637412060000000
TCGA-19-1790.1	4	2_REGULATION_OF_GENE_EXPRESSION	585	4	0.0246015943792660470000000
TCGA-14-0817.9	85	2_CELL_CYCLE_PROCESS	163	9	0.0246091919666609450000000
TCGA-28-6450.11	139	2_CELL_PROJECTION	76	8	0.0246166424863923090000000
TCGA-32-1986.12	17	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	4	0.0246212694433850970000000
TCGA-06-0875.7	78	0_HALLMARK_MYC_TARGETS_V1	178	9	0.0246302006287410050000000
TCGA-02-0021.4	170	0_HALLMARK_COAGULATION	125	11	0.0246423677347781430000000
TCGA-02-0071.12	116	0_HALLMARK_APOPTOSIS	150	10	0.0246459997343331450000000
TCGA-12-0821.9	81	2_CELL_CYCLE_GO_0007049	265	11	0.0247030399801645120000000
TCGA-81-5910.12	128	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0247206992764572200000000
TCGA-19-5954.17	208	0_HALLMARK_UV_RESPONSE_DN	122	12	0.0247272358936872940000000
TCGA-06-0141.1	45	0_HALLMARK_ANGIOGENESIS	32	4	0.0247589220381118950000000
TCGA-02-0085.1	45	0_HALLMARK_ANGIOGENESIS	32	4	0.0247589220381118950000000
TCGA-08-0389.4	56	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	18	0.0247761864350785000000000
TCGA-06-0195.8	56	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	18	0.0247761864350785000000000
TCGA-08-0354.5	18	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0248264313147486400000000
TCGA-08-0354.5	18	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	82	4	0.0248475556823249120000000
TCGA-02-0033.5	144	0_HALLMARK_COMPLEMENT	176	12	0.0248503381977231600000000
TCGA-14-0786.4	62	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0248813056335427940000000
TCGA-28-5204.5	5	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	2	0.0249406052421289500000000
TCGA-06-0155.1	5	2_NEGATIVE_REGULATION_OF_TRANSCRIPTION_FACTOR_ACTIVITY	12	2	0.0249406052421289500000000
TCGA-06-1804.6	30	2_CELL_CYCLE_GO_0007049	265	7	0.0249636115190772400000000
TCGA-02-0034.5	6	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	3	0.0249893619370755720000000
TCGA-06-0133.6	57	2_SIGNAL_TRANSDUCTION	1442	22	0.0249913904389719930000000
TCGA-08-0353.8	100	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0250335183259282650000000
TCGA-02-2483.10	100	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0250335183259282650000000
TCGA-26-5132.7	100	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0250335183259282650000000
TCGA-06-0211.8	62	2_DNA_REPLICATION	82	6	0.0250450196027425870000000
TCGA-32-2615.7	77	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0250550304642287480000000
TCGA-06-0744.4	11	2_SECRETION	142	4	0.0251341159604884370000000
TCGA-02-0028.9	182	2_RESPONSE_TO_WOUNDING	163	13	0.0251500684162210280000000
TCGA-32-2634.10	118	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0251565265833357080000000
TCGA-32-2491.14	244	0_HALLMARK_UV_RESPONSE_DN	122	13	0.0251797766214462150000000
TCGA-19-5954.17	208	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0251943515547278330000000
TCGA-28-5218.5	208	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0251943515547278330000000
TCGA-19-2623.11	153	2_CYTOSKELETAL_PART	194	13	0.0252119990573863450000000
TCGA-02-0058.1	110	2_CYTOSKELETAL_PART	194	11	0.0252503446690631360000000
TCGA-19-1790.18	201	2_NEURON_PROJECTION	16	5	0.0252907882901313820000000
TCGA-02-0052.3	116	1_KEGG_P53_SIGNALING_PATHWAY	66	7	0.0253725390074983900000000
TCGA-06-2570.8	95	1_KEGG_DNA_REPLICATION	32	5	0.0253797717489338060000000
TCGA-08-0389.4	56	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0253821463674158940000000
TCGA-26-5139.10	163	1_KEGG_DNA_REPLICATION	32	6	0.0253986211963304830000000
TCGA-14-0787.6	40	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0254589360378588430000000
TCGA-41-2575.49	136	2_CHROMOSOMAL_PART	78	8	0.0254655182871791200000000
TCGA-12-5299.5	6	2_AGING	10	2	0.0255038385357461980000000
TCGA-06-0143.6	63	2_EXTRACELLULAR_REGION	346	11	0.0255371224828837980000000
TCGA-14-3476.17	53	2_RECEPTOR_ACTIVITY	499	12	0.0255388455389756290000000
TCGA-19-2625.9	146	2_CELL_CYCLE_PHASE	146	11	0.0255423964894031480000000
TCGA-08-0375.6	65	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0255673473810236750000000
TCGA-02-0014.10	70	2_SYNAPTIC_TRANSMISSION	152	8	0.0255983486508498500000000
TCGA-06-5856.13	152	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0255983486508498500000000
TCGA-06-5856.13	152	1_KEGG_VIRAL_MYOCARDITIS	70	8	0.0255983486508498500000000
TCGA-12-5301.9	11	2_HEMOSTASIS	44	3	0.0256055881027338030000000
TCGA-06-0686.1	7	2_PLASMA_MEMBRANE	1096	6	0.0256621783987742540000000
TCGA-06-0187.9	4	1_KEGG_WNT_SIGNALING_PATHWAY	149	3	0.0256901058880807530000000
TCGA-41-3392.31	136	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0256903249220525390000000
TCGA-06-6391.6	30	0_HALLMARK_MITOTIC_SPINDLE	175	6	0.0257078999883612080000000
TCGA-02-0047.8	185	2_CYTOPLASM	1461	51	0.0257240559748201330000000
TCGA-27-1833.7	17	0_HALLMARK_SPERMATOGENESIS	88	4	0.0257652079374858230000000
TCGA-02-0003.9	227	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	9	0.0257847556324734030000000
TCGA-06-6390.9	82	1_KEGG_ALLOGRAFT_REJECTION	37	5	0.0257954777325723650000000
TCGA-06-0197.1	57	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	13	0.0257976396332109880000000
TCGA-41-3393.5	88	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	7	0.0258072953952650580000000
TCGA-06-0213.9	74	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	4	0.0258205996007586020000000
TCGA-06-6391.6	30	2_CHROMOSOME	102	5	0.0258287029006259890000000
TCGA-27-2526.7	71	0_HALLMARK_APOPTOSIS	150	8	0.0258398815582789360000000
TCGA-27-1831.9	85	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0258490187103131460000000
TCGA-28-5214.11	124	1_KEGG_GLIOMA	62	7	0.0258540655067500020000000
TCGA-28-2513.12	134	0_HALLMARK_ALLOGRAFT_REJECTION	190	12	0.0258737597026900720000000
TCGA-27-1838.17	131	2_CELL_CYCLE_PROCESS	163	11	0.0258808611377219880000000
TCGA-26-1439.11	10	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0259180248147695100000000
TCGA-14-0786.2	10	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0259180248147695100000000
TCGA-26-1439.11	10	2_REGULATION_OF_CELL_CYCLE	160	4	0.0259700797769711890000000
TCGA-08-0359.5	37	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0260140063824797870000000
TCGA-19-5958.4	35	1_KEGG_PROSTATE_CANCER	87	5	0.0260240377687215900000000
TCGA-12-0619.11	123	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	6	0.0260294255044958950000000
TCGA-06-2563.10	123	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	6	0.0260294255044958950000000
TCGA-02-0010.18	184	2_CELL_CYCLE_GO_0007049	265	17	0.0260335878129025720000000
TCGA-06-0143.6	63	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0261149625630409180000000
TCGA-02-0026.1	61	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0261785000842998450000000
TCGA-02-0115.4	3	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0262061173364548270000000
TCGA-26-5139.4	3	2_MRNA_BINDING	22	2	0.0262061173364548270000000
TCGA-06-0143.3	3	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0262061173364548270000000
TCGA-06-0750.9	3	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0262061173364548270000000
TCGA-27-1834.9	3	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0262061173364548270000000
TCGA-06-0882.9	3	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0262061173364548270000000
TCGA-19-2620.6	3	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0262061173364548270000000
TCGA-06-0208.3	3	2_KINASE_INHIBITOR_ACTIVITY	22	2	0.0262061173364548270000000
TCGA-14-1823.15	87	2_NEUROLOGICAL_SYSTEM_PROCESS	296	12	0.0262092183870243770000000
TCGA-12-1597.6	51	2_SYNAPTIC_TRANSMISSION	152	7	0.0262608799439488890000000
TCGA-06-5856.13	152	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	51	7	0.0262608799439492290000000
TCGA-19-5947.4	267	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	8	0.0263189641412750410000000
TCGA-02-0007.17	217	2_PROTEIN_HOMODIMERIZATION_ACTIVITY	99	11	0.0263565212358250650000000
TCGA-14-0790.9	104	2_MITOTIC_CELL_CYCLE	134	9	0.0263782467117041480000000
TCGA-06-0747.12	80	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0264660624390326070000000
TCGA-14-1825.8	80	0_HALLMARK_MITOTIC_SPINDLE	175	9	0.0264660624390326070000000
TCGA-02-0058.1	110	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	11	0.0265016478406066850000000
TCGA-19-1390.13	110	1_KEGG_FOCAL_ADHESION	195	11	0.0265016478406066850000000
TCGA-06-0645.9	136	2_COLLAGEN	23	5	0.0265043000021544310000000
TCGA-41-3392.31	136	2_COLLAGEN	23	5	0.0265043000021544310000000
TCGA-41-2575.49	136	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	5	0.0265043000021544310000000
TCGA-19-1390.13	110	1_KEGG_PANCREATIC_CANCER	70	7	0.0265130405345932880000000
TCGA-06-5415.7	7	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	5	0.0265181096002835020000000
TCGA-28-5209.15	194	2_CELL_DEVELOPMENT	511	26	0.0265846732795448630000000
TCGA-08-0354.5	18	0_HALLMARK_MYC_TARGETS_V1	178	5	0.0266285806050122200000000
TCGA-26-5134.6	18	0_HALLMARK_MYC_TARGETS_V1	178	5	0.0266285806050122200000000
TCGA-02-2486.9	141	1_KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	99	9	0.0266339150880548940000000
TCGA-02-0015.16	115	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0266689651003901680000000
TCGA-19-1790.18	201	1_KEGG_LEISHMANIA_INFECTION	70	9	0.0267023515701484450000000
TCGA-76-6191.6	96	0_HALLMARK_ANGIOGENESIS	32	5	0.0267103527731613750000000
TCGA-32-1986.12	17	0_HALLMARK_ALLOGRAFT_REJECTION	190	5	0.0268117205988593790000000
TCGA-76-4925.9	83	1_KEGG_GLIOMA	62	6	0.0268595375335749340000000
TCGA-06-2558.6	74	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	16	0.0268610149656003630000000
TCGA-14-0813.10	53	2_EXTRACELLULAR_REGION_PART	269	9	0.0268670982134290580000000
TCGA-02-0099.11	141	2_SYNAPTIC_TRANSMISSION	152	11	0.0268784749489470560000000
TCGA-02-0007.17	217	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	50	8	0.0269173220934847270000000
TCGA-06-5412.7	153	2_MEMBRANE_PART	1217	39	0.0269221636078089900000000
TCGA-02-0001.5	117	2_SIGNAL_TRANSDUCTION	1442	36	0.0269431338267472650000000
TCGA-28-5220.7	15	2_CHROMOSOME	102	4	0.0269600618191137320000000
TCGA-28-2514.9	62	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	14	0.0269615945119516700000000
TCGA-06-5418.4	24	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	3	0.0269744403085637080000000
TCGA-02-0060.19	281	2_ORGAN_DEVELOPMENT	460	31	0.0269933716311087300000000
TCGA-19-5958.4	35	1_KEGG_BLADDER_CANCER	42	4	0.0270137036842340480000000
TCGA-19-5954.17	208	2_EXTRACELLULAR_MATRIX	85	10	0.0270283576375070640000000
TCGA-28-5209.15	194	0_HALLMARK_HYPOXIA	154	13	0.0270468556163608840000000
TCGA-32-2634.10	118	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	44	6	0.0270544076863930770000000
TCGA-28-1753.13	174	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0270684197629888040000000
TCGA-28-5208.28	220	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	13	0.0271115132469654590000000
TCGA-76-4934.4	20	2_TRANSPORT	600	8	0.0271511386588309360000000
TCGA-32-2494.10	173	2_IMMUNE_SYSTEM_PROCESS	283	17	0.0271938527233067490000000
TCGA-06-0171.7	57	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0272468833541430820000000
TCGA-28-5204.3	4	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	152	3	0.0272776960460178530000000
TCGA-28-5216.8	162	2_AXON	10	4	0.0272779166593763930000000
TCGA-02-2483.10	100	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	9	0.0272932014845755180000000
TCGA-19-5960.9	134	2_NUCLEAR_CHROMOSOME	39	6	0.0273124489271820630000000
TCGA-08-0359.5	37	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	5	0.0273714761638222700000000
TCGA-06-5412.7	153	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0274073405616095770000000
TCGA-12-0692.6	11	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0274171005872328730000000
TCGA-02-2470.4	11	2_REGULATION_OF_PHOSPHORYLATION	45	3	0.0274171005872328730000000
TCGA-06-0188.11	66	2_CELL_CYCLE_PROCESS	163	8	0.0274208383288783230000000
TCGA-26-5139.10	163	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0274208383288786700000000
TCGA-32-1979.4	12	2_REGULATION_OF_GROWTH	41	3	0.0274491943317552790000000
TCGA-32-1979.4	12	2_KINASE_REGULATOR_ACTIVITY	41	3	0.0274491943317552790000000
TCGA-19-5960.9	134	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0274499442154947860000000
TCGA-06-0744.10	36	2_KINASE_REGULATOR_ACTIVITY	41	4	0.0274821371078044700000000
TCGA-02-0060.19	281	2_EXTRACELLULAR_MATRIX_PART	51	9	0.0275052540775322030000000
TCGA-06-0192.10	126	2_EXTRACELLULAR_MATRIX	85	8	0.0275689176070342650000000
TCGA-76-6193.13	271	1_KEGG_P53_SIGNALING_PATHWAY	66	10	0.0275805459144768810000000
TCGA-28-1753.13	174	2_INTERPHASE	62	8	0.0275834948355460390000000
TCGA-08-0386.4	73	1_KEGG_BLADDER_CANCER	42	5	0.0275865797821405540000000
TCGA-06-0169.5	42	2_EXTRACELLULAR_REGION	346	9	0.0275886102428799620000000
TCGA-32-1979.4	12	2_REGULATION_OF_MOLECULAR_FUNCTION	286	5	0.0275897927489065390000000
TCGA-08-0357.4	36	2_CELL_CYCLE_PHASE	146	6	0.0275933378017017670000000
TCGA-02-0089.5	91	2_EXTRACELLULAR_MATRIX	85	7	0.0276084592228192230000000
TCGA-08-0375.6	65	2_COLLAGEN	23	4	0.0276769547199569310000000
TCGA-08-0375.6	65	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0276769547199569310000000
TCGA-06-0158.4	65	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0276769547199569310000000
TCGA-02-0052.3	116	2_SYNAPTIC_TRANSMISSION	152	10	0.0276787377834672510000000
TCGA-06-0152.10	19	0_HALLMARK_E2F_TARGETS	169	5	0.0276828895154963080000000
TCGA-02-0043.10	184	1_KEGG_PATHWAYS_IN_CANCER	323	19	0.0277373312183948170000000
TCGA-02-0010.18	184	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0277909629247263710000000
TCGA-02-0010.18	184	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0277909629247263710000000
TCGA-12-3650.17	101	0_HALLMARK_MITOTIC_SPINDLE	175	10	0.0278623192253490760000000
TCGA-06-0650.2	82	2_SIGNAL_TRANSDUCTION	1442	28	0.0278859564317045640000000
TCGA-12-0616.1	20	2_REGULATION_OF_CELL_CYCLE	160	5	0.0279102127189761740000000
TCGA-26-5139.10	163	2_AXON	10	4	0.0279497892458735190000000
TCGA-06-0878.10	115	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0279544150712939390000000
TCGA-27-2523.12	112	2_CELL_CELL_SIGNALING	353	15	0.0280932942707507320000000
TCGA-02-0025.5	88	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0281420518875829110000000
TCGA-06-0649.13	88	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0281420518875829110000000
TCGA-15-0742.13	74	2_CELL_CELL_SIGNALING	353	12	0.0281485444392821330000000
TCGA-02-0001.5	117	0_HALLMARK_P53_PATHWAY	151	10	0.0281794043553331570000000
TCGA-76-4935.8	21	2_SYNAPTIC_TRANSMISSION	152	5	0.0281848871213757520000000
TCGA-02-2485.14	172	2_DNA_REPLICATION	82	9	0.0282154433034696870000000
TCGA-06-2565.10	38	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0282213268303839260000000
TCGA-02-0003.9	227	2_CYTOSKELETAL_PART	194	16	0.0282236772743277120000000
TCGA-02-0084.1	25	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	5	0.0282426023103538070000000
TCGA-28-5208.28	220	2_MICROTUBULE_CYTOSKELETON	117	12	0.0283298717359507790000000
TCGA-06-0877.7	4	2_ENZYME_BINDING	154	3	0.0283714692935312720000000
TCGA-08-0348.3	4	2_ENZYME_BINDING	154	3	0.0283714692935312720000000
TCGA-06-0143.3	3	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	3	0.0284081953381820140000000
TCGA-08-0358.5	5	1_KEGG_CELL_CYCLE	114	3	0.0284130855179195000000000
TCGA-16-1045.10	81	2_EXTRACELLULAR_REGION_PART	269	11	0.0284260353800721010000000
TCGA-06-0169.5	42	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	8	0.0284378681892485660000000
TCGA-76-4931.10	86	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0284459736261262580000000
TCGA-19-5951.10	138	2_COLLAGEN	23	5	0.0284512661301550740000000
TCGA-02-0024.6	206	2_NEURON_PROJECTION	16	5	0.0284914990090760420000000
TCGA-28-2501.3	51	0_HALLMARK_HYPOXIA	154	7	0.0285949469461538530000000
TCGA-06-5412.1	28	2_INFLAMMATORY_RESPONSE	112	5	0.0285971547827364030000000
TCGA-06-0184.11	108	2_TRANSMISSION_OF_NERVE_IMPULSE	164	10	0.0286142171540830840000000
TCGA-08-0245.4	85	2_REPLICATION_FORK	18	4	0.0286620454700956020000000
TCGA-14-0817.9	85	2_REPLICATION_FORK	18	4	0.0286620454700956020000000
TCGA-06-0237.4	66	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0286691077427411980000000
TCGA-14-0789.11	3	2_REGULATION_OF_HEART_CONTRACTION	23	2	0.0286999094862919950000000
TCGA-41-3392.4	3	2_REGULATION_OF_HEART_CONTRACTION	23	2	0.0286999094862919950000000
TCGA-19-2623.13	3	2_REGULATION_OF_HEART_CONTRACTION	23	2	0.0286999094862919950000000
TCGA-06-1804.4	3	2_REGULATION_OF_HEART_CONTRACTION	23	2	0.0286999094862919950000000
TCGA-02-0080.1	3	2_REGULATION_OF_HEART_CONTRACTION	23	2	0.0286999094862919950000000
TCGA-27-2521.10	94	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0287056498054606980000000
TCGA-26-1439.10	84	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	6	0.0287788248906247590000000
TCGA-06-0879.9	84	1_KEGG_GLIOMA	62	6	0.0287788248906247590000000
TCGA-02-0048.9	84	1_KEGG_GLIOMA	62	6	0.0287788248906247590000000
TCGA-08-0246.6	62	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0287788248906247590000000
TCGA-06-0221.13	45	1_KEGG_PATHWAYS_IN_CANCER	323	9	0.0288217215409141140000000
TCGA-06-0213.9	74	2_NEUROLOGICAL_SYSTEM_PROCESS	296	11	0.0288499334018800550000000
TCGA-06-0190.8	143	1_KEGG_ALLOGRAFT_REJECTION	37	6	0.0288899382847980020000000
TCGA-06-0195.8	56	2_NON_MEMBRANE_BOUND_ORGANELLE	476	12	0.0288947070695707540000000
TCGA-06-0195.8	56	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	12	0.0288947070695707540000000
TCGA-02-0071.12	116	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	20	0.0289440559930628090000000
TCGA-06-0130.3	155	2_CYTOSKELETAL_PART	194	13	0.0289980170233705740000000
TCGA-28-5209.15	194	2_KINASE_REGULATOR_ACTIVITY	41	7	0.0290442820256603880000000
TCGA-32-4208.28	140	2_CELL_CELL_SIGNALING	353	17	0.0290915446971655550000000
TCGA-32-2632.16	229	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0291204389023001740000000
TCGA-19-1390.13	110	1_KEGG_MELANOMA	71	7	0.0291333473850450900000000
TCGA-02-0114.20	132	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0291503592605680610000000
TCGA-32-2634.10	118	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	29	0.0291852049178759480000000
TCGA-06-0192.10	126	2_CELL_CELL_SIGNALING	353	16	0.0292185529496770120000000
TCGA-14-0871.20	216	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0292508326672666350000000
TCGA-12-0688.10	93	2_SYNAPTIC_TRANSMISSION	152	9	0.0292837755830600740000000
TCGA-32-4209.2	56	1_KEGG_FOCAL_ADHESION	195	8	0.0293019399549772770000000
TCGA-12-5301.9	11	2_WOUND_HEALING	46	3	0.0293112565607940270000000
TCGA-76-4926.9	66	2_COLLAGEN	23	4	0.0294150875298671500000000
TCGA-76-4926.9	66	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0294150875298671500000000
TCGA-06-0237.4	66	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0294150875298671500000000
TCGA-12-5295.8	66	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0294150875298671500000000
TCGA-06-0188.11	66	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0294150875298671500000000
TCGA-06-0152.10	19	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0294275740997699160000000
TCGA-06-0148.4	5	2_REGULATION_OF_ACTION_POTENTIAL	13	2	0.0294690166449979130000000
TCGA-28-2513.5	5	2_KINESIN_COMPLEX	13	2	0.0294690166449979130000000
TCGA-19-5954.5	5	2_KINESIN_COMPLEX	13	2	0.0294690166449979130000000
TCGA-19-2624.19	5	2_HORMONE_SECRETION	13	2	0.0294690166449979130000000
TCGA-28-5204.5	5	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	2	0.0294690166449979130000000
TCGA-32-4211.7	5	2_KINESIN_COMPLEX	13	2	0.0294690166449979130000000
TCGA-32-4213.12	5	2_KINESIN_COMPLEX	13	2	0.0294690166449979130000000
TCGA-06-0138.3	5	2_KINESIN_COMPLEX	13	2	0.0294690166449979130000000
TCGA-14-0789.11	3	2_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	246	3	0.0294778619888376830000000
TCGA-26-1439.7	3	2_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	246	3	0.0294778619888376830000000
TCGA-32-2494.8	3	2_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	246	3	0.0294778619888376830000000
TCGA-14-1825.5	3	2_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	246	3	0.0294778619888376830000000
TCGA-06-0646.4	63	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0294800545329577180000000
TCGA-06-0646.4	63	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0294800545329577180000000
TCGA-06-0743.14	63	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0294800545329577180000000
TCGA-06-2558.6	74	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0294890432386015790000000
TCGA-76-4934.7	47	0_HALLMARK_ANGIOGENESIS	32	4	0.0294990557084694530000000
TCGA-76-4934.7	47	1_KEGG_DNA_REPLICATION	32	4	0.0294990557084694530000000
TCGA-06-1804.7	47	0_HALLMARK_ANGIOGENESIS	32	4	0.0294990557084694530000000
TCGA-06-0148.6	69	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0295307118596308710000000
TCGA-12-0620.1	2	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	2	0.0295377562976043940000000
TCGA-06-0133.2	2	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	2	0.0295377562976043940000000
TCGA-02-0023.1	2	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	2	0.0295377562976043940000000
TCGA-06-0127.4	2	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	2	0.0295377562976043940000000
TCGA-08-0355.3	2	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	2	0.0295377562976043940000000
TCGA-02-2483.10	100	0_HALLMARK_MYC_TARGETS_V1	178	10	0.0295843374977138410000000
TCGA-02-2483.10	100	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	10	0.0295843374977138410000000
TCGA-06-5415.3	8	2_PLASMA_MEMBRANE_PART	901	6	0.0295980269921324800000000
TCGA-06-0221.4	8	2_PLASMA_MEMBRANE_PART	901	6	0.0295980269921324800000000
TCGA-32-1979.4	12	2_MITOTIC_CELL_CYCLE	134	4	0.0296338655206708940000000
TCGA-06-0210.6	103	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0296605628956279590000000
TCGA-06-0877.7	4	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	4	0.0296746730768696620000000
TCGA-16-0861.5	4	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	4	0.0296746730768696620000000
TCGA-08-0348.3	4	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	4	0.0296746730768696620000000
TCGA-19-2631.1	6	2_INTEGRAL_TO_PLASMA_MEMBRANE	751	5	0.0296911989040185290000000
TCGA-19-2620.8	6	2_INTEGRAL_TO_PLASMA_MEMBRANE	751	5	0.0296911989040185290000000
TCGA-06-5858.19	205	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0296912900206575060000000
TCGA-19-1790.18	201	0_HALLMARK_APOPTOSIS	150	13	0.0297571694487097390000000
TCGA-32-1986.8	87	2_RESPONSE_TO_WOUNDING	163	9	0.0297680746519623820000000
TCGA-02-0007.17	217	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0297898860043201950000000
TCGA-76-6285.5	106	2_CHROMOSOME	102	8	0.0298152790577167170000000
TCGA-06-0879.9	84	0_HALLMARK_E2F_TARGETS	169	9	0.0298507293046445630000000
TCGA-06-2561.5	42	0_HALLMARK_ALLOGRAFT_REJECTION	190	7	0.0299251911112038420000000
TCGA-28-5214.11	124	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	11	0.0299974266448539560000000
TCGA-06-0139.1	179	2_RESPONSE_TO_STRESS	427	22	0.0300126461876302040000000
TCGA-06-0237.4	66	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0300569817098825240000000
TCGA-32-1977.3	8	1_KEGG_P53_SIGNALING_PATHWAY	66	3	0.0300569817098825280000000
TCGA-32-1982.6	8	1_KEGG_P53_SIGNALING_PATHWAY	66	3	0.0300569817098825280000000
TCGA-06-0192.10	126	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	86	8	0.0300602585265403110000000
TCGA-06-2563.10	123	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0301851656380469940000000
TCGA-32-4719.15	123	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0301851656380469940000000
TCGA-06-2557.11	177	2_REGULATION_OF_PHOSPHORYLATION	45	7	0.0302495554684388230000000
TCGA-14-0871.20	216	2_EXTRACELLULAR_MATRIX_PART	51	8	0.0302711523568688150000000
TCGA-19-2625.9	146	0_HALLMARK_UV_RESPONSE_DN	122	10	0.0303373692841092600000000
TCGA-06-2558.6	74	1_KEGG_MELANOMA	71	6	0.0304131306854982970000000
TCGA-19-2625.9	146	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	207	13	0.0304450138166463100000000
TCGA-28-5208.28	220	2_NEUROLOGICAL_SYSTEM_PROCESS	296	20	0.0305297354854789510000000
TCGA-12-0616.1	20	2_CELL_CYCLE_PROCESS	163	5	0.0305401029823035820000000
TCGA-02-0033.5	144	2_ION_BINDING	210	13	0.0305931252502582780000000
TCGA-06-0140.2	25	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	3	0.0306113994383935860000000
TCGA-02-0033.5	144	2_REGULATION_OF_APOPTOSIS	309	16	0.0306252659871849510000000
TCGA-06-0130.3	155	2_CELL_CELL_SIGNALING	353	18	0.0306385708385166140000000
TCGA-08-0359.5	37	2_CELL_DEVELOPMENT	511	10	0.0306924331481436100000000
TCGA-27-1838.17	131	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0307143920756421590000000
TCGA-87-5896.6	131	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	8	0.0307143920756421590000000
TCGA-06-0154.2	5	2_MICROTUBULE_CYTOSKELETON	117	3	0.0307220441228683830000000
TCGA-32-4211.7	5	2_MICROTUBULE_CYTOSKELETON	117	3	0.0307220441228683830000000
TCGA-08-0359.5	37	2_EXTRACELLULAR_MATRIX	85	5	0.0307483380261754160000000
TCGA-12-5299.6	38	2_NEUROLOGICAL_SYSTEM_PROCESS	296	8	0.0307548031949340700000000
TCGA-06-0184.11	108	2_GROWTH_FACTOR_ACTIVITY	49	6	0.0307614946539774560000000
TCGA-28-2509.6	59	2_MITOTIC_CELL_CYCLE	134	7	0.0307805399847745280000000
TCGA-06-0143.6	63	2_CELL_CELL_SIGNALING	353	11	0.0308006887132501630000000
TCGA-06-0743.14	63	2_CELL_CELL_SIGNALING	353	11	0.0308006887132501630000000
TCGA-08-0245.4	85	2_INTERPHASE	62	6	0.0308073816639807890000000
TCGA-27-1837.5	85	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	6	0.0308073816639807890000000
TCGA-27-1837.5	85	2_INTERPHASE	62	6	0.0308073816639807890000000
TCGA-27-1831.9	85	1_KEGG_GLIOMA	62	6	0.0308073816639807890000000
TCGA-06-5859.9	125	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	8	0.0308891351339018460000000
TCGA-32-1986.8	87	0_HALLMARK_COAGULATION	125	8	0.0308891351339018460000000
TCGA-32-2634.10	118	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0309008129851857070000000
TCGA-06-2567.9	156	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0309304967037717270000000
TCGA-06-2565.10	38	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	4	0.0309734259749390140000000
TCGA-41-3393.4	12	2_CYTOSKELETON	293	5	0.0310245103172351950000000
TCGA-27-2528.10	99	0_HALLMARK_ANGIOGENESIS	32	5	0.0310313093865767530000000
TCGA-06-5408.3	99	1_KEGG_DNA_REPLICATION	32	5	0.0310313093865767530000000
TCGA-14-0787.7	14	2_INTEGRAL_TO_MEMBRANE	956	8	0.0310462828495043090000000
TCGA-12-0620.1	2	2_REGULATION_OF_GROWTH	41	2	0.0310525130308136710000000
TCGA-12-0620.1	2	2_KINASE_REGULATOR_ACTIVITY	41	2	0.0310525130308136710000000
TCGA-76-4931.4	2	2_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY	41	2	0.0310525130308136710000000
TCGA-32-2634.8	2	2_G_PROTEIN_SIGNALING_COUPLED_TO_IP3_SECOND_MESSENGERPHOSPHOLIPASE_C_ACTIVATING	41	2	0.0310525130308136710000000
TCGA-06-0133.2	2	2_REGULATION_OF_GROWTH	41	2	0.0310525130308136710000000
TCGA-06-0133.2	2	2_KINASE_REGULATOR_ACTIVITY	41	2	0.0310525130308136710000000
TCGA-02-0023.1	2	2_REGULATION_OF_GROWTH	41	2	0.0310525130308136710000000
TCGA-02-0023.1	2	2_KINASE_REGULATOR_ACTIVITY	41	2	0.0310525130308136710000000
TCGA-02-0064.2	2	2_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY	41	2	0.0310525130308136710000000
TCGA-06-0127.4	2	2_REGULATION_OF_GROWTH	41	2	0.0310525130308136710000000
TCGA-06-0127.4	2	2_KINASE_REGULATOR_ACTIVITY	41	2	0.0310525130308136710000000
TCGA-08-0355.3	2	2_REGULATION_OF_GROWTH	41	2	0.0310525130308136710000000
TCGA-08-0355.3	2	2_KINASE_REGULATOR_ACTIVITY	41	2	0.0310525130308136710000000
TCGA-06-0126.9	2	2_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY	41	2	0.0310525130308136710000000
TCGA-02-2485.14	172	1_KEGG_SMALL_CELL_LUNG_CANCER	83	9	0.0311580821884803290000000
TCGA-06-0219.6	6	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0311625552311513430000000
TCGA-16-0861.4	6	2_REGULATION_OF_HORMONE_SECRETION	11	2	0.0311625552311513430000000
TCGA-08-0244.4	6	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0311625552311513430000000
TCGA-12-5299.5	6	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0311625552311513430000000
TCGA-14-1823.12	6	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0311625552311513430000000
TCGA-14-1829.11	6	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0311625552311513430000000
TCGA-14-2554.9	6	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0311625552311513430000000
TCGA-19-5954.17	208	0_HALLMARK_ALLOGRAFT_REJECTION	190	15	0.0311970612716078070000000
TCGA-27-2521.10	94	2_NUCLEOPLASM	233	11	0.0311981298873511770000000
TCGA-06-0216.6	67	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0312323009627943830000000
TCGA-14-1829.14	67	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0312323009627943830000000
TCGA-32-2495.11	67	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0312323009627943830000000
TCGA-02-0010.18	184	2_REPLICATION_FORK	18	5	0.0312697860679294410000000
TCGA-28-2509.6	59	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0312765883522959570000000
TCGA-19-2631.1	6	2_INTRINSIC_TO_PLASMA_MEMBRANE	759	5	0.0312874223930922830000000
TCGA-19-2620.8	6	2_INTRINSIC_TO_PLASMA_MEMBRANE	759	5	0.0312874223930922830000000
TCGA-06-5410.3	3	2_G_PROTEIN_SIGNALING_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY	24	2	0.0313067792044568680000000
TCGA-32-2494.10	173	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	11	0.0313384476983860700000000
TCGA-41-2575.49	136	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0314211681626601210000000
TCGA-32-1979.4	12	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	4	0.0314211681626605580000000
TCGA-28-5208.28	220	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0314512210926766320000000
TCGA-41-5651.5	112	1_KEGG_FOCAL_ADHESION	195	11	0.0314705944736433510000000
TCGA-26-5133.10	75	1_KEGG_BLADDER_CANCER	42	5	0.0314922806059099450000000
TCGA-26-5133.10	75	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0314922806059099450000000
TCGA-02-0068.1	72	2_SYNAPTIC_TRANSMISSION	152	8	0.0315858294311422150000000
TCGA-32-5222.9	70	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0316901438248445990000000
TCGA-19-5947.4	267	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	8	0.0317250674606158260000000
TCGA-28-5208.28	220	2_REGULATION_OF_KINASE_ACTIVITY	138	13	0.0317401057344196960000000
TCGA-06-5858.19	205	0_HALLMARK_KRAS_SIGNALING_UP	148	13	0.0317785421399446600000000
TCGA-27-2523.12	112	2_REGULATION_OF_CELL_CYCLE	160	10	0.0317951423990469260000000
TCGA-06-0877.7	4	2_REGULATION_OF_CELL_CYCLE	160	3	0.0318266408848765020000000
TCGA-16-0861.5	4	2_REGULATION_OF_CELL_CYCLE	160	3	0.0318266408848765020000000
TCGA-08-0348.3	4	2_REGULATION_OF_CELL_CYCLE	160	3	0.0318266408848765020000000
TCGA-02-0089.5	91	2_APOPTOSIS_GO	389	14	0.0318340328965490550000000
TCGA-02-0033.5	144	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	16	0.0318742911084763660000000
TCGA-06-0241.8	53	1_KEGG_THYROID_CANCER	29	4	0.0319294394959756460000000
TCGA-02-2486.9	141	2_CELL_CELL_SIGNALING	353	17	0.0319719475791199960000000
TCGA-08-0245.4	85	2_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0319783691822775950000000
TCGA-08-0245.4	85	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0319783691822775950000000
TCGA-06-6390.9	82	2_EXTRACELLULAR_REGION_PART	269	11	0.0320135489959585130000000
TCGA-19-2625.9	146	0_HALLMARK_MYC_TARGETS_V1	178	12	0.0320191447320727000000000
TCGA-19-5954.17	208	2_CELL_CYCLE_PHASE	146	13	0.0320482256390555300000000
TCGA-06-0124.6	55	2_POLYSACCHARIDE_BINDING	28	4	0.0320615364162070910000000
TCGA-32-2495.11	67	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0320811797457751790000000
TCGA-02-0011.1	288	0_HALLMARK_ALLOGRAFT_REJECTION	190	18	0.0321298010437417180000000
TCGA-06-0189.3	118	2_SYNAPTIC_TRANSMISSION	152	10	0.0321727317251054020000000
TCGA-06-5859.9	125	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION_RESULTING_IN_INDUCTION_OF_APOPTOSIS	13	4	0.0321730133008122090000000
TCGA-06-5859.9	125	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0321730133008122090000000
TCGA-19-1790.18	201	2_CELL_CELL_SIGNALING	353	21	0.0321820915485842780000000
TCGA-19-5952.11	193	2_RESPONSE_TO_STRESS	427	23	0.0321959821374650230000000
TCGA-12-5299.5	6	1_KEGG_PATHWAYS_IN_CANCER	323	4	0.0321978006081273250000000
TCGA-06-0176.8	95	1_KEGG_PATHWAYS_IN_CANCER	323	13	0.0322495385431663460000000
TCGA-14-4157.7	101	2_RESPONSE_TO_ENDOGENOUS_STIMULUS	178	10	0.0323067950386391400000000
TCGA-06-2559.11	101	0_HALLMARK_MYC_TARGETS_V1	178	10	0.0323067950386391400000000
TCGA-32-1979.10	116	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	13	0.0323185834371348470000000
TCGA-02-0010.18	184	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	8	0.0323468630567728050000000
TCGA-12-1597.6	51	2_DNA_METABOLIC_PROCESS	218	8	0.0323613262913917050000000
TCGA-02-0060.19	281	2_REGULATION_OF_BODY_FLUID_LEVELS	52	9	0.0324067200989394330000000
TCGA-02-0069.13	16	0_HALLMARK_ANGIOGENESIS	32	3	0.0324201581449730660000000
TCGA-19-1790.1	4	2_NEGATIVE_REGULATION_OF_TRANSCRIPTION	161	3	0.0324283364351023660000000
TCGA-12-1597.6	51	1_KEGG_GLIOMA	62	5	0.0325146069377441890000000
TCGA-28-2514.9	62	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0325146069377441890000000
TCGA-06-0214.9	62	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0325146069377441890000000
TCGA-02-0069.12	62	0_HALLMARK_MYC_TARGETS_V1	178	8	0.0325340867815244390000000
TCGA-08-0353.8	100	0_HALLMARK_ANGIOGENESIS	32	5	0.0325865582431348260000000
TCGA-26-5132.7	100	0_HALLMARK_ANGIOGENESIS	32	5	0.0325865582431348260000000
TCGA-02-2486.1	2	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	2	0.0326051386823529720000000
TCGA-41-3393.5	88	2_RESPONSE_TO_WOUNDING	163	9	0.0326751577047995410000000
TCGA-06-5413.11	142	2_COLLAGEN	23	5	0.0326795337600033350000000
TCGA-02-0089.5	91	2_PROGRAMMED_CELL_DEATH	390	14	0.0327623418563233670000000
TCGA-06-5858.19	205	2_CYTOSKELETON	293	19	0.0327928322850718000000000
TCGA-14-0781.7	155	1_KEGG_MELANOMA	71	8	0.0328074782135617180000000
TCGA-41-3393.5	88	2_ORGAN_DEVELOPMENT	460	15	0.0328755607357947150000000
TCGA-27-1831.9	85	0_HALLMARK_E2F_TARGETS	169	9	0.0328793089513890750000000
TCGA-26-1439.11	10	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	3	0.0328812302044254950000000
TCGA-06-0744.4	11	2_SYNAPTIC_TRANSMISSION	152	4	0.0328936470545088400000000
TCGA-06-0882.1	11	2_SYNAPTIC_TRANSMISSION	152	4	0.0328936470545088400000000
TCGA-02-0038.3	199	2_NUCLEAR_LUMEN	302	19	0.0329050487669533200000000
TCGA-32-2491.14	244	2_COLLAGEN	23	6	0.0329077998465846230000000
TCGA-06-2558.6	74	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	6	0.0329737286813117580000000
TCGA-14-0787.6	40	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	3	0.0329994754730336200000000
TCGA-14-0781.7	155	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	30	0.0330334339825125380000000
TCGA-19-5947.4	267	2_GROWTH_FACTOR_BINDING	31	7	0.0330507566426396500000000
TCGA-19-5952.11	193	1_KEGG_BLADDER_CANCER	42	7	0.0331255350801419810000000
TCGA-06-0174.37	141	2_CHROMOSOMAL_PART	78	8	0.0331371763014245490000000
TCGA-06-0128.8	74	1_KEGG_FOCAL_ADHESION	195	9	0.0331406088536535110000000
TCGA-06-5858.7	5	2_RNA_PROCESSING	120	3	0.0331520143320469670000000
TCGA-06-2562.7	57	1_KEGG_PATHWAYS_IN_CANCER	323	10	0.0331573796544493150000000
TCGA-27-1830.7	57	1_KEGG_PATHWAYS_IN_CANCER	323	10	0.0331573796544493150000000
TCGA-06-0197.1	57	1_KEGG_PATHWAYS_IN_CANCER	323	10	0.0331573796544493150000000
TCGA-14-4157.7	101	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	6	0.0332104711280645020000000
TCGA-06-2559.11	101	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	53	6	0.0332104711280645020000000
TCGA-19-5954.17	208	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	10	0.0332595765697195760000000
TCGA-32-1979.4	12	2_REGULATION_OF_KINASE_ACTIVITY	138	4	0.0332867996532204070000000
TCGA-19-5951.10	138	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0332867996532204140000000
TCGA-28-1753.13	174	0_HALLMARK_MITOTIC_SPINDLE	175	13	0.0332902218556034440000000
TCGA-16-1048.13	97	0_HALLMARK_KRAS_SIGNALING_UP	148	9	0.0332955667849653480000000
TCGA-28-6450.11	139	2_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0334413591422059520000000
TCGA-28-6450.11	139	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	20	0.0334413591422059520000000
TCGA-06-5415.7	7	2_REGULATION_OF_CELL_PROLIFERATION	265	4	0.0334868332356718990000000
TCGA-76-6285.5	106	2_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0334912877916897640000000
TCGA-76-6285.5	106	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	17	0.0334912877916897640000000
TCGA-08-0350.2	46	2_MICROTUBULE_CYTOSKELETON	117	6	0.0335096928433249110000000
TCGA-14-0787.7	14	2_INTRINSIC_TO_MEMBRANE	966	8	0.0335442783643831110000000
TCGA-06-5418.4	24	2_RECEPTOR_ACTIVITY	499	8	0.0335549606993084810000000
TCGA-12-0821.9	81	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0335563086474521340000000
TCGA-28-1747.5	81	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0335563086474521340000000
TCGA-41-2572.8	76	1_KEGG_BLADDER_CANCER	42	5	0.0336000231096091690000000
TCGA-06-0219.6	6	2_ENZYME_INHIBITOR_ACTIVITY	96	3	0.0336127719057555330000000
TCGA-08-0244.4	6	2_ENZYME_INHIBITOR_ACTIVITY	96	3	0.0336127719057555330000000
TCGA-12-5299.5	6	2_ENZYME_INHIBITOR_ACTIVITY	96	3	0.0336127719057555330000000
TCGA-14-1823.12	6	2_ENZYME_INHIBITOR_ACTIVITY	96	3	0.0336127719057555330000000
TCGA-14-1829.11	6	2_ENZYME_INHIBITOR_ACTIVITY	96	3	0.0336127719057555330000000
TCGA-14-2554.9	6	2_ENZYME_INHIBITOR_ACTIVITY	96	3	0.0336127719057555330000000
TCGA-02-0058.1	110	2_TRANSMISSION_OF_NERVE_IMPULSE	164	10	0.0336390117661829880000000
TCGA-16-0861.5	4	2_CELL_CYCLE_PROCESS	163	3	0.0336542818791223390000000
TCGA-06-2561.7	4	2_CELL_CYCLE_PROCESS	163	3	0.0336542818791223390000000
TCGA-02-0089.5	91	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	14	0.0337144980110341970000000
TCGA-06-0646.4	63	2_EXTRACELLULAR_MATRIX	85	6	0.0338069613302584280000000
TCGA-06-0743.14	63	2_EXTRACELLULAR_MATRIX	85	6	0.0338069613302584280000000
TCGA-02-0089.5	91	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	11	0.0338285342119449060000000
TCGA-28-5213.9	143	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	6	0.0338825280527880610000000
TCGA-02-0102.8	82	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0338888457894677970000000
TCGA-06-0650.2	82	0_HALLMARK_COMPLEMENT	176	9	0.0339088102055608160000000
TCGA-06-0185.13	71	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0339706816056931790000000
TCGA-06-0221.13	45	1_KEGG_MELANOMA	71	5	0.0339706816056932060000000
TCGA-32-1986.3	3	1_KEGG_HOMOLOGOUS_RECOMBINATION	25	2	0.0340267024370096980000000
TCGA-02-0060.19	281	2_CELL_DEVELOPMENT	511	33	0.0340625368219682130000000
TCGA-28-5219.9	47	1_KEGG_LONG_TERM_POTENTIATION	68	5	0.0341297993852604650000000
TCGA-06-0132.3	2	1_KEGG_PROTEASOME	43	2	0.0341956332522223360000000
TCGA-06-2559.11	101	0_HALLMARK_ANGIOGENESIS	32	5	0.0342019299126508080000000
TCGA-06-0744.3	12	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	299	5	0.0342277582665007560000000
TCGA-27-2519.7	113	2_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	195	11	0.0342444569334933790000000
TCGA-26-5139.10	163	1_KEGG_LONG_TERM_POTENTIATION	68	8	0.0342744207838610520000000
TCGA-02-0025.5	88	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0343115878675180970000000
TCGA-27-1832.11	88	2_TRANSMISSION_OF_NERVE_IMPULSE	164	9	0.0343115878675180970000000
TCGA-28-5218.5	208	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	126	12	0.0343378303525287980000000
TCGA-28-5218.5	208	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	12	0.0343378303525287980000000
TCGA-76-4927.8	93	1_KEGG_FOCAL_ADHESION	195	10	0.0343609124483700640000000
TCGA-06-0155.1	5	2_NEGATIVE_REGULATION_OF_DNA_BINDING	14	2	0.0343732357986305870000000
TCGA-06-0157.7	89	2_REPLICATION_FORK	18	4	0.0343985027796720330000000
TCGA-06-0189.3	118	0_HALLMARK_UV_RESPONSE_DN	122	9	0.0344087000759307000000000
TCGA-87-5896.6	131	2_EXTRACELLULAR_REGION_PART	269	14	0.0344603456709286840000000
TCGA-28-5207.12	188	2_CELL_CYCLE_GO_0007049	265	17	0.0345062021871725970000000
TCGA-27-2518.5	20	2_GLYCOSAMINOGLYCAN_BINDING	26	3	0.0345574839004615590000000
TCGA-12-0616.1	20	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	3	0.0345574839004615590000000
TCGA-14-0871.20	216	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	7	0.0345656306601928520000000
TCGA-28-2502.9	56	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	13	0.0346178919613045480000000
TCGA-02-0015.16	115	2_ENZYME_INHIBITOR_ACTIVITY	96	8	0.0346838176656936380000000
TCGA-06-2557.11	177	0_HALLMARK_KRAS_SIGNALING_UP	148	12	0.0347086442484346450000000
TCGA-19-5950.7	113	1_KEGG_MELANOMA	71	7	0.0347325193968295800000000
TCGA-28-5220.7	15	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0347395363672943630000000
TCGA-76-4935.7	15	2_SPINDLE	35	3	0.0347395363672943630000000
TCGA-14-0781.7	155	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	12	0.0347545600664434310000000
TCGA-06-0210.6	103	0_HALLMARK_COMPLEMENT	176	10	0.0348200067762580650000000
TCGA-06-0184.11	108	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	19	0.0348863941085175570000000
TCGA-02-0083.21	135	2_DNA_REPLICATION	82	8	0.0349600994678232330000000
TCGA-08-0360.3	144	2_COLLAGEN	23	5	0.0349696527873333480000000
TCGA-06-2569.5	144	1_KEGG_MISMATCH_REPAIR	23	5	0.0349696527873333480000000
TCGA-06-2569.5	144	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	5	0.0349696527873333480000000
TCGA-02-0052.3	116	2_CELL_CYCLE_GO_0007049	265	13	0.0350186328960326100000000
TCGA-02-0038.3	199	2_BIOPOLYMER_METABOLIC_PROCESS	1367	51	0.0350591317868897900000000
TCGA-06-0141.1	45	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	14	0.0350604665960207100000000
TCGA-06-0644.16	142	2_CELL_CELL_SIGNALING	353	17	0.0351037436808205180000000
TCGA-06-0148.6	69	2_COLLAGEN	23	4	0.0351129873514772280000000
TCGA-06-0148.6	69	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0351129873514772280000000
TCGA-06-0241.8	53	2_CHROMOSOME	102	6	0.0351355926199646980000000
TCGA-06-0646.4	63	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0351744622296814860000000
TCGA-06-0743.14	63	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0351744622296814860000000
TCGA-19-2624.29	130	2_INTERPHASE	62	7	0.0351858523214066620000000
TCGA-32-2638.17	159	2_EXTRACELLULAR_MATRIX_PART	51	7	0.0351912124223623110000000
TCGA-14-0813.5	5	2_PLASMA_MEMBRANE	1096	5	0.0352153345328339380000000
TCGA-06-5859.2	5	2_PLASMA_MEMBRANE	1096	5	0.0352153345328339380000000
TCGA-32-1979.4	12	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	4	0.0352329194988013630000000
TCGA-06-0188.11	66	0_HALLMARK_UV_RESPONSE_DN	122	7	0.0352697035173785490000000
TCGA-76-6193.13	271	1_KEGG_BLADDER_CANCER	42	8	0.0353269462177599260000000
TCGA-81-5910.12	128	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0353336780805344610000000
TCGA-06-0158.4	65	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0353403099141801490000000
TCGA-14-0871.20	216	2_CONDENSED_CHROMOSOME	26	6	0.0353456180702922120000000
TCGA-08-0350.2	46	1_KEGG_PANCREATIC_CANCER	70	5	0.0353514929489730230000000
TCGA-06-0877.8	61	2_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION	9	3	0.0353667571923798050000000
TCGA-32-2491.14	244	2_CELL_PROLIFERATION_GO_0008283	436	27	0.0354140119309849930000000
TCGA-02-0114.20	132	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0354656015222799340000000
TCGA-02-2470.4	11	2_CELL_CYCLE_ARREST_GO_0007050	49	3	0.0355072572748806810000000
TCGA-27-1836.8	49	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	3	0.0355072572748806880000000
TCGA-19-5947.4	267	1_KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	99	12	0.0355109204126806200000000
TCGA-32-2638.17	159	1_KEGG_LEISHMANIA_INFECTION	70	8	0.0355173777840732950000000
TCGA-27-1832.11	88	2_CELL_CELL_SIGNALING	353	13	0.0355646333754059480000000
TCGA-06-5859.9	125	2_IMMUNE_SYSTEM_PROCESS	283	14	0.0355724236323599270000000
TCGA-02-0003.9	227	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0355936164032487410000000
TCGA-02-0025.5	88	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	8	0.0356136836065549590000000
TCGA-41-3393.5	88	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	8	0.0356136836065549590000000
TCGA-06-0237.4	66	0_HALLMARK_E2F_TARGETS	169	8	0.0356524581339148290000000
TCGA-32-4210.14	109	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION	30	5	0.0356711750476520280000000
TCGA-06-0686.1	7	2_METABOTROPIC_GLUTAMATEGABA_B_LIKE_RECEPTOR_ACTIVITY	10	2	0.0356852135313086850000000
TCGA-19-2624.29	130	1_KEGG_BLADDER_CANCER	42	6	0.0356989293322648930000000
TCGA-32-2491.14	244	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	13	0.0357185147886886210000000
TCGA-32-2615.7	77	1_KEGG_BLADDER_CANCER	42	5	0.0358160789092043590000000
TCGA-12-0620.3	2	2_PHOSPHOLIPID_METABOLIC_PROCESS	44	2	0.0358239967404215130000000
TCGA-16-1045.2	2	2_PHOSPHOLIPID_METABOLIC_PROCESS	44	2	0.0358239967404215130000000
TCGA-32-2634.8	2	2_PHOSPHOINOSITIDE_MEDIATED_SIGNALING	44	2	0.0358239967404215130000000
TCGA-08-0380.1	2	2_PHOSPHOLIPID_METABOLIC_PROCESS	44	2	0.0358239967404215130000000
TCGA-12-0692.1	2	2_PHOSPHOLIPID_METABOLIC_PROCESS	44	2	0.0358239967404215130000000
TCGA-06-0743.6	2	2_PHOSPHOLIPID_METABOLIC_PROCESS	44	2	0.0358239967404215130000000
TCGA-06-5414.13	102	0_HALLMARK_ANGIOGENESIS	32	5	0.0358790562191773700000000
TCGA-16-1048.13	97	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0358867389812064230000000
TCGA-32-5222.9	70	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0358981190269426140000000
TCGA-32-2494.10	173	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	9	0.0359836129605733970000000
TCGA-06-5415.7	7	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	5	0.0359917504554645090000000
TCGA-32-4211.14	71	1_KEGG_ENDOCYTOSIS	157	8	0.0360056686285288860000000
TCGA-02-0102.8	82	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0360086931971543570000000
TCGA-14-0789.11	3	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	263	3	0.0360497710229460910000000
TCGA-26-1439.7	3	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	263	3	0.0360497710229460910000000
TCGA-32-2494.8	3	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	263	3	0.0360497710229460910000000
TCGA-14-1825.5	3	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	263	3	0.0360497710229460910000000
TCGA-14-0786.2	10	0_HALLMARK_G2M_CHECKPOINT	174	4	0.0361738249966255950000000
TCGA-28-1753.13	174	2_SPINDLE_ORGANIZATION_AND_BIOGENESIS	10	4	0.0361738249966260940000000
TCGA-06-0878.10	115	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	9	0.0362411937984601290000000
TCGA-08-0389.4	56	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	7	0.0362567450401486270000000
TCGA-06-2570.8	95	2_MICROTUBULE_CYTOSKELETON	117	8	0.0364235146265702860000000
TCGA-28-5216.8	162	2_DNA_METABOLIC_PROCESS	218	14	0.0365100095989140190000000
TCGA-02-0060.19	281	1_KEGG_ASTHMA	30	7	0.0365143427783499940000000
TCGA-27-1838.17	131	2_EXTRACELLULAR_MATRIX	85	8	0.0366156435893711180000000
TCGA-87-5896.6	131	2_EXTRACELLULAR_MATRIX	85	8	0.0366156435893711180000000
TCGA-02-0007.17	217	2_NEURON_PROJECTION	16	5	0.0366490105790045690000000
TCGA-06-2565.10	38	2_RESPONSE_TO_DNA_DAMAGE_STIMULUS	145	6	0.0366670150676522350000000
TCGA-06-5858.19	205	0_HALLMARK_APOPTOSIS	150	13	0.0366967405157609460000000
TCGA-81-5910.12	128	2_ENZYME_REGULATOR_ACTIVITY	277	14	0.0367093182047371560000000
TCGA-02-0075.8	128	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	8	0.0367164073121081860000000
TCGA-28-1753.13	174	0_HALLMARK_ANGIOGENESIS	32	6	0.0368297843687730090000000
TCGA-02-0115.4	3	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0368596551300117080000000
TCGA-06-0750.9	3	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0368596551300117080000000
TCGA-27-1834.9	3	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0368596551300117080000000
TCGA-06-0649.4	3	2_CHROMOSOME_SEGREGATION	26	2	0.0368596551300117080000000
TCGA-06-0882.9	3	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0368596551300117080000000
TCGA-19-2620.6	3	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0368596551300117080000000
TCGA-06-0208.3	3	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	2	0.0368596551300117080000000
TCGA-02-0115.4	3	2_CELL_CYCLE_GO_0007049	265	3	0.0368816644842981170000000
TCGA-02-0115.4	3	2_REGULATION_OF_CELL_PROLIFERATION	265	3	0.0368816644842981170000000
TCGA-06-0143.3	3	2_CELL_CYCLE_GO_0007049	265	3	0.0368816644842981170000000
TCGA-06-0750.9	3	2_CELL_CYCLE_GO_0007049	265	3	0.0368816644842981170000000
TCGA-06-0750.9	3	2_REGULATION_OF_CELL_PROLIFERATION	265	3	0.0368816644842981170000000
TCGA-27-1834.9	3	2_CELL_CYCLE_GO_0007049	265	3	0.0368816644842981170000000
TCGA-27-1834.9	3	2_REGULATION_OF_CELL_PROLIFERATION	265	3	0.0368816644842981170000000
TCGA-06-0882.9	3	2_CELL_CYCLE_GO_0007049	265	3	0.0368816644842981170000000
TCGA-06-0882.9	3	2_REGULATION_OF_CELL_PROLIFERATION	265	3	0.0368816644842981170000000
TCGA-19-2620.6	3	2_CELL_CYCLE_GO_0007049	265	3	0.0368816644842981170000000
TCGA-06-0208.3	3	2_CELL_CYCLE_GO_0007049	265	3	0.0368816644842981170000000
TCGA-06-0213.9	74	0_HALLMARK_P53_PATHWAY	151	8	0.0369004893007628540000000
TCGA-02-0021.4	170	2_REGULATION_OF_CELL_PROLIFERATION	265	16	0.0369161388442567910000000
TCGA-27-1838.17	131	2_INTERPHASE	62	7	0.0369825135803019960000000
TCGA-08-0351.1	10	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	4	0.0370009650442499270000000
TCGA-28-5208.28	220	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	13	0.0370480668220050520000000
TCGA-08-0360.3	144	0_HALLMARK_HYPOXIA	154	11	0.0370739916816765070000000
TCGA-19-5960.9	134	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	10	0.0371239193540929340000000
TCGA-32-4210.14	109	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	12	0.0371528021756706290000000
TCGA-08-0389.4	56	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0371723091777262860000000
TCGA-06-5411.4	23	1_KEGG_PANCREATIC_CANCER	70	4	0.0371810309914580930000000
TCGA-06-2562.7	57	2_REGULATION_OF_TRANSPORT	57	5	0.0372306565523174980000000
TCGA-06-0644.16	142	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0372617111540135620000000
TCGA-06-5413.11	142	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0372617111540135620000000
TCGA-27-2523.12	112	2_CELL_CYCLE_PROCESS	163	10	0.0373687192531794510000000
TCGA-06-0141.1	45	0_HALLMARK_UV_RESPONSE_DN	122	6	0.0373708283429909010000000
TCGA-02-0115.1	36	0_HALLMARK_HYPOXIA	154	6	0.0373824750142011110000000
TCGA-06-0744.10	36	2_ENZYME_BINDING	154	6	0.0373824750142011110000000
TCGA-87-5896.6	131	2_EXTRACELLULAR_REGION	346	16	0.0373959030421258660000000
TCGA-32-2498.13	133	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	84	8	0.0374654746148279370000000
TCGA-32-4211.14	71	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0374669198521472220000000
TCGA-26-5135.9	71	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0374669198521472220000000
TCGA-12-0620.1	2	2_REGULATION_OF_PHOSPHORYLATION	45	2	0.0374902291469508260000000
TCGA-12-0620.3	2	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	2	0.0374902291469508260000000
TCGA-16-1045.2	2	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	2	0.0374902291469508260000000
TCGA-06-0210.3	2	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	2	0.0374902291469508260000000
TCGA-08-0380.1	2	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	2	0.0374902291469508260000000
TCGA-06-0133.2	2	2_REGULATION_OF_PHOSPHORYLATION	45	2	0.0374902291469508260000000
TCGA-12-0692.1	2	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	2	0.0374902291469508260000000
TCGA-02-0023.1	2	2_REGULATION_OF_PHOSPHORYLATION	45	2	0.0374902291469508260000000
TCGA-06-0137.8	2	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	2	0.0374902291469508260000000
TCGA-06-0743.6	2	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	2	0.0374902291469508260000000
TCGA-06-0127.4	2	2_REGULATION_OF_PHOSPHORYLATION	45	2	0.0374902291469508260000000
TCGA-08-0355.3	2	2_REGULATION_OF_PHOSPHORYLATION	45	2	0.0374902291469508260000000
TCGA-32-4208.19	2	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	2	0.0374902291469508260000000
TCGA-32-1979.10	116	1_KEGG_LEISHMANIA_INFECTION	70	7	0.0375083004156193740000000
TCGA-06-0877.7	4	0_HALLMARK_E2F_TARGETS	169	3	0.0375158387711221760000000
TCGA-02-0113.1	4	0_HALLMARK_E2F_TARGETS	169	3	0.0375158387711221760000000
TCGA-06-2561.7	4	0_HALLMARK_E2F_TARGETS	169	3	0.0375158387711221760000000
TCGA-08-0348.3	4	0_HALLMARK_E2F_TARGETS	169	3	0.0375158387711221760000000
TCGA-06-0210.6	103	0_HALLMARK_ANGIOGENESIS	32	5	0.0376195937897114630000000
TCGA-27-1834.10	39	2_NEUROLOGICAL_SYSTEM_PROCESS	296	8	0.0376510599390746100000000
TCGA-02-0089.5	91	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	6	0.0376646003921656610000000
TCGA-02-0003.9	227	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	39	0.0377279641712986310000000
TCGA-27-2521.10	94	1_KEGG_FOCAL_ADHESION	195	10	0.0377705259859192480000000
TCGA-27-1834.10	39	1_KEGG_ECM_RECEPTOR_INTERACTION	84	5	0.0378027272909334380000000
TCGA-28-2502.9	56	2_CELL_CYCLE_GO_0007049	265	9	0.0378536851012380650000000
TCGA-28-2502.9	56	2_REGULATION_OF_CELL_PROLIFERATION	265	9	0.0378536851012380650000000
TCGA-08-0357.4	36	1_KEGG_PATHWAYS_IN_CANCER	323	8	0.0378787962319279970000000
TCGA-06-0744.10	36	1_KEGG_PATHWAYS_IN_CANCER	323	8	0.0378787962319279970000000
TCGA-08-0350.2	46	1_KEGG_MELANOMA	71	5	0.0378921858206048640000000
TCGA-28-2502.9	56	2_CELL_CYCLE_PHASE	146	7	0.0379092919676089910000000
TCGA-06-0195.8	56	2_CELL_CYCLE_PHASE	146	7	0.0379092919676089910000000
TCGA-06-0744.4	11	2_TRANSPORT	600	6	0.0379404247312271280000000
TCGA-06-0882.1	11	2_TRANSPORT	600	6	0.0379404247312271280000000
TCGA-28-5207.12	188	2_TRANSMISSION_OF_NERVE_IMPULSE	164	13	0.0379683670414805720000000
TCGA-02-0009.6	188	2_TRANSMISSION_OF_NERVE_IMPULSE	164	13	0.0379683670414805720000000
TCGA-02-0080.3	20	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	9	0.0379872252821363480000000
TCGA-06-0211.8	62	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0381214758035259420000000
TCGA-14-0787.6	40	2_DNA_REPLICATION	82	5	0.0381539788639522690000000
TCGA-08-0347.7	25	2_EXTRACELLULAR_REGION	346	7	0.0381721814727416920000000
TCGA-06-0211.8	62	0_HALLMARK_APICAL_JUNCTION	182	8	0.0382120449722460060000000
TCGA-06-0174.37	141	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0382298767033390770000000
TCGA-32-2615.7	77	1_KEGG_MELANOMA	71	6	0.0382411118643349040000000
TCGA-06-5412.1	28	2_RESPONSE_TO_STRESS	427	8	0.0385110786503468150000000
TCGA-19-5954.17	208	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	7	0.0385111932996210840000000
TCGA-76-6193.13	271	1_KEGG_SMALL_CELL_LUNG_CANCER	83	11	0.0385516504983826200000000
TCGA-08-0390.1	54	2_SYNAPTIC_TRANSMISSION	152	7	0.0385828938804423650000000
TCGA-06-6391.6	30	2_REPLICATION_FORK	18	3	0.0385830313708215790000000
TCGA-76-4926.9	66	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	6	0.0386035930016442870000000
TCGA-06-0188.11	66	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0386035930016442870000000
TCGA-14-0781.7	155	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	7	0.0386336855278581540000000
TCGA-32-5222.9	70	2_CELL_CYCLE_GO_0007049	265	10	0.0386659215528803520000000
TCGA-32-5222.9	70	2_REGULATION_OF_CELL_PROLIFERATION	265	10	0.0386659215528803520000000
TCGA-02-0014.10	70	2_REGULATION_OF_CELL_PROLIFERATION	265	10	0.0386659215528803520000000
TCGA-06-0143.6	63	2_GTPASE_ACTIVATOR_ACTIVITY	52	5	0.0387177942573288870000000
TCGA-06-0878.10	115	2_CELL_CELL_SIGNALING	353	15	0.0387443039335419740000000
TCGA-02-0026.1	61	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	9	0.0387544892356942940000000
TCGA-14-1034.7	97	1_KEGG_ECM_RECEPTOR_INTERACTION	84	7	0.0388238327533100840000000
TCGA-27-2524.5	75	0_HALLMARK_APOPTOSIS	150	8	0.0388398274309619750000000
TCGA-26-1439.11	10	2_PROTEIN_KINASE_BINDING	56	3	0.0388433771246084260000000
TCGA-32-1979.10	116	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	126	9	0.0388526547076666270000000
TCGA-02-0114.20	132	2_INTERPHASE	62	7	0.0388542994615642400000000
TCGA-27-1835.3	4	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0388654804350540490000000
TCGA-14-0790.1	4	1_KEGG_CALCIUM_SIGNALING_PATHWAY	171	3	0.0388654804350540490000000
TCGA-06-0878.10	115	1_KEGG_MELANOMA	71	7	0.0389375194235959820000000
TCGA-02-0015.16	115	1_KEGG_MELANOMA	71	7	0.0389375194235959820000000
TCGA-12-5301.7	46	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0389483853084105070000000
TCGA-27-1830.7	57	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	839	16	0.0389563924140294350000000
TCGA-32-2491.14	244	2_STRUCTURAL_MOLECULE_ACTIVITY	206	17	0.0390053802807551480000000
TCGA-14-1034.7	97	0_HALLMARK_P53_PATHWAY	151	9	0.0390864627547865000000000
TCGA-12-0619.11	123	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0391479538790850120000000
TCGA-06-2563.10	123	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0391479538790850120000000
TCGA-32-4719.15	123	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0391479538790850120000000
TCGA-27-1833.7	17	1_KEGG_DNA_REPLICATION	32	3	0.0392767620707011180000000
TCGA-06-0178.2	17	1_KEGG_DNA_REPLICATION	32	3	0.0392767620707011180000000
TCGA-06-5411.4	23	2_MITOSIS	71	4	0.0393372960988377930000000
TCGA-32-4211.14	71	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0393372960988377930000000
TCGA-02-0107.3	71	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0393372960988377930000000
TCGA-27-2526.7	71	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0393372960988377930000000
TCGA-26-5135.9	71	2_COLLAGEN	23	4	0.0393372960988377930000000
TCGA-26-5135.9	71	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0393372960988377930000000
TCGA-02-0024.6	206	2_NUCLEUS	1110	45	0.0393405034907122410000000
TCGA-27-1837.5	85	2_CELL_CYCLE_GO_0007049	265	11	0.0393665667428181950000000
TCGA-02-0048.9	84	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	9	0.0394322201150851950000000
TCGA-32-2632.16	229	2_APOPTOSIS_GO	389	24	0.0394428635175595800000000
TCGA-06-0143.3	3	2_PHOSPHORYLATION	271	3	0.0394539326108679160000000
TCGA-06-5411.3	19	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	4	0.0395372246175941660000000
TCGA-02-0033.1	4	0_HALLMARK_MYOGENESIS	172	3	0.0395522167582792670000000
TCGA-19-5960.9	134	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0395592285513641710000000
TCGA-06-2570.8	95	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0395658737532512130000000
TCGA-26-1439.11	10	0_HALLMARK_MYC_TARGETS_V1	178	4	0.0395662726311373570000000
TCGA-06-6391.7	5	2_SPINDLE_MICROTUBULE	15	2	0.0396530230797492790000000
TCGA-06-0155.1	5	2_NEGATIVE_REGULATION_OF_BINDING	15	2	0.0396530230797492790000000
TCGA-02-0001.5	117	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	70	7	0.0396624062948363890000000
TCGA-32-2632.16	229	2_POSITIVE_REGULATION_OF_HYDROLASE_ACTIVITY	50	8	0.0397382127267134620000000
TCGA-32-4210.14	109	2_REGULATION_OF_MOLECULAR_FUNCTION	286	13	0.0399287873181157290000000
TCGA-28-5207.12	188	2_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0399421992549760240000000
TCGA-28-5207.12	188	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	24	0.0399421992549760240000000
TCGA-06-0875.7	78	1_KEGG_OOCYTE_MEIOSIS	105	7	0.0400163965720893230000000
TCGA-06-5413.11	142	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	7	0.0400217663553223830000000
TCGA-02-0007.17	217	0_HALLMARK_ESTROGEN_RESPONSE_LATE	143	13	0.0402031606640789120000000
TCGA-06-0157.7	89	2_CELL_CELL_SIGNALING	353	13	0.0402661812517924320000000
TCGA-06-0145.17	11	2_REGULATION_OF_CELL_CYCLE	160	4	0.0402723659758339180000000
TCGA-02-2470.4	11	2_REGULATION_OF_CELL_CYCLE	160	4	0.0402723659758339180000000
TCGA-41-3392.31	136	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0403314409364684960000000
TCGA-26-1439.10	84	2_EXTRACELLULAR_REGION_PART	269	11	0.0403798339784573190000000
TCGA-32-2494.10	173	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	7	0.0403918055428435920000000
TCGA-06-0241.8	53	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	13	0.0404137969968988500000000
TCGA-06-5858.19	205	2_CELL_PROLIFERATION_GO_0008283	436	24	0.0404190871215178090000000
TCGA-19-2619.14	100	2_DNA_REPLICATION	82	7	0.0404367123156119460000000
TCGA-28-5208.28	220	2_ENZYME_REGULATOR_ACTIVITY	277	19	0.0404422778459001190000000
TCGA-76-4925.9	83	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0404743550227065690000000
TCGA-06-0158.4	65	2_EXTRACELLULAR_MATRIX	85	6	0.0405127253256778800000000
TCGA-06-0171.7	57	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0405564569040093440000000
TCGA-08-0350.2	46	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	5	0.0405727897023140380000000
TCGA-06-2557.11	177	0_HALLMARK_ANGIOGENESIS	32	6	0.0405780691638063100000000
TCGA-06-2557.11	177	1_KEGG_DNA_REPLICATION	32	6	0.0405780691638063100000000
TCGA-76-4934.4	20	2_NEUROLOGICAL_SYSTEM_PROCESS	296	6	0.0406285252703951560000000
TCGA-16-1045.10	81	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	5	0.0406564976452885580000000
TCGA-76-4935.8	21	2_TRANSMISSION_OF_NERVE_IMPULSE	164	5	0.0407126836727636430000000
TCGA-02-0080.3	20	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	4	0.0407356439613131350000000
TCGA-08-0386.4	73	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0407389574774763150000000
TCGA-27-1836.8	49	2_NON_MEMBRANE_BOUND_ORGANELLE	476	11	0.0407596803961143080000000
TCGA-27-1836.8	49	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	11	0.0407596803961143080000000
TCGA-06-0129.11	110	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	12	0.0407655917665188380000000
TCGA-06-5418.4	24	2_SECRETION	142	5	0.0407827447716107020000000
TCGA-27-2527.6	79	1_KEGG_PANCREATIC_CANCER	70	6	0.0408322153280805330000000
TCGA-28-2514.11	4	0_HALLMARK_G2M_CHECKPOINT	174	3	0.0409497479382751740000000
TCGA-19-1390.12	10	2_PLASMA_MEMBRANE	1096	7	0.0409845668246639970000000
TCGA-06-0211.7	10	2_PLASMA_MEMBRANE	1096	7	0.0409845668246639970000000
TCGA-06-0158.4	65	2_EXTRACELLULAR_MATRIX_PART	51	5	0.0410006288962179510000000
TCGA-06-5408.3	99	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0410054195777568510000000
TCGA-02-0083.21	135	2_CELL_CYCLE_GO_0007049	265	14	0.0410519152864712580000000
TCGA-02-0010.18	184	0_HALLMARK_UV_RESPONSE_DN	122	11	0.0411187497669634960000000
TCGA-32-2632.16	229	2_PROGRAMMED_CELL_DEATH	390	24	0.0411345374331303570000000
TCGA-06-0192.10	126	1_KEGG_PATHWAYS_IN_CANCER	323	15	0.0411763564628957680000000
TCGA-76-4928.15	78	1_KEGG_MELANOMA	71	6	0.0411840708554659170000000
TCGA-06-2563.10	123	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	10	0.0412305111847223460000000
TCGA-06-0174.37	141	2_INTRACELLULAR_ORGANELLE_PART	912	30	0.0412347751217859230000000
TCGA-19-5947.4	267	1_KEGG_VIRAL_MYOCARDITIS	70	10	0.0412534115887414200000000
TCGA-08-0360.3	144	2_RESPONSE_TO_STRESS	427	19	0.0412773070443485310000000
TCGA-12-1597.6	51	2_CELL_CYCLE_PROCESS	163	7	0.0413322736118436060000000
TCGA-19-2631.15	84	1_KEGG_P53_SIGNALING_PATHWAY	66	6	0.0413471417339731850000000
TCGA-02-0010.18	184	2_CYTOSKELETAL_PART	194	14	0.0414384162644867650000000
TCGA-27-1831.9	85	0_HALLMARK_G2M_CHECKPOINT	174	9	0.0414770145166326180000000
TCGA-06-5858.19	205	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	7	0.0415059042768266900000000
TCGA-32-1979.4	12	2_CELL_CYCLE_PHASE	146	4	0.0415761621937782570000000
TCGA-19-2629.15	146	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	4	0.0415761621937782570000000
TCGA-02-0068.1	72	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0415841286962998010000000
TCGA-06-5411.4	23	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	72	4	0.0415841286962998010000000
TCGA-06-0213.9	74	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	45	5	0.0415868097169330430000000
TCGA-06-2558.6	74	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0415868097169330430000000
TCGA-02-0034.4	88	2_MICROTUBULE_ASSOCIATED_COMPLEX	38	5	0.0416244316027229860000000
TCGA-19-1790.1	4	2_TRANSCRIPTION	667	4	0.0416286942640039580000000
TCGA-06-0219.2	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	3	0.0416606337696162480000000
TCGA-02-0033.1	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	3	0.0416606337696162480000000
TCGA-02-0016.4	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	3	0.0416606337696162480000000
TCGA-02-0003.9	227	2_EXTRACELLULAR_REGION_PART	269	19	0.0416884825526865200000000
TCGA-76-4929.8	91	2_NEUROLOGICAL_SYSTEM_PROCESS	296	12	0.0416888917556290510000000
TCGA-06-2558.6	74	2_NUCLEUS	1110	22	0.0417012906599406530000000
TCGA-06-1804.7	47	1_KEGG_PATHWAYS_IN_CANCER	323	9	0.0417280463065513030000000
TCGA-28-2509.6	59	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	11	0.0417415756636428520000000
TCGA-32-2491.14	244	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	31	0.0417873834944900090000000
TCGA-32-2634.10	118	0_HALLMARK_DNA_REPAIR	125	9	0.0418087869472038510000000
TCGA-06-5415.3	8	2_INTEGRAL_TO_MEMBRANE	956	6	0.0418172466617442730000000
TCGA-06-0221.4	8	2_INTEGRAL_TO_MEMBRANE	956	6	0.0418172466617442730000000
TCGA-08-0375.6	65	2_CELL_CELL_SIGNALING	353	11	0.0418712280767255950000000
TCGA-19-1390.13	110	2_NUCLEAR_PART	466	17	0.0419053711474963180000000
TCGA-32-2634.10	118	1_KEGG_PANCREATIC_CANCER	70	7	0.0419176203249487720000000
TCGA-02-0026.1	61	2_REGULATION_OF_APOPTOSIS	309	10	0.0419620587728707360000000
TCGA-76-6191.6	96	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	6	0.0420045806805275230000000
TCGA-76-4934.7	47	0_HALLMARK_MYC_TARGETS_V1	178	7	0.0421262237515068120000000
TCGA-19-5960.9	134	2_REGULATION_OF_KINASE_ACTIVITY	138	10	0.0421528407688084510000000
TCGA-06-1804.7	47	1_KEGG_MELANOMA	71	5	0.0421570167940513580000000
TCGA-28-5219.9	47	1_KEGG_MELANOMA	71	5	0.0421570167940513580000000
TCGA-02-0028.9	182	2_NERVOUS_SYSTEM_DEVELOPMENT	307	18	0.0422115740650016170000000
TCGA-32-2494.10	173	1_KEGG_P53_SIGNALING_PATHWAY	66	8	0.0422215856153615520000000
TCGA-12-3653.55	255	1_KEGG_MISMATCH_REPAIR	23	6	0.0422556836093221990000000
TCGA-12-0688.10	93	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0422563241460211380000000
TCGA-02-0089.5	91	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	17	0.0422575857502395930000000
TCGA-02-0099.11	141	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0424258878229750590000000
TCGA-06-0155.10	74	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0424433948667860620000000
TCGA-12-5301.9	11	2_REGULATION_OF_BODY_FLUID_LEVELS	52	3	0.0425104701586711680000000
TCGA-26-1442.5	27	1_KEGG_PATHWAYS_IN_CANCER	323	7	0.0425311094111926950000000
TCGA-28-6450.11	139	2_CYTOSKELETON	293	15	0.0426476780328550810000000
TCGA-08-0347.4	16	2_PROTEIN_KINASE_REGULATOR_ACTIVITY	35	3	0.0426478195790247410000000
TCGA-06-0875.7	78	2_CELL_CYCLE_PHASE	146	8	0.0426655870168431430000000
TCGA-02-0060.19	281	2_MEMBRANE	1443	69	0.0427095646588030940000000
TCGA-26-5133.10	75	2_SYNAPTIC_TRANSMISSION	152	8	0.0427460387775662820000000
TCGA-02-0011.1	288	1_KEGG_ASTHMA	30	7	0.0428031290176131910000000
TCGA-19-5960.9	134	1_KEGG_GLIOMA	62	7	0.0428330240302346390000000
TCGA-76-4935.7	15	2_INTRACELLULAR_ORGANELLE_PART	912	8	0.0428612590921049340000000
TCGA-32-2632.16	229	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	24	0.0428915438333245320000000
TCGA-02-0024.6	206	2_MITOTIC_SPINDLE_ORGANIZATION_AND_BIOGENESIS	9	4	0.0429033066370303470000000
TCGA-76-6282.11	185	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	62	8	0.0429977834573892350000000
TCGA-12-1597.6	51	2_TRANSMISSION_OF_NERVE_IMPULSE	164	7	0.0429983873306318960000000
TCGA-06-0168.3	4	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	2	0.0430609549672630320000000
TCGA-32-2632.1	4	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	2	0.0430609549672630320000000
TCGA-02-0003.1	4	1_KEGG_PROTEIN_EXPORT	20	2	0.0430609549672630320000000
TCGA-32-2491.13	4	2_GLUTAMATE_RECEPTOR_ACTIVITY	20	2	0.0430609549672630320000000
TCGA-02-0026.1	61	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	10	0.0431445807703425000000000
TCGA-06-2559.11	101	2_DNA_REPLICATION	82	7	0.0431466608372673910000000
TCGA-06-0156.4	80	1_KEGG_BLADDER_CANCER	42	5	0.0431533640788741150000000
TCGA-08-0245.4	85	2_MITOTIC_CELL_CYCLE	134	8	0.0431538757051569200000000
TCGA-06-2557.11	177	1_KEGG_ECM_RECEPTOR_INTERACTION	84	9	0.0431581232538593500000000
TCGA-06-6390.9	82	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	41	5	0.0431590164266232590000000
TCGA-06-0876.9	106	1_KEGG_DNA_REPLICATION	32	5	0.0432386130167234300000000
TCGA-76-6285.5	106	1_KEGG_DNA_REPLICATION	32	5	0.0432386130167234300000000
TCGA-06-0139.1	179	0_HALLMARK_ANGIOGENESIS	32	6	0.0432437123459877140000000
TCGA-02-0052.3	116	2_REGULATION_OF_CELL_CYCLE	160	10	0.0432476230160242850000000
TCGA-32-1982.9	89	2_INTERLEUKIN_RECEPTOR_ACTIVITY	19	4	0.0432586650661373260000000
TCGA-06-0168.4	22	2_EXTRACELLULAR_REGION_PART	269	6	0.0432628193506289440000000
TCGA-06-0241.8	53	2_DNA_METABOLIC_PROCESS	218	8	0.0432940528416005320000000
TCGA-02-0114.20	132	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	5	0.0433294918097578000000000
TCGA-12-5301.9	11	2_RESPONSE_TO_WOUNDING	163	4	0.0433312537512027880000000
TCGA-27-2518.5	20	2_POLYSACCHARIDE_BINDING	28	3	0.0434249680067028830000000
TCGA-02-0099.11	141	2_REGULATION_OF_CELL_CYCLE	160	11	0.0435073034305145310000000
TCGA-28-2502.9	56	2_STRUCTURAL_MOLECULE_ACTIVITY	206	8	0.0435706606974802170000000
TCGA-27-1832.11	88	0_HALLMARK_E2F_TARGETS	169	9	0.0435814560681950860000000
TCGA-06-5415.7	7	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	2	0.0435998655566067140000000
TCGA-41-4097.6	48	1_KEGG_LEISHMANIA_INFECTION	70	5	0.0436564978482496470000000
TCGA-41-4097.6	48	1_KEGG_VIRAL_MYOCARDITIS	70	5	0.0436564978482496470000000
TCGA-08-0353.8	100	1_KEGG_SMALL_CELL_LUNG_CANCER	83	7	0.0437820491517615930000000
TCGA-08-0353.8	100	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0437820491517615930000000
TCGA-26-5132.7	100	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	7	0.0437820491517615930000000
TCGA-19-1790.1	4	2_NEGATIVE_REGULATION_OF_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	178	3	0.0438423177555505510000000
TCGA-06-0171.7	57	2_CELL_CYCLE_GO_0007049	265	9	0.0438634389963123980000000
TCGA-32-1979.10	116	1_KEGG_FOCAL_ADHESION	195	11	0.0438748577587205340000000
TCGA-14-1825.8	80	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	70	6	0.0438871372046481660000000
TCGA-02-0010.18	184	1_KEGG_FOCAL_ADHESION	195	14	0.0438920954165342440000000
TCGA-08-0386.4	73	2_COLLAGEN	23	4	0.0439238986118415250000000
TCGA-41-5651.5	112	2_NUCLEUS	1110	29	0.0440176114701843480000000
TCGA-14-0790.9	104	2_DNA_METABOLIC_PROCESS	218	11	0.0440187194778548720000000
TCGA-27-1835.6	86	2_CELL_CYCLE_GO_0007049	265	11	0.0440353590615281190000000
TCGA-76-4931.10	86	2_CELL_CYCLE_GO_0007049	265	11	0.0440353590615281190000000
TCGA-41-2575.49	136	1_KEGG_ECM_RECEPTOR_INTERACTION	84	8	0.0440424601634705270000000
TCGA-06-0129.11	110	2_MICROTUBULE_CYTOSKELETON_ORGANIZATION_AND_BIOGENESIS	31	5	0.0440476871428828400000000
TCGA-14-0781.7	155	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	15	0.0440744166862010390000000
TCGA-28-5219.9	47	2_SIGNAL_TRANSDUCTION	1442	19	0.0441558149992154970000000
TCGA-06-0187.8	6	2_KINESIN_COMPLEX	13	2	0.0441692097132310650000000
TCGA-02-0034.5	6	2_REGULATION_OF_ACTION_POTENTIAL	13	2	0.0441692097132310650000000
TCGA-15-0742.7	6	2_KINESIN_COMPLEX	13	2	0.0441692097132310650000000
TCGA-16-0861.4	6	2_HORMONE_SECRETION	13	2	0.0441692097132310650000000
TCGA-06-0125.9	75	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0441942433552662620000000
TCGA-26-5133.10	75	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0441942433552662620000000
TCGA-02-0083.21	135	1_KEGG_BLADDER_CANCER	42	6	0.0442364343945357490000000
TCGA-28-5207.12	188	2_CELL_DEVELOPMENT	511	25	0.0442368539073416460000000
TCGA-76-4926.9	66	2_EXTRACELLULAR_MATRIX	85	6	0.0442456408364733450000000
TCGA-06-0750.12	52	2_BASEMENT_MEMBRANE	32	4	0.0442459162279842870000000
TCGA-19-5955.9	110	2_IMMUNE_RESPONSE	206	11	0.0442471498894710100000000
TCGA-19-5955.9	110	2_STRUCTURAL_MOLECULE_ACTIVITY	206	11	0.0442471498894710100000000
TCGA-76-4935.7	15	2_ORGANELLE_PART	916	8	0.0442676306656603070000000
TCGA-06-0644.16	142	1_KEGG_PATHWAYS_IN_CANCER	323	16	0.0443180035761451820000000
TCGA-19-5947.4	267	2_PLASMA_MEMBRANE	1096	54	0.0443200517643725370000000
TCGA-06-0744.4	11	2_TRANSMISSION_OF_NERVE_IMPULSE	164	4	0.0443879322006386630000000
TCGA-06-0882.1	11	2_TRANSMISSION_OF_NERVE_IMPULSE	164	4	0.0443879322006386630000000
TCGA-28-5220.7	15	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	5	0.0443900057489099230000000
TCGA-02-0014.10	70	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0444302265873108000000000
TCGA-06-5415.3	8	2_INTRINSIC_TO_MEMBRANE	966	6	0.0444303900422031580000000
TCGA-06-0221.4	8	2_INTRINSIC_TO_MEMBRANE	966	6	0.0444303900422031580000000
TCGA-06-0176.8	95	2_REPLICATION_FORK	18	4	0.0445316737274248500000000
TCGA-12-0620.1	2	2_CELL_CYCLE_ARREST_GO_0007050	49	2	0.0445338479563702760000000
TCGA-08-0389.3	2	2_REGULATION_OF_CELL_DIFFERENTIATION	49	2	0.0445338479563702760000000
TCGA-06-5858.9	2	2_GROWTH_FACTOR_ACTIVITY	49	2	0.0445338479563702760000000
TCGA-06-0133.2	2	2_CELL_CYCLE_ARREST_GO_0007050	49	2	0.0445338479563702760000000
TCGA-02-0023.1	2	2_CELL_CYCLE_ARREST_GO_0007050	49	2	0.0445338479563702760000000
TCGA-06-0127.4	2	2_CELL_CYCLE_ARREST_GO_0007050	49	2	0.0445338479563702760000000
TCGA-08-0355.3	2	2_CELL_CYCLE_ARREST_GO_0007050	49	2	0.0445338479563702760000000
TCGA-19-5954.17	208	2_MITOTIC_SPINDLE_ORGANIZATION_AND_BIOGENESIS	9	4	0.0445681866130557550000000
TCGA-41-3392.31	136	2_CELL_CYCLE_GO_0007049	265	14	0.0446319286380856130000000
TCGA-41-2571.7	72	2_CHROMOSOMAL_PART	78	6	0.0446354076307664760000000
TCGA-02-0080.3	20	2_EXTRACELLULAR_MATRIX	85	4	0.0447627618927979310000000
TCGA-19-2625.9	146	2_CHROMOSOME	102	9	0.0448170091444309510000000
TCGA-19-5951.10	138	1_KEGG_SMALL_CELL_LUNG_CANCER	83	8	0.0448287332295431720000000
TCGA-06-0174.37	141	2_ORGANELLE_PART	916	30	0.0448420295721302930000000
TCGA-19-5952.11	193	2_CELL_PROLIFERATION_GO_0008283	436	23	0.0448579133328168910000000
TCGA-41-2575.49	136	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0448802122845944270000000
TCGA-02-0083.21	135	1_KEGG_GLIOMA	62	7	0.0449449888722914460000000
TCGA-06-2570.8	95	2_CELL_PROLIFERATION_GO_0008283	436	15	0.0449603702662094570000000
TCGA-19-1790.1	4	2_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	680	4	0.0449779907393258950000000
TCGA-06-0241.8	53	2_G2_M_TRANSITION_OF_MITOTIC_CELL_CYCLE	11	3	0.0450324139562053790000000
TCGA-14-1829.14	67	1_KEGG_ECM_RECEPTOR_INTERACTION	84	6	0.0450937337467030440000000
TCGA-06-0155.1	5	2_TRANSCRIPTION_REPRESSOR_ACTIVITY	133	3	0.0451535210427901000000000
TCGA-28-2502.9	56	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	150	7	0.0451549891098207630000000
TCGA-32-2634.10	118	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	6	0.0451574476243609830000000
TCGA-32-1977.11	107	0_HALLMARK_ANGIOGENESIS	32	5	0.0452498589725404900000000
TCGA-06-5415.7	7	2_REGULATION_OF_MOLECULAR_FUNCTION	286	4	0.0452600680792458740000000
TCGA-26-5139.10	163	2_CATION_BINDING	165	12	0.0452708862001477420000000
TCGA-02-0024.6	206	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	22	0.0452870567372050670000000
TCGA-06-0210.6	103	2_CELL_CELL_SIGNALING	353	14	0.0453313795920839980000000
TCGA-08-0245.4	85	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	5	0.0454437657199110720000000
TCGA-19-5952.11	193	2_HEMOSTASIS	44	7	0.0454553565395460980000000
TCGA-02-0003.9	227	2_NEURON_PROJECTION	16	5	0.0455524140536296420000000
TCGA-02-0058.1	110	2_CELL_PROJECTION	76	7	0.0456593435727772680000000
TCGA-27-1836.8	49	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	576	12	0.0456727356196048800000000
TCGA-27-2521.10	94	0_HALLMARK_UV_RESPONSE_DN	122	8	0.0456935971890208640000000
TCGA-12-0618.5	41	1_KEGG_SMALL_CELL_LUNG_CANCER	83	5	0.0457797573209215090000000
TCGA-14-1456.4	41	1_KEGG_SMALL_CELL_LUNG_CANCER	83	5	0.0457797573209215090000000
TCGA-16-1045.10	81	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	5	0.0458422971611958390000000
TCGA-12-0821.9	81	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0458422971611958390000000
TCGA-28-1747.5	81	2_CELL_CYCLE_CHECKPOINT_GO_0000075	42	5	0.0458422971611958390000000
TCGA-32-1986.8	87	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	11	0.0458507068637542880000000
TCGA-08-0345.2	77	1_KEGG_FOCAL_ADHESION	195	9	0.0458616068712936480000000
TCGA-02-0114.20	132	1_KEGG_PROSTATE_CANCER	87	8	0.0458994849898939770000000
TCGA-19-4068.7	14	2_CELL_CYCLE_GO_0007049	265	5	0.0459564986004090750000000
TCGA-06-0154.13	76	2_GABA_RECEPTOR_ACTIVITY	8	3	0.0459921007217419030000000
TCGA-08-0375.6	65	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0460085838849794500000000
TCGA-19-2620.6	3	2_NEGATIVE_REGULATION_OF_GROWTH	29	2	0.0460364494323195760000000
TCGA-06-0208.3	3	2_NEGATIVE_REGULATION_OF_GROWTH	29	2	0.0460364494323195760000000
TCGA-32-2491.14	244	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	48	8	0.0460405200410073520000000
TCGA-02-0047.8	185	2_AXON	10	4	0.0460605594823019010000000
TCGA-14-0790.9	104	2_PATTERN_BINDING	33	5	0.0460613372945733530000000
TCGA-27-2521.10	94	2_REGULATION_OF_CATALYTIC_ACTIVITY	243	11	0.0461129363518771660000000
TCGA-41-2575.49	136	1_KEGG_BLADDER_CANCER	42	6	0.0461264774068807990000000
TCGA-02-0010.18	184	2_ENZYME_REGULATOR_ACTIVITY	277	17	0.0461276332713310490000000
TCGA-28-5204.5	5	2_MITOTIC_CELL_CYCLE	134	3	0.0461801646003470800000000
TCGA-12-0619.11	123	2_SYNAPTIC_TRANSMISSION	152	10	0.0462420007631705390000000
TCGA-06-0878.10	115	1_KEGG_ASTHMA	30	5	0.0462423165962909600000000
TCGA-32-2491.14	244	0_HALLMARK_KRAS_SIGNALING_UP	148	14	0.0463156774320375860000000
TCGA-15-0742.13	74	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0463589992214815320000000
TCGA-06-0213.9	74	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0463589992214815320000000
TCGA-06-2558.6	74	2_COLLAGEN	23	4	0.0463589992214815320000000
TCGA-06-0155.10	74	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0463589992214815320000000
TCGA-06-0128.8	74	2_COLLAGEN	23	4	0.0463589992214815320000000
TCGA-06-0128.8	74	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0463589992214815320000000
TCGA-32-2634.8	2	2_POSITIVE_REGULATION_OF_HYDROLASE_ACTIVITY	50	2	0.0463894249545511590000000
TCGA-14-0787.6	40	1_KEGG_BLADDER_CANCER	42	4	0.0463973559358683980000000
TCGA-06-0143.3	3	2_REGULATION_OF_MOLECULAR_FUNCTION	286	3	0.0464017325533472720000000
TCGA-76-6191.6	96	2_REPLICATION_FORK	18	4	0.0464125355705201220000000
TCGA-08-0347.4	16	2_REGULATION_OF_MITOSIS	36	3	0.0464768432537030070000000
TCGA-06-0130.3	155	0_HALLMARK_G2M_CHECKPOINT	174	12	0.0465034181584294130000000
TCGA-76-6282.11	185	1_KEGG_FOCAL_ADHESION	195	14	0.0466354821976094900000000
TCGA-02-0028.9	182	0_HALLMARK_COAGULATION	125	11	0.0466751612578947820000000
TCGA-32-1982.9	89	2_TRANSMEMBRANE_RECEPTOR_ACTIVITY	358	13	0.0466793537591443100000000
TCGA-19-1390.13	110	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	136	9	0.0467011402943875440000000
TCGA-02-0047.8	185	2_GLYCOPROTEIN_METABOLIC_PROCESS	46	7	0.0467285759191804410000000
TCGA-06-0173.35	120	1_KEGG_PANCREATIC_CANCER	70	7	0.0467461160255879110000000
TCGA-06-5412.7	153	2_COLLAGEN	23	5	0.0468699032895574660000000
TCGA-19-2623.11	153	2_COLLAGEN	23	5	0.0468699032895574660000000
TCGA-19-2623.11	153	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	5	0.0468699032895574660000000
TCGA-76-6282.11	185	0_HALLMARK_INFLAMMATORY_RESPONSE	170	13	0.0469005115716533490000000
TCGA-02-0023.3	24	1_KEGG_MELANOMA	71	4	0.0469376215636570570000000
TCGA-08-0354.5	18	1_KEGG_DNA_REPLICATION	32	3	0.0470236848562999300000000
TCGA-02-0054.3	93	2_CYTOSKELETON	293	12	0.0470786401706747990000000
TCGA-02-0027.3	81	1_KEGG_VIRAL_MYOCARDITIS	70	6	0.0471234586552133140000000
TCGA-27-1836.8	49	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	12	3	0.0471703011137011230000000
TCGA-06-0187.10	55	1_KEGG_GLIOMA	62	5	0.0471925026805698270000000
TCGA-32-2491.14	244	2_GABA_RECEPTOR_ACTIVITY	8	4	0.0473249641441825800000000
TCGA-06-0154.13	76	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0473593345672863390000000
TCGA-41-2572.8	76	2_REGULATION_OF_PHOSPHORYLATION	45	5	0.0473593345672863390000000
TCGA-19-5951.10	138	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	13	4	0.0475368859127874990000000
TCGA-19-2619.10	8	2_NEUROTRANSMITTER_SECRETION	10	2	0.0475534190944951330000000
TCGA-06-0750.13	8	2_METABOTROPIC_GLUTAMATEGABA_B_LIKE_RECEPTOR_ACTIVITY	10	2	0.0475534190944951330000000
TCGA-19-5952.6	8	2_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY	10	2	0.0475534190944951330000000
TCGA-06-5415.3	8	2_METABOTROPIC_GLUTAMATEGABA_B_LIKE_RECEPTOR_ACTIVITY	10	2	0.0475534190944951330000000
TCGA-06-0221.4	8	2_METABOTROPIC_GLUTAMATEGABA_B_LIKE_RECEPTOR_ACTIVITY	10	2	0.0475534190944951330000000
TCGA-06-0686.1	7	2_MEMBRANE_PART	1217	6	0.0475816676565092510000000
TCGA-16-0861.5	4	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0475869615927705170000000
TCGA-06-2561.7	4	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	21	2	0.0475869615927705170000000
TCGA-02-0016.2	29	2_SIGNAL_TRANSDUCTION	1442	14	0.0476438143989191820000000
TCGA-14-0813.10	53	0_HALLMARK_ANGIOGENESIS	32	4	0.0477443844293630600000000
TCGA-06-0241.8	53	1_KEGG_DNA_REPLICATION	32	4	0.0477443844293630600000000
TCGA-26-5136.6	160	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	169	12	0.0477526468824592820000000
TCGA-19-5960.9	134	2_REGULATION_OF_TRANSFERASE_ACTIVITY	140	10	0.0477556110965481270000000
TCGA-06-2569.5	144	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	40	6	0.0478011393215236470000000
TCGA-41-5651.5	112	2_EXTRACELLULAR_MATRIX_PART	51	6	0.0478325108753670100000000
TCGA-06-0141.1	45	0_HALLMARK_ALLOGRAFT_REJECTION	190	7	0.0478360003268892480000000
TCGA-02-0115.1	36	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	816	12	0.0478789642655046070000000
TCGA-06-5408.3	99	2_EXTRACELLULAR_MATRIX	85	7	0.0479232489463259570000000
TCGA-19-1790.1	4	2_REGULATION_OF_METABOLIC_PROCESS	691	4	0.0479664745098075730000000
TCGA-06-5417.5	79	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	72	6	0.0480154884625289130000000
TCGA-28-2509.6	59	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	58	5	0.0480406212243636860000000
TCGA-32-1970.14	94	2_REGULATION_OF_CELL_CYCLE	160	9	0.0480773352306995560000000
TCGA-06-2570.8	95	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	60	6	0.0481548516434163600000000
TCGA-76-4934.7	47	0_HALLMARK_UV_RESPONSE_DN	122	6	0.0482392374056662830000000
TCGA-19-2620.7	47	0_HALLMARK_UV_RESPONSE_DN	122	6	0.0482392374056662830000000
TCGA-02-0010.18	184	2_DNA_REPLICATION	82	9	0.0482736585001385110000000
TCGA-19-2624.29	130	2_POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS	613	22	0.0483178726791501230000000
TCGA-06-2564.7	92	2_INTERPHASE	62	6	0.0484712421670811800000000
TCGA-14-1456.4	41	1_KEGG_ECM_RECEPTOR_INTERACTION	84	5	0.0485226094699029100000000
TCGA-27-2528.10	99	2_SYNAPTIC_TRANSMISSION	152	9	0.0485558895346326420000000
TCGA-06-0237.4	66	2_CELL_CELL_SIGNALING	353	11	0.0485923110535418990000000
TCGA-12-5295.8	66	2_CELL_CELL_SIGNALING	353	11	0.0485923110535418990000000
TCGA-08-0354.7	47	0_HALLMARK_APICAL_JUNCTION	182	7	0.0486161062567943700000000
TCGA-06-1804.7	47	0_HALLMARK_APICAL_JUNCTION	182	7	0.0486161062567943700000000
TCGA-06-0650.2	82	1_KEGG_BLADDER_CANCER	42	5	0.0486597419324949210000000
TCGA-06-6390.9	82	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	5	0.0486597419324949210000000
TCGA-28-5209.15	194	2_CELL_PROLIFERATION_GO_0008283	436	23	0.0487564907639172350000000
TCGA-06-0188.11	66	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	26	4	0.0488855560676359420000000
TCGA-06-0125.9	75	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0488918471932992750000000
TCGA-26-5133.10	75	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	23	4	0.0488918471932992750000000
TCGA-06-5858.19	205	1_KEGG_TYPE_I_DIABETES_MELLITUS	42	7	0.0488999656790120030000000
TCGA-19-1790.18	201	2_POSITIVE_REGULATION_OF_CELL_PROLIFERATION	135	12	0.0489360199720797470000000
TCGA-12-3652.19	88	2_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0490819020879918470000000
TCGA-12-3652.19	88	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	15	0.0490819020879918470000000
TCGA-81-5910.12	128	2_REGULATION_OF_PHOSPHORYLATION	45	6	0.0490856814020888200000000
TCGA-08-0245.4	85	1_KEGG_PATHWAYS_IN_CANCER	323	12	0.0490924566601431830000000
TCGA-06-5412.7	153	2_EXTRACELLULAR_REGION_PART	269	15	0.0491784933019739150000000
TCGA-06-0189.3	118	2_EXTRACELLULAR_REGION_PART	269	13	0.0492955791026815430000000
TCGA-19-5960.8	3	1_KEGG_ASTHMA	30	2	0.0493212794277251910000000
TCGA-02-0107.3	71	2_TRANSMISSION_OF_NERVE_IMPULSE	164	8	0.0493415662005384230000000
TCGA-26-5134.2	14	2_EXTRACELLULAR_REGION_PART	269	5	0.0493992640899181960000000
TCGA-32-2638.17	159	1_KEGG_PATHWAYS_IN_CANCER	323	17	0.0494548549977350190000000
TCGA-12-0616.1	20	2_NUCLEUS	1110	10	0.0494873034727393370000000
TCGA-41-3915.10	109	0_HALLMARK_ANGIOGENESIS	32	5	0.0494903590655870610000000
TCGA-28-5214.11	124	2_SYNAPTIC_TRANSMISSION	152	10	0.0496130773311924260000000
TCGA-06-0875.7	78	2_NON_MEMBRANE_BOUND_ORGANELLE	476	14	0.0496362476096895160000000
TCGA-06-0875.7	78	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	14	0.0496362476096895160000000
TCGA-14-0817.9	85	0_HALLMARK_MYC_TARGETS_V1	178	9	0.0496670714051625560000000
TCGA-06-0221.13	45	2_CELL_PROLIFERATION_GO_0008283	436	10	0.0497021400134846080000000
TCGA-32-1979.4	12	1_KEGG_PATHWAYS_IN_CANCER	323	5	0.0497208392519993340000000
TCGA-06-2565.10	38	2_REGULATION_OF_PHOSPHORYLATION	45	4	0.0497745423989952790000000
TCGA-06-0145.4	7	2_CYTOSKELETON	293	4	0.0497910042045328630000000
TCGA-14-1034.7	97	1_KEGG_FOCAL_ADHESION	195	10	0.0497974266437015910000000
TCGA-06-0148.6	69	1_KEGG_SMALL_CELL_LUNG_CANCER	83	6	0.0498762512862392090000000
TCGA-14-0781.7	155	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	23	5	0.0498975395705597010000000
TCGA-26-5132.7	100	0_HALLMARK_P53_PATHWAY	151	9	0.0499512094210445980000000
TCGA-02-2470.4	11	0_HALLMARK_E2F_TARGETS	169	4	0.0499587815258596070000000
TCGA-27-1836.8	49	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	7	0.0499703492464302280000000
